The Williams Companies, Inc.969457100US969457100404/28/2026Election of Director for a One-Year Term: VACANTOTHERElection of Directors (Majority Voting)ISSUER298992.0000000.000000FOR298992.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Stephen W. BergstromDIRECTOR ELECTIONSISSUER298992.0000000.000000FOR298992.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Michael A. CreelDIRECTOR ELECTIONSISSUER298992.0000000.000000FOR298992.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Carri A. LockhartDIRECTOR ELECTIONSISSUER298992.0000000.000000FOR298992.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Richard E. MuncriefDIRECTOR ELECTIONSISSUER298992.0000000.000000FOR298992.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Peter A. RagaussDIRECTOR ELECTIONSISSUER298992.0000000.000000FOR298992.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Rose M. RobesonDIRECTOR ELECTIONSISSUER298992.0000000.000000FOR298992.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Scott D. SheffieldDIRECTOR ELECTIONSISSUER298992.0000000.000000FOR298992.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: William H. SpenceDIRECTOR ELECTIONSISSUER298992.0000000.000000FOR298992.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Jesse J. TysonDIRECTOR ELECTIONSISSUER298992.0000000.000000FOR298992.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Chad J. ZamarinDIRECTOR ELECTIONSISSUER298992.0000000.000000FOR298992.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/28/2026Approve, on an Advisory Basis, the Compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER298992.0000000.000000FOR298992.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/28/2026Approve, on an Advisory Basis, the Compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER298992.0000000.000000FOR298992.000000FOR1S000045418The Williams Companies, Inc.969457100US969457100404/28/2026Approve the Amendment and Restatement of The Williams Companies, Inc. 2007 Incentive Plan to Increase the Number of Issuable Shares from 50,000,000 to 85,000,000, Remove the Plan Expiration Date, Increase the Annual Director Equity Grant Limit, Eliminate Share Recycling for Tax Withholding, Remove Certain Change in Control Provisions, and Make Other Amendments.COMPENSATIONISSUER298992.0000000.000000FOR298992.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/28/2026Approve the Amendment and Restatement of The Williams Companies, Inc. 2007 Employee Stock Purchase Plan to Increase the Number of Issuable Shares from 5,200,000 to 7,200,000, Extend the Term Six Years, and Make Other Amendments.COMPENSATIONISSUER298992.0000000.000000FOR298992.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/28/2026Ratify the Selection of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year ending December 31, 2026.AUDIT-RELATEDISSUER298992.0000000.000000FOR298992.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/29/2026Election of Class III Directors: Maryann T. MannenDIRECTOR ELECTIONSISSUER63772.0000000.000000FOR63772.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/29/2026Election of Class III Directors: Eileen P. PatersonDIRECTOR ELECTIONSISSUER63772.0000000.000000FOR63772.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/29/2026Election of Class III Directors: J. Michael SticeDIRECTOR ELECTIONSISSUER63772.0000000.000000FOR63772.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/29/2026Election of Class III Directors: John P. SurmaDIRECTOR ELECTIONSISSUER63772.0000000.000000FOR63772.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/29/2026Ratification of the appointment of PricewaterhouseCoopers LLP as the company's independent auditor for 2026.AUDIT-RELATEDISSUER63772.0000000.000000FOR63772.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/29/2026Approval, on an advisory basis, of the company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER63772.0000000.000000FOR63772.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/29/2026Approval, on an advisory basis, of the company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER63772.0000000.000000FOR63772.000000FOR1S000045418Marathon Petroleum Corporation56585A102US56585A102504/29/2026Approval of an amendment to the company's Restated Certificate of Incorporation to declassify the Board of Directors.SHAREHOLDER RIGHTS AND DEFENSESISSUER63772.0000000.000000FOR63772.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/29/2026Approval of an amendment to the company's Restated Certificate of Incorporation to eliminate supermajority provisions.CORPORATE GOVERNANCEISSUER63772.0000000.000000FOR63772.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/06/2026Elect Director M.M. (Mike) AsharDIRECTOR ELECTIONSISSUER1590.0000000.000000FOR1590.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/06/2026Elect Director Gaurdie E. BanisterDIRECTOR ELECTIONSISSUER1590.0000000.000000FOR1590.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/06/2026Elect Director Susan M. CunninghamDIRECTOR ELECTIONSISSUER1590.0000000.000000FOR1590.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/06/2026Elect Director Gregory L. EbelDIRECTOR ELECTIONSISSUER1590.0000000.000000FOR1590.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/06/2026Elect Director Jason B. FewDIRECTOR ELECTIONSISSUER1590.0000000.000000FOR1590.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/06/2026Elect Director Douglas L. FosheeDIRECTOR ELECTIONSISSUER1590.0000000.000000FOR1590.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/06/2026Elect Director Theresa B.Y. JangDIRECTOR ELECTIONSISSUER1590.0000000.000000FOR1590.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/06/2026Elect Director Teresa S. MaddenDIRECTOR ELECTIONSISSUER1590.0000000.000000FOR1590.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/06/2026Elect Director Manjit MinhasDIRECTOR ELECTIONSISSUER1590.0000000.000000FOR1590.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/06/2026Elect Director Stephen S. PolozDIRECTOR ELECTIONSISSUER1590.0000000.000000FOR1590.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/06/2026Elect Director S. Jane RoweDIRECTOR ELECTIONSISSUER1590.0000000.000000FOR1590.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/06/2026Elect Director Steven W. WilliamsDIRECTOR ELECTIONSISSUER1590.0000000.000000FOR1590.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/06/2026Approve PricewaterhouseCoopers LLP as Auditors and Authorize Board to Fix Their RemunerationAUDIT-RELATEDISSUER1590.0000000.000000FOR1590.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/06/2026Advisory Vote on Executive Compensation ApproachCOMPENSATIONISSUER1590.0000000.000000FOR1590.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/06/2026Re-approve Shareholder Rights PlanSHAREHOLDER RIGHTS AND DEFENSESISSUER1590.0000000.000000FOR1590.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/07/2026Elect Director Scott BonhamDIRECTOR ELECTIONSISSUER91257.0000000.000000FOR91257.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/07/2026Elect Director Cheryl F. CampbellDIRECTOR ELECTIONSISSUER91257.0000000.000000FOR91257.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/07/2026Elect Director Michael R. CulbertDIRECTOR ELECTIONSISSUER91257.0000000.000000FOR91257.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/07/2026Elect Director William D. JohnsonDIRECTOR ELECTIONSISSUER91257.0000000.000000FOR91257.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/07/2026Elect Director Susan C. JonesDIRECTOR ELECTIONSISSUER91257.0000000.000000FOR91257.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/07/2026Elect Director John E. LoweDIRECTOR ELECTIONSISSUER91257.0000000.000000FOR91257.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/07/2026Elect Director Dawn Madahbee LeachDIRECTOR ELECTIONSISSUER91257.0000000.000000FOR91257.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/07/2026Elect Director Francois L. PoirierDIRECTOR ELECTIONSISSUER91257.0000000.000000FOR91257.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/07/2026Elect Director Una PowerDIRECTOR ELECTIONSISSUER91257.0000000.000000FOR91257.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/07/2026Elect Director Mary Pat SalomoneDIRECTOR ELECTIONSISSUER91257.0000000.000000FOR91257.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/07/2026Elect Director Siim A. VanaseljaDIRECTOR ELECTIONSISSUER91257.0000000.000000FOR91257.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/07/2026Elect Director Thierry VandalDIRECTOR ELECTIONSISSUER91257.0000000.000000FOR91257.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/07/2026Elect Director Dheeraj "D" VermaDIRECTOR ELECTIONSISSUER91257.0000000.000000FOR91257.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/07/2026Approve KPMG LLP as Auditors and Authorize Board to Fix Their RemunerationAUDIT-RELATEDISSUER91257.0000000.000000FOR91257.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/07/2026Advisory Vote on Executive Compensation ApproachCOMPENSATIONISSUER91257.0000000.000000FOR91257.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/07/2026Elect directors to serve until the 2027 Annual Meeting of Stockholders: Fred M. DiazDIRECTOR ELECTIONSISSUER25951.0000000.000000FOR25951.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/07/2026Elect directors to serve until the 2027 Annual Meeting of Stockholders: H. Paulett EberhartDIRECTOR ELECTIONSISSUER25951.0000000.000000FOR25951.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/07/2026Elect directors to serve until the 2027 Annual Meeting of Stockholders: Marie A. FfolkesDIRECTOR ELECTIONSISSUER25951.0000000.000000FOR25951.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/07/2026Elect directors to serve until the 2027 Annual Meeting of Stockholders: Kimberly S. GreeneDIRECTOR ELECTIONSISSUER25951.0000000.000000FOR25951.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/07/2026Elect directors to serve until the 2027 Annual Meeting of Stockholders: Deborah P. MajorasDIRECTOR ELECTIONSISSUER25951.0000000.000000FOR25951.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/07/2026Elect directors to serve until the 2027 Annual Meeting of Stockholders: Eric D. MullinsDIRECTOR ELECTIONSISSUER25951.0000000.000000FOR25951.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/07/2026Elect directors to serve until the 2027 Annual Meeting of Stockholders: Robert L. ReymondDIRECTOR ELECTIONSISSUER25951.0000000.000000FOR25951.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/07/2026Elect directors to serve until the 2027 Annual Meeting of Stockholders: R. Lane RiggsDIRECTOR ELECTIONSISSUER25951.0000000.000000FOR25951.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/07/2026Elect directors to serve until the 2027 Annual Meeting of Stockholders: Randall J. WeisenburgerDIRECTOR ELECTIONSISSUER25951.0000000.000000FOR25951.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/07/2026Elect directors to serve until the 2027 Annual Meeting of Stockholders: Rayford Wilkins, Jr.DIRECTOR ELECTIONSISSUER25951.0000000.000000FOR25951.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/07/2026Advisory vote to approve the 2025 compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER25951.0000000.000000FOR25951.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/07/2026Advisory vote to approve the 2025 compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER25951.0000000.000000FOR25951.000000FOR1S000045418Valero Energy Corporation91913Y100US91913Y100105/07/2026Ratify the appointment of KPMG LLP as Valero's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER25951.0000000.000000FOR25951.000000FORS000045418HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Anne-Marie N. AinsworthDIRECTOR ELECTIONSISSUER25216.0000000.000000FOR25216.000000FORS000045418HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Anna C. CatalanoDIRECTOR ELECTIONSISSUER25216.0000000.000000FOR25216.000000FORS000045418HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Leldon E. EcholsDIRECTOR ELECTIONSISSUER25216.0000000.000000FOR25216.000000FORS000045418HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Manuel J. FernandezDIRECTOR ELECTIONSISSUER25216.0000000.000000FOR25216.000000FORS000045418HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Rhoman J. HardyDIRECTOR ELECTIONSISSUER25216.0000000.000000FOR25216.000000FORS000045418HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Jeanne M. JohnsDIRECTOR ELECTIONSISSUER25216.0000000.000000FOR25216.000000FORS000045418HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: R. Craig KnockeDIRECTOR ELECTIONSISSUER25216.0000000.000000FOR25216.000000FORS000045418HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Robert J. KostelnikDIRECTOR ELECTIONSISSUER25216.0000000.000000FOR25216.000000FORS000045418HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Ross B. MatthewsDIRECTOR ELECTIONSISSUER25216.0000000.000000FOR25216.000000FORS000045418HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Franklin MyersDIRECTOR ELECTIONSISSUER25216.0000000.000000FOR25216.000000FORS000045418HF Sinclair Corporation403949100US403949100005/13/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER25216.0000000.000000FOR25216.000000FORS000045418HF Sinclair Corporation403949100US403949100005/13/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER25216.0000000.000000FOR25216.000000FOR1S000045418HF Sinclair Corporation403949100US403949100005/13/2026Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2026 fiscal year.AUDIT-RELATEDISSUER25216.0000000.000000FOR25216.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/13/2026Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2027: Richard D. KinderDIRECTOR ELECTIONSISSUER514397.0000000.000000FOR514397.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/13/2026Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2027: Kimberly A. DangDIRECTOR ELECTIONSISSUER514397.0000000.000000FOR514397.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/13/2026Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2027: Amy W. ChronisDIRECTOR ELECTIONSISSUER514397.0000000.000000FOR514397.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/13/2026Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2027: Ted A. GardnerDIRECTOR ELECTIONSISSUER514397.0000000.000000FOR514397.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/13/2026Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2027: Anthony W. Hall, Jr.DIRECTOR ELECTIONSISSUER514397.0000000.000000FOR514397.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/13/2026Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2027: Steven J. KeanDIRECTOR ELECTIONSISSUER514397.0000000.000000FOR514397.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/13/2026Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2027: Michael C. MorganDIRECTOR ELECTIONSISSUER514397.0000000.000000FOR514397.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/13/2026Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2027: Arthur C. ReichstetterDIRECTOR ELECTIONSISSUER514397.0000000.000000FOR514397.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/13/2026Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2027: C. Park ShaperDIRECTOR ELECTIONSISSUER514397.0000000.000000FOR514397.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/13/2026Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2027: William A. SmithDIRECTOR ELECTIONSISSUER514397.0000000.000000FOR514397.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/13/2026Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2027: Robert F. VagtDIRECTOR ELECTIONSISSUER514397.0000000.000000FOR514397.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/13/2026Ratification of the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026AUDIT-RELATEDISSUER514397.0000000.000000FOR514397.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/13/2026Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the Proxy StatementSECTION 14A SAY-ON-PAY VOTESISSUER514397.0000000.000000FOR514397.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/13/2026Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the Proxy StatementSECTION 14A SAY-ON-PAY VOTESISSUER514397.0000000.000000FOR514397.000000FOR1S000045418Phillips 66718546104US718546104005/13/2026Election of four Class III Directors named in this Proxy Statement to hold office until the 2029 Annual Meeting: Gregory J. HayesDIRECTOR ELECTIONSISSUER22355.0000000.000000FOR22355.000000FORS000045418Phillips 66718546104US718546104005/13/2026Election of four Class III Directors named in this Proxy Statement to hold office until the 2029 Annual Meeting: Charles M. HolleyDIRECTOR ELECTIONSISSUER22355.0000000.000000FOR22355.000000FORS000045418Phillips 66718546104US718546104005/13/2026Election of four Class III Directors named in this Proxy Statement to hold office until the 2029 Annual Meeting: Denise R. SingletonDIRECTOR ELECTIONSISSUER22355.0000000.000000FOR22355.000000FORS000045418Phillips 66718546104US718546104005/13/2026Election of four Class III Directors named in this Proxy Statement to hold office until the 2029 Annual Meeting: Howard I. UngerleiderDIRECTOR ELECTIONSISSUER22355.0000000.000000FOR22355.000000FORS000045418Phillips 66718546104US718546104005/13/2026Advisory vote to approve our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER22355.0000000.000000FOR22355.000000FORS000045418Phillips 66718546104US718546104005/13/2026Advisory vote to approve our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER22355.0000000.000000FOR22355.000000FOR1S000045418Phillips 66718546104US718546104005/13/2026Ratification of the appointment of our independent registered public accounting firm, Ernst & Young LLP.AUDIT-RELATEDISSUER22355.0000000.000000FOR22355.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/14/2026Election of Directors: Jack A. FuscoDIRECTOR ELECTIONSISSUER87694.0000000.000000FOR87694.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/14/2026Election of Directors: Patricia K. CollawnDIRECTOR ELECTIONSISSUER87694.0000000.000000FOR87694.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/14/2026Election of Directors: Brian E. EdwardsDIRECTOR ELECTIONSISSUER87694.0000000.000000FOR87694.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/14/2026Election of Directors: Denise GrayDIRECTOR ELECTIONSISSUER87694.0000000.000000FOR87694.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/14/2026Election of Directors: Lorraine MitchelmoreDIRECTOR ELECTIONSISSUER87694.0000000.000000FOR87694.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/14/2026Election of Directors: W. Benjamin MorelandDIRECTOR ELECTIONSISSUER87694.0000000.000000FOR87694.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/14/2026Election of Directors: Scott PeakDIRECTOR ELECTIONSISSUER87694.0000000.000000FOR87694.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/14/2026Election of Directors: Donald F. Robillard, Jr.DIRECTOR ELECTIONSISSUER87694.0000000.000000FOR87694.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/14/2026Election of Directors: Neal A. ShearDIRECTOR ELECTIONSISSUER87694.0000000.000000FOR87694.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/14/2026Approve, on an advisory and non-binding basis, the compensation of the Company's named executive officers for 2025.SECTION 14A SAY-ON-PAY VOTESISSUER87694.0000000.000000FOR87694.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/14/2026Approve, on an advisory and non-binding basis, the compensation of the Company's named executive officers for 2025.SECTION 14A SAY-ON-PAY VOTESISSUER87694.0000000.000000FOR87694.000000FOR1S000045418Cheniere Energy, Inc.16411R208US16411R208505/14/2026Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER87694.0000000.000000FOR87694.000000FORS000045418Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: Deborah L. ByersDIRECTOR ELECTIONSISSUER5025.0000000.000000FOR5025.000000FORS000045418Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: David I. FoleyDIRECTOR ELECTIONSISSUER5025.0000000.000000FOR5025.000000FORS000045418Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: Michael KumarDIRECTOR ELECTIONSISSUER5025.0000000.000000FOR5025.000000FORS000045418Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: D. Mark LelandDIRECTOR ELECTIONSISSUER5025.0000000.000000FOR5025.000000FORS000045418Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: Kevin S. McCarthyDIRECTOR ELECTIONSISSUER5025.0000000.000000FOR5025.000000FORS000045418Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: John-Paul (JP) MunfaDIRECTOR ELECTIONSISSUER5025.0000000.000000FOR5025.000000FORS000045418Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: William OrdemannDIRECTOR ELECTIONSISSUER5025.0000000.000000FOR5025.000000FORS000045418Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: Karen PuttermanDIRECTOR ELECTIONSISSUER5025.0000000.000000FOR5025.000000FORS000045418Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: Laura A. SuggDIRECTOR ELECTIONSISSUER5025.0000000.000000FOR5025.000000FORS000045418Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: Jamie WelchDIRECTOR ELECTIONSISSUER5025.0000000.000000FOR5025.000000FORS000045418Kinetik Holdings Inc.02215L209US02215L209705/19/2026Approval of a non-binding resolution regarding the compensation of named executive officers for 2025 (say-on-pay).SECTION 14A SAY-ON-PAY VOTESISSUER5025.0000000.000000FOR5025.000000FORS000045418Kinetik Holdings Inc.02215L209US02215L209705/19/2026Approval of a non-binding resolution regarding the compensation of named executive officers for 2025 (say-on-pay).SECTION 14A SAY-ON-PAY VOTESISSUER5025.0000000.000000FOR5025.000000FOR1S000045418Kinetik Holdings Inc.02215L209US02215L209705/19/2026Ratification of the appointment of KPMG LLP as the Company's independent auditor for fiscal year 2026.AUDIT-RELATEDISSUER5025.0000000.000000FOR5025.000000FORS000045418ONEOK, Inc.682680103US682680103605/20/2026Election of 10 directors: Brian L. DerksenDIRECTOR ELECTIONSISSUER91229.0000000.000000FOR91229.000000FORS000045418ONEOK, Inc.682680103US682680103605/20/2026Election of 10 directors: Julie H. EdwardsDIRECTOR ELECTIONSISSUER91229.0000000.000000FOR91229.000000FORS000045418ONEOK, Inc.682680103US682680103605/20/2026Election of 10 directors: Lori A. GobillotDIRECTOR ELECTIONSISSUER91229.0000000.000000FOR91229.000000FORS000045418ONEOK, Inc.682680103US682680103605/20/2026Election of 10 directors: Mark W. HeldermanDIRECTOR ELECTIONSISSUER91229.0000000.000000FOR91229.000000FORS000045418ONEOK, Inc.682680103US682680103605/20/2026Election of 10 directors: Randall J. LarsonDIRECTOR ELECTIONSISSUER91229.0000000.000000FOR91229.000000FORS000045418ONEOK, Inc.682680103US682680103605/20/2026Election of 10 directors: Mark A. McCollumDIRECTOR ELECTIONSISSUER91229.0000000.000000FOR91229.000000FORS000045418ONEOK, Inc.682680103US682680103605/20/2026Election of 10 directors: Pierce H. Norton IIDIRECTOR ELECTIONSISSUER91229.0000000.000000FOR91229.000000FORS000045418ONEOK, Inc.682680103US682680103605/20/2026Election of 10 directors: Precious Williams OwodunniDIRECTOR ELECTIONSISSUER91229.0000000.000000FOR91229.000000FORS000045418ONEOK, Inc.682680103US682680103605/20/2026Election of 10 directors: Eduardo A. RodriguezDIRECTOR ELECTIONSISSUER91229.0000000.000000FOR91229.000000FORS000045418ONEOK, Inc.682680103US682680103605/20/2026Election of 10 directors: Wayne T. SmithDIRECTOR ELECTIONSISSUER91229.0000000.000000FOR91229.000000FORS000045418ONEOK, Inc.682680103US682680103605/20/2026Ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm of ONEOK, Inc. for the year ending December 31, 2026.AUDIT-RELATEDISSUER91229.0000000.000000FOR91229.000000FORS000045418ONEOK, Inc.682680103US682680103605/20/2026An advisory vote to approve ONEOK, Inc.'s executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER91229.0000000.000000FOR91229.000000FORS000045418ONEOK, Inc.682680103US682680103605/20/2026An advisory vote to approve ONEOK, Inc.'s executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER91229.0000000.000000FOR91229.000000FOR1S000045418Plains All American Pipeline, L.P.726503105US726503105105/20/2026The election of four Class I directors to serve on the Board until the 2029 annual meeting: Willie ChiangDIRECTOR ELECTIONSISSUER3089991.0000000.000000FOR3089991.000000FORS000045418Plains All American Pipeline, L.P.726503105US726503105105/20/2026The election of four Class I directors to serve on the Board until the 2029 annual meeting: Ellen DeSanctisDIRECTOR ELECTIONSISSUER3089991.0000000.000000FOR3089991.000000FORS000045418Plains All American Pipeline, L.P.726503105US726503105105/20/2026The election of four Class I directors to serve on the Board until the 2029 annual meeting: Alexandra PrunerDIRECTOR ELECTIONSISSUER3089991.0000000.000000FOR3089991.000000FORS000045418Plains All American Pipeline, L.P.726503105US726503105105/20/2026The election of four Class I directors to serve on the Board until the 2029 annual meeting: Lawrence ZiembaDIRECTOR ELECTIONSISSUER3089991.0000000.000000FOR3089991.000000FORS000045418Plains All American Pipeline, L.P.726503105US726503105105/20/2026Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER3089991.0000000.000000FOR3089991.000000FORS000045418Plains All American Pipeline, L.P.726503105US726503105105/20/2026The approval, on a non-binding advisory basis, of our 2025 named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3089991.0000000.000000FOR3089991.000000FORS000045418Plains All American Pipeline, L.P.726503105US726503105105/20/2026The approval, on a non-binding advisory basis, of our 2025 named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3089991.0000000.000000FOR3089991.000000FOR1S000045418Targa Resources Corp.87612G101US87612G101305/21/2026To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: Paul W. ChungDIRECTOR ELECTIONSISSUER93591.0000000.000000FOR93591.000000FORS000045418Targa Resources Corp.87612G101US87612G101305/21/2026To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: Charles R. CrispDIRECTOR ELECTIONSISSUER93591.0000000.000000FOR93591.000000FORS000045418Targa Resources Corp.87612G101US87612G101305/21/2026To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: Laura C. FultonDIRECTOR ELECTIONSISSUER93591.0000000.000000FOR93591.000000FORS000045418Targa Resources Corp.87612G101US87612G101305/21/2026To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: R. Keith TeagueDIRECTOR ELECTIONSISSUER93591.0000000.000000FOR93591.000000FORS000045418Targa Resources Corp.87612G101US87612G101305/21/2026To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2026.AUDIT-RELATEDISSUER93591.0000000.000000FOR93591.000000FORS000045418Targa Resources Corp.87612G101US87612G101305/21/2026To approve, on an advisory basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2025.SECTION 14A SAY-ON-PAY VOTESISSUER93591.0000000.000000FOR93591.000000FORS000045418Targa Resources Corp.87612G101US87612G101305/21/2026To approve, on an advisory basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2025.SECTION 14A SAY-ON-PAY VOTESISSUER93591.0000000.000000FOR93591.000000FOR1S000045418Venture Global, Inc.92333F101US92333F101205/27/2026Election of the 7 director nominees named in this proxy statement: Robert PenderDIRECTOR ELECTIONSISSUER38447.0000000.000000FOR38447.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/27/2026Election of the 7 director nominees named in this proxy statement: Michael SabelDIRECTOR ELECTIONSISSUER38447.0000000.000000FOR38447.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/27/2026Election of the 7 director nominees named in this proxy statement: Andrew OrekarDIRECTOR ELECTIONSISSUER38447.0000000.000000FOR38447.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/27/2026Election of the 7 director nominees named in this proxy statement: Sari GranatDIRECTOR ELECTIONSISSUER38447.0000000.000000FOR38447.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/27/2026Election of the 7 director nominees named in this proxy statement: Jimmy StatonDIRECTOR ELECTIONSISSUER38447.0000000.000000FOR38447.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/27/2026Election of the 7 director nominees named in this proxy statement: Thomas ReidDIRECTOR ELECTIONSISSUER38447.0000000.000000FOR38447.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/27/2026Election of the 7 director nominees named in this proxy statement: Roderick ChristieDIRECTOR ELECTIONSISSUER38447.0000000.000000FOR38447.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/27/2026Ratification of selection of Ernst & Young LLP ("EY") as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER38447.0000000.000000FOR38447.000000FORS000045418Wave Life Sciences Ltd.94352A104US94352A104308/05/2025The election of the nominees for director: Paul B. Bolno, M.D., MBADIRECTOR ELECTIONSISSUER7433.0000000FOR7433.000000FORS000047353Wave Life Sciences Ltd.94352A104US94352A104308/05/2025The election of the nominees for director: Mark H. N. Corrigan, M.D.DIRECTOR ELECTIONSISSUER7433.0000000FOR7433.000000FORS000047353Wave Life Sciences Ltd.94352A104US94352A104308/05/2025The election of the nominees for director: Christian HenryDIRECTOR ELECTIONSISSUER7433.0000000FOR7433.000000FORS000047353Wave Life Sciences Ltd.94352A104US94352A104308/05/2025The election of the nominees for director: Peter Kolchinsky, Ph.D.DIRECTOR ELECTIONSISSUER7433.0000000FOR7433.000000FORS000047353Wave Life Sciences Ltd.94352A104US94352A104308/05/2025The election of the nominees for director: Adrian RawcliffeDIRECTOR ELECTIONSISSUER7433.0000000FOR7433.000000FORS000047353Wave Life Sciences Ltd.94352A104US94352A104308/05/2025The election of the nominees for director: Ken TakanashiDIRECTOR ELECTIONSISSUER7433.0000000FOR7433.000000FORS000047353Wave Life Sciences Ltd.94352A104US94352A104308/05/2025The election of the nominees for director: Aik Na TanDIRECTOR ELECTIONSISSUER7433.0000000FOR7433.000000FORS000047353Wave Life Sciences Ltd.94352A104US94352A104308/05/2025The election of the nominees for director: Gregory L. Verdine, Ph.D.DIRECTOR ELECTIONSISSUER7433.0000000FOR7433.000000FORS000047353Wave Life Sciences Ltd.94352A104US94352A104308/05/2025The election of the nominees for director: Heidi L. Wagner, J.D.DIRECTOR ELECTIONSISSUER7433.0000000FOR7433.000000FORS000047353Wave Life Sciences Ltd.94352A104US94352A104308/05/2025To approve the re-appointment of KPMG LLP to serve as our independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2025, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP's remuneration for services provided through the date of our 2026 Annual General Meeting of Shareholders.AUDIT-RELATEDISSUER7433.0000000FOR7433.000000FORS000047353Wave Life Sciences Ltd.94352A104US94352A104308/05/2025To approve our payment of cash and equity-based compensation to non-employee directors for service on the Board of Directors and its committees, in the manner and on the basis set forth under "Proposal 3: Non-Employee Directors' Compensation" in the proxy statement.COMPENSATIONISSUER7433.0000000FOR7433.000000FORS000047353Wave Life Sciences Ltd.94352A104US94352A104308/05/2025To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis as set forth under "Proposal 4: Approval of an Amendment to the 2021 Equity Incentive Plan, as amended" in the proxy statement.COMPENSATIONISSUER7433.0000000AGAINST7433.000000AGAINSTS000047353Wave Life Sciences Ltd.94352A104US94352A104308/05/2025To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd.CAPITAL STRUCTUREISSUER7433.0000000AGAINST7433.000000AGAINSTS000047353Wave Life Sciences Ltd.94352A104US94352A104308/05/2025To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statementSECTION 14A SAY-ON-PAY VOTESISSUER7433.0000000FOR7433.000000FORS000047353Wave Life Sciences Ltd.94352A104US94352A104308/05/2025To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statementSECTION 14A SAY-ON-PAY VOTESISSUER7433.0000000FOR7433.000000FOR4S000047353Wave Life Sciences Ltd.94352A104US94352A104308/05/2025To approve, on a non-binding, advisory basis only, the frequency of holding future shareholder advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER7433.0000000ONE YEAR7433.000000FORS000047353Wave Life Sciences Ltd.94352A104US94352A104308/05/2025To approve, on a non-binding, advisory basis only, the frequency of holding future shareholder advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER7433.0000000ONE YEAR7433.000000FOR4S000047353Immunovant, Inc.45258J102US45258J102508/27/2025To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Jacob BauerDIRECTOR ELECTIONSISSUER1.0000005814.000000FOR1.000000FORS000047353Immunovant, Inc.45258J102US45258J102508/27/2025To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Douglas HughesDIRECTOR ELECTIONSISSUER1.0000005814.000000WITHHOLD1.000000AGAINSTS000047353Immunovant, Inc.45258J102US45258J102508/27/2025To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Robert SusmanDIRECTOR ELECTIONSISSUER1.0000005814.000000FOR1.000000FORS000047353Immunovant, Inc.45258J102US45258J102508/27/2025To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2026.AUDIT-RELATEDISSUER1.0000005814.000000FOR1.000000FORS000047353Immunovant, Inc.45258J102US45258J102508/27/2025To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000005814.000000FOR1.000000FORS000047353Immunovant, Inc.45258J102US45258J102508/27/2025To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000005814.000000FOR1.000000FOR4S000047353Replimune Group, Inc.76029N106US76029N106309/03/2025Election of Directors: Kapil DhingraDIRECTOR ELECTIONSISSUER11267.0000000FOR11267.000000FORS000047353Replimune Group, Inc.76029N106US76029N106309/03/2025Election of Directors: Christy OligerDIRECTOR ELECTIONSISSUER11267.0000000FOR11267.000000FORS000047353Replimune Group, Inc.76029N106US76029N106309/03/2025Election of Directors: Joseph SlatteryDIRECTOR ELECTIONSISSUER11267.0000000FOR11267.000000FORS000047353Replimune Group, Inc.76029N106US76029N106309/03/2025Election of Directors: Michael GollerDIRECTOR ELECTIONSISSUER11267.0000000FOR11267.000000FORS000047353Replimune Group, Inc.76029N106US76029N106309/03/2025Election of Directors: Philip Astley-SparkeDIRECTOR ELECTIONSISSUER11267.0000000FOR11267.000000FORS000047353Replimune Group, Inc.76029N106US76029N106309/03/2025To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Replimune Group, Inc. for the fiscal year ending March 31, 2026.AUDIT-RELATEDISSUER11267.0000000FOR11267.000000FORS000047353Replimune Group, Inc.76029N106US76029N106309/03/2025To approve, on a non-binding advisory basis, the compensation of Replimune Group, Inc.'s named executive officers for the fiscal year ended March 31, 2025.SECTION 14A SAY-ON-PAY VOTESISSUER11267.0000000FOR11267.000000FORS000047353Replimune Group, Inc.76029N106US76029N106309/03/2025To approve, on a non-binding advisory basis, the compensation of Replimune Group, Inc.'s named executive officers for the fiscal year ended March 31, 2025.SECTION 14A SAY-ON-PAY VOTESISSUER11267.0000000FOR11267.000000FOR4S000047353Replimune Group, Inc.76029N106US76029N106309/03/2025To approve an amendment to Replimune Group, Inc.'s 2018 Omnibus Incentive Compensation Plan (the "Plan Amendment").COMPENSATIONISSUER11267.0000000AGAINST11267.000000AGAINSTS000047353Altimmune, Inc.02155H200US02155H200409/25/2025Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Mitchel Sayare, Ph.D.DIRECTOR ELECTIONSISSUER188.00000016830.000000FOR188.000000FORS000047353Altimmune, Inc.02155H200US02155H200409/25/2025Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Vipin K. Garg, Ph.D.DIRECTOR ELECTIONSISSUER188.00000016830.000000FOR188.000000FORS000047353Altimmune, Inc.02155H200US02155H200409/25/2025Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: John M. GillDIRECTOR ELECTIONSISSUER188.00000016830.000000FOR188.000000FORS000047353Altimmune, Inc.02155H200US02155H200409/25/2025Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Philip L. HodgesDIRECTOR ELECTIONSISSUER188.00000016830.000000WITHHOLD188.000000AGAINSTS000047353Altimmune, Inc.02155H200US02155H200409/25/2025Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Diane Jorkasky, M.D.DIRECTOR ELECTIONSISSUER188.00000016830.000000WITHHOLD188.000000AGAINSTS000047353Altimmune, Inc.02155H200US02155H200409/25/2025Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Wayne PisanoDIRECTOR ELECTIONSISSUER188.00000016830.000000FOR188.000000FORS000047353Altimmune, Inc.02155H200US02155H200409/25/2025Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Klaus O. Schafer, M.D., MPHDIRECTOR ELECTIONSISSUER188.00000016830.000000WITHHOLD188.000000AGAINSTS000047353Altimmune, Inc.02155H200US02155H200409/25/2025Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Catherine Sohn, Pharm DDIRECTOR ELECTIONSISSUER188.00000016830.000000WITHHOLD188.000000AGAINSTS000047353Altimmune, Inc.02155H200US02155H200409/25/2025Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Teri LawverDIRECTOR ELECTIONSISSUER188.00000016830.000000FOR188.000000FORS000047353Altimmune, Inc.02155H200US02155H200409/25/2025Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Jerome DursoDIRECTOR ELECTIONSISSUER188.00000016830.000000FOR188.000000FORS000047353Altimmune, Inc.02155H200US02155H200409/25/2025Vote to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER188.00000016830.000000FOR188.000000FORS000047353Altimmune, Inc.02155H200US02155H200409/25/2025Hold an advisory vote on compensation of the Company's named executive officers as disclosed in the attached Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER188.00000016830.000000AGAINST188.000000AGAINSTS000047353Altimmune, Inc.02155H200US02155H200409/25/2025Hold an advisory vote on compensation of the Company's named executive officers as disclosed in the attached Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER188.00000016830.000000AGAINST188.000000AGAINST4S000047353Altimmune, Inc.02155H200US02155H200409/25/2025Approve the authorization to adjourn the Annual Meeting, if necessary or appropriate, to solicit additional proxies in favor of the foregoing proposals if there are not sufficient votes to approve the proposals.CORPORATE GOVERNANCEISSUER188.00000016830.000000AGAINST188.000000AGAINSTS000047353KalVista Pharmaceuticals, Inc.483497103US483497103210/01/2025The election of two Class I directors to hold office until the earliest of our 2028 annual meeting of stockholders and such individual's death, resignation or removal and the election and qualification of his or her successor: Benjamin L. PalleikoDIRECTOR ELECTIONSISSUER9296.0000000FOR9296.000000FORS000047353KalVista Pharmaceuticals, Inc.483497103US483497103210/01/2025The election of two Class I directors to hold office until the earliest of our 2028 annual meeting of stockholders and such individual's death, resignation or removal and the election and qualification of his or her successor: Brian J.G. PereiraDIRECTOR ELECTIONSISSUER9296.0000000AGAINST9296.000000AGAINSTS000047353KalVista Pharmaceuticals, Inc.483497103US483497103210/01/2025The ratification of the selection by the audit committee of our Board, of Deloitte & Touche LLP as our independent registered public accounting firm for our eight-month transition period ending December 31, 2025.AUDIT-RELATEDISSUER9296.0000000FOR9296.000000FORS000047353KalVista Pharmaceuticals, Inc.483497103US483497103210/01/2025Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER9296.0000000FOR9296.000000FORS000047353KalVista Pharmaceuticals, Inc.483497103US483497103210/01/2025Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER9296.0000000FOR9296.000000FOR4S000047353Prothena Corporation plcG72800108IE00B91XRN2011/19/2025To approve a reduction in the Company's capital to create distributable reserves.CAPITAL STRUCTUREISSUER22443.0000000FOR22443.000000FORS000047353CureVac NVN2451R105NL001543603111/25/2025Approve Merger of CureVac N.V. with and into CureVac Merger B.V.EXTRAORDINARY TRANSACTIONSISSUER21336.0000000FOR21336.000000FORS000047353CureVac NVN2451R105NL001543603111/25/2025Approve Legal Downstream Merger, Sale and Transfer of All Outstanding Shares of CureVac SE by CureVac Merger B.V, and Cancellation of All Outstanding class A shares of CureVac Merger B.VEXTRAORDINARY TRANSACTIONSISSUER21336.0000000FOR21336.000000FORS000047353CureVac NVN2451R105NL001543603111/25/2025Approve Discharge of Management BoardCORPORATE GOVERNANCEISSUER21336.0000000FOR21336.000000FORS000047353CureVac NVN2451R105NL001543603111/25/2025Approve Discharge of Supervisory BoardCORPORATE GOVERNANCEISSUER21336.0000000FOR21336.000000FORS000047353CureVac NVN2451R105NL001543603111/25/2025Elect Ramon Zapata Gomez to Management BoardCORPORATE GOVERNANCEISSUER21336.0000000FOR21336.000000FORS000047353CureVac NVN2451R105NL001543603111/25/2025Elect Sierk Poetting to Supervisory BoardDIRECTOR ELECTIONSISSUER21336.0000000FOR21336.000000FORS000047353CureVac NVN2451R105NL001543603111/25/2025Elect James Ryan to Supervisory BoardDIRECTOR ELECTIONSISSUER21336.0000000FOR21336.000000FORS000047353CureVac NVN2451R105NL001543603111/25/2025Elect Annemarie Hanekamp to Supervisory BoardDIRECTOR ELECTIONSISSUER21336.0000000FOR21336.000000FORS000047353Zymeworks Inc.98985Y108US98985Y108212/30/2025Election of Directors: Carlos CampoyDIRECTOR ELECTIONSISSUER9121.0000000FOR9121.000000FORS000047353Zymeworks Inc.98985Y108US98985Y108212/30/2025Election of Directors: Alessandra CesanoDIRECTOR ELECTIONSISSUER9121.0000000WITHHOLD9121.000000AGAINSTS000047353Zymeworks Inc.98985Y108US98985Y108212/30/2025Election of Directors: Robert E. LandryDIRECTOR ELECTIONSISSUER9121.0000000FOR9121.000000FORS000047353Zymeworks Inc.98985Y108US98985Y108212/30/2025Advisory vote on the compensation of our named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER9121.0000000FOR9121.000000FORS000047353Zymeworks Inc.98985Y108US98985Y108212/30/2025Advisory vote on the compensation of our named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER9121.0000000FOR9121.000000FOR4S000047353Zymeworks Inc.98985Y108US98985Y108212/30/2025Appointment of Auditors Ratification of the appointment of KPMG LLP, chartered professional accountants, as auditors for the year ending December 31, 2025AUDIT-RELATEDISSUER9121.0000000FOR9121.000000FORS000047353Astria Therapeutics, Inc.04635X102US04635X102801/21/2026To adopt the Agreement and Plan of Merger, dated as of October 14, 2025 by and among BioCryst Pharmaceuticals, Inc. ("BioCryst"), Axel Merger Sub, Inc., a wholly owned subsidiary of BioCryst ("Merger Sub"), and Astria Therapeutics, Inc. ("Astria"), under which Merger Sub will merge with and into Astria, with Astria surviving and becoming a wholly owned subsidiary of BioCryst (the "Merger") (the "Merger Proposal").EXTRAORDINARY TRANSACTIONSISSUER24635.0000000FOR24635.000000FORS000047353Astria Therapeutics, Inc.04635X102US04635X102801/21/2026To cast a vote, on a non-binding, advisory basis, to approve the Merger-related named executive officer compensation as disclosed in the table entitled "Golden Parachute Compensation" and its accompanying footnotes which is included in the section of the proxy statement entitled "The Merger-Interests of Astria's Directors and Executive Officers in the Merger," as required by Section 14A of the Securities Exchange Act of 1934, as amended, which was enacted as part of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010.SECTION 14A SAY-ON-PAY VOTESISSUER24635.0000000FOR24635.000000FORS000047353Astria Therapeutics, Inc.04635X102US04635X102801/21/2026To cast a vote, on a non-binding, advisory basis, to approve the Merger-related named executive officer compensation as disclosed in the table entitled "Golden Parachute Compensation" and its accompanying footnotes which is included in the section of the proxy statement entitled "The Merger-Interests of Astria's Directors and Executive Officers in the Merger," as required by Section 14A of the Securities Exchange Act of 1934, as amended, which was enacted as part of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010.SECTION 14A SAY-ON-PAY VOTESISSUER24635.0000000FOR24635.000000FOR4S000047353Astria Therapeutics, Inc.04635X102US04635X102801/21/2026To approve one or more adjournments of the Special Meeting to a later date or dates if there are not sufficient votes for adoption of the Merger Proposal on the date on which the Special Meeting is held.CORPORATE GOVERNANCEISSUER24635.0000000FOR24635.000000FORS000047353Ventyx Biosciences, Inc.92332V107US92332V107003/03/2026To adopt the Agreement and Plan of Merger (as it may be amended from time to time), dated as of January 7, 2026, by and among Eli Lilly and Company, RYLS Merger Corporation ("merger sub"), and Ventyx Biosciences, Inc. (the "merger agreement");EXTRAORDINARY TRANSACTIONSISSUER34399.0000000FOR34399.000000FORS000047353Ventyx Biosciences, Inc.92332V107US92332V107003/03/2026To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Ventyx Biosciences, Inc. to its named executive officers in connection with the merger of merger sub with and into Ventyx Biosciences, Inc.; andSECTION 14A SAY-ON-PAY VOTESISSUER34399.0000000FOR34399.000000FORS000047353Ventyx Biosciences, Inc.92332V107US92332V107003/03/2026To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Ventyx Biosciences, Inc. to its named executive officers in connection with the merger of merger sub with and into Ventyx Biosciences, Inc.; andSECTION 14A SAY-ON-PAY VOTESISSUER34399.0000000FOR34399.000000FOR4S000047353Ventyx Biosciences, Inc.92332V107US92332V107003/03/2026To adjourn the special meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the merger agreement at the time of the special meeting.CORPORATE GOVERNANCEISSUER34399.0000000FOR34399.000000FORS000047353Altimmune, Inc.02155H200US02155H200404/16/2026Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: Jerome DursoDIRECTOR ELECTIONSISSUER54791.0000000FOR54791.000000FORS000047353Altimmune, Inc.02155H200US02155H200404/16/2026Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: John M. GillDIRECTOR ELECTIONSISSUER54791.0000000FOR54791.000000FORS000047353Altimmune, Inc.02155H200US02155H200404/16/2026Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: Philip L. HodgesDIRECTOR ELECTIONSISSUER54791.0000000FOR54791.000000FORS000047353Altimmune, Inc.02155H200US02155H200404/16/2026Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: Diane Jorkasky, M.D.DIRECTOR ELECTIONSISSUER54791.0000000FOR54791.000000FORS000047353Altimmune, Inc.02155H200US02155H200404/16/2026Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: Teri LawverDIRECTOR ELECTIONSISSUER54791.0000000FOR54791.000000FORS000047353Altimmune, Inc.02155H200US02155H200404/16/2026Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: Wayne PisanoDIRECTOR ELECTIONSISSUER54791.0000000FOR54791.000000FORS000047353Altimmune, Inc.02155H200US02155H200404/16/2026Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: Mitchel Sayare, Ph.D.DIRECTOR ELECTIONSISSUER54791.0000000FOR54791.000000FORS000047353Altimmune, Inc.02155H200US02155H200404/16/2026Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: Klaus O. Schafer, M.D., MPHDIRECTOR ELECTIONSISSUER54791.0000000FOR54791.000000FORS000047353Altimmune, Inc.02155H200US02155H200404/16/2026Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: Catherine Sohn, Pharm DDIRECTOR ELECTIONSISSUER54791.0000000FOR54791.000000FORS000047353Altimmune, Inc.02155H200US02155H200404/16/2026Vote to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER54791.0000000FOR54791.000000FORS000047353Altimmune, Inc.02155H200US02155H200404/16/2026Hold an advisory vote on compensation of the Company's named executive officers as disclosed in the attached Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER54791.0000000FOR54791.000000FORS000047353Altimmune, Inc.02155H200US02155H200404/16/2026Hold an advisory vote on compensation of the Company's named executive officers as disclosed in the attached Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER54791.0000000FOR54791.000000FOR4S000047353Altimmune, Inc.02155H200US02155H200404/16/2026Vote to approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended to increase the number of authorized shares of the Company's common stock.CAPITAL STRUCTUREISSUER54791.0000000FOR54791.000000FORS000047353Altimmune, Inc.02155H200US02155H200404/16/2026Vote to approve an amendment to the Company's 2019 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock reserved under the Company's 2019 Employee Stock Purchase Plan.COMPENSATIONISSUER54791.0000000FOR54791.000000FORS000047353Altimmune, Inc.02155H200US02155H200404/16/2026Approve the authorization to adjourn the Annual Meeting, if necessary or appropriate, to solicit additional proxies in favor of the foregoing proposals if there are not sufficient votes to approve the proposals.CORPORATE GOVERNANCEISSUER54791.0000000FOR54791.000000FORS000047353Biohaven Ltd.G1110E107VGG1110E107904/28/2026Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. HeffernanDIRECTOR ELECTIONSISSUER25043.0000000AGAINST25043.000000AGAINSTS000047353Biohaven Ltd.G1110E107VGG1110E107904/28/2026Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Irina Antonijevic, M.D., Ph.D.DIRECTOR ELECTIONSISSUER25043.0000000AGAINST25043.000000AGAINSTS000047353Biohaven Ltd.G1110E107VGG1110E107904/28/2026Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Robert J. HuginDIRECTOR ELECTIONSISSUER25043.0000000AGAINST25043.000000AGAINSTS000047353Biohaven Ltd.G1110E107VGG1110E107904/28/2026Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year 2026.AUDIT-RELATEDISSUER25043.0000000FOR25043.000000FORS000047353Biohaven Ltd.G1110E107VGG1110E107904/28/2026A non-binding advisory vote on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER25043.0000000FOR25043.000000FORS000047353Biohaven Ltd.G1110E107VGG1110E107904/28/2026A non-binding advisory vote on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER25043.0000000FOR25043.000000FOR4S000047353Zenas BioPharma, Inc.98937L105US98937L105205/11/2026To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: James BoylanDIRECTOR ELECTIONSISSUER1.0000007112.000000AGAINST1.000000AGAINSTS000047353Zenas BioPharma, Inc.98937L105US98937L105205/11/2026To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Patrick EnrightDIRECTOR ELECTIONSISSUER1.0000007112.000000AGAINST1.000000AGAINSTS000047353Zenas BioPharma, Inc.98937L105US98937L105205/11/2026To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER1.0000007112.000000FOR1.000000FORS000047353Celcuity Inc.15102K100US15102K100705/14/2026Elect eight directors: Richard E. BullerDIRECTOR ELECTIONSISSUER1.0000002741.000000WITHHOLD1.000000AGAINSTS000047353Celcuity Inc.15102K100US15102K100705/14/2026Elect eight directors: David F. DalveyDIRECTOR ELECTIONSISSUER1.0000002741.000000WITHHOLD1.000000AGAINSTS000047353Celcuity Inc.15102K100US15102K100705/14/2026Elect eight directors: Leo T. FurchtDIRECTOR ELECTIONSISSUER1.0000002741.000000WITHHOLD1.000000AGAINSTS000047353Celcuity Inc.15102K100US15102K100705/14/2026Elect eight directors: Lance G. LaingDIRECTOR ELECTIONSISSUER1.0000002741.000000FOR1.000000FORS000047353Celcuity Inc.15102K100US15102K100705/14/2026Elect eight directors: Polly A. MurphyDIRECTOR ELECTIONSISSUER1.0000002741.000000WITHHOLD1.000000AGAINSTS000047353Celcuity Inc.15102K100US15102K100705/14/2026Elect eight directors: Richard J. NigonDIRECTOR ELECTIONSISSUER1.0000002741.000000FOR1.000000FORS000047353Celcuity Inc.15102K100US15102K100705/14/2026Elect eight directors: Charles R. RompDIRECTOR ELECTIONSISSUER1.0000002741.000000FOR1.000000FORS000047353Celcuity Inc.15102K100US15102K100705/14/2026Elect eight directors: Brian F. SullivanDIRECTOR ELECTIONSISSUER1.0000002741.000000FOR1.000000FORS000047353Celcuity Inc.15102K100US15102K100705/14/2026To ratify the appointment of Boulay PLLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER1.0000002741.000000FOR1.000000FORS000047353Celcuity Inc.15102K100US15102K100705/14/2026To approve, on an advisory basis, named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000002741.000000FOR1.000000FORS000047353Celcuity Inc.15102K100US15102K100705/14/2026To approve, on an advisory basis, named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000002741.000000FOR1.000000FOR4S000047353Celcuity Inc.15102K100US15102K100705/14/2026To approve the Celcuity Inc. 2026 Stock Incentive Plan.COMPENSATIONISSUER1.0000002741.000000AGAINST1.000000AGAINSTS000047353Celcuity Inc.15102K100US15102K100705/14/2026To approve the Celcuity Inc. Amended and Restated Employee Stock Purchase Plan.COMPENSATIONISSUER1.0000002741.000000FOR1.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/14/2026That the annual report and accounts for the year ended December 31, 2025, together with the directors' report and independent auditor's report thereon, be received and adopted.CORPORATE GOVERNANCEISSUER119704.0000000FOR119704.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/14/2026That PricewaterhouseCoopers LLP ("PwC") be re-appointed as auditors to hold office from the conclusion of the annual general meeting until the conclusion of the next annual general meeting at which the Company's annual report and accounts are presented.AUDIT-RELATEDISSUER119704.0000000FOR119704.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/14/2026That the Audit and Risk Committee be authorized to determine PwC's remuneration for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER119704.0000000FOR119704.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/14/2026That the directors' remuneration report (excluding the directors' remuneration policy), as set out in the Company's annual report and accounts for the year ended December 31, 2025, be approved.COMPENSATIONISSUER119704.0000000FOR119704.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/14/2026That the directors' remuneration policy as set out in the Company's annual report and accounts for the year ended December 31, 2025, which takes effect from the end of the annual general meeting, be approved.COMPENSATIONISSUER119704.0000000FOR119704.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/14/2026That the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.SECTION 14A SAY-ON-PAY VOTESISSUER119704.0000000FOR119704.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/14/2026That the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.SECTION 14A SAY-ON-PAY VOTESISSUER119704.0000000FOR119704.000000FOR4S000047353Mereo BioPharma Group Plc589492107US589492107205/14/2026That Justin Roberts be re-appointed as a director of the Company.DIRECTOR ELECTIONSISSUER119704.0000000AGAINST119704.000000AGAINSTS000047353Mereo BioPharma Group Plc589492107US589492107205/14/2026That Dr. Daniel Shames be re-appointed as a director of the Company.DIRECTOR ELECTIONSISSUER119704.0000000FOR119704.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/14/2026That Marc Yoskowitz be re-appointed as a director of the CompanyDIRECTOR ELECTIONSISSUER119704.0000000FOR119704.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/14/2026That the Directors be generally and unconditionally authorized in accordance with section 551 of the Companies Act 2006 (the "Act") to exercise all the powers of the Company to allot shares in the Company or to grant rights to subscribe for, or to convert securities into, shares in the Company up to a maximum aggregate nominal amount of pounds3,591,354.73, such authority to expire on June 30, 2029, save that the Company may, before such expiry, make offers or agreements which would, or might, require shares to be allotted or rights to subscribe for or to convert any securities into shares to be granted after such expiry and the Directors may allot shares or grant such rights under any such offer or agreement as if the authority conferred by this Resolution had not expired. Such authority shall replace the authority granted pursuant to section 551 of the Act at the annual general meeting of the Company held on May 22, 2023 to the extent not utilized at the date this Resolution is passedCAPITAL STRUCTUREISSUER119704.0000000AGAINST119704.000000AGAINSTS000047353Mereo BioPharma Group Plc589492107US589492107205/14/2026That, subject to Resolution 10 being passed, the Directors be generally empowered pursuant to section 570 and section 573 of the Act to allot equity securities for cash pursuant to the authority given by Resolution 10 and to sell equity securities held as treasury shares for cash pursuant to section 727 of the Act, in each case as if section 561(1) of the Act did not apply to any such allotment or sale, provided that this power shall be limited to the allotment or sale of equity securities up to an aggregate nominal value of pounds3,591,354.73, such power to expire on June 30, 2029, save that the Company may, before such expiry, make offers or agreements which would or might require equity securities to be allotted and equity securities held as treasury shares to be sold after such expiry, and the Directors may allot equity securities and sell equity securities held as treasury shares in pursuance of any such offer or agreement as if the power conferred hereby had not expired. Such power shall replace the power granted pursuant to section 570 and section 573 of the Act at the annual general meeting of the Company held on May 22, 2023 to the extent not utilized at the date this Resolution is passed.CAPITAL STRUCTUREISSUER119704.0000000AGAINST119704.000000AGAINSTS000047353Prothena Corporation plcG72800108IE00B91XRN2005/14/2026To elect, by separate resolutions, two directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Shane M. CookeDIRECTOR ELECTIONSISSUER27194.0000000FOR27194.000000FORS000047353Prothena Corporation plcG72800108IE00B91XRN2005/14/2026To elect, by separate resolutions, two directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Dennis J. SelkoeDIRECTOR ELECTIONSISSUER27194.0000000FOR27194.000000FORS000047353Prothena Corporation plcG72800108IE00B91XRN2005/14/2026To ratify, in a non-binding vote, the appointment of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year 2026, and to authorize, in a binding vote, the Company's Board of Directors, acting through its Audit Committee, to approve the remuneration of that auditor.AUDIT-RELATEDISSUER27194.0000000FOR27194.000000FORS000047353Prothena Corporation plcG72800108IE00B91XRN2005/14/2026To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting.SECTION 14A SAY-ON-PAY VOTESISSUER27194.0000000FOR27194.000000FORS000047353Prothena Corporation plcG72800108IE00B91XRN2005/14/2026To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting.SECTION 14A SAY-ON-PAY VOTESISSUER27194.0000000FOR27194.000000FOR4S000047353Rigel Pharmaceuticals, Inc.766559702US766559702405/14/2026Election of Directors: Alison Hannah, M.D.DIRECTOR ELECTIONSISSUER7080.0000000FOR7080.000000FORS000047353Rigel Pharmaceuticals, Inc.766559702US766559702405/14/2026Election of Directors: Walter Moos, Ph.D.DIRECTOR ELECTIONSISSUER7080.0000000FOR7080.000000FORS000047353Rigel Pharmaceuticals, Inc.766559702US766559702405/14/2026Election of Directors: Raul RodriguezDIRECTOR ELECTIONSISSUER7080.0000000FOR7080.000000FORS000047353Rigel Pharmaceuticals, Inc.766559702US766559702405/14/2026To approve an amendment to our 2018 Equity Incentive Plan, as amended (the "Amended 2018 Plan"), to add an additional 500,000 shares to the number of shares of common stock authorized for issuance under the Amended 2018 Plan.COMPENSATIONISSUER7080.0000000AGAINST7080.000000AGAINSTS000047353Rigel Pharmaceuticals, Inc.766559702US766559702405/14/2026To approve an amendment to our 2000 Employee Stock Purchase Plan, as amended (the "Amended 2000 ESPP"), to, among other things, add an additional 360,000 shares to the number of shares of common stock authorized for issuance under the Amended 2000 ESPP.COMPENSATIONISSUER7080.0000000FOR7080.000000FORS000047353Rigel Pharmaceuticals, Inc.766559702US766559702405/14/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER7080.0000000FOR7080.000000FORS000047353Rigel Pharmaceuticals, Inc.766559702US766559702405/14/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER7080.0000000FOR7080.000000FOR4S000047353Rigel Pharmaceuticals, Inc.766559702US766559702405/14/2026To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER7080.0000000FOR7080.000000FORS000047353Nurix Therapeutics, Inc.67080M103US67080M103605/15/2026Election of Class III Directors: Arthur T. Sands, M.D., Ph.D.DIRECTOR ELECTIONSISSUER15141.0000000WITHHOLD15141.000000AGAINSTS000047353Nurix Therapeutics, Inc.67080M103US67080M103605/15/2026Election of Class III Directors: Roger Dansey, M.D.DIRECTOR ELECTIONSISSUER15141.0000000FOR15141.000000FORS000047353Nurix Therapeutics, Inc.67080M103US67080M103605/15/2026Election of Class III Directors: Paul M. SilvaDIRECTOR ELECTIONSISSUER15141.0000000WITHHOLD15141.000000AGAINSTS000047353Nurix Therapeutics, Inc.67080M103US67080M103605/15/2026Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending November 30, 2026.AUDIT-RELATEDISSUER15141.0000000FOR15141.000000FORS000047353Nurix Therapeutics, Inc.67080M103US67080M103605/15/2026To approve, a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER15141.0000000FOR15141.000000FORS000047353Nurix Therapeutics, Inc.67080M103US67080M103605/15/2026To approve, a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER15141.0000000FOR15141.000000FOR4S000047353Invivyd, Inc.00534A102US00534A102505/19/2026To elect the six nominees for director named in the Proxy Statement for a one-year term expiring at the 2027 Annual Meeting of Stockholders of Invivyd, Inc. (the "Company"): Tamsin BerryDIRECTOR ELECTIONSISSUER124462.0000000FOR124462.000000FORS000047353Invivyd, Inc.00534A102US00534A102505/19/2026To elect the six nominees for director named in the Proxy Statement for a one-year term expiring at the 2026 Annual Meeting of Stockholders of Invivyd, Inc. (the "Company"): Paul B. Bolno, M.D.DIRECTOR ELECTIONSISSUER124462.0000000FOR124462.000000FORS000047353Invivyd, Inc.00534A102US00534A102505/19/2026To elect the six nominees for director named in the Proxy Statement for a one-year term expiring at the 2027 Annual Meeting of Stockholders of Invivyd, Inc. (the "Company"): Marc EliaDIRECTOR ELECTIONSISSUER124462.0000000WITHHOLD124462.000000AGAINSTS000047353Invivyd, Inc.00534A102US00534A102505/19/2026To elect the six nominees for director named in the Proxy Statement for a one-year term expiring at the 2027 Annual Meeting of Stockholders of Invivyd, Inc. (the "Company"): Terrance McGuireDIRECTOR ELECTIONSISSUER124462.0000000FOR124462.000000FORS000047353Invivyd, Inc.00534A102US00534A102505/19/2026To elect the six nominees for director named in the Proxy Statement for a one-year term expiring at the 2027 Annual Meeting of Stockholders of Invivyd, Inc. (the "Company"): Kevin F. McLaughlinDIRECTOR ELECTIONSISSUER124462.0000000FOR124462.000000FORS000047353Invivyd, Inc.00534A102US00534A102505/19/2026To elect the six nominees for director named in the Proxy Statement for a one-year term expiring at the 2027 Annual Meeting of Stockholders of Invivyd, Inc. (the "Company"): Ajay RoyanDIRECTOR ELECTIONSISSUER124462.0000000FOR124462.000000FORS000047353Invivyd, Inc.00534A102US00534A102505/19/2026To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER124462.0000000FOR124462.000000FORS000047353Viking Therapeutics, Inc.92686J106US92686J106005/19/2026ELECTION OF DIRECTOR NOMINEES FOR CLASS II (term to expire in 2029): J. Matthew SingletonDIRECTOR ELECTIONSISSUER1.0000007786.000000WITHHOLD1.000000AGAINSTS000047353Viking Therapeutics, Inc.92686J106US92686J106005/19/2026ELECTION OF DIRECTOR NOMINEES FOR CLASS II (term to expire in 2029): S. Kathryn Rouan, Ph.D.DIRECTOR ELECTIONSISSUER1.0000007786.000000WITHHOLD1.000000AGAINSTS000047353Viking Therapeutics, Inc.92686J106US92686J106005/19/2026TO RATIFY THE SELECTION OF CBIZ CPAS P.C. AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2026.AUDIT-RELATEDISSUER1.0000007786.000000FOR1.000000FORS000047353Viking Therapeutics, Inc.92686J106US92686J106005/19/2026TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000007786.000000AGAINST1.000000AGAINSTS000047353Viking Therapeutics, Inc.92686J106US92686J106005/19/2026TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000007786.000000AGAINST1.000000AGAINST4S000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106605/20/2026The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Peter Fong, Ph.D.DIRECTOR ELECTIONSISSUER85177.0000000FOR85177.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106605/20/2026The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Carsten BoessDIRECTOR ELECTIONSISSUER85177.0000000FOR85177.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106605/20/2026The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Mikael Dolsten, M.D., Ph.D.DIRECTOR ELECTIONSISSUER85177.0000000FOR85177.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106605/20/2026The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Fady Malik, M.D., Ph.D.DIRECTOR ELECTIONSISSUER85177.0000000FOR85177.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106605/20/2026The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Gaurav Shah, M.D.DIRECTOR ELECTIONSISSUER85177.0000000FOR85177.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106605/20/2026The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: David P. SouthwellDIRECTOR ELECTIONSISSUER85177.0000000WITHHOLD85177.000000AGAINSTS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106605/20/2026The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Roderick Wong, M.D.DIRECTOR ELECTIONSISSUER85177.0000000FOR85177.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106605/20/2026The ratification of the appointment of Eisner Amper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER85177.0000000FOR85177.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106605/20/2026A non-binding, advisory vote on the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER85177.0000000FOR85177.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106605/20/2026A non-binding, advisory vote on the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER85177.0000000FOR85177.000000FOR4S000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106605/20/2026The approval of the proposed stock option exchange program; andCOMPENSATIONISSUER85177.0000000AGAINST85177.000000AGAINSTS000047353Dianthus Therapeutics, Inc.252828108US252828108005/21/2026To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Sujay KangoDIRECTOR ELECTIONSISSUER1.0000006471.000000FOR1.000000FORS000047353Dianthus Therapeutics, Inc.252828108US252828108005/21/2026To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorgeDIRECTOR ELECTIONSISSUER1.0000006471.000000WITHHOLD1.000000AGAINSTS000047353Dianthus Therapeutics, Inc.252828108US252828108005/21/2026To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Jonathan Violin, Ph.D.DIRECTOR ELECTIONSISSUER1.0000006471.000000FOR1.000000FORS000047353Dianthus Therapeutics, Inc.252828108US252828108005/21/2026To approve, on an advisory basis, the compensation paid to our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER1.0000006471.000000FOR1.000000FORS000047353Dianthus Therapeutics, Inc.252828108US252828108005/21/2026To approve, on an advisory basis, the compensation paid to our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER1.0000006471.000000FOR1.000000FOR4S000047353Dianthus Therapeutics, Inc.252828108US252828108005/21/2026To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1.0000006471.000000FOR1.000000FORS000047353Mineralys Therapeutics, Inc.603170101US603170101305/21/2026Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Srinivas Akkaraju, M.D., Ph.D.DIRECTOR ELECTIONSISSUER7389.0000000WITHHOLD7389.000000AGAINSTS000047353Mineralys Therapeutics, Inc.603170101US603170101305/21/2026Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Brian Taylor Slingsby, M.D., Ph.D., M.P.H.DIRECTOR ELECTIONSISSUER7389.0000000WITHHOLD7389.000000AGAINSTS000047353Mineralys Therapeutics, Inc.603170101US603170101305/21/2026Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Daphne KarydasDIRECTOR ELECTIONSISSUER7389.0000000FOR7389.000000FORS000047353Mineralys Therapeutics, Inc.603170101US603170101305/21/2026Ratify the appointment of Ernst & Young LLP as Mineralys Therapeutics, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER7389.0000000FOR7389.000000FORS000047353Vera Therapeutics, Inc.92337R101US92337R101405/21/2026To elect the three Class II directors named below to hold office until the Company's 2029 annual meeting of stockholders: Michael M. Morrissey, Ph.D.DIRECTOR ELECTIONSISSUER5797.0000000WITHHOLD5797.000000AGAINSTS000047353Vera Therapeutics, Inc.92337R101US92337R101405/21/2026To elect the three Class II directors named below to hold office until the Company's 2029 annual meeting of stockholders: Patrick G. EnrightDIRECTOR ELECTIONSISSUER5797.0000000FOR5797.000000FORS000047353Vera Therapeutics, Inc.92337R101US92337R101405/21/2026To elect the three Class II directors named below to hold office until the Company's 2029 annual meeting of stockholders: James R. MeyersDIRECTOR ELECTIONSISSUER5797.0000000FOR5797.000000FORS000047353Vera Therapeutics, Inc.92337R101US92337R101405/21/2026To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER5797.0000000FOR5797.000000FORS000047353Vera Therapeutics, Inc.92337R101US92337R101405/21/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER5797.0000000FOR5797.000000FORS000047353Vera Therapeutics, Inc.92337R101US92337R101405/21/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER5797.0000000FOR5797.000000FOR4S000047353Verastem, Inc.92337C203US92337C203505/21/2026Election of Directors: Michael BaileyDIRECTOR ELECTIONSISSUER1.00000030045.000000FOR1.000000FORS000047353Verastem, Inc.92337C203US92337C203505/21/2026Election of Directors: Brian StuglikDIRECTOR ELECTIONSISSUER1.00000030045.000000FOR1.000000FORS000047353Verastem, Inc.92337C203US92337C203505/21/2026Election of Directors: Karin TollefsonDIRECTOR ELECTIONSISSUER1.00000030045.000000FOR1.000000FORS000047353Verastem, Inc.92337C203US92337C203505/21/2026To approve the adoption of the Company's Amended and Restated 2021 Equity Incentive PlanCOMPENSATIONISSUER1.00000030045.000000AGAINST1.000000AGAINSTS000047353Verastem, Inc.92337C203US92337C203505/21/2026To approve the adoption of the Company's Amended and Restated 2018 Employee Stock Purchase PlanCOMPENSATIONISSUER1.00000030045.000000FOR1.000000FORS000047353Verastem, Inc.92337C203US92337C203505/21/2026To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1.00000030045.000000FOR1.000000FORS000047353Verastem, Inc.92337C203US92337C203505/21/2026To approve an advisory vote on the compensation of the named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000030045.000000FOR1.000000FORS000047353Verastem, Inc.92337C203US92337C203505/21/2026To approve an advisory vote on the compensation of the named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000030045.000000FOR1.000000FOR4S000047353Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Lindsay Androski, JD, MBA, CFADIRECTOR ELECTIONSISSUER57895.0000000FOR57895.000000FORS000047353Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Robert Alan BeardsleyDIRECTOR ELECTIONSISSUER57895.0000000FOR57895.000000FORS000047353Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Joseph BishopDIRECTOR ELECTIONSISSUER57895.0000000FOR57895.000000FORS000047353Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Matthew GlineDIRECTOR ELECTIONSISSUER57895.0000000FOR57895.000000FORS000047353Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Roger Sawhney, MDDIRECTOR ELECTIONSISSUER57895.0000000FOR57895.000000FORS000047353Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To approve the adoption of the Arbutus Biopharma Corporation 2026 Omnibus Share and Incentive Plan;COMPENSATIONISSUER57895.0000000FOR57895.000000FORS000047353Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular; andSECTION 14A SAY-ON-PAY VOTESISSUER57895.0000000FOR57895.000000FORS000047353Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular; andSECTION 14A SAY-ON-PAY VOTESISSUER57895.0000000FOR57895.000000FOR4S000047353Arbutus Biopharma Corporation03879J100CA03879J100305/26/2026To approve the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER57895.0000000FOR57895.000000FORS000047353Vir Biotechnology, Inc.92764N102US92764N102805/26/2026To elect the following three nominees for director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Robert More, MBADIRECTOR ELECTIONSISSUER40759.0000000FOR40759.000000FORS000047353Vir Biotechnology, Inc.92764N102US92764N102805/26/2026To elect the following three nominees for director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Janet Napolitano, J.D.DIRECTOR ELECTIONSISSUER40759.0000000WITHHOLD40759.000000AGAINSTS000047353Vir Biotechnology, Inc.92764N102US92764N102805/26/2026To elect the following three nominees for director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Elliott Sigal, M.D., Ph.D.DIRECTOR ELECTIONSISSUER40759.0000000FOR40759.000000FORS000047353Vir Biotechnology, Inc.92764N102US92764N102805/26/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER40759.0000000FOR40759.000000FORS000047353Vir Biotechnology, Inc.92764N102US92764N102805/26/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER40759.0000000FOR40759.000000FOR4S000047353Vir Biotechnology, Inc.92764N102US92764N102805/26/2026To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER40759.0000000FOR40759.000000FORS000047353Compass Pathways Plc20451W101US20451W101805/27/2026To re-elect as a director Justin GoverDIRECTOR ELECTIONSISSUER38539.0000000FOR38539.000000FORS000047353Compass Pathways Plc20451W101US20451W101805/27/2026To re-elect as a director Daphne KarydasDIRECTOR ELECTIONSISSUER38539.0000000FOR38539.000000FORS000047353Compass Pathways Plc20451W101US20451W101805/27/2026To elect as a director Kathleen TregoningDIRECTOR ELECTIONSISSUER38539.0000000FOR38539.000000FORS000047353Compass Pathways Plc20451W101US20451W101805/27/2026To re-elect as a director Jeffrey JonasDIRECTOR ELECTIONSISSUER38539.0000000FOR38539.000000FORS000047353Compass Pathways Plc20451W101US20451W101805/27/2026To re-appoint PricewaterhouseCoopers LLP (UK) as UK statutory auditors of the CompanyAUDIT-RELATEDISSUER38539.0000000FOR38539.000000FORS000047353Compass Pathways Plc20451W101US20451W101805/27/2026To ratify the appointment of PricewaterhouseCoopers LLP (US) as the Company's independent registered public accounting firmAUDIT-RELATEDISSUER38539.0000000FOR38539.000000FORS000047353Compass Pathways Plc20451W101US20451W101805/27/2026To authorise the Audit and Risk Committee to determine the auditors' remuneration for the fiscal year ending 31 December 2026AUDIT-RELATEDISSUER38539.0000000FOR38539.000000FORS000047353Compass Pathways Plc20451W101US20451W101805/27/2026To receive the UK statutory annual accounts and reports for the fiscal year ended 31 December 2025 and to note that the Directors do not recommend the payment of any dividend for the year ended 31 December 2025CORPORATE GOVERNANCEISSUER38539.0000000FOR38539.000000FORS000047353Compass Pathways Plc20451W101US20451W101805/27/2026To receive and approve on an advisory basis the Company's UK statutory directors' remuneration report for the year ended 31 December 2025COMPENSATIONISSUER38539.0000000FOR38539.000000FORS000047353Compass Pathways Plc20451W101US20451W101805/27/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the year ended 31 December 2025SECTION 14A SAY-ON-PAY VOTESISSUER38539.0000000FOR38539.000000FORS000047353Compass Pathways Plc20451W101US20451W101805/27/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the year ended 31 December 2025SECTION 14A SAY-ON-PAY VOTESISSUER38539.0000000FOR38539.000000FOR4S000047353Cytokinetics, Incorporated23282W605US23282W605705/27/2026Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D.DIRECTOR ELECTIONSISSUER4303.0000000FOR4303.000000FORS000047353Cytokinetics, Incorporated23282W605US23282W605705/27/2026Election of Class I Directors for terms expiring in 2029: Wendell Wierenga, Ph.D.DIRECTOR ELECTIONSISSUER4303.0000000FOR4303.000000FORS000047353Cytokinetics, Incorporated23282W605US23282W605705/27/2026Election of Class I Directors for terms expiring in 2029: Nancy J. WysenskiDIRECTOR ELECTIONSISSUER4303.0000000FOR4303.000000FORS000047353Cytokinetics, Incorporated23282W605US23282W605705/27/2026To approve the amendment and restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of authorized shares reserved for issuance thereunder by 1,000,000 shares of common stock.COMPENSATIONISSUER4303.0000000FOR4303.000000FORS000047353Cytokinetics, Incorporated23282W605US23282W605705/27/2026To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER4303.0000000FOR4303.000000FORS000047353Cytokinetics, Incorporated23282W605US23282W605705/27/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER4303.0000000FOR4303.000000FORS000047353Cytokinetics, Incorporated23282W605US23282W605705/27/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER4303.0000000FOR4303.000000FOR4S000047353Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026Election of Class I Directors for terms expiring in 2029: Mark McKennaDIRECTOR ELECTIONSISSUER1909.0000006300.000000FOR1909.000000FORS000047353Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026Election of Class I Directors for terms expiring in 2029: Cameron Turtle, D.Phil.DIRECTOR ELECTIONSISSUER1909.0000006300.000000FOR1909.000000FORS000047353Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026Election of Class I Directors for terms expiring in 2029: Laurie StelzerDIRECTOR ELECTIONSISSUER1909.0000006300.000000WITHHOLD1909.000000AGAINSTS000047353Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1909.0000006300.000000FOR1909.000000FORS000047353Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1909.0000006300.000000FOR1909.000000FOR4S000047353Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER1909.0000006300.000000FOR1909.000000FORS000047353Spyre Therapeutics, Inc.00773J202US00773J202405/27/2026To approve the Company's amended and restated 2016 Employee Stock Purchase Plan.COMPENSATIONISSUER1909.0000006300.000000FOR1909.000000FORS000047353ProKidney Corp.74291D104US74291D104605/28/2026Election of Directors: William F. DoyleDIRECTOR ELECTIONSISSUER21228.00000096311.000000WITHHOLD21228.000000AGAINSTS000047353ProKidney Corp.74291D104US74291D104605/28/2026Election of Directors: Alan M. Lotvin, M.D.DIRECTOR ELECTIONSISSUER21228.00000096311.000000WITHHOLD21228.000000AGAINSTS000047353ProKidney Corp.74291D104US74291D104605/28/2026Election of Directors: Brian J.G. Pereira, M.D.DIRECTOR ELECTIONSISSUER21228.00000096311.000000FOR21228.000000FORS000047353ProKidney Corp.74291D104US74291D104605/28/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER21228.00000096311.000000FOR21228.000000FORS000047353Tyra Biosciences, Inc.90240B106US90240B106105/28/2026To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Habib J. DableDIRECTOR ELECTIONSISSUER1942.00000010254.000000FOR1942.000000FORS000047353Tyra Biosciences, Inc.90240B106US90240B106105/28/2026To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Susan Moran, M.D., M.S.C.E.DIRECTOR ELECTIONSISSUER1942.00000010254.000000FOR1942.000000FORS000047353Tyra Biosciences, Inc.90240B106US90240B106105/28/2026To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Robert MoreDIRECTOR ELECTIONSISSUER1942.00000010254.000000WITHHOLD1942.000000AGAINSTS000047353Tyra Biosciences, Inc.90240B106US90240B106105/28/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1942.00000010254.000000FOR1942.000000FORS000047353REGENXBIO Inc.75901B107US75901B107005/29/2026Election of three Class II Directors: Jean Bennett, M.D., Ph.D.DIRECTOR ELECTIONSISSUER19660.0000000WITHHOLD19660.000000AGAINSTS000047353REGENXBIO Inc.75901B107US75901B107005/29/2026Election of three Class II Directors: A.N. "Jerry" Karabelas, Ph.D.DIRECTOR ELECTIONSISSUER19660.0000000FOR19660.000000FORS000047353REGENXBIO Inc.75901B107US75901B107005/29/2026Election of three Class II Directors: Daniel TasseDIRECTOR ELECTIONSISSUER19660.0000000FOR19660.000000FORS000047353REGENXBIO Inc.75901B107US75901B107005/29/2026To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER19660.0000000FOR19660.000000FORS000047353REGENXBIO Inc.75901B107US75901B107005/29/2026Advisory vote on the compensation paid to the Company's executive employees.SECTION 14A SAY-ON-PAY VOTESISSUER19660.0000000FOR19660.000000FORS000047353REGENXBIO Inc.75901B107US75901B107005/29/2026Advisory vote on the compensation paid to the Company's executive employees.SECTION 14A SAY-ON-PAY VOTESISSUER19660.0000000FOR19660.000000FOR4S000047353REGENXBIO Inc.75901B107US75901B107005/29/2026To approve a stock option exchange for our non-executive employees.COMPENSATIONISSUER19660.0000000AGAINST19660.000000AGAINSTS000047353REGENXBIO Inc.75901B107US75901B107005/29/2026To approve a stock option exchange for our executive employees.COMPENSATIONISSUER19660.0000000AGAINST19660.000000AGAINSTS000047353Taysha Gene Therapies, Inc.877619106US877619106106/01/2026To elect the Board's Class III Director nominees, Sean P. Nolan and Laura Sepp-Lorenzino, Ph.D. to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Sean P. NolanDIRECTOR ELECTIONSISSUER44862.0000000WITHHOLD44862.000000AGAINSTS000047353Taysha Gene Therapies, Inc.877619106US877619106106/01/2026To elect the Board's Class III Director nominees, Sean P. Nolan and Laura Sepp-Lorenzino, Ph.D. to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Laura Sepp-Lorenzino, Ph.D.DIRECTOR ELECTIONSISSUER44862.0000000WITHHOLD44862.000000AGAINSTS000047353Taysha Gene Therapies, Inc.877619106US877619106106/01/2026To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026.AUDIT-RELATEDISSUER44862.0000000FOR44862.000000FORS000047353Taysha Gene Therapies, Inc.877619106US877619106106/01/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER44862.0000000AGAINST44862.000000AGAINSTS000047353Taysha Gene Therapies, Inc.877619106US877619106106/01/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER44862.0000000AGAINST44862.000000AGAINST4S000047353Taysha Gene Therapies, Inc.877619106US877619106106/01/2026To indicate, on a non-binding advisory basis, the preferred frequency of future stockholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER44862.0000000ONE YEAR44862.000000FORS000047353Taysha Gene Therapies, Inc.877619106US877619106106/01/2026To indicate, on a non-binding advisory basis, the preferred frequency of future stockholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER44862.0000000ONE YEAR44862.000000FOR4S000047353Kodiak Sciences Inc.50015M109US50015M109906/02/2026Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. BancroftDIRECTOR ELECTIONSISSUER10909.0000000WITHHOLD10909.000000AGAINSTS000047353Kodiak Sciences Inc.50015M109US50015M109906/02/2026Elect three Class II directors nominated by our board and named in this proxy statement: Bassil I. Dahiyat, Ph.D.DIRECTOR ELECTIONSISSUER10909.0000000FOR10909.000000FORS000047353Kodiak Sciences Inc.50015M109US50015M109906/02/2026Elect three Class II directors nominated by our board and named in this proxy statement: Taiyin Yang, Ph.D.DIRECTOR ELECTIONSISSUER10909.0000000FOR10909.000000FORS000047353Kodiak Sciences Inc.50015M109US50015M109906/02/2026Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER10909.0000000FOR10909.000000FORS000047353Kodiak Sciences Inc.50015M109US50015M109906/02/2026Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER10909.0000000FOR10909.000000FOR4S000047353Kodiak Sciences Inc.50015M109US50015M109906/02/2026Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER10909.0000000FOR10909.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Adoption of the Dutch statutory annual accounts for the fiscal year ended December 31, 2025.CORPORATE GOVERNANCEISSUER7472.0000000FOR7472.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Discharge from liability for the Company's directors with respect to the performance of their duties during the fiscal year ended December 31, 2025.CORPORATE GOVERNANCEISSUER7472.0000000FOR7472.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Instruction to Deloitte Accountants B.V. as the Company's external auditor of the Company's Dutch statutory annual accounts and Dutch statutory board report for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER7472.0000000FOR7472.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Ratification of the selection of Deloitte Accountants B.V. as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 by the audit committee of the Company's Board of Directors.AUDIT-RELATEDISSUER7472.0000000FOR7472.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Reappointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name: John W. Smither until the 2030 annual general meetingDIRECTOR ELECTIONSISSUER7472.0000000FOR7472.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Reappointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name: Janneke van der Kamp until the 2030 annual general meetingDIRECTOR ELECTIONSISSUER7472.0000000AGAINST7472.000000AGAINSTS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Extension of authorization for the Board of Directors to issue ordinary shares (or rights to subscribe for ordinary shares) in the Company's capital.CAPITAL STRUCTUREISSUER7472.0000000AGAINST7472.000000AGAINSTS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Extension of authorization for the Board of Directors to limit or exclude pre-emption rights.CAPITAL STRUCTUREISSUER7472.0000000AGAINST7472.000000AGAINSTS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Approval of the NewAmsterdam Pharma Company N.V. 2026 Employee Stock Purchase Plan.COMPENSATIONISSUER7472.0000000FOR7472.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Non-binding, advisory vote to approve the 2025 compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER7472.0000000FOR7472.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/02/2026Non-binding, advisory vote to approve the 2025 compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER7472.0000000FOR7472.000000FOR4S000047353Oruka Therapeutics, Inc.687604108US687604108706/02/2026Election of Class II Directors for terms expiring in 2029: Lawrence KleinDIRECTOR ELECTIONSISSUER8605.0000000FOR8605.000000FORS000047353Oruka Therapeutics, Inc.687604108US687604108706/02/2026Election of Class II Directors for terms expiring in 2029: Chris MartinDIRECTOR ELECTIONSISSUER8605.0000000FOR8605.000000FORS000047353Oruka Therapeutics, Inc.687604108US687604108706/02/2026To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Oruka Therapeutics, Inc. for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER8605.0000000FOR8605.000000FORS000047353Oruka Therapeutics, Inc.687604108US687604108706/02/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8605.0000000FOR8605.000000FORS000047353Oruka Therapeutics, Inc.687604108US687604108706/02/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8605.0000000FOR8605.000000FOR4S000047353Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To elect the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Tomas KiselakDIRECTOR ELECTIONSISSUER8039.0000000FOR8039.000000FORS000047353Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To elect the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Jennifer K. MosesDIRECTOR ELECTIONSISSUER8039.0000000FOR8039.000000FORS000047353Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER8039.0000000FOR8039.000000FORS000047353Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8039.0000000FOR8039.000000FORS000047353Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8039.0000000FOR8039.000000FOR4S000047353Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To approve, on an advisory basis, the frequency of holding an advisory vote on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8039.0000000ONE YEAR8039.000000FORS000047353Viridian Therapeutics, Inc.92790C104US92790C104506/02/2026To approve, on an advisory basis, the frequency of holding an advisory vote on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8039.0000000ONE YEAR8039.000000FOR4S000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Dawn SvoronosDIRECTOR ELECTIONSISSUER5895.0000000FOR5895.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gillian CannonDIRECTOR ELECTIONSISSUER5895.0000000FOR5895.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Steven GannonDIRECTOR ELECTIONSISSUER5895.0000000FOR5895.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Elizabeth GarofaloDIRECTOR ELECTIONSISSUER5895.0000000FOR5895.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Justin GoverDIRECTOR ELECTIONSISSUER5895.0000000FOR5895.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Patrick MachadoDIRECTOR ELECTIONSISSUER5895.0000000FOR5895.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Ian MortimerDIRECTOR ELECTIONSISSUER5895.0000000FOR5895.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gary PatouDIRECTOR ELECTIONSISSUER5895.0000000FOR5895.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To approve, on an advisory basis, the compensation of the Corporation's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER5895.0000000FOR5895.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To approve, on an advisory basis, the compensation of the Corporation's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER5895.0000000FOR5895.000000FOR4S000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Corporation's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER5895.0000000ONE YEAR5895.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Corporation's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER5895.0000000ONE YEAR5895.000000FOR4S000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To approve the Corporation's 2026 Equity Incentive Plan;COMPENSATIONISSUER5895.0000000AGAINST5895.000000AGAINSTS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To appoint PricewaterhouseCoopers LLP as the Corporation's auditor to hold office until the next annual meeting of the Corporation;AUDIT-RELATEDISSUER5895.0000000FOR5895.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To authorize the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the auditors of the Corporation; andAUDIT-RELATEDISSUER5895.0000000FOR5895.000000FORS000047353Beam Therapeutics Inc.07373V105US07373V105206/03/2026Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: John EvansDIRECTOR ELECTIONSISSUER9493.0000000FOR9493.000000FORS000047353Beam Therapeutics Inc.07373V105US07373V105206/03/2026Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: John Maraganore, Ph.D.DIRECTOR ELECTIONSISSUER9493.0000000AGAINST9493.000000AGAINSTS000047353Beam Therapeutics Inc.07373V105US07373V105206/03/2026Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: Christi ShawDIRECTOR ELECTIONSISSUER9493.0000000AGAINST9493.000000AGAINSTS000047353Beam Therapeutics Inc.07373V105US07373V105206/03/2026Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER9493.0000000FOR9493.000000FORS000047353Beam Therapeutics Inc.07373V105US07373V105206/03/2026Approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER9493.0000000FOR9493.000000FORS000047353Beam Therapeutics Inc.07373V105US07373V105206/03/2026Approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER9493.0000000FOR9493.000000FOR4S000047353Denali Therapeutics Inc.24823R105US24823R105906/03/2026ELECTION OF DIRECTORS: Jennifer CookDIRECTOR ELECTIONSISSUER1.00000014446.000000WITHHOLD1.000000AGAINSTS000047353Denali Therapeutics Inc.24823R105US24823R105906/03/2026ELECTION OF DIRECTORS: David Schenkein, M.D.DIRECTOR ELECTIONSISSUER1.00000014446.000000WITHHOLD1.000000AGAINSTS000047353Denali Therapeutics Inc.24823R105US24823R105906/03/2026ELECTION OF DIRECTORS: Ryan Watts, Ph.D.DIRECTOR ELECTIONSISSUER1.00000014446.000000FOR1.000000FORS000047353Denali Therapeutics Inc.24823R105US24823R105906/03/2026Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1.00000014446.000000FOR1.000000FORS000047353Denali Therapeutics Inc.24823R105US24823R105906/03/2026Advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000014446.000000FOR1.000000FORS000047353Denali Therapeutics Inc.24823R105US24823R105906/03/2026Advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000014446.000000FOR1.000000FOR4S000047353Inhibrx Biosciences, Inc.45720N103US45720N103706/03/2026To elect two Class II directors, nominated by our Board of Directors, to serve until our 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or until their respective earlier death, resignation, or removal: Douglas G. ForsythDIRECTOR ELECTIONSISSUER3263.0000000WITHHOLD3263.000000AGAINSTS000047353Inhibrx Biosciences, Inc.45720N103US45720N103706/03/2026To elect two Class II directors, nominated by our Board of Directors, to serve until our 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or until their respective earlier death, resignation, or removal: Kimberly ManhardDIRECTOR ELECTIONSISSUER3263.0000000FOR3263.000000FORS000047353Inhibrx Biosciences, Inc.45720N103US45720N103706/03/2026To ratify the appointment by the Audit Committee of the Board of Directors of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER3263.0000000FOR3263.000000FORS000047353Keros Therapeutics, Inc.492327101US492327101306/03/2026To elect the two (2) nominees for Class III director named below to hold office until the 2029 Annual Meeting of Stockholders: Jean-Jacques BienaimeDIRECTOR ELECTIONSISSUER12075.0000000WITHHOLD12075.000000AGAINSTS000047353Keros Therapeutics, Inc.492327101US492327101306/03/2026To elect the two (2) nominees for Class III director named below to hold office until the 2029 Annual Meeting of Stockholders: Charles NewtonDIRECTOR ELECTIONSISSUER12075.0000000FOR12075.000000FORS000047353Keros Therapeutics, Inc.492327101US492327101306/03/2026To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER12075.0000000FOR12075.000000FORS000047353Keros Therapeutics, Inc.492327101US492327101306/03/2026To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER12075.0000000FOR12075.000000FORS000047353Keros Therapeutics, Inc.492327101US492327101306/03/2026To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER12075.0000000FOR12075.000000FOR4S000047353Neurogene Inc.64135M105US64135M105306/03/2026Election of Class III Directors for terms expiring in 2029: Robert Baffi, Ph.D.DIRECTOR ELECTIONSISSUER12416.0000000WITHHOLD12416.000000AGAINSTS000047353Neurogene Inc.64135M105US64135M105306/03/2026Election of Class III Directors for terms expiring in 2029: Rohan PalekarDIRECTOR ELECTIONSISSUER12416.0000000FOR12416.000000FORS000047353Neurogene Inc.64135M105US64135M105306/03/2026To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER12416.0000000FOR12416.000000FORS000047353Neurogene Inc.64135M105US64135M105306/03/2026To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER12416.0000000FOR12416.000000FOR4S000047353Neurogene Inc.64135M105US64135M105306/03/2026To ratify on an advisory (non-binding) basis the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER12416.0000000FOR12416.000000FORS000047353Neurogene Inc.64135M105US64135M105306/03/2026To hold a non-binding advisory vote on whether future non-binding advisory votes on the compensation paid by the company to its named executive officers should be held every one, two or three years.SECTION 14A SAY-ON-PAY VOTESISSUER12416.0000000ONE YEAR12416.000000FORS000047353Neurogene Inc.64135M105US64135M105306/03/2026To hold a non-binding advisory vote on whether future non-binding advisory votes on the compensation paid by the company to its named executive officers should be held every one, two or three years.SECTION 14A SAY-ON-PAY VOTESISSUER12416.0000000ONE YEAR12416.000000FOR4S000047353Stoke Therapeutics, Inc.86150R107US86150R107706/03/2026Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: G. Clare Kahn, Ph.D.DIRECTOR ELECTIONSISSUER8019.0000000FOR8019.000000FORS000047353Stoke Therapeutics, Inc.86150R107US86150R107706/03/2026Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Adrian Krainer, Ph.D.DIRECTOR ELECTIONSISSUER8019.0000000WITHHOLD8019.000000AGAINSTS000047353Stoke Therapeutics, Inc.86150R107US86150R107706/03/2026Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Julie Anne SmithDIRECTOR ELECTIONSISSUER8019.0000000FOR8019.000000FORS000047353Stoke Therapeutics, Inc.86150R107US86150R107706/03/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER8019.0000000FOR8019.000000FORS000047353Stoke Therapeutics, Inc.86150R107US86150R107706/03/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8019.0000000AGAINST8019.000000AGAINSTS000047353Stoke Therapeutics, Inc.86150R107US86150R107706/03/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8019.0000000AGAINST8019.000000AGAINST4S000047353Amylyx Pharmaceuticals, Inc.03237H101US03237H101406/04/2026Election of Directors: To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: George Mclean Milne Jr., Ph.D.DIRECTOR ELECTIONSISSUER19828.0000000WITHHOLD19828.000000AGAINSTS000047353Amylyx Pharmaceuticals, Inc.03237H101US03237H101406/04/2026Election of Directors: To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Paul FonteyneDIRECTOR ELECTIONSISSUER19828.0000000FOR19828.000000FORS000047353Amylyx Pharmaceuticals, Inc.03237H101US03237H101406/04/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER19828.0000000FOR19828.000000FORS000047353Amylyx Pharmaceuticals, Inc.03237H101US03237H101406/04/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER19828.0000000AGAINST19828.000000AGAINSTS000047353Amylyx Pharmaceuticals, Inc.03237H101US03237H101406/04/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER19828.0000000AGAINST19828.000000AGAINST4S000047353Assembly Biosciences, Inc.045396207US045396207006/04/2026Election of Directors: Anthony E. AltigDIRECTOR ELECTIONSISSUER7195.0000000FOR7195.000000FORS000047353Assembly Biosciences, Inc.045396207US045396207006/04/2026Election of Directors: Tomas Cihlar, Ph.D.DIRECTOR ELECTIONSISSUER7195.0000000FOR7195.000000FORS000047353Assembly Biosciences, Inc.045396207US045396207006/04/2026Election of Directors: Gina ConsylmanDIRECTOR ELECTIONSISSUER7195.0000000FOR7195.000000FORS000047353Assembly Biosciences, Inc.045396207US045396207006/04/2026Election of Directors: Robert D. Cook IIDIRECTOR ELECTIONSISSUER7195.0000000FOR7195.000000FORS000047353Assembly Biosciences, Inc.045396207US045396207006/04/2026Election of Directors: Sir Michael Houghton, Ph.D.DIRECTOR ELECTIONSISSUER7195.0000000FOR7195.000000FORS000047353Assembly Biosciences, Inc.045396207US045396207006/04/2026Election of Directors: Lisa R. Johnson-Pratt, M.D.DIRECTOR ELECTIONSISSUER7195.0000000FOR7195.000000FORS000047353Assembly Biosciences, Inc.045396207US045396207006/04/2026Election of Directors: Susan Mahony, Ph.D.DIRECTOR ELECTIONSISSUER7195.0000000FOR7195.000000FORS000047353Assembly Biosciences, Inc.045396207US045396207006/04/2026Election of Directors: John G. McHutchison, A.O., M.D.DIRECTOR ELECTIONSISSUER7195.0000000FOR7195.000000FORS000047353Assembly Biosciences, Inc.045396207US045396207006/04/2026Election of Directors: Jason A. OkazakiDIRECTOR ELECTIONSISSUER7195.0000000FOR7195.000000FORS000047353Assembly Biosciences, Inc.045396207US045396207006/04/2026Approval, on a non-binding advisory basis, of our named executive officers' compensation.SECTION 14A SAY-ON-PAY VOTESISSUER7195.0000000FOR7195.000000FORS000047353Assembly Biosciences, Inc.045396207US045396207006/04/2026Approval, on a non-binding advisory basis, of our named executive officers' compensation.SECTION 14A SAY-ON-PAY VOTESISSUER7195.0000000FOR7195.000000FOR4S000047353Assembly Biosciences, Inc.045396207US045396207006/04/2026Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER7195.0000000FOR7195.000000FORS000047353Assembly Biosciences, Inc.045396207US045396207006/04/2026Approval of an amendment to our Amended and Restated 2018 Stock Incentive Plan to increase the number of shares reserved for issuance thereunder by 1,200,000 shares.COMPENSATIONISSUER7195.0000000FOR7195.000000FORS000047353Assembly Biosciences, Inc.045396207US045396207006/04/2026Approval of an amendment to our Second Amended and Restated 2018 Employee Stock Purchase Plan to increase the authorized number of shares reserved for issuance thereunder to 515,000 shares.COMPENSATIONISSUER7195.0000000FOR7195.000000FORS000047353Atai Beckley, Inc.04650F101US04650F101206/04/2026Election of Class I directors: Sabrina Martucci JohnsonDIRECTOR ELECTIONSISSUER1.00000060548.000000FOR1.000000FORS000047353Atai Beckley, Inc.04650F101US04650F101206/04/2026Election of Class I directors: Amir Kalali, M.D.DIRECTOR ELECTIONSISSUER1.00000060548.000000FOR1.000000FORS000047353Atai Beckley, Inc.04650F101US04650F101206/04/2026Election of Class I directors: Andrea Heslin SmileyDIRECTOR ELECTIONSISSUER1.00000060548.000000FOR1.000000FORS000047353Atai Beckley, Inc.04650F101US04650F101206/04/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER1.00000060548.000000FOR1.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309606/04/2026ELECTION OF DIRECTORS: Frank LitvackDIRECTOR ELECTIONSISSUER498.0000009484.000000WITHHOLD498.000000AGAINSTS000047353Capricor Therapeutics, Inc.14070B309US14070B309606/04/2026ELECTION OF DIRECTORS: Linda MarbanDIRECTOR ELECTIONSISSUER498.0000009484.000000FOR498.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309606/04/2026ELECTION OF DIRECTORS: David MusketDIRECTOR ELECTIONSISSUER498.0000009484.000000FOR498.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309606/04/2026ELECTION OF DIRECTORS: George DunbarDIRECTOR ELECTIONSISSUER498.0000009484.000000FOR498.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309606/04/2026ELECTION OF DIRECTORS: Karimah Es SabarDIRECTOR ELECTIONSISSUER498.0000009484.000000FOR498.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309606/04/2026ELECTION OF DIRECTORS: Paul AuwaerterDIRECTOR ELECTIONSISSUER498.0000009484.000000FOR498.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309606/04/2026ELECTION OF DIRECTORS: Philip GotwalsDIRECTOR ELECTIONSISSUER498.0000009484.000000FOR498.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309606/04/2026ELECTION OF DIRECTORS: Michael KelliherDIRECTOR ELECTIONSISSUER498.0000009484.000000FOR498.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309606/04/2026RATIFICATION OF THE SELECTION OF ROSE, SNYDER & JACOBS LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2026AUDIT-RELATEDISSUER498.0000009484.000000FOR498.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309606/04/2026APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASISSECTION 14A SAY-ON-PAY VOTESISSUER498.0000009484.000000FOR498.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309606/04/2026APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASISSECTION 14A SAY-ON-PAY VOTESISSUER498.0000009484.000000FOR498.000000FOR4S000047353Capricor Therapeutics, Inc.14070B309US14070B309606/04/2026APPROVAL OF FREQUENCY OF FUTURE NON-BINDING ADVISORY VOTES ON NAMED EXECUTIVE OFFICER COMPENSATION, ONA NON-BINDING ADVISORY BASISSECTION 14A SAY-ON-PAY VOTESISSUER498.0000009484.000000ONE YEAR498.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309606/04/2026APPROVAL OF FREQUENCY OF FUTURE NON-BINDING ADVISORY VOTES ON NAMED EXECUTIVE OFFICER COMPENSATION, ONA NON-BINDING ADVISORY BASISSECTION 14A SAY-ON-PAY VOTESISSUER498.0000009484.000000ONE YEAR498.000000FOR4S000047353Capricor Therapeutics, Inc.14070B309US14070B309606/04/2026APPROVAL OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION REGARDING OFFICER EXCULPATIONCORPORATE GOVERNANCEISSUER498.0000009484.000000FOR498.000000FORS000047353CG Oncology, Inc.156944100US156944100906/04/2026To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Christina RossiDIRECTOR ELECTIONSISSUER1.0000006343.000000FOR1.000000FORS000047353CG Oncology, Inc.156944100US156944100906/04/2026To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Victor Tong, Jr.DIRECTOR ELECTIONSISSUER1.0000006343.000000WITHHOLD1.000000AGAINSTS000047353CG Oncology, Inc.156944100US156944100906/04/2026To ratify the appointment by the Audit Committee of the Board of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1.0000006343.000000FOR1.000000FORS000047353CG Oncology, Inc.156944100US156944100906/04/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000006343.000000FOR1.000000FORS000047353CG Oncology, Inc.156944100US156944100906/04/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000006343.000000FOR1.000000FOR4S000047353CG Oncology, Inc.156944100US156944100906/04/2026To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000006343.000000ONE YEAR1.000000FORS000047353CG Oncology, Inc.156944100US156944100906/04/2026To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000006343.000000ONE YEAR1.000000FOR4S000047353Edgewise Therapeutics, Inc.28036F105US28036F105706/04/2026Elect the directors named in the attached Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: Laura BregeDIRECTOR ELECTIONSISSUER10997.0000000FOR10997.000000FORS000047353Edgewise Therapeutics, Inc.28036F105US28036F105706/04/2026Elect the directors named in the attached Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: Badreddin Edris, Ph.D.DIRECTOR ELECTIONSISSUER10997.0000000WITHHOLD10997.000000AGAINSTS000047353Edgewise Therapeutics, Inc.28036F105US28036F105706/04/2026Elect the directors named in the attached Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: Jonathan Root, M.D.DIRECTOR ELECTIONSISSUER10997.0000000WITHHOLD10997.000000AGAINSTS000047353Edgewise Therapeutics, Inc.28036F105US28036F105706/04/2026Ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER10997.0000000FOR10997.000000FORS000047353Edgewise Therapeutics, Inc.28036F105US28036F105706/04/2026Conduct an advisory vote on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER10997.0000000FOR10997.000000FORS000047353Edgewise Therapeutics, Inc.28036F105US28036F105706/04/2026Conduct an advisory vote on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER10997.0000000FOR10997.000000FOR4S000047353Gossamer Bio, Inc.38341P102US38341P102106/04/2026Election of Class II Directors: Russell CoxDIRECTOR ELECTIONSISSUER72154.0000000WITHHOLD72154.000000AGAINSTS000047353Gossamer Bio, Inc.38341P102US38341P102106/04/2026Election of Class II Directors: Faheem HasnainDIRECTOR ELECTIONSISSUER72154.0000000WITHHOLD72154.000000AGAINSTS000047353Gossamer Bio, Inc.38341P102US38341P102106/04/2026Ratification of the appointment of Ernst & Young LLP as our independent registered public accountants for the year ending December 31, 2026.AUDIT-RELATEDISSUER72154.0000000FOR72154.000000FORS000047353Gossamer Bio, Inc.38341P102US38341P102106/04/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER72154.0000000FOR72154.000000FORS000047353Gossamer Bio, Inc.38341P102US38341P102106/04/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER72154.0000000FOR72154.000000FOR4S000047353MBX Biosciences, Inc.55287L101US55287L101706/04/2026Election of two Class II Directors, each to serve until the Company's 2029 Annual Meeting of Stockholders or until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Patrick J. HeronDIRECTOR ELECTIONSISSUER8698.0000000WITHHOLD8698.000000AGAINSTS000047353MBX Biosciences, Inc.55287L101US55287L101706/04/2026Election of two Class II Directors, each to serve until the Company's 2029 Annual Meeting of Stockholders or until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Edward T. MathersDIRECTOR ELECTIONSISSUER8698.0000000WITHHOLD8698.000000AGAINSTS000047353MBX Biosciences, Inc.55287L101US55287L101706/04/2026Ratification of the appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year ending December 31, 2026.AUDIT-RELATEDISSUER8698.0000000FOR8698.000000FORS000047353MoonLake Immunotherapeutics61559X104KY61559X104506/04/2026Election of the Class I director nominee to serve until the 2029 Annual General Meeting of Shareholders and until his successor is duly elected and qualified: Spike LoyDIRECTOR ELECTIONSISSUER17562.0000000FOR17562.000000FORS000047353MoonLake Immunotherapeutics61559X104KY61559X104506/04/2026Ratification, by ordinary resolution, of the selection of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER17562.0000000FOR17562.000000FORS000047353MoonLake Immunotherapeutics61559X104KY61559X104506/04/2026Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER17562.0000000FOR17562.000000FORS000047353MoonLake Immunotherapeutics61559X104KY61559X104506/04/2026Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER17562.0000000FOR17562.000000FOR4S000047353MoonLake Immunotherapeutics61559X104KY61559X104506/04/2026Approval of an amendment and restatement of the Company's 2022 Equity Incentive Plan.COMPENSATIONISSUER17562.0000000FOR17562.000000FORS000047353Nektar Therapeutics640268306US640268306306/04/2026Election of Directors: Howard W. RobinDIRECTOR ELECTIONSISSUER4748.0000000FOR4748.000000FORS000047353Nektar Therapeutics640268306US640268306306/04/2026To approve an amendment to our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 3,000,000 shares.COMPENSATIONISSUER4748.0000000FOR4748.000000FORS000047353Nektar Therapeutics640268306US640268306306/04/2026To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER4748.0000000FOR4748.000000FORS000047353Nektar Therapeutics640268306US640268306306/04/2026To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote).SECTION 14A SAY-ON-PAY VOTESISSUER4748.0000000FOR4748.000000FORS000047353Nektar Therapeutics640268306US640268306306/04/2026To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote).SECTION 14A SAY-ON-PAY VOTESISSUER4748.0000000FOR4748.000000FOR4S000047353Sana Biotechnology, Inc.799566104US799566104506/04/2026To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Hans E. BishopDIRECTOR ELECTIONSISSUER50536.0000000WITHHOLD50536.000000AGAINSTS000047353Sana Biotechnology, Inc.799566104US799566104506/04/2026To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Robert NelsenDIRECTOR ELECTIONSISSUER50536.0000000WITHHOLD50536.000000AGAINSTS000047353Sana Biotechnology, Inc.799566104US799566104506/04/2026To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Alise S. Reicin, M.D.DIRECTOR ELECTIONSISSUER50536.0000000WITHHOLD50536.000000AGAINSTS000047353Sana Biotechnology, Inc.799566104US799566104506/04/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER50536.0000000FOR50536.000000FORS000047353Savara Inc.805111101US805111101606/04/2026To elect six directors to hold office until the next Annual Meeting of Stockholders: Matthew PaulsDIRECTOR ELECTIONSISSUER37537.0000000FOR37537.000000FORS000047353Savara Inc.805111101US805111101606/04/2026To elect six directors to hold office until the next Annual Meeting of Stockholders: Nevan ElamDIRECTOR ELECTIONSISSUER37537.0000000FOR37537.000000FORS000047353Savara Inc.805111101US805111101606/04/2026To elect six directors to hold office until the next Annual Meeting of Stockholders: Richard J. HawkinsDIRECTOR ELECTIONSISSUER37537.0000000FOR37537.000000FORS000047353Savara Inc.805111101US805111101606/04/2026To elect six directors to hold office until the next Annual Meeting of Stockholders: Joseph S. McCrackenDIRECTOR ELECTIONSISSUER37537.0000000FOR37537.000000FORS000047353Savara Inc.805111101US805111101606/04/2026To elect six directors to hold office until the next Annual Meeting of Stockholders: David A. RamsayDIRECTOR ELECTIONSISSUER37537.0000000FOR37537.000000FORS000047353Savara Inc.805111101US805111101606/04/2026To elect six directors to hold office until the next Annual Meeting of Stockholders: An van Es-JohanssonDIRECTOR ELECTIONSISSUER37537.0000000FOR37537.000000FORS000047353Savara Inc.805111101US805111101606/04/2026To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of our common stock from 300,000,000 to 600,000,000.CAPITAL STRUCTUREISSUER37537.0000000FOR37537.000000FORS000047353Savara Inc.805111101US805111101606/04/2026To approve the amendment of the Savara Inc. 2024 Omnibus Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 18,900,000.COMPENSATIONISSUER37537.0000000FOR37537.000000FORS000047353Savara Inc.805111101US805111101606/04/2026To ratify the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER37537.0000000FOR37537.000000FORS000047353Savara Inc.805111101US805111101606/04/2026To approve, on an advisory basis, the compensation of our named executives.SECTION 14A SAY-ON-PAY VOTESISSUER37537.0000000FOR37537.000000FORS000047353Savara Inc.805111101US805111101606/04/2026To approve, on an advisory basis, the compensation of our named executives.SECTION 14A SAY-ON-PAY VOTESISSUER37537.0000000FOR37537.000000FOR4S000047353Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: David HallalDIRECTOR ELECTIONSISSUER1401.0000004140.000000WITHHOLD1401.000000AGAINSTS000047353Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Kristina BurowDIRECTOR ELECTIONSISSUER1401.0000004140.000000WITHHOLD1401.000000AGAINSTS000047353Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Michael GilmanDIRECTOR ELECTIONSISSUER1401.0000004140.000000WITHHOLD1401.000000AGAINSTS000047353Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Katie PengDIRECTOR ELECTIONSISSUER1401.0000004140.000000WITHHOLD1401.000000AGAINSTS000047353Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1401.0000004140.000000FOR1401.000000FORS000047353Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1401.0000004140.000000AGAINST1401.000000AGAINSTS000047353Scholar Rock Holding Corporation80706P103US80706P103006/04/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1401.0000004140.000000AGAINST1401.000000AGAINST4S000047353Tango Therapeutics, Inc.87583X109US87583X109006/04/2026Election of Class II Directors: Malte Peters, M.D.DIRECTOR ELECTIONSISSUER5580.00000022200.000000WITHHOLD5580.000000AGAINSTS000047353Tango Therapeutics, Inc.87583X109US87583X109006/04/2026Election of Class II Directors: Kanishka PothulaDIRECTOR ELECTIONSISSUER5580.00000022200.000000WITHHOLD5580.000000AGAINSTS000047353Tango Therapeutics, Inc.87583X109US87583X109006/04/2026Election of Class II Directors: Mace Rothenberg, M.D.DIRECTOR ELECTIONSISSUER5580.00000022200.000000WITHHOLD5580.000000AGAINSTS000047353Tango Therapeutics, Inc.87583X109US87583X109006/04/2026To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER5580.00000022200.000000FOR5580.000000FORS000047353Tango Therapeutics, Inc.87583X109US87583X109006/04/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5580.00000022200.000000FOR5580.000000FORS000047353Tango Therapeutics, Inc.87583X109US87583X109006/04/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5580.00000022200.000000FOR5580.000000FOR4S000047353Xeris Biopharma Holdings, Inc.98422E103US98422E103806/04/2026To elect two Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Dawn HalkuffDIRECTOR ELECTIONSISSUER36228.0000000WITHHOLD36228.000000AGAINSTS000047353Xeris Biopharma Holdings, Inc.98422E103US98422E103806/04/2026To elect two Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: John JohnsonDIRECTOR ELECTIONSISSUER36228.0000000WITHHOLD36228.000000AGAINSTS000047353Xeris Biopharma Holdings, Inc.98422E103US98422E103806/04/2026To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER36228.0000000FOR36228.000000FORS000047353Xeris Biopharma Holdings, Inc.98422E103US98422E103806/04/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER36228.0000000FOR36228.000000FORS000047353Xeris Biopharma Holdings, Inc.98422E103US98422E103806/04/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER36228.0000000FOR36228.000000FOR4S000047353Dyne Therapeutics, Inc.26818M108US26818M108006/05/2026To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: David LubnerDIRECTOR ELECTIONSISSUER13479.0000000WITHHOLD13479.000000AGAINSTS000047353Dyne Therapeutics, Inc.26818M108US26818M108006/05/2026To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Brian PosnerDIRECTOR ELECTIONSISSUER13479.0000000FOR13479.000000FORS000047353Dyne Therapeutics, Inc.26818M108US26818M108006/05/2026To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Jason RhodesDIRECTOR ELECTIONSISSUER13479.0000000WITHHOLD13479.000000AGAINSTS000047353Dyne Therapeutics, Inc.26818M108US26818M108006/05/2026To vote, on an advisory basis, to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER13479.0000000FOR13479.000000FORS000047353Dyne Therapeutics, Inc.26818M108US26818M108006/05/2026To vote, on an advisory basis, to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER13479.0000000FOR13479.000000FOR4S000047353Dyne Therapeutics, Inc.26818M108US26818M108006/05/2026To approve an amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 200,000,000 shares to 400,000,000 shares.CAPITAL STRUCTUREISSUER13479.0000000FOR13479.000000FORS000047353Dyne Therapeutics, Inc.26818M108US26818M108006/05/2026To approve an amendment to our Restated Certificate of Incorporation to provide for officer exculpation.CORPORATE GOVERNANCEISSUER13479.0000000FOR13479.000000FORS000047353Dyne Therapeutics, Inc.26818M108US26818M108006/05/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER13479.0000000FOR13479.000000FORS000047353Prime Medicine, Inc.74168J101US74168J101606/05/2026To elect Michael Kelly and David Schenkein, M.D. as Class I Directors: Michael KellyDIRECTOR ELECTIONSISSUER813.00000062542.000000FOR813.000000FORS000047353Prime Medicine, Inc.74168J101US74168J101606/05/2026To elect Michael Kelly and David Schenkein, M.D. as Class I Directors: David Schenkein, M.D.DIRECTOR ELECTIONSISSUER813.00000062542.000000WITHHOLD813.000000AGAINSTS000047353Prime Medicine, Inc.74168J101US74168J101606/05/2026To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER813.00000062542.000000FOR813.000000FORS000047353Maze Therapeutics, Inc.578784100US578784100706/08/2026Election of Class I Directors: Jason Coloma, Ph.D.DIRECTOR ELECTIONSISSUER6684.0000000WITHHOLD6684.000000AGAINSTS000047353Maze Therapeutics, Inc.578784100US578784100706/08/2026Election of Class I Directors: Neil Kumar, Ph.D.DIRECTOR ELECTIONSISSUER6684.0000000WITHHOLD6684.000000AGAINSTS000047353Maze Therapeutics, Inc.578784100US578784100706/08/2026Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER6684.0000000FOR6684.000000FORS000047353Tectonic Therapeutic, Inc.878972108US878972108606/08/2026Election of Directors: Timothy A. Springer, Ph.D.DIRECTOR ELECTIONSISSUER5759.0000007385.000000WITHHOLD5759.000000AGAINSTS000047353Tectonic Therapeutic, Inc.878972108US878972108606/08/2026Election of Directors: Stefan Vitorovic, M.S., M.B.A.DIRECTOR ELECTIONSISSUER5759.0000007385.000000FOR5759.000000FORS000047353Tectonic Therapeutic, Inc.878972108US878972108606/08/2026Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER5759.0000007385.000000FOR5759.000000FORS000047353Tectonic Therapeutic, Inc.878972108US878972108606/08/2026Advisory approval of the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER5759.0000007385.000000FOR5759.000000FORS000047353Tectonic Therapeutic, Inc.878972108US878972108606/08/2026Advisory approval of the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER5759.0000007385.000000FOR5759.000000FOR4S000047353Apogee Therapeutics, Inc.03770N101US03770N101906/09/2026Election of Class III Directors for terms expiring in 2029: Mark C. McKennaDIRECTOR ELECTIONSISSUER3369.0000000FOR3369.000000FORS000047353Apogee Therapeutics, Inc.03770N101US03770N101906/09/2026Election of Class III Directors for terms expiring in 2029: Jennifer FoxDIRECTOR ELECTIONSISSUER3369.0000000FOR3369.000000FORS000047353Apogee Therapeutics, Inc.03770N101US03770N101906/09/2026Election of Class III Directors for terms expiring in 2029: William (BJ) Jones, Jr.DIRECTOR ELECTIONSISSUER3369.0000000WITHHOLD3369.000000AGAINSTS000047353Apogee Therapeutics, Inc.03770N101US03770N101906/09/2026Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER3369.0000000FOR3369.000000FORS000047353Apogee Therapeutics, Inc.03770N101US03770N101906/09/2026Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER3369.0000000FOR3369.000000FORS000047353Apogee Therapeutics, Inc.03770N101US03770N101906/09/2026Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER3369.0000000FOR3369.000000FOR4S000047353Bicara Therapeutics Inc.055477103US055477103206/09/2026To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Christopher Bowden, M.D.DIRECTOR ELECTIONSISSUER14055.0000000WITHHOLD14055.000000AGAINSTS000047353Bicara Therapeutics Inc.055477103US055477103206/09/2026To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Carolyn Ng, Ph.D.DIRECTOR ELECTIONSISSUER14055.0000000WITHHOLD14055.000000AGAINSTS000047353Bicara Therapeutics Inc.055477103US055477103206/09/2026To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; andAUDIT-RELATEDISSUER14055.0000000FOR14055.000000FORS000047353Cogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dr. Chris CainDIRECTOR ELECTIONSISSUER6168.0000000WITHHOLD6168.000000AGAINSTS000047353Cogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Arlene M. MorrisDIRECTOR ELECTIONSISSUER6168.0000000WITHHOLD6168.000000AGAINSTS000047353Cogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Todd ShegogDIRECTOR ELECTIONSISSUER6168.0000000WITHHOLD6168.000000AGAINSTS000047353Cogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER6168.0000000FOR6168.000000FORS000047353Cogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6168.0000000FOR6168.000000FORS000047353Cogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6168.0000000FOR6168.000000FOR4S000047353enGene Holdings Inc.29286X101CA29286X101506/09/2026To elect four director nominees to serve as directors to each hold office for a three-year term expiring on the 2029 annual meeting of shareholders. Election of Director: Philip Astley-SparkeDIRECTOR ELECTIONSISSUER32625.0000000FOR32625.000000FORS000047353enGene Holdings Inc.29286X101CA29286X101506/09/2026To elect four director nominees to serve as directors to each hold office for a three-year term expiring on the 2029 annual meeting of shareholders. Election of Director: Ronald H.W. CooperDIRECTOR ELECTIONSISSUER32625.0000000FOR32625.000000FORS000047353enGene Holdings Inc.29286X101CA29286X101506/09/2026To elect four director nominees to serve as directors to each hold office for a three-year term expiring on the 2029 annual meeting of shareholders. Election of Director: Dr. William GrossmanDIRECTOR ELECTIONSISSUER32625.0000000FOR32625.000000FORS000047353enGene Holdings Inc.29286X101CA29286X101506/09/2026To elect four director nominees to serve as directors to each hold office for a three-year term expiring on the 2029 annual meeting of shareholders. Election of Director: Michael HeffernanDIRECTOR ELECTIONSISSUER32625.0000000FOR32625.000000FORS000047353enGene Holdings Inc.29286X101CA29286X101506/09/2026To appoint KPMG LLP as the Company's auditor for the ensuing year and authorize the directors to approve the remuneration to be paid to the auditorAUDIT-RELATEDISSUER32625.0000000FOR32625.000000FORS000047353Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Richard Fair, M.B.A.DIRECTOR ELECTIONSISSUER1.00000015405.000000FOR1.000000FORS000047353Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Lori Kunkel, M.D.DIRECTOR ELECTIONSISSUER1.00000015405.000000WITHHOLD1.000000AGAINSTS000047353Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1.00000015405.000000FOR1.000000FORS000047353Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To amend our amended and restated certificate of incorporation, as amended, to increase our authorized shares of common stock from 100,000,000 shares to 200,000,000 shares.CAPITAL STRUCTUREISSUER1.00000015405.000000FOR1.000000FORS000047353Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To approve, in an advisory (non-binding) vote, the compensation of our named executive officers as disclosed in our proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000015405.000000FOR1.000000FORS000047353Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To approve, in an advisory (non-binding) vote, the compensation of our named executive officers as disclosed in our proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000015405.000000FOR1.000000FOR4S000047353Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To approve, in an advisory (non-binding) vote, the frequency of future stockholder advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000015405.000000ONE YEAR1.000000FORS000047353Enliven Therapeutics, Inc.29337E102US29337E102906/09/2026To approve, in an advisory (non-binding) vote, the frequency of future stockholder advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000015405.000000ONE YEAR1.000000FOR4S000047353Immunome, Inc.45257U108US45257U108806/09/2026To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: James BoylanDIRECTOR ELECTIONSISSUER13272.0000000WITHHOLD13272.000000AGAINSTS000047353Immunome, Inc.45257U108US45257U108806/09/2026To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: Sandra Swain, M.D.DIRECTOR ELECTIONSISSUER13272.0000000FOR13272.000000FORS000047353Immunome, Inc.45257U108US45257U108806/09/2026To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: Philip WagenheimDIRECTOR ELECTIONSISSUER13272.0000000FOR13272.000000FORS000047353Immunome, Inc.45257U108US45257U108806/09/2026To ratify the appointment of Ernst & Young LLP our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER13272.0000000FOR13272.000000FORS000047353Immunome, Inc.45257U108US45257U108806/09/2026To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER13272.0000000FOR13272.000000FORS000047353Immunome, Inc.45257U108US45257U108806/09/2026To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER13272.0000000FOR13272.000000FOR4S000047353Immunome, Inc.45257U108US45257U108806/09/2026To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER13272.0000000ONE YEAR13272.000000FORS000047353Immunome, Inc.45257U108US45257U108806/09/2026To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER13272.0000000ONE YEAR13272.000000FOR4S000047353Intellia Therapeutics, Inc.45826J105US45826J105106/09/2026Election of three class I directors to our board of directors, each to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Muna Bhanji, R.Ph.DIRECTOR ELECTIONSISSUER28797.0000000FOR28797.000000FORS000047353Intellia Therapeutics, Inc.45826J105US45826J105106/09/2026Election of three class I directors to our board of directors, each to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Brian GoffDIRECTOR ELECTIONSISSUER28797.0000000AGAINST28797.000000AGAINSTS000047353Intellia Therapeutics, Inc.45826J105US45826J105106/09/2026Election of three class I directors to our board of directors, each to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Jesse Goodman, M.D., M.P.H.DIRECTOR ELECTIONSISSUER28797.0000000AGAINST28797.000000AGAINSTS000047353Intellia Therapeutics, Inc.45826J105US45826J105106/09/2026Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER28797.0000000FOR28797.000000FORS000047353Intellia Therapeutics, Inc.45826J105US45826J105106/09/2026Approval, on a non-binding advisory basis, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER28797.0000000AGAINST28797.000000AGAINSTS000047353Intellia Therapeutics, Inc.45826J105US45826J105106/09/2026Approval, on a non-binding advisory basis, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER28797.0000000AGAINST28797.000000AGAINST4S000047353Jade Biosciences, Inc.008064206US008064206106/09/2026To elect two Class II Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Christopher Cain, Ph.D.DIRECTOR ELECTIONSISSUER17040.000000300.000000WITHHOLD17040.000000AGAINSTS000047353Jade Biosciences, Inc.008064206US008064206106/09/2026To elect two Class II Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Tom FrohlichDIRECTOR ELECTIONSISSUER17040.000000300.000000FOR17040.000000FORS000047353Jade Biosciences, Inc.008064206US008064206106/09/2026To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER17040.000000300.000000FOR17040.000000FORS000047353Jade Biosciences, Inc.008064206US008064206106/09/2026To approve an amendment to our Articles of Incorporation to waive jury trials in certain circumstances; andCORPORATE GOVERNANCEISSUER17040.000000300.000000FOR17040.000000FORS000047353Relay Therapeutics, Inc.75943R102US75943R102306/09/2026To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Douglas S. IngramDIRECTOR ELECTIONSISSUER32347.0000000WITHHOLD32347.000000AGAINSTS000047353Relay Therapeutics, Inc.75943R102US75943R102306/09/2026To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Claire Mazumdar, Ph.D.DIRECTOR ELECTIONSISSUER32347.0000000WITHHOLD32347.000000AGAINSTS000047353Relay Therapeutics, Inc.75943R102US75943R102306/09/2026To consider and act upon an advisory vote on the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER32347.0000000FOR32347.000000FORS000047353Relay Therapeutics, Inc.75943R102US75943R102306/09/2026To consider and act upon an advisory vote on the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER32347.0000000FOR32347.000000FOR4S000047353Relay Therapeutics, Inc.75943R102US75943R102306/09/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER32347.0000000FOR32347.000000FORS000047353Relay Therapeutics, Inc.75943R102US75943R102306/09/2026To approve an amendment to our Fourth Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our common stock from 300,000,000 to 450,000,000; andCAPITAL STRUCTUREISSUER32347.0000000FOR32347.000000FORS000047353Upstream Bio, Inc.91678A107US91678A107906/09/2026To elect two class II directors to Upstream's board of directors, each to serve until the 2029 annual meeting of Upstream's stockholders, and until his respective successor has been duly elected and qualified, or until his earlier death, resignation or removal: H. Edward Fleming, Jr., M.D.DIRECTOR ELECTIONSISSUER9570.0000000WITHHOLD9570.000000AGAINSTS000047353Upstream Bio, Inc.91678A107US91678A107906/09/2026To elect two class II directors to Upstream's board of directors, each to serve until the 2029 annual meeting of Upstream's stockholders, and until his respective successor has been duly elected and qualified, or until his earlier death, resignation or removal: Liam Ratcliffe, M.B.Ch.B., Ph.D.DIRECTOR ELECTIONSISSUER9570.0000000FOR9570.000000FORS000047353Upstream Bio, Inc.91678A107US91678A107906/09/2026To ratify the appointment of PricewaterhouseCoopers LLP as Upstream's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER9570.0000000FOR9570.000000FORS000047353Compass Therapeutics, Inc.20454B104US20454B104406/10/2026To elect two class III directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal: Thomas J. Schuetz, M.D., Ph.D.DIRECTOR ELECTIONSISSUER1.00000050339.000000WITHHOLD1.000000AGAINSTS000047353Compass Therapeutics, Inc.20454B104US20454B104406/10/2026To elect two class III directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal: Richard S. Lindahl, M.B.A.DIRECTOR ELECTIONSISSUER1.00000050339.000000WITHHOLD1.000000AGAINSTS000047353Compass Therapeutics, Inc.20454B104US20454B104406/10/2026To ratify the appointment of CohnReznick LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1.00000050339.000000FOR1.000000FORS000047353Compass Therapeutics, Inc.20454B104US20454B104406/10/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000050339.000000FOR1.000000FORS000047353Compass Therapeutics, Inc.20454B104US20454B104406/10/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000050339.000000FOR1.000000FOR4S000047353Compass Therapeutics, Inc.20454B104US20454B104406/10/2026To approve, on a non-binding, advisory basis, the holding of future advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000050339.000000ONE YEAR1.000000FORS000047353Compass Therapeutics, Inc.20454B104US20454B104406/10/2026To approve, on a non-binding, advisory basis, the holding of future advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000050339.000000ONE YEAR1.000000FOR4S000047353Palvella Therapeutics, Inc.697947109US697947109006/10/2026Election of three director nominees to serve as Class III directors whose term will expire in 2029: George M. JenkinsDIRECTOR ELECTIONSISSUER1.0000002632.000000FOR1.000000FORS000047353Palvella Therapeutics, Inc.697947109US697947109006/10/2026Election of three director nominees to serve as Class III directors whose term will expire in 2029: Todd C. DavisDIRECTOR ELECTIONSISSUER1.0000002632.000000WITHHOLD1.000000AGAINSTS000047353Palvella Therapeutics, Inc.697947109US697947109006/10/2026Election of three director nominees to serve as Class III directors whose term will expire in 2029: John Doux, M.D.DIRECTOR ELECTIONSISSUER1.0000002632.000000FOR1.000000FORS000047353Palvella Therapeutics, Inc.697947109US697947109006/10/2026Ratification of the appointment of Ernst & Young as the Company's independent registered public accounting firm for the 2026 fiscal year.AUDIT-RELATEDISSUER1.0000002632.000000FOR1.000000FORS000047353Palvella Therapeutics, Inc.697947109US697947109006/10/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000002632.000000FOR1.000000FORS000047353Palvella Therapeutics, Inc.697947109US697947109006/10/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000002632.000000FOR1.000000FOR4S000047353Palvella Therapeutics, Inc.697947109US697947109006/10/2026Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000002632.000000ONE YEAR1.000000FORS000047353Palvella Therapeutics, Inc.697947109US697947109006/10/2026Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000002632.000000ONE YEAR1.000000FOR4S000047353Palvella Therapeutics, Inc.697947109US697947109006/10/2026Approval of an amendment to the 2024 Equity Incentive Plan to increase the authorized shares issuable under the 2024 Plan by 750,000 shares.COMPENSATIONISSUER1.0000002632.000000AGAINST1.000000AGAINSTS000047353Palvella Therapeutics, Inc.697947109US697947109006/10/2026Approval of an adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve Proposal 5.CORPORATE GOVERNANCEISSUER1.0000002632.000000AGAINST1.000000AGAINSTS000047353Praxis Precision Medicines, Inc.74006W207US74006W207006/10/2026To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Gregory NordenDIRECTOR ELECTIONSISSUER966.0000000FOR966.000000FORS000047353Praxis Precision Medicines, Inc.74006W207US74006W207006/10/2026To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Marcio SouzaDIRECTOR ELECTIONSISSUER966.0000000FOR966.000000FORS000047353Praxis Precision Medicines, Inc.74006W207US74006W207006/10/2026To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William YoungDIRECTOR ELECTIONSISSUER966.0000000WITHHOLD966.000000AGAINSTS000047353Praxis Precision Medicines, Inc.74006W207US74006W207006/10/2026To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER966.0000000FOR966.000000FORS000047353Praxis Precision Medicines, Inc.74006W207US74006W207006/10/2026To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion.SECTION 14A SAY-ON-PAY VOTESISSUER966.0000000FOR966.000000FORS000047353Praxis Precision Medicines, Inc.74006W207US74006W207006/10/2026To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion.SECTION 14A SAY-ON-PAY VOTESISSUER966.0000000FOR966.000000FOR4S000047353Rapport Therapeutics, Inc.75383L102US75383L102606/10/2026To elect James Healy, M.D., Ph.D., Robert J. Perez, and Raymond Sanchez, M.D. as Class II Directors: James Healy, M.D., Ph.D.DIRECTOR ELECTIONSISSUER1.0000008580.000000FOR1.000000FORS000047353Rapport Therapeutics, Inc.75383L102US75383L102606/10/2026To elect James Healy, M.D., Ph.D., Robert J. Perez, and Raymond Sanchez, M.D. as Class II Directors: Robert J. PerezDIRECTOR ELECTIONSISSUER1.0000008580.000000WITHHOLD1.000000AGAINSTS000047353Rapport Therapeutics, Inc.75383L102US75383L102606/10/2026To elect James Healy, M.D., Ph.D., Robert J. Perez, and Raymond Sanchez, M.D. as Class II Directors: Raymond Sanchez, M.D.DIRECTOR ELECTIONSISSUER1.0000008580.000000FOR1.000000FORS000047353Rapport Therapeutics, Inc.75383L102US75383L102606/10/2026To ratify the appointment of PricewaterhouseCoopers LLP as Rapport's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1.0000008580.000000FOR1.000000FORS000047353Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Robert W. DugganDIRECTOR ELECTIONSISSUER1.00000014782.000000WITHHOLD1.000000AGAINSTS000047353Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Mahkam ZanganehDIRECTOR ELECTIONSISSUER1.00000014782.000000WITHHOLD1.000000AGAINSTS000047353Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Manmeet S. SoniDIRECTOR ELECTIONSISSUER1.00000014782.000000WITHHOLD1.000000AGAINSTS000047353Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Kenneth A. ClarkDIRECTOR ELECTIONSISSUER1.00000014782.000000WITHHOLD1.000000AGAINSTS000047353Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Robert BoothDIRECTOR ELECTIONSISSUER1.00000014782.000000FOR1.000000FORS000047353Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Alessandra CesanoDIRECTOR ELECTIONSISSUER1.00000014782.000000FOR1.000000FORS000047353Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Yu (Michelle) XiaDIRECTOR ELECTIONSISSUER1.00000014782.000000WITHHOLD1.000000AGAINSTS000047353Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Mostafa RonaghiDIRECTOR ELECTIONSISSUER1.00000014782.000000FOR1.000000FORS000047353Summit Therapeutics Inc.86627T108US86627T108806/10/2026ELECTION OF DIRECTORS: Jeff HuberDIRECTOR ELECTIONSISSUER1.00000014782.000000FOR1.000000FORS000047353Summit Therapeutics Inc.86627T108US86627T108806/10/2026Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1.00000014782.000000FOR1.000000FORS000047353Summit Therapeutics Inc.86627T108US86627T108806/10/2026Approval, by a non-binding advisory vote, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000014782.000000AGAINST1.000000AGAINSTS000047353Summit Therapeutics Inc.86627T108US86627T108806/10/2026Approval, by a non-binding advisory vote, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000014782.000000AGAINST1.000000AGAINST4S000047353Summit Therapeutics Inc.86627T108US86627T108806/10/2026Approval of an amendment to the Summit Therapeutics Inc. 2020 Stock Incentive Plan to Increase the Number of Shares of Common Stock.COMPENSATIONISSUER1.00000014782.000000AGAINST1.000000AGAINSTS000047353uniQure N.V.N90064101NL001069665406/10/2026Adoption of the 2025 Dutch statutory annual accounts for the fiscal year ended December 31, 2025.CORPORATE GOVERNANCEISSUER17760.0000000FOR17760.000000FORS000047353uniQure N.V.N90064101NL001069665406/10/2026Discharge of liability of the members of the Board for their management during the fiscal year ended December 31, 2025.CORPORATE GOVERNANCEISSUER17760.0000000FOR17760.000000FORS000047353uniQure N.V.N90064101NL001069665406/10/2026Reappointment of Madhavan Balachandran as non-executive director.DIRECTOR ELECTIONSISSUER17760.0000000FOR17760.000000FORS000047353uniQure N.V.N90064101NL001069665406/10/2026Reappointment of Jack Kaye as non-executive director.DIRECTOR ELECTIONSISSUER17760.0000000FOR17760.000000FORS000047353uniQure N.V.N90064101NL001069665406/10/2026Reappointment of Leonard Post, Ph.D. as non-executive director.DIRECTOR ELECTIONSISSUER17760.0000000FOR17760.000000FORS000047353uniQure N.V.N90064101NL001069665406/10/2026Designation of the Board as the competent body to issue Ordinary Shares and grant rights to subscribe for Ordinary Shares.CAPITAL STRUCTUREISSUER17760.0000000FOR17760.000000FORS000047353uniQure N.V.N90064101NL001069665406/10/2026Designation of the Board as the competent body to exclude or limit preemptive rights upon the issuance of Ordinary Shares.CAPITAL STRUCTUREISSUER17760.0000000FOR17760.000000FORS000047353uniQure N.V.N90064101NL001069665406/10/2026Reauthorization of the Board to repurchase Ordinary Shares.CAPITAL STRUCTUREISSUER17760.0000000FOR17760.000000FORS000047353uniQure N.V.N90064101NL001069665406/10/2026Appointment of KPMG Accountants N.V. as external auditor of the Company for the fiscal year 2026.AUDIT-RELATEDISSUER17760.0000000FOR17760.000000FORS000047353uniQure N.V.N90064101NL001069665406/10/2026Approval, on an advisory basis, of the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER17760.0000000FOR17760.000000FORS000047353uniQure N.V.N90064101NL001069665406/10/2026Approval, on an advisory basis, of the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER17760.0000000FOR17760.000000FOR4S000047353uniQure N.V.N90064101NL001069665406/10/2026Approval, on an advisory basis, of the frequency of advisory votes on the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER17760.0000000ONE YEAR17760.000000FORS000047353uniQure N.V.N90064101NL001069665406/10/2026Approval, on an advisory basis, of the frequency of advisory votes on the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER17760.0000000ONE YEAR17760.000000FOR4S000047353uniQure N.V.N90064101NL001069665406/10/2026Resolution to adopt the Amendment and Restatement of the 2014 Share Incentive Plan.COMPENSATIONISSUER17760.0000000FOR17760.000000FORS000047353uniQure N.V.N90064101NL001069665406/10/2026Resolution to adopt the amendment to the Articles of Association to reflect Dutch large company regime.CORPORATE GOVERNANCEISSUER17760.0000000AGAINST17760.000000AGAINSTS000047353uniQure N.V.N90064101NL001069665406/10/2026Resolution to adopt the amendment to the Articles of Association to increase the authorized share capital and number of Ordinary Shares.CAPITAL STRUCTUREISSUER17760.0000000FOR17760.000000FORS000047353uniQure N.V.N90064101NL001069665406/10/2026Resolution to adopt the amendment to the Articles of Association to include a federal forum selection provision.SHAREHOLDER RIGHTS AND DEFENSESCORPORATE GOVERNANCEISSUER17760.0000000FOR17760.000000FORS000047353AbCellera Biologics Inc.00288U106CA00288U106606/11/2026To elect two class III directors to our Board of Directors, to serve until the 2029 Annual Meeting of Shareholders or until their successors has been duly elected and qualified, or until their earlier death, resignation or removal: John S. Montalbano, CFADIRECTOR ELECTIONSISSUER1.00000071755.000000AGAINST1.000000AGAINSTS000047353AbCellera Biologics Inc.00288U106CA00288U106606/11/2026To elect two class III directors to our Board of Directors, to serve until the 2029 Annual Meeting of Shareholders or until their successors has been duly elected and qualified, or until their earlier death, resignation or removal: Stephen R. Quake, D.Phil.DIRECTOR ELECTIONSISSUER1.00000071755.000000FOR1.000000FORS000047353AbCellera Biologics Inc.00288U106CA00288U106606/11/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER1.00000071755.000000FOR1.000000FORS000047353AbCellera Biologics Inc.00288U106CA00288U106606/11/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, or Say-on-Pay;SECTION 14A SAY-ON-PAY VOTESISSUER1.00000071755.000000FOR1.000000FORS000047353AbCellera Biologics Inc.00288U106CA00288U106606/11/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, or Say-on-Pay;SECTION 14A SAY-ON-PAY VOTESISSUER1.00000071755.000000FOR1.000000FOR4S000047353Annexon, Inc.03589W102US03589W102706/11/2026To elect the two nominees for director to serve as Class III directors to hold office until the 2029 annual meeting of stockholders: Bettina M. Cockroft, M.D.DIRECTOR ELECTIONSISSUER52265.0000000WITHHOLD52265.000000AGAINSTS000047353Annexon, Inc.03589W102US03589W102706/11/2026To elect the two nominees for director to serve as Class III directors to hold office until the 2029 annual meeting of stockholders: Douglas Love, Esq.DIRECTOR ELECTIONSISSUER52265.0000000WITHHOLD52265.000000AGAINSTS000047353Annexon, Inc.03589W102US03589W102706/11/2026To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER52265.0000000FOR52265.000000FORS000047353Annexon, Inc.03589W102US03589W102706/11/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER52265.0000000FOR52265.000000FORS000047353Annexon, Inc.03589W102US03589W102706/11/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER52265.0000000FOR52265.000000FOR4S000047353Annexon, Inc.03589W102US03589W102706/11/2026To approve an amendment to the Company's amended and restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 to 500,000,000.CAPITAL STRUCTUREISSUER52265.0000000FOR52265.000000FORS000047353Arcus Biosciences, Inc.03969F109US03969F109306/11/2026Election of Directors: Dietmar Berger, M.D., Ph.D.DIRECTOR ELECTIONSISSUER12064.0000000WITHHOLD12064.000000AGAINSTS000047353Arcus Biosciences, Inc.03969F109US03969F109306/11/2026Election of Directors: David Lacey, M.D.DIRECTOR ELECTIONSISSUER12064.0000000WITHHOLD12064.000000AGAINSTS000047353Arcus Biosciences, Inc.03969F109US03969F109306/11/2026Election of Directors: Nicole LambertDIRECTOR ELECTIONSISSUER12064.0000000WITHHOLD12064.000000AGAINSTS000047353Arcus Biosciences, Inc.03969F109US03969F109306/11/2026Election of Directors: Johanna MercierDIRECTOR ELECTIONSISSUER12064.0000000WITHHOLD12064.000000AGAINSTS000047353Arcus Biosciences, Inc.03969F109US03969F109306/11/2026To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER12064.0000000FOR12064.000000FORS000047353Arcus Biosciences, Inc.03969F109US03969F109306/11/2026To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER12064.0000000FOR12064.000000FORS000047353Arcus Biosciences, Inc.03969F109US03969F109306/11/2026To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER12064.0000000FOR12064.000000FOR4S000047353Corvus Pharmaceuticals, Inc.221015100US221015100506/11/2026To elect two Class I Directors with terms to expire at the 2029 annual meeting of stockholders: Richard A. Miller, M.D.DIRECTOR ELECTIONSISSUER31034.0000000FOR31034.000000FORS000047353Corvus Pharmaceuticals, Inc.221015100US221015100506/11/2026To elect two Class I Directors with terms to expire at the 2029 annual meeting of stockholders: Linda S. Grais, M.D. J.D.DIRECTOR ELECTIONSISSUER31034.0000000FOR31034.000000FORS000047353Corvus Pharmaceuticals, Inc.221015100US221015100506/11/2026To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER31034.0000000FOR31034.000000FORS000047353Corvus Pharmaceuticals, Inc.221015100US221015100506/11/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER31034.0000000FOR31034.000000FORS000047353Corvus Pharmaceuticals, Inc.221015100US221015100506/11/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER31034.0000000FOR31034.000000FOR4S000047353Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026Election of Directors to hold office until the 2027 annual general meeting of shareholders: Robert BarrowDIRECTOR ELECTIONSISSUER20698.0000000FOR20698.000000FORS000047353Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026Election of Directors to hold office until the 2027 annual general meeting of shareholders: Suzanne Bruhn, Ph.D.DIRECTOR ELECTIONSISSUER20698.0000000FOR20698.000000FORS000047353Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026Election of Directors to hold office until the 2027 annual general meeting of shareholders: Roger Crystal, M.D.DIRECTOR ELECTIONSISSUER20698.0000000FOR20698.000000FORS000047353Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026Election of Directors to hold office until the 2027 annual general meeting of shareholders: David GryskaDIRECTOR ELECTIONSISSUER20698.0000000FOR20698.000000FORS000047353Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026Election of Directors to hold office until the 2027 annual general meeting of shareholders: Andreas KrebsDIRECTOR ELECTIONSISSUER20698.0000000FOR20698.000000FORS000047353Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026Election of Directors to hold office until the 2027 annual general meeting of shareholders: Carol A. ValloneDIRECTOR ELECTIONSISSUER20698.0000000FOR20698.000000FORS000047353Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026Election of Directors to hold office until the 2027 annual general meeting of shareholders: Roger AdsettDIRECTOR ELECTIONSISSUER20698.0000000FOR20698.000000FORS000047353Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026To appoint KPMG LLP as independent registered public accounting firm (auditor) for the Company until the 2027 annual general meeting of shareholders.AUDIT-RELATEDISSUER20698.0000000FOR20698.000000FORS000047353Definium Therapeutics, Inc.24477V105CA24477V105806/11/2026To consider, and if deemed advisable, approve the amendment to the Definium Therapeutics, Inc. 2025 Equity Incentive Plan (the "2025 Equity Incentive Plan") to increase the number of common shares available for issuance under the 2025 Equity Incentive Plan by 5,000,000 common shares.COMPENSATIONISSUER20698.0000000FOR20698.000000FORS000047353Janux Therapeutics, Inc.47103J105US47103J105106/11/2026To elect the two nominees for Class II director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Natasha HerndayDIRECTOR ELECTIONSISSUER16976.0000000WITHHOLD16976.000000AGAINSTS000047353Janux Therapeutics, Inc.47103J105US47103J105106/11/2026To elect the two nominees for Class II director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Eric DobmeierDIRECTOR ELECTIONSISSUER16976.0000000FOR16976.000000FORS000047353Janux Therapeutics, Inc.47103J105US47103J105106/11/2026To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER16976.0000000FOR16976.000000FORS000047353Janux Therapeutics, Inc.47103J105US47103J105106/11/2026To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER16976.0000000FOR16976.000000FORS000047353Janux Therapeutics, Inc.47103J105US47103J105106/11/2026To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER16976.0000000FOR16976.000000FOR4S000047353MeiraGTx Holdings PlcG59665102KYG59665102906/11/2026Election of Directors: Ellen Hukkelhoven, Ph.D.DIRECTOR ELECTIONSISSUER29120.0000000FOR29120.000000FORS000047353MeiraGTx Holdings PlcG59665102KYG59665102906/11/2026Election of Directors: Nicole SeligmanDIRECTOR ELECTIONSISSUER29120.0000000FOR29120.000000FORS000047353MeiraGTx Holdings PlcG59665102KYG59665102906/11/2026Election of Directors: Debra Yu, M.D.DIRECTOR ELECTIONSISSUER29120.0000000WITHHOLD29120.000000AGAINSTS000047353MeiraGTx Holdings PlcG59665102KYG59665102906/11/2026To ratify, by ordinary resolution, the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER29120.0000000FOR29120.000000FORS000047353Monte Rosa Therapeutics, Inc.61225M102US61225M102706/11/2026To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Andrew Schiff, M.D.DIRECTOR ELECTIONSISSUER15926.0000000FOR15926.000000FORS000047353Monte Rosa Therapeutics, Inc.61225M102US61225M102706/11/2026To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Chandra P. Leo, M.D.DIRECTOR ELECTIONSISSUER15926.0000000FOR15926.000000FORS000047353Monte Rosa Therapeutics, Inc.61225M102US61225M102706/11/2026To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Anthony Manning, Ph.D.DIRECTOR ELECTIONSISSUER15926.0000000WITHHOLD15926.000000AGAINSTS000047353Monte Rosa Therapeutics, Inc.61225M102US61225M102706/11/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; andAUDIT-RELATEDISSUER15926.0000000FOR15926.000000FORS000047353Centessa Pharmaceuticals Plc152309100US152309100706/12/2026To re-appoint as a director Carol Stuckley, M.B.A., who retires by rotation in accordance with the Company's articles of association.DIRECTOR ELECTIONSISSUER9798.0000000FOR9798.000000FORS000047353Centessa Pharmaceuticals Plc152309100US152309100706/12/2026To re-appoint as a director Brett Zbar, M.D., who retires by rotation in accordance with the Company's articles of association.DIRECTOR ELECTIONSISSUER9798.0000000FOR9798.000000FORS000047353Centessa Pharmaceuticals Plc152309100US152309100706/12/2026To re-appoint as a director Mathias Hukkelhoven, Ph.D., who retires by rotation in accordance with the Company's articles of association.DIRECTOR ELECTIONSISSUER9798.0000000AGAINST9798.000000AGAINSTS000047353Centessa Pharmaceuticals Plc152309100US152309100706/12/2026To re-appoint KPMG LLP, a United Kingdom entity, as UK statutory auditors of the Company, to hold office until the conclusion of the next meeting at which the Company's annual accounts and reports are laid before the Company.AUDIT-RELATEDISSUER9798.0000000FOR9798.000000FORS000047353Centessa Pharmaceuticals Plc152309100US152309100706/12/2026To ratify the re-appointment of KPMG LLP, a Delaware limited liability partnership, as the Company's independent registered public accounting firm, for the financial year ending December 31, 2026.AUDIT-RELATEDISSUER9798.0000000FOR9798.000000FORS000047353Centessa Pharmaceuticals Plc152309100US152309100706/12/2026To authorize the Audit Committee to determine the Company's auditors' remuneration for the financial year ending December 31, 2026.AUDIT-RELATEDISSUER9798.0000000FOR9798.000000FORS000047353Centessa Pharmaceuticals Plc152309100US152309100706/12/2026To receive and adopt our UK statutory annual accounts and reports for the financial year ended December 31, 2025 and to note that the Company's directors do not recommend the payment of any dividend for the financial year ended December 31, 2025.CORPORATE GOVERNANCEISSUER9798.0000000FOR9798.000000FORS000047353Centessa Pharmaceuticals Plc152309100US152309100706/12/2026To receive and approve, on an advisory basis, the Company's U.K. statutory directors' remuneration report for the financial year ended December 31, 2025, which is set forth as Annex A to the attached proxy statement.COMPENSATIONISSUER9798.0000000FOR9798.000000FORS000047353Centessa Pharmaceuticals Plc152309100US152309100706/12/2026IMPORTANT: if you wish to vote FOR the Scheme, sign your name in the box marked "FOR the Scheme", or if you wish to vote AGAINST the Scheme, sign your name in the box marked "AGAINST the Scheme". If you sign in both boxes, or if you do not sign in either, then this Form of Proxy will be invalid.EXTRAORDINARY TRANSACTIONSISSUER9798.0000000FOR9798.000000FORS000047353Centessa Pharmaceuticals Plc152309100US152309100706/12/2026For the purposes of giving effect to the Scheme: (a) to authorise the directors of the Company (or a duly authorised committee thereof) to take all such actions as they may consider necessary or appropriate for carrying the Scheme into effect; and (b) with effect from the passing of this resolution, to amend the articles of association of the Company as set out in the Notice of General Meeting.CORPORATE GOVERNANCEISSUER9798.0000000FOR9798.000000FORS000047353Vaxcyte, Inc.92243G108US92243G108506/15/2026Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Olivier Brandicourt, M.D.DIRECTOR ELECTIONSISSUER5836.0000000WITHHOLD5836.000000AGAINSTS000047353Vaxcyte, Inc.92243G108US92243G108506/15/2026Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Halley Gilbert, J.D.DIRECTOR ELECTIONSISSUER5836.0000000WITHHOLD5836.000000AGAINSTS000047353Vaxcyte, Inc.92243G108US92243G108506/15/2026Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Grant E. Pickering, M.B.A.DIRECTOR ELECTIONSISSUER5836.0000000FOR5836.000000FORS000047353Vaxcyte, Inc.92243G108US92243G108506/15/2026Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER5836.0000000FOR5836.000000FORS000047353Vaxcyte, Inc.92243G108US92243G108506/15/2026Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5836.0000000FOR5836.000000FORS000047353Vaxcyte, Inc.92243G108US92243G108506/15/2026Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5836.0000000FOR5836.000000FOR4S000047353Cullinan Therapeutics, Inc.230031106US230031106306/16/2026Election of the following individuals nominated to serve as Class III directors, for a three-year term ending at the annual meeting of stockholders to be held in 2029: Nadim AhmedDIRECTOR ELECTIONSISSUER21790.0000000WITHHOLD21790.000000AGAINSTS000047353Cullinan Therapeutics, Inc.230031106US230031106306/16/2026Election of the following individuals nominated to serve as Class III directors, for a three-year term ending at the annual meeting of stockholders to be held in 2029: Stephen WebsterDIRECTOR ELECTIONSISSUER21790.0000000WITHHOLD21790.000000AGAINSTS000047353Cullinan Therapeutics, Inc.230031106US230031106306/16/2026Proposal to ratify the appointment of KPMG LLP as Cullinan Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER21790.0000000FOR21790.000000FORS000047353Cullinan Therapeutics, Inc.230031106US230031106306/16/2026Proposal to vote, on an advisory basis, to approve our named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER21790.0000000FOR21790.000000FORS000047353Cullinan Therapeutics, Inc.230031106US230031106306/16/2026Proposal to vote, on an advisory basis, to approve our named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER21790.0000000FOR21790.000000FOR4S000047353IDEAYA Biosciences, Inc.45166A102US45166A102506/16/2026To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Yujiro S. HataDIRECTOR ELECTIONSISSUER2610.0000005024.000000FOR2610.000000FORS000047353IDEAYA Biosciences, Inc.45166A102US45166A102506/16/2026To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: M. Garret Hampton, Ph.D.DIRECTOR ELECTIONSISSUER2610.0000005024.000000WITHHOLD2610.000000AGAINSTS000047353IDEAYA Biosciences, Inc.45166A102US45166A102506/16/2026To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Catherine J. Mackey, Ph.D.DIRECTOR ELECTIONSISSUER2610.0000005024.000000FOR2610.000000FORS000047353IDEAYA Biosciences, Inc.45166A102US45166A102506/16/2026To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER2610.0000005024.000000FOR2610.000000FORS000047353IDEAYA Biosciences, Inc.45166A102US45166A102506/16/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; andSECTION 14A SAY-ON-PAY VOTESISSUER2610.0000005024.000000FOR2610.000000FORS000047353IDEAYA Biosciences, Inc.45166A102US45166A102506/16/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; andSECTION 14A SAY-ON-PAY VOTESISSUER2610.0000005024.000000FOR2610.000000FOR4S000047353Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/16/2026Election of Directors. To elect eight director nominees numbered 01 through 08 to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified: Mark Currie, Ph.D.DIRECTOR ELECTIONSISSUER72558.0000000FOR72558.000000FORS000047353Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/16/2026Election of Directors. To elect eight director nominees numbered 01 through 08 to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified: Alexander Denner, Ph.D.DIRECTOR ELECTIONSISSUER72558.0000000FOR72558.000000FORS000047353Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/16/2026Election of Directors. To elect eight director nominees numbered 01 through 08 to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified: Jon DuaneDIRECTOR ELECTIONSISSUER72558.0000000FOR72558.000000FORS000047353Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/16/2026Election of Directors. To elect eight director nominees numbered 01 through 08 to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified: Marla KesslerDIRECTOR ELECTIONSISSUER72558.0000000FOR72558.000000FORS000047353Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/16/2026Election of Directors. To elect eight director nominees numbered 01 through 08 to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified: Thomas McCourtDIRECTOR ELECTIONSISSUER72558.0000000FOR72558.000000FORS000047353Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/16/2026Election of Directors. To elect eight director nominees numbered 01 through 08 to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified: Julie McHughDIRECTOR ELECTIONSISSUER72558.0000000FOR72558.000000FORS000047353Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/16/2026Election of Directors. To elect eight director nominees numbered 01 through 08 to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified: Catherine MoukheibirDIRECTOR ELECTIONSISSUER72558.0000000FOR72558.000000FORS000047353Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/16/2026Election of Directors. To elect eight director nominees numbered 01 through 08 to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified: Jay ShepardDIRECTOR ELECTIONSISSUER72558.0000000FOR72558.000000FORS000047353Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/16/2026Approval, by non-binding advisory vote, of the compensation paid to the named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER72558.0000000FOR72558.000000FORS000047353Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/16/2026Approval, by non-binding advisory vote, of the compensation paid to the named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER72558.0000000FOR72558.000000FOR4S000047353Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/16/2026Approval of an amendment to Ironwood Pharmaceuticals, Inc. Amended and Restated 2019 Equity Incentive Plan to increase the number of shares available for issuance thereunder by 10,000,000 shares.COMPENSATIONISSUER72558.0000000FOR72558.000000FORS000047353Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/16/2026Ratification of the selection of KPMG LLP as Ironwood Pharmaceuticals, Inc.'s independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER72558.0000000FOR72558.000000FORS000047353Liquidia Corporation53635D202US53635D202706/16/2026Election of Directors: David JohnsonDIRECTOR ELECTIONSISSUER7781.0000000FOR7781.000000FORS000047353Liquidia Corporation53635D202US53635D202706/16/2026Election of Directors: Katie Rielly-GauvinDIRECTOR ELECTIONSISSUER7781.0000000WITHHOLD7781.000000AGAINSTS000047353Liquidia Corporation53635D202US53635D202706/16/2026Election of Directors: Ramandeep SinghDIRECTOR ELECTIONSISSUER7781.0000000WITHHOLD7781.000000AGAINSTS000047353Liquidia Corporation53635D202US53635D202706/16/2026To ratify the Appointment of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the Year Ending December 31, 2026.AUDIT-RELATEDISSUER7781.0000000FOR7781.000000FORS000047353Liquidia Corporation53635D202US53635D202706/16/2026To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER7781.0000000FOR7781.000000FORS000047353Liquidia Corporation53635D202US53635D202706/16/2026To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER7781.0000000FOR7781.000000FOR4S000047353Nuvalent, Inc.670703107US670703107506/16/2026Election of the following nominees as Class II directors: Michael L. Meyers, M.D., Ph.D.DIRECTOR ELECTIONSISSUER2378.000000100.000000WITHHOLD2378.000000AGAINSTS000047353Nuvalent, Inc.670703107US670703107506/16/2026Election of the following nominees as Class II directors: Ron SquarerDIRECTOR ELECTIONSISSUER2378.000000100.000000FOR2378.000000FORS000047353Nuvalent, Inc.670703107US670703107506/16/2026To approve, on an advisory basis, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER2378.000000100.000000FOR2378.000000FORS000047353Nuvalent, Inc.670703107US670703107506/16/2026To approve, on an advisory basis, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER2378.000000100.000000FOR2378.000000FOR4S000047353Nuvalent, Inc.670703107US670703107506/16/2026To ratify the appointment of KPMG LLP as Nuvalent, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER2378.000000100.000000FOR2378.000000FORS000047353Xencor, Inc.98401F105US98401F105706/16/2026Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Bassil I. DahiyatDIRECTOR ELECTIONSISSUER15723.0000000FOR15723.000000FORS000047353Xencor, Inc.98401F105US98401F105706/16/2026Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Raymond J. DeshaiesDIRECTOR ELECTIONSISSUER15723.0000000FOR15723.000000FORS000047353Xencor, Inc.98401F105US98401F105706/16/2026Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Ellen G. FeigalDIRECTOR ELECTIONSISSUER15723.0000000FOR15723.000000FORS000047353Xencor, Inc.98401F105US98401F105706/16/2026Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Kevin C. GormanDIRECTOR ELECTIONSISSUER15723.0000000FOR15723.000000FORS000047353Xencor, Inc.98401F105US98401F105706/16/2026Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Kurt A. GustafsonDIRECTOR ELECTIONSISSUER15723.0000000FOR15723.000000FORS000047353Xencor, Inc.98401F105US98401F105706/16/2026Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Barbara KlenckeDIRECTOR ELECTIONSISSUER15723.0000000FOR15723.000000FORS000047353Xencor, Inc.98401F105US98401F105706/16/2026Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. A. Bruce MontgomeryDIRECTOR ELECTIONSISSUER15723.0000000FOR15723.000000FORS000047353Xencor, Inc.98401F105US98401F105706/16/2026Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Richard J. RanieriDIRECTOR ELECTIONSISSUER15723.0000000FOR15723.000000FORS000047353Xencor, Inc.98401F105US98401F105706/16/2026Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Todd E. SimpsonDIRECTOR ELECTIONSISSUER15723.0000000FOR15723.000000FORS000047353Xencor, Inc.98401F105US98401F105706/16/2026Ratification of selection by the Audit Committee of the Board of KPMG LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER15723.0000000FOR15723.000000FORS000047353Xencor, Inc.98401F105US98401F105706/16/2026Approval of the amendment to the Company's Amended and Restated 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 4,000,000 shares; andCOMPENSATIONISSUER15723.0000000AGAINST15723.000000AGAINSTS000047353Xencor, Inc.98401F105US98401F105706/16/2026Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers, as disclosed in this Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER15723.0000000FOR15723.000000FORS000047353Xencor, Inc.98401F105US98401F105706/16/2026Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers, as disclosed in this Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER15723.0000000FOR15723.000000FOR4S0000473534D Molecular Therapeutics, Inc.35104E100US35104E100106/17/2026Election of three Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Nancy Miller-RichDIRECTOR ELECTIONSISSUER21946.0000002016.000000FOR21946.000000FORS0000473534D Molecular Therapeutics, Inc.35104E100US35104E100106/17/2026Election of three Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: John F. Milligan, Ph.D.DIRECTOR ELECTIONSISSUER21946.0000002016.000000FOR21946.000000FORS0000473534D Molecular Therapeutics, Inc.35104E100US35104E100106/17/2026Election of three Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Shawn Cline Tomasello, MBADIRECTOR ELECTIONSISSUER21946.0000002016.000000WITHHOLD21946.000000AGAINSTS0000473534D Molecular Therapeutics, Inc.35104E100US35104E100106/17/2026Ratification of the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER21946.0000002016.000000FOR21946.000000FORS0000473534D Molecular Therapeutics, Inc.35104E100US35104E100106/17/2026Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote").SECTION 14A SAY-ON-PAY VOTESISSUER21946.0000002016.000000FOR21946.000000FORS0000473534D Molecular Therapeutics, Inc.35104E100US35104E100106/17/2026Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote").SECTION 14A SAY-ON-PAY VOTESISSUER21946.0000002016.000000FOR21946.000000FOR4S000047353Bicycle Therapeutics Plc088786108US088786108806/17/2026To re-elect as a director Felix Baker, who retires in accordance with the Articles of Association.DIRECTOR ELECTIONSISSUER34866.0000000FOR34866.000000FORS000047353Bicycle Therapeutics Plc088786108US088786108806/17/2026To re-elect as a director Herve Hoppenot, who retires in accordance with the Articles of Association.DIRECTOR ELECTIONSISSUER34866.0000000FOR34866.000000FORS000047353Bicycle Therapeutics Plc088786108US088786108806/17/2026To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER34866.0000000FOR34866.000000FORS000047353Bicycle Therapeutics Plc088786108US088786108806/17/2026To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER34866.0000000FOR34866.000000FOR4S000047353Bicycle Therapeutics Plc088786108US088786108806/17/2026To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER34866.0000000FOR34866.000000FORS000047353Bicycle Therapeutics Plc088786108US088786108806/17/2026To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders.AUDIT-RELATEDISSUER34866.0000000FOR34866.000000FORS000047353Bicycle Therapeutics Plc088786108US088786108806/17/2026To authorize the Audit Committee to determine our U.K. statutory auditors' remuneration for the year ending December 31, 2026.AUDIT-RELATEDISSUER34866.0000000FOR34866.000000FORS000047353Bicycle Therapeutics Plc088786108US088786108806/17/2026To receive and adopt our U.K. statutory annual accounts and reports for the year ended December 31, 2025 (the "2025 U.K. Annual Report").CORPORATE GOVERNANCEISSUER34866.0000000FOR34866.000000FORS000047353Bicycle Therapeutics Plc088786108US088786108806/17/2026To approve our directors' remuneration report for the year ended December 31, 2025, which is set forth as Annex A to the proxy statement (excluding the directors' remuneration policy set out on pages A-3 to A-22 of the directors' remuneration report and referenced in Proposal 9).COMPENSATIONISSUER34866.0000000FOR34866.000000FORS000047353Bicycle Therapeutics Plc088786108US088786108806/17/2026To approve the directors' remuneration policy, which is set out on pages A-3 to A-22 of Annex A to the proxy statement.COMPENSATIONISSUER34866.0000000FOR34866.000000FORS000047353CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To elect two directors with terms to expire at the 2029 Annual Meeting of Stockholders: Matthew P. YoungDIRECTOR ELECTIONSISSUER61994.0000000FOR61994.000000FORS000047353CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To elect two directors with terms to expire at the 2029 Annual Meeting of Stockholders: Elaine V. Jones, Ph.D.DIRECTOR ELECTIONSISSUER61994.0000000AGAINST61994.000000AGAINSTS000047353CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER61994.0000000FOR61994.000000FORS000047353CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 shares to 600,000,000 shares;CAPITAL STRUCTUREISSUER61994.0000000FOR61994.000000FORS000047353CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan;COMPENSATIONISSUER61994.0000000FOR61994.000000FORS000047353CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To approve an amendment to our Amended and Restated Employee Stock Purchase Plan;COMPENSATIONISSUER61994.0000000FOR61994.000000FORS000047353CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; andSECTION 14A SAY-ON-PAY VOTESISSUER61994.0000000FOR61994.000000FORS000047353CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; andSECTION 14A SAY-ON-PAY VOTESISSUER61994.0000000FOR61994.000000FOR4S000047353CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER61994.0000000ONE YEAR61994.000000FORS000047353CytomX Therapeutics, Inc.23284F105US23284F105706/17/2026To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER61994.0000000ONE YEAR61994.000000FOR4S000047353Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Sean Bohen, M.D., Ph.D.DIRECTOR ELECTIONSISSUER7859.0000000FOR7859.000000FORS000047353Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Scott GarlandDIRECTOR ELECTIONSISSUER7859.0000000FOR7859.000000FORS000047353Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Yi LarsonDIRECTOR ELECTIONSISSUER7859.0000000WITHHOLD7859.000000AGAINSTS000047353Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Andrew RappaportDIRECTOR ELECTIONSISSUER7859.0000000FOR7859.000000FORS000047353Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER7859.0000000FOR7859.000000FORS000047353Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER7859.0000000FOR7859.000000FOR4S000047353Olema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER7859.0000000FOR7859.000000FORS000047353Protagonist Therapeutics, Inc.74366E102US74366E102906/17/2026To elect the Class I director nominees named below to hold office until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dinesh V. Patel, Ph.D.DIRECTOR ELECTIONSISSUER1.0000002723.000000WITHHOLD1.000000AGAINSTS000047353Protagonist Therapeutics, Inc.74366E102US74366E102906/17/2026To elect the Class I director nominees named below to hold office until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Lewis T. "Rusty" Williams, M.D., Ph.D.DIRECTOR ELECTIONSISSUER1.0000002723.000000WITHHOLD1.000000AGAINSTS000047353Protagonist Therapeutics, Inc.74366E102US74366E102906/17/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000002723.000000FOR1.000000FORS000047353Protagonist Therapeutics, Inc.74366E102US74366E102906/17/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000002723.000000FOR1.000000FOR4S000047353Protagonist Therapeutics, Inc.74366E102US74366E102906/17/2026To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1.0000002723.000000FOR1.000000FORS000047353Protagonist Therapeutics, Inc.74366E102US74366E102906/17/2026To approve the adoption of the Company's 2026 Equity Incentive Plan.COMPENSATIONISSUER1.0000002723.000000AGAINST1.000000AGAINSTS000047353Recursion Pharmaceuticals, Inc.75629V104US75629V104406/17/2026Election of Directors: Najat Khan, Ph.D.DIRECTOR ELECTIONSISSUER1.00000059988.000000WITHHOLD1.000000AGAINSTS000047353Recursion Pharmaceuticals, Inc.75629V104US75629V104406/17/2026Election of Directors: Franziska Michor, Ph.D.DIRECTOR ELECTIONSISSUER1.00000059988.000000WITHHOLD1.000000AGAINSTS000047353Recursion Pharmaceuticals, Inc.75629V104US75629V104406/17/2026Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000059988.000000AGAINST1.000000AGAINSTS000047353Recursion Pharmaceuticals, Inc.75629V104US75629V104406/17/2026Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000059988.000000AGAINST1.000000AGAINST4S000047353Recursion Pharmaceuticals, Inc.75629V104US75629V104406/17/2026Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1.00000059988.000000FOR1.000000FORS000047353Sionna Therapeutics, Inc.829401108US829401108006/17/2026To elect four class II directors to serve until our 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: H. Edward Fleming, Jr., M.D.DIRECTOR ELECTIONSISSUER6073.0000000FOR6073.000000FORS000047353Sionna Therapeutics, Inc.829401108US829401108006/17/2026To elect four class II directors to serve until our 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Marcella Kuhlman Ruddy, M.D.DIRECTOR ELECTIONSISSUER6073.0000000WITHHOLD6073.000000AGAINSTS000047353Sionna Therapeutics, Inc.829401108US829401108006/17/2026To elect four class II directors to serve until our 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Peter A. Thompson, M.D.DIRECTOR ELECTIONSISSUER6073.0000000WITHHOLD6073.000000AGAINSTS000047353Sionna Therapeutics, Inc.829401108US829401108006/17/2026To elect four class II directors to serve until our 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Joanne Louise Viney, Ph.D.DIRECTOR ELECTIONSISSUER6073.0000000FOR6073.000000FORS000047353Sionna Therapeutics, Inc.829401108US829401108006/17/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER6073.0000000FOR6073.000000FORS000047353Structure Therapeutics Inc.86366E106US86366E106406/17/2026Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Ted W. Love, M.D.DIRECTOR ELECTIONSISSUER3873.0000000FOR3873.000000FORS000047353Structure Therapeutics Inc.86366E106US86366E106406/17/2026Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Raymond Stevens, Ph.D.DIRECTOR ELECTIONSISSUER3873.0000000FOR3873.000000FORS000047353Structure Therapeutics Inc.86366E106US86366E106406/17/2026Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Daniel G. WelchDIRECTOR ELECTIONSISSUER3873.0000000FOR3873.000000FORS000047353Structure Therapeutics Inc.86366E106US86366E106406/17/2026To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER3873.0000000FOR3873.000000FORS000047353Structure Therapeutics Inc.86366E106US86366E106406/17/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER3873.0000000FOR3873.000000FORS000047353Structure Therapeutics Inc.86366E106US86366E106406/17/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER3873.0000000FOR3873.000000FOR4S000047353Allogene Therapeutics, Inc.019770106US019770106506/18/2026Election of Directors: Deborah MessemerDIRECTOR ELECTIONSISSUER172026.0000000WITHHOLD172026.000000AGAINSTS000047353Allogene Therapeutics, Inc.019770106US019770106506/18/2026Election of Directors: Vicki Sato, Ph.D.DIRECTOR ELECTIONSISSUER172026.0000000WITHHOLD172026.000000AGAINSTS000047353Allogene Therapeutics, Inc.019770106US019770106506/18/2026Election of Directors: Owen Witte, M.D.DIRECTOR ELECTIONSISSUER172026.0000000WITHHOLD172026.000000AGAINSTS000047353Allogene Therapeutics, Inc.019770106US019770106506/18/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER172026.0000000FOR172026.000000FORS000047353Allogene Therapeutics, Inc.019770106US019770106506/18/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER172026.0000000FOR172026.000000FOR4S000047353Allogene Therapeutics, Inc.019770106US019770106506/18/2026To approve, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER172026.0000000ONE YEAR172026.000000FORS000047353Allogene Therapeutics, Inc.019770106US019770106506/18/2026To approve, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER172026.0000000ONE YEAR172026.000000FOR4S000047353Allogene Therapeutics, Inc.019770106US019770106506/18/2026To approve an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of common stock from 400,000,000 shares to 800,000,000 shares.CAPITAL STRUCTUREISSUER172026.0000000FOR172026.000000FORS000047353Allogene Therapeutics, Inc.019770106US019770106506/18/2026To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER172026.0000000FOR172026.000000FORS000047353Arrivent BioPharma, Inc.04272N102US04272N102806/18/2026Election of Directors: James Healy, M.D., Ph.D.DIRECTOR ELECTIONSISSUER10635.0000000WITHHOLD10635.000000AGAINSTS000047353Arrivent BioPharma, Inc.04272N102US04272N102806/18/2026Election of Directors: John Hohneker, M.D.DIRECTOR ELECTIONSISSUER10635.0000000WITHHOLD10635.000000AGAINSTS000047353Arrivent BioPharma, Inc.04272N102US04272N102806/18/2026Election of Directors: Stuart Lutzker, M.D., Ph.D.DIRECTOR ELECTIONSISSUER10635.0000000FOR10635.000000FORS000047353Arrivent BioPharma, Inc.04272N102US04272N102806/18/2026To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER10635.0000000FOR10635.000000FORS000047353Disc Medicine, Inc.254604101US254604101106/18/2026To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: Donald Nicholson, Ph.D.DIRECTOR ELECTIONSISSUER2827.0000000WITHHOLD2827.000000AGAINSTS000047353Disc Medicine, Inc.254604101US254604101106/18/2026To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: John Quisel, J.D., Ph.D.DIRECTOR ELECTIONSISSUER2827.0000000FOR2827.000000FORS000047353Disc Medicine, Inc.254604101US254604101106/18/2026To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: William White, M.P.P., J.D.DIRECTOR ELECTIONSISSUER2827.0000000FOR2827.000000FORS000047353Disc Medicine, Inc.254604101US254604101106/18/2026To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER2827.0000000FOR2827.000000FORS000047353Disc Medicine, Inc.254604101US254604101106/18/2026To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER2827.0000000FOR2827.000000FOR4S000047353Disc Medicine, Inc.254604101US254604101106/18/2026To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER2827.0000000FOR2827.000000FORS000047353EyePoint, Inc.30233G209US30233G209306/18/2026Election of Directors: Goran Ando, M.D.DIRECTOR ELECTIONSISSUER16244.0000000FOR16244.000000FORS000047353EyePoint, Inc.30233G209US30233G209306/18/2026Election of Directors: Jay S. Duker, M.D.DIRECTOR ELECTIONSISSUER16244.0000000FOR16244.000000FORS000047353EyePoint, Inc.30233G209US30233G209306/18/2026Election of Directors: John B. Landis, Ph.D.DIRECTOR ELECTIONSISSUER16244.0000000FOR16244.000000FORS000047353EyePoint, Inc.30233G209US30233G209306/18/2026Election of Directors: Wendy DiCiccoDIRECTOR ELECTIONSISSUER16244.0000000FOR16244.000000FORS000047353EyePoint, Inc.30233G209US30233G209306/18/2026Election of Directors: Karen ZaderejDIRECTOR ELECTIONSISSUER16244.0000000FOR16244.000000FORS000047353EyePoint, Inc.30233G209US30233G209306/18/2026Election of Directors: Stuart DutyDIRECTOR ELECTIONSISSUER16244.0000000FOR16244.000000FORS000047353EyePoint, Inc.30233G209US30233G209306/18/2026Election of Directors: Fred HassanDIRECTOR ELECTIONSISSUER16244.0000000FOR16244.000000FORS000047353EyePoint, Inc.30233G209US30233G209306/18/2026Election of Directors: Reginald Sanders, M.D.DIRECTOR ELECTIONSISSUER16244.0000000FOR16244.000000FORS000047353EyePoint, Inc.30233G209US30233G209306/18/2026To approve Amendment No. 3 to the EyePoint, Inc. 2023 Long-Term Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 4,900,000 shares.COMPENSATIONISSUER16244.0000000AGAINST16244.000000AGAINSTS000047353EyePoint, Inc.30233G209US30233G209306/18/2026To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER16244.0000000FOR16244.000000FORS000047353EyePoint, Inc.30233G209US30233G209306/18/2026To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER16244.0000000FOR16244.000000FOR4S000047353EyePoint, Inc.30233G209US30233G209306/18/2026To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER16244.0000000FOR16244.000000FORS000047353Immatics N.V.N44445109NL001528594106/18/2026Adopt Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER34512.0000000FOR34512.000000FORS000047353Immatics N.V.N44445109NL001528594106/18/2026Approve Discharge of DirectorsCORPORATE GOVERNANCEISSUER34512.0000000FOR34512.000000FORS000047353Immatics N.V.N44445109NL001528594106/18/2026Reelect H. Singh Jasuja as Executive Director IIIDIRECTOR ELECTIONSISSUER34512.0000000FOR34512.000000FORS000047353Immatics N.V.N44445109NL001528594106/18/2026Reelect M.P. Hothum as Non-Executive Director IIIDIRECTOR ELECTIONSISSUER34512.0000000FOR34512.000000FORS000047353Immatics N.V.N44445109NL001528594106/18/2026Reelect A.L. Stone as Non-Executive Director IIIDIRECTOR ELECTIONSISSUER34512.0000000AGAINST34512.000000AGAINSTS000047353Immatics N.V.N44445109NL001528594106/18/2026Authorize Repurchase of Ordinary Shares or Depositary ReceiptsCAPITAL STRUCTUREISSUER34512.0000000AGAINST34512.000000AGAINSTS000047353Immatics N.V.N44445109NL001528594106/18/2026Approve 2026 Stock Option and Incentive PlanCOMPENSATIONISSUER34512.0000000AGAINST34512.000000AGAINSTS000047353Immatics N.V.N44445109NL001528594106/18/2026Ratify PricewaterhouseCoopers Accountants N.V. as AuditorsAUDIT-RELATEDISSUER34512.0000000FOR34512.000000FORS000047353Omeros Corporation682143102US682143102906/18/2026Election of Directors: Thomas J. CableDIRECTOR ELECTIONSISSUER799.00000024792.000000AGAINST799.000000AGAINSTS000047353Omeros Corporation682143102US682143102906/18/2026Election of Directors: Peter A. Demopulos, M.D.DIRECTOR ELECTIONSISSUER799.00000024792.000000FOR799.000000FORS000047353Omeros Corporation682143102US682143102906/18/2026Election of Directors: Diana T. Perkinson, M.D.DIRECTOR ELECTIONSISSUER799.00000024792.000000AGAINST799.000000AGAINSTS000047353Omeros Corporation682143102US682143102906/18/2026Approval of advisory resolution on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER799.00000024792.000000FOR799.000000FORS000047353Omeros Corporation682143102US682143102906/18/2026Approval of advisory resolution on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER799.00000024792.000000FOR799.000000FOR4S000047353Omeros Corporation682143102US682143102906/18/2026Approval of the Amended and Restated Omeros Corporation Omnibus Incentive Compensation Plan.COMPENSATIONISSUER799.00000024792.000000AGAINST799.000000AGAINSTS000047353Omeros Corporation682143102US682143102906/18/2026Ratification of Ernst & Young LLP as independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER799.00000024792.000000FOR799.000000FORS000047353ORIC Pharmaceuticals, Inc.68622P109US68622P109306/18/2026To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Jacob M. Chacko, M.D.DIRECTOR ELECTIONSISSUER27692.0000000FOR27692.000000FORS000047353ORIC Pharmaceuticals, Inc.68622P109US68622P109306/18/2026To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Mardi C. DierDIRECTOR ELECTIONSISSUER27692.0000000WITHHOLD27692.000000AGAINSTS000047353ORIC Pharmaceuticals, Inc.68622P109US68622P109306/18/2026To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER27692.0000000FOR27692.000000FORS000047353ORIC Pharmaceuticals, Inc.68622P109US68622P109306/18/2026To approve the ORIC Pharmaceuticals, Inc. 2020 Equity Incentive Plan, as amended and restated.COMPENSATIONISSUER27692.0000000AGAINST27692.000000AGAINSTS000047353ORIC Pharmaceuticals, Inc.68622P109US68622P109306/18/2026To approve, on an advisory basis, executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER27692.0000000FOR27692.000000FORS000047353ORIC Pharmaceuticals, Inc.68622P109US68622P109306/18/2026To approve, on an advisory basis, executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER27692.0000000FOR27692.000000FOR4S000047353ORIC Pharmaceuticals, Inc.68622P109US68622P109306/18/2026To approve, on an advisory basis, the frequency of future advisory votes on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER27692.0000000ONE YEAR27692.000000FORS000047353ORIC Pharmaceuticals, Inc.68622P109US68622P109306/18/2026To approve, on an advisory basis, the frequency of future advisory votes on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER27692.0000000ONE YEAR27692.000000FOR4S000047353Precigen, Inc.74017N105US74017N105406/18/2026Company Proposal - Election of Directors: Randal KirkDIRECTOR ELECTIONSISSUER5596.00000064799.000000FOR5596.000000FORS000047353Precigen, Inc.74017N105US74017N105406/18/2026Company Proposal - Election of Directors: Cesar AlvarezDIRECTOR ELECTIONSISSUER5596.00000064799.000000FOR5596.000000FORS000047353Precigen, Inc.74017N105US74017N105406/18/2026Company Proposal - Election of Directors: Steven FrankDIRECTOR ELECTIONSISSUER5596.00000064799.000000FOR5596.000000FORS000047353Precigen, Inc.74017N105US74017N105406/18/2026Company Proposal - Election of Directors: Vinita GuptaDIRECTOR ELECTIONSISSUER5596.00000064799.000000AGAINST5596.000000AGAINSTS000047353Precigen, Inc.74017N105US74017N105406/18/2026Company Proposal - Election of Directors: Fred HassanDIRECTOR ELECTIONSISSUER5596.00000064799.000000FOR5596.000000FORS000047353Precigen, Inc.74017N105US74017N105406/18/2026Company Proposal - Election of Directors: Jeffrey KindlerDIRECTOR ELECTIONSISSUER5596.00000064799.000000FOR5596.000000FORS000047353Precigen, Inc.74017N105US74017N105406/18/2026Company Proposal - Election of Directors: Nancy Howell AgeeDIRECTOR ELECTIONSISSUER5596.00000064799.000000FOR5596.000000FORS000047353Precigen, Inc.74017N105US74017N105406/18/2026Company Proposal - Election of Directors: Helen SabzevariDIRECTOR ELECTIONSISSUER5596.00000064799.000000FOR5596.000000FORS000047353Precigen, Inc.74017N105US74017N105406/18/2026Company Proposal - Election of Directors: James TurleyDIRECTOR ELECTIONSISSUER5596.00000064799.000000FOR5596.000000FORS000047353Precigen, Inc.74017N105US74017N105406/18/2026Company Proposal - Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER5596.00000064799.000000FOR5596.000000FORS000047353Precigen, Inc.74017N105US74017N105406/18/2026Company Proposal - Advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER5596.00000064799.000000FOR5596.000000FORS000047353Precigen, Inc.74017N105US74017N105406/18/2026Company Proposal - Advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER5596.00000064799.000000FOR5596.000000FOR4S000047353Precigen, Inc.74017N105US74017N105406/18/2026Company Proposal - Approval of an amendment to the 2023 Omnibus Incentive Plan.COMPENSATIONISSUER5596.00000064799.000000FOR5596.000000FORS000047353Revolution Medicines, Inc.76155X100US76155X100006/18/2026To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Alexis BorisyDIRECTOR ELECTIONSISSUER3290.0000000WITHHOLD3290.000000AGAINSTS000047353Revolution Medicines, Inc.76155X100US76155X100006/18/2026To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Mark A. Goldsmith, M.D., Ph.D.DIRECTOR ELECTIONSISSUER3290.0000000FOR3290.000000FORS000047353Revolution Medicines, Inc.76155X100US76155X100006/18/2026To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026; andAUDIT-RELATEDISSUER3290.0000000FOR3290.000000FORS000047353Revolution Medicines, Inc.76155X100US76155X100006/18/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").SECTION 14A SAY-ON-PAY VOTESISSUER3290.0000000FOR3290.000000FORS000047353Revolution Medicines, Inc.76155X100US76155X100006/18/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").SECTION 14A SAY-ON-PAY VOTESISSUER3290.0000000FOR3290.000000FOR4S000047353Monopar Therapeutics Inc.61023L207US61023L207906/22/2026Election of Directors: Christopher M. StarrDIRECTOR ELECTIONSISSUER3350.000000349.000000WITHHOLD3350.000000AGAINSTS000047353Monopar Therapeutics Inc.61023L207US61023L207906/22/2026Election of Directors: Chandler D. RobinsonDIRECTOR ELECTIONSISSUER3350.000000349.000000WITHHOLD3350.000000AGAINSTS000047353Monopar Therapeutics Inc.61023L207US61023L207906/22/2026Election of Directors: Raymond W. AndersonDIRECTOR ELECTIONSISSUER3350.000000349.000000FOR3350.000000FORS000047353Monopar Therapeutics Inc.61023L207US61023L207906/22/2026Election of Directors: Kim R. TsuchimotoDIRECTOR ELECTIONSISSUER3350.000000349.000000WITHHOLD3350.000000AGAINSTS000047353Monopar Therapeutics Inc.61023L207US61023L207906/22/2026Election of Directors: Lavina TalukdarDIRECTOR ELECTIONSISSUER3350.000000349.000000FOR3350.000000FORS000047353Monopar Therapeutics Inc.61023L207US61023L207906/22/2026Election of Directors: Nicole SweenyDIRECTOR ELECTIONSISSUER3350.000000349.000000FOR3350.000000FORS000047353Monopar Therapeutics Inc.61023L207US61023L207906/22/2026To approve the compensation of our named executive officers on an advisory, non-binding basis.SECTION 14A SAY-ON-PAY VOTESISSUER3350.000000349.000000AGAINST3350.000000AGAINSTS000047353Monopar Therapeutics Inc.61023L207US61023L207906/22/2026To approve the compensation of our named executive officers on an advisory, non-binding basis.SECTION 14A SAY-ON-PAY VOTESISSUER3350.000000349.000000AGAINST3350.000000AGAINST4S000047353Monopar Therapeutics Inc.61023L207US61023L207906/22/2026To approve the 2026 Stock Incentive Plan.COMPENSATIONISSUER3350.000000349.000000AGAINST3350.000000AGAINSTS000047353Monopar Therapeutics Inc.61023L207US61023L207906/22/2026To ratify the selection of BPM LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER3350.000000349.000000FOR3350.000000FORS000047353Wave Life Sciences Ltd.94352A104US94352A104306/22/2026To approve the scheme of arrangement under Singapore law among Wave Life Sciences Ltd., a public company limited by shares incorporated under the laws of the Republic of Singapore ("Wave-Singapore"), the shareholders of Wave-Singapore and Wave Life Sciences, Inc., a Delaware corporation, subject to approval of the High Court of the Republic of Singapore, as set forth in Wave-Singapore's notice of, and proxy statement relating to, the Special Meeting of Wave-Singapore shareholders.EXTRAORDINARY TRANSACTIONSISSUER16665.0000000FOR16665.000000FORS000047353Arvinas, Inc.04335A105US04335A105106/24/2026Election of two Class II directors: Leslie V. Norwalk, Esq.DIRECTOR ELECTIONSISSUER21940.0000000WITHHOLD21940.000000AGAINSTS000047353Arvinas, Inc.04335A105US04335A105106/24/2026Election of two Class II directors: Randy Teel, Ph.D.DIRECTOR ELECTIONSISSUER21940.0000000FOR21940.000000FORS000047353Arvinas, Inc.04335A105US04335A105106/24/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER21940.0000000FOR21940.000000FORS000047353Arvinas, Inc.04335A105US04335A105106/24/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER21940.0000000FOR21940.000000FOR4S000047353Arvinas, Inc.04335A105US04335A105106/24/2026Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER21940.0000000FOR21940.000000FORS000047353Fulcrum Therapeutics, Inc.359616109US359616109706/24/2026Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Sonja BanksDIRECTOR ELECTIONSISSUER1251.00000019979.000000WITHHOLD1251.000000AGAINSTS000047353Fulcrum Therapeutics, Inc.359616109US359616109706/24/2026Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Alan EzekowitzDIRECTOR ELECTIONSISSUER1251.00000019979.000000FOR1251.000000FORS000047353Fulcrum Therapeutics, Inc.359616109US359616109706/24/2026Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Colin HillDIRECTOR ELECTIONSISSUER1251.00000019979.000000FOR1251.000000FORS000047353Fulcrum Therapeutics, Inc.359616109US359616109706/24/2026A non-binding advisory vote to approve the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER1251.00000019979.000000FOR1251.000000FORS000047353Fulcrum Therapeutics, Inc.359616109US359616109706/24/2026A non-binding advisory vote to approve the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER1251.00000019979.000000FOR1251.000000FOR4S000047353Fulcrum Therapeutics, Inc.359616109US359616109706/24/2026Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; andAUDIT-RELATEDISSUER1251.00000019979.000000FOR1251.000000FORS000047353Kymera Therapeutics, Inc.501575104US501575104406/24/2026To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Bruce Booth, D.Phil.DIRECTOR ELECTIONSISSUER3077.0000000WITHHOLD3077.000000AGAINSTS000047353Kymera Therapeutics, Inc.501575104US501575104406/24/2026To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Nello Mainolfi, Ph.D.DIRECTOR ELECTIONSISSUER3077.0000000WITHHOLD3077.000000AGAINSTS000047353Kymera Therapeutics, Inc.501575104US501575104406/24/2026To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: John Maraganore, Ph.D.DIRECTOR ELECTIONSISSUER3077.0000000WITHHOLD3077.000000AGAINSTS000047353Kymera Therapeutics, Inc.501575104US501575104406/24/2026To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Elena Ridloff, CFADIRECTOR ELECTIONSISSUER3077.0000000WITHHOLD3077.000000AGAINSTS000047353Kymera Therapeutics, Inc.501575104US501575104406/24/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER3077.0000000FOR3077.000000FORS000047353Kymera Therapeutics, Inc.501575104US501575104406/24/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER3077.0000000FOR3077.000000FOR4S000047353Kymera Therapeutics, Inc.501575104US501575104406/24/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER3077.0000000FOR3077.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: Harry H. Penner, Jr.DIRECTOR ELECTIONSISSUER10032.0000000FOR10032.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: Anthony S. MarucciDIRECTOR ELECTIONSISSUER10032.0000000FOR10032.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: Keith L. BrownlieDIRECTOR ELECTIONSISSUER10032.0000000FOR10032.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: Cheryl L. CohenDIRECTOR ELECTIONSISSUER10032.0000000FOR10032.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: Herbert J. ConradDIRECTOR ELECTIONSISSUER10032.0000000FOR10032.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: Rita I. Jain, M.D.DIRECTOR ELECTIONSISSUER10032.0000000FOR10032.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: James J. MarinoDIRECTOR ELECTIONSISSUER10032.0000000FOR10032.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: Garry A. Neil, M.D.DIRECTOR ELECTIONSISSUER10032.0000000FOR10032.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026Election of Directors: Denice TorresDIRECTOR ELECTIONSISSUER10032.0000000FOR10032.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER10032.0000000FOR10032.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026To approve an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 3,400,000 shares to 12,900,000 shares and a clarification regarding the tax withholding provisions applicable to awards under the 2021 Incentive Plan.COMPENSATIONISSUER10032.0000000FOR10032.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER10032.0000000FOR10032.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/25/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER10032.0000000FOR10032.000000FOR4S000047353GH Research plcG3855L106IE000GID8VI006/25/2026Elect Director Florian SchonhartingDIRECTOR ELECTIONSISSUER21175.0000000AGAINST21175.000000AGAINSTS000047353GH Research plcG3855L106IE000GID8VI006/25/2026Elect Director Michael ForerDIRECTOR ELECTIONSISSUER21175.0000000FOR21175.000000FORS000047353GH Research plcG3855L106IE000GID8VI006/25/2026Elect Director Dermot HanleyDIRECTOR ELECTIONSISSUER21175.0000000FOR21175.000000FORS000047353GH Research plcG3855L106IE000GID8VI006/25/2026Elect Director Duncan MooreDIRECTOR ELECTIONSISSUER21175.0000000FOR21175.000000FORS000047353GH Research plcG3855L106IE000GID8VI006/25/2026Approve PricewaterhouseCoopers Ireland as Auditors and Authorize Board to Fix Their RemunerationAUDIT-RELATEDISSUER21175.0000000FOR21175.000000FORS000047353Lexeo Therapeutics, Inc.52886X107US52886X107206/25/2026The election of Paula HJ Cholmondeley, Brenda Cooperstone and R. Nolan Townsend as Class III directors: Paula HJ CholmondeleyDIRECTOR ELECTIONSISSUER33521.0000000FOR33521.000000FORS000047353Lexeo Therapeutics, Inc.52886X107US52886X107206/25/2026The election of Paula HJ Cholmondeley, Brenda Cooperstone and R. Nolan Townsend as Class III directors: Brenda CooperstoneDIRECTOR ELECTIONSISSUER33521.0000000WITHHOLD33521.000000AGAINSTS000047353Lexeo Therapeutics, Inc.52886X107US52886X107206/25/2026The election of Paula HJ Cholmondeley, Brenda Cooperstone and R. Nolan Townsend as Class III directors: R. Nolan TownsendDIRECTOR ELECTIONSISSUER33521.0000000FOR33521.000000FORS000047353Lexeo Therapeutics, Inc.52886X107US52886X107206/25/2026The ratification of the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER33521.0000000FOR33521.000000FORS000047353Erasca, Inc.29479A108US29479A108806/26/2026To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Alexander W. CasdinDIRECTOR ELECTIONSISSUER76668.0000000WITHHOLD76668.000000AGAINSTS000047353Erasca, Inc.29479A108US29479A108806/26/2026To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Julie Hambleton, M.D.DIRECTOR ELECTIONSISSUER76668.0000000WITHHOLD76668.000000AGAINSTS000047353Erasca, Inc.29479A108US29479A108806/26/2026To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Michael D. Varney, Ph.D.DIRECTOR ELECTIONSISSUER76668.0000000WITHHOLD76668.000000AGAINSTS000047353Erasca, Inc.29479A108US29479A108806/26/2026To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026AUDIT-RELATEDISSUER76668.0000000FOR76668.000000FORS000047353Pharvaris NVN69605108NL00150005Y406/26/2026Adopt Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER13659.0000000FOR13659.000000FORS000047353Pharvaris NVN69605108NL00150005Y406/26/2026Ratify PricewaterhouseCoopers Accountants N.V. as AuditorsAUDIT-RELATEDISSUER13659.0000000FOR13659.000000FORS000047353Pharvaris NVN69605108NL00150005Y406/26/2026Approve Discharge of DirectorsCORPORATE GOVERNANCEISSUER13659.0000000FOR13659.000000FORS000047353Pharvaris NVN69605108NL00150005Y406/26/2026Authorize Repurchase of Ordinary Shares and Depositary ReceiptsCAPITAL STRUCTUREISSUER13659.0000000FOR13659.000000FORS000047353Pharvaris NVN69605108NL00150005Y406/26/2026Reelect Margareta Elisabeth Bjork as Non-Executive DirectorDIRECTOR ELECTIONSISSUER13659.0000000FOR13659.000000FORS000047353Septerna, Inc.81734D104US81734D104606/26/2026To elect two Class II directors to our board of directors, each to serve until our 2029 Annual Meeting of Stockholders and until his or her respective successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Shalini SharpDIRECTOR ELECTIONSISSUER10849.0000000WITHHOLD10849.000000AGAINSTS000047353Septerna, Inc.81734D104US81734D104606/26/2026To elect two Class II directors to our board of directors, each to serve until our 2029 Annual Meeting of Stockholders and until his or her respective successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Jake SimsonDIRECTOR ELECTIONSISSUER10849.0000000WITHHOLD10849.000000AGAINSTS000047353Septerna, Inc.81734D104US81734D104606/26/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; andAUDIT-RELATEDISSUER10849.0000000FOR10849.000000FORS000047353Alumis Inc.022307102US022307102006/30/2026To elect the three Class II director nominees named below to serve until the Company's 2029 annual meeting of stockholders: James B. Tananbaum, M.D.DIRECTOR ELECTIONSISSUER24225.0000000FOR24225.000000FORS000047353Alumis Inc.022307102US022307102006/30/2026To elect the three Class II director nominees named below to serve until the Company's 2029 annual meeting of stockholders: Lynn Tetrault, J.D.DIRECTOR ELECTIONSISSUER24225.0000000FOR24225.000000FORS000047353Alumis Inc.022307102US022307102006/30/2026To elect the three Class II director nominees named below to serve until the Company's 2029 annual meeting of stockholders: Zhengbin (Bing) Yao, Ph.D.DIRECTOR ELECTIONSISSUER24225.0000000WITHHOLD24225.000000AGAINSTS000047353Alumis Inc.022307102US022307102006/30/2026To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for the Company's fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER24225.0000000FOR24225.000000FORS000047353Y-mAbs Therapeutics, Inc.984241109US984241109507/11/2025Election of Class I Director: David N. GillDIRECTOR ELECTIONSISSUER42025.0000000WITHHOLD42025.000000AGAINSTS000047354Y-mAbs Therapeutics, Inc.984241109US984241109507/11/2025To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER42025.0000000FOR42025.000000FORS000047354Y-mAbs Therapeutics, Inc.984241109US984241109507/11/2025To approve, on a non-binding advisory vote basis, the compensation of the Company's named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER42025.0000000FOR42025.000000FORS000047354Y-mAbs Therapeutics, Inc.984241109US984241109507/11/2025To approve, on a non-binding advisory vote basis, the compensation of the Company's named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER42025.0000000FOR42025.000000FOR4S000047354Roivant Sciences Ltd.G76279101BMG76279101709/10/2025To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Matthew GlineDIRECTOR ELECTIONSISSUER38744.0000000WITHHOLD38744.000000AGAINSTS000047354Roivant Sciences Ltd.G76279101BMG76279101709/10/2025To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Keith ManchesterDIRECTOR ELECTIONSISSUER38744.0000000WITHHOLD38744.000000AGAINSTS000047354Roivant Sciences Ltd.G76279101BMG76279101709/10/2025To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Melissa EpperlyDIRECTOR ELECTIONSISSUER38744.0000000WITHHOLD38744.000000AGAINSTS000047354Roivant Sciences Ltd.G76279101BMG76279101709/10/2025To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Roivant's independent registered public accounting firm for Roivant's fiscal year ending March 31, 2026, to appoint Ernst & Young LLP as auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for Roivant's fiscal year ending March 31, 2026, and to authorize the Board of Directors, through the Audit Committee, to set the remuneration for Ernst & Young LLP as Roivant's auditor for Roivant's fiscal year ending March 31, 2026.AUDIT-RELATEDISSUER38744.0000000FOR38744.000000FORS000047354Roivant Sciences Ltd.G76279101BMG76279101709/10/2025To cast a non-binding, advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER38744.0000000AGAINST38744.000000AGAINSTS000047354Roivant Sciences Ltd.G76279101BMG76279101709/10/2025To cast a non-binding, advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER38744.0000000AGAINST38744.000000AGAINST4S000047354Moderna, Inc.60770K107US60770K107911/12/2025To approve a one-time stock option exchange program for non-Executive Committee employees of Moderna, Inc. (the "Option Exchange Proposal")COMPENSATIONISSUER16248.0000000FOR16248.000000FORS000047354Moderna, Inc.60770K107US60770K107911/12/2025To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Option Exchange Proposal (the "Adjournment Proposal").CORPORATE GOVERNANCEISSUER16248.0000000FOR16248.000000FORS000047354Amicus Therapeutics, Inc.03152W109US03152W109903/03/2026To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated December 19, 2025, by and among Amicus Therapeutics, Inc., a Delaware corporation ("Amicus"), BioMarin Pharmaceutical Inc., a Delaware corporation ("BioMarin"), and Lynx Merger Sub 1, Inc., a Delaware corporation and wholly owned subsidiary of BioMarin ("Merger Sub"), pursuant to which Merger Sub will merge with and into Amicus (the "Merger"), and Amicus will become a direct or indirect wholly owned subsidiary of BioMarin.EXTRAORDINARY TRANSACTIONSISSUER64777.0000000FOR64777.000000FORS000047354Amicus Therapeutics, Inc.03152W109US03152W109903/03/2026To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger.SECTION 14A SAY-ON-PAY VOTESISSUER64777.0000000FOR64777.000000FORS000047354Amicus Therapeutics, Inc.03152W109US03152W109903/03/2026To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger.SECTION 14A SAY-ON-PAY VOTESISSUER64777.0000000FOR64777.000000FOR4S000047354Amicus Therapeutics, Inc.03152W109US03152W109903/03/2026To approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of the adoption of the Merger Agreement at the time of the special meeting.CORPORATE GOVERNANCEISSUER64777.0000000FOR64777.000000FORS000047354Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/19/2026Election of Directors: Christopher AnzaloneDIRECTOR ELECTIONSISSUER9749.0000000FOR9749.000000FORS000047354Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/19/2026Election of Directors: Mauro FerrariDIRECTOR ELECTIONSISSUER9749.0000000FOR9749.000000FORS000047354Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/19/2026Election of Directors: Hongbo LuDIRECTOR ELECTIONSISSUER9749.0000000FOR9749.000000FORS000047354Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/19/2026Election of Directors: Adeoye OlukotunDIRECTOR ELECTIONSISSUER9749.0000000FOR9749.000000FORS000047354Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/19/2026Election of Directors: Michael S. PerryDIRECTOR ELECTIONSISSUER9749.0000000FOR9749.000000FORS000047354Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/19/2026Election of Directors: Victoria VakienerDIRECTOR ELECTIONSISSUER9749.0000000FOR9749.000000FORS000047354Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/19/2026Election of Directors: William WaddillDIRECTOR ELECTIONSISSUER9749.0000000FOR9749.000000FORS000047354Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/19/2026Advisory Vote to Approve Executive Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER9749.0000000AGAINST9749.000000AGAINSTS000047354Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/19/2026Advisory Vote to Approve Executive Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER9749.0000000AGAINST9749.000000AGAINST4S000047354Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/19/2026Approval of the Arrowhead Pharmaceuticals, Inc. Amended and Restated 2021 Incentive Plan.COMPENSATIONISSUER9749.0000000FOR9749.000000FORS000047354Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/19/2026Ratification of the selection of KPMG LLP as independent auditors of the Company for the fiscal year ending September 30, 2026.AUDIT-RELATEDISSUER9749.0000000FOR9749.000000FORS000047354Ascendis Pharma A/SK08588103DK006061575503/23/2026Elect Chair of MeetingCORPORATE GOVERNANCEISSUER3172.0000000FOR3172.000000FORS000047354Ascendis Pharma A/SK08588103DK006061575503/23/2026Accept Financial Statements and Statutory Reports; Approve Discharge of Management and BoardCAPITAL STRUCTURECORPORATE GOVERNANCEISSUER3172.0000000FOR3172.000000FORS000047354Ascendis Pharma A/SK08588103DK006061575503/23/2026Approve Treatment of Net LossCAPITAL STRUCTUREISSUER3172.0000000FOR3172.000000FORS000047354Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect Albert Cha as DirectorDIRECTOR ELECTIONSISSUER3172.0000000FOR3172.000000FORS000047354Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect Lars Holtug as DirectorDIRECTOR ELECTIONSISSUER3172.0000000FOR3172.000000FORS000047354Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect Jan Moller Mikkelsen as DirectorDIRECTOR ELECTIONSISSUER3172.0000000FOR3172.000000FORS000047354Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect Lisa Jane Morrison as DirectorDIRECTOR ELECTIONSISSUER3172.0000000FOR3172.000000FORS000047354Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect William Carl Fairey Jr as DirectorDIRECTOR ELECTIONSISSUER3172.0000000FOR3172.000000FORS000047354Ascendis Pharma A/SK08588103DK006061575503/23/2026Reelect Siham Imani as DirectorDIRECTOR ELECTIONSISSUER3172.0000000FOR3172.000000FORS000047354Ascendis Pharma A/SK08588103DK006061575503/23/2026Elect Jean-Jacques Bienaime as New DirectorDIRECTOR ELECTIONSISSUER3172.0000000FOR3172.000000FORS000047354Ascendis Pharma A/SK08588103DK006061575503/23/2026Ratify Deloitte as AuditorAUDIT-RELATEDISSUER3172.0000000FOR3172.000000FORS000047354Ascendis Pharma A/SK08588103DK006061575503/23/2026Authorize Share Repurchase ProgramCAPITAL STRUCTUREISSUER3172.0000000FOR3172.000000FORS000047354Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D.DIRECTOR ELECTIONSISSUER6469.0000000FOR6469.000000FORS000047354Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D.DIRECTOR ELECTIONSISSUER6469.0000000FOR6469.000000FORS000047354Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D.DIRECTOR ELECTIONSISSUER6469.0000000FOR6469.000000FORS000047354Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Kelly A. KramerDIRECTOR ELECTIONSISSUER6469.0000000FOR6469.000000FORS000047354Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D.DIRECTOR ELECTIONSISSUER6469.0000000FOR6469.000000FORS000047354Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Harish ManwaniDIRECTOR ELECTIONSISSUER6469.0000000FOR6469.000000FORS000047354Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Daniel P. O'DayDIRECTOR ELECTIONSISSUER6469.0000000FOR6469.000000FORS000047354Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Javier J. RodriguezDIRECTOR ELECTIONSISSUER6469.0000000FOR6469.000000FORS000047354Gilead Sciences, Inc.375558103US375558103604/30/2026To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Anthony WeltersDIRECTOR ELECTIONSISSUER6469.0000000FOR6469.000000FORS000047354Gilead Sciences, Inc.375558103US375558103604/30/2026To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER6469.0000000FOR6469.000000FORS000047354Gilead Sciences, Inc.375558103US375558103604/30/2026To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER6469.0000000FOR6469.000000FORS000047354Gilead Sciences, Inc.375558103US375558103604/30/2026To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER6469.0000000FOR6469.000000FOR4S000047354Gilead Sciences, Inc.375558103US375558103604/30/2026To approve the amended and restated Gilead Sciences, Inc. 2022 Equity Incentive Plan.COMPENSATIONISSUER6469.0000000FOR6469.000000FORS000047354Gilead Sciences, Inc.375558103US375558103604/30/2026To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting.CORPORATE GOVERNANCESECURITY HOLDER6469.0000000AGAINST6469.000000FORS000047354Gilead Sciences, Inc.375558103US375558103604/30/2026To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting.OTHER SOCIAL ISSUESSECURITY HOLDER6469.0000000AGAINST6469.000000FORS000047354Gilead Sciences, Inc.375558103US375558103604/30/2026To vote on a stockholder proposal requesting a report on the risks of ESG and DEI executive compensation metrics, if properly presented at the Annual Meeting.ENVIRONMENT OR CLIMATEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESSECURITY HOLDER6469.0000000AGAINST6469.000000FORS000047354Halozyme Therapeutics, Inc.40637H109US40637H109505/05/2026Election of Class I Directors: Bernadette ConnaughtonDIRECTOR ELECTIONSISSUER12521.0000000FOR12521.000000FORS000047354Halozyme Therapeutics, Inc.40637H109US40637H109505/05/2026Election of Class I Directors: Matthew L. PosardDIRECTOR ELECTIONSISSUER12521.0000000FOR12521.000000FORS000047354Halozyme Therapeutics, Inc.40637H109US40637H109505/05/2026To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER12521.0000000FOR12521.000000FORS000047354Halozyme Therapeutics, Inc.40637H109US40637H109505/05/2026To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER12521.0000000FOR12521.000000FOR4S000047354Halozyme Therapeutics, Inc.40637H109US40637H109505/05/2026To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER12521.0000000FOR12521.000000FORS000047354Moderna, Inc.60770K107US60770K107905/06/2026To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Sandra Horning, M.D.DIRECTOR ELECTIONSISSUER26440.0000000AGAINST26440.000000AGAINSTS000047354Moderna, Inc.60770K107US60770K107905/06/2026To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Abbas HussainDIRECTOR ELECTIONSISSUER26440.0000000FOR26440.000000FORS000047354Moderna, Inc.60770K107US60770K107905/06/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER26440.0000000AGAINST26440.000000AGAINSTS000047354Moderna, Inc.60770K107US60770K107905/06/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER26440.0000000AGAINST26440.000000AGAINST4S000047354Moderna, Inc.60770K107US60770K107905/06/2026To approve, on a non-binding, advisory basis, the frequency of future non-binding advisory votes to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER26440.0000000ONE YEAR26440.000000FORS000047354Moderna, Inc.60770K107US60770K107905/06/2026To approve, on a non-binding, advisory basis, the frequency of future non-binding advisory votes to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER26440.0000000ONE YEAR26440.000000FOR4S000047354Moderna, Inc.60770K107US60770K107905/06/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER26440.0000000FOR26440.000000FORS000047354Insmed Incorporated457669307US457669307505/13/2026Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Elizabeth McKee AndersonDIRECTOR ELECTIONSISSUER3952.0000000FOR3952.000000FORS000047354Insmed Incorporated457669307US457669307505/13/2026Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Clarissa Desjardins, Ph.D.DIRECTOR ELECTIONSISSUER3952.0000000FOR3952.000000FORS000047354Insmed Incorporated457669307US457669307505/13/2026An advisory vote on the 2025 compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3952.0000000FOR3952.000000FORS000047354Insmed Incorporated457669307US457669307505/13/2026An advisory vote on the 2025 compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3952.0000000FOR3952.000000FOR4S000047354Insmed Incorporated457669307US457669307505/13/2026Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER3952.0000000FOR3952.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/13/2026Election of Directors: Sangeeta BhatiaDIRECTOR ELECTIONSISSUER1723.0000000FOR1723.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/13/2026Election of Directors: Lloyd CarneyDIRECTOR ELECTIONSISSUER1723.0000000FOR1723.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/13/2026Election of Directors: Alan GarberDIRECTOR ELECTIONSISSUER1723.0000000FOR1723.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/13/2026Election of Directors: Reshma KewalramaniDIRECTOR ELECTIONSISSUER1723.0000000FOR1723.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/13/2026Election of Directors: Michel LagardeDIRECTOR ELECTIONSISSUER1723.0000000FOR1723.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/13/2026Election of Directors: Jeffrey LeidenDIRECTOR ELECTIONSISSUER1723.0000000FOR1723.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/13/2026Election of Directors: Diana McKenzieDIRECTOR ELECTIONSISSUER1723.0000000FOR1723.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/13/2026Election of Directors: Bruce SachsDIRECTOR ELECTIONSISSUER1723.0000000FOR1723.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/13/2026Election of Directors: Jennifer SchneiderDIRECTOR ELECTIONSISSUER1723.0000000FOR1723.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/13/2026Election of Directors: Nancy ThornberryDIRECTOR ELECTIONSISSUER1723.0000000FOR1723.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/13/2026Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER1723.0000000FOR1723.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/13/2026Advisory vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1723.0000000FOR1723.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/13/2026Advisory vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1723.0000000FOR1723.000000FOR4S000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/13/2026Approval of 2026 Stock and Option Plan.COMPENSATIONISSUER1723.0000000FOR1723.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/13/2026Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent.CORPORATE GOVERNANCESECURITY HOLDER1723.0000000FOR1723.000000AGAINSTS000047354Harmony Biosciences Holdings, Inc.413197104US413197104005/14/2026The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Geno J. GermanoDIRECTOR ELECTIONSISSUER19228.0000000FOR19228.000000FORS000047354Harmony Biosciences Holdings, Inc.413197104US413197104005/14/2026The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Troy IgnelziDIRECTOR ELECTIONSISSUER19228.0000000FOR19228.000000FORS000047354Harmony Biosciences Holdings, Inc.413197104US413197104005/14/2026The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Ron PhilipDIRECTOR ELECTIONSISSUER19228.0000000WITHHOLD19228.000000AGAINSTS000047354Harmony Biosciences Holdings, Inc.413197104US413197104005/14/2026The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Andreas Wicki, Ph.D.DIRECTOR ELECTIONSISSUER19228.0000000WITHHOLD19228.000000AGAINSTS000047354Harmony Biosciences Holdings, Inc.413197104US413197104005/14/2026Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER19228.0000000FOR19228.000000FORS000047354Harmony Biosciences Holdings, Inc.413197104US413197104005/14/2026Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensation disclosure rules.SECTION 14A SAY-ON-PAY VOTESISSUER19228.0000000AGAINST19228.000000AGAINSTS000047354Harmony Biosciences Holdings, Inc.413197104US413197104005/14/2026Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensation disclosure rules.SECTION 14A SAY-ON-PAY VOTESISSUER19228.0000000AGAINST19228.000000AGAINST4S000047354Ultragenyx Pharmaceutical Inc.90400D108US90400D108105/14/2026Nominees: Emil D. Kakkis, M.D., Ph.D.DIRECTOR ELECTIONSISSUER21500.0000000FOR21500.000000FORS000047354Ultragenyx Pharmaceutical Inc.90400D108US90400D108105/14/2026Nominees: Shehnaaz Suliman, M.D.DIRECTOR ELECTIONSISSUER21500.0000000FOR21500.000000FORS000047354Ultragenyx Pharmaceutical Inc.90400D108US90400D108105/14/2026Nominees: Daniel G. WelchDIRECTOR ELECTIONSISSUER21500.0000000FOR21500.000000FORS000047354Ultragenyx Pharmaceutical Inc.90400D108US90400D108105/14/2026Approval of the Third Amended and Restated 2023 Incentive Plan.COMPENSATIONISSUER21500.0000000AGAINST21500.000000AGAINSTS000047354Ultragenyx Pharmaceutical Inc.90400D108US90400D108105/14/2026Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER21500.0000000FOR21500.000000FORS000047354Ultragenyx Pharmaceutical Inc.90400D108US90400D108105/14/2026Advisory (non-binding) vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER21500.0000000FOR21500.000000FORS000047354Ultragenyx Pharmaceutical Inc.90400D108US90400D108105/14/2026Advisory (non-binding) vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER21500.0000000FOR21500.000000FOR4S000047354BioNTech SE09075V102US09075V102605/15/2026Approve Allocation of Income and Omission of DividendsCAPITAL STRUCTUREISSUER8904.0000000FOR8904.000000FORS000047354BioNTech SE09075V102US09075V102605/15/2026Approve Discharge of Management Board for Fiscal Year 2025CORPORATE GOVERNANCEISSUER8904.0000000FOR8904.000000FORS000047354BioNTech SE09075V102US09075V102605/15/2026Approve Discharge of Supervisory Board for Fiscal Year 2025CORPORATE GOVERNANCEISSUER8904.0000000FOR8904.000000FORS000047354BioNTech SE09075V102US09075V102605/15/2026Ratify EY GmbH & Co. KG as Auditors for Fiscal Year 2026 and for the Review of Interim Financial Statements for the Fiscal Year 2026 and the First Quarter of Fiscal Year 2027AUDIT-RELATEDISSUER8904.0000000FOR8904.000000FORS000047354BioNTech SE09075V102US09075V102605/15/2026Approve Remuneration ReportCOMPENSATIONISSUER8904.0000000AGAINST8904.000000AGAINSTS000047354BioNTech SE09075V102US09075V102605/15/2026Approve Increase in Size of Board to Eight MembersCORPORATE GOVERNANCEISSUER8904.0000000FOR8904.000000FORS000047354BioNTech SE09075V102US09075V102605/15/2026Reelect Helmut Jeggle to the Supervisory BoardDIRECTOR ELECTIONSISSUER8904.0000000FOR8904.000000FORS000047354BioNTech SE09075V102US09075V102605/15/2026Reelect Anja Morawietz to the Supervisory BoardDIRECTOR ELECTIONSISSUER8904.0000000FOR8904.000000FORS000047354BioNTech SE09075V102US09075V102605/15/2026Reelect Rudolf Staudigl to the Supervisory BoardDIRECTOR ELECTIONSISSUER8904.0000000FOR8904.000000FORS000047354BioNTech SE09075V102US09075V102605/15/2026Elect Susanne Schaffert to the Supervisory BoardDIRECTOR ELECTIONSISSUER8904.0000000FOR8904.000000FORS000047354BioNTech SE09075V102US09075V102605/15/2026Elect Iris Loew-Friedrich to the Supervisory BoardDIRECTOR ELECTIONSISSUER8904.0000000AGAINST8904.000000AGAINSTS000047354BioNTech SE09075V102US09075V102605/15/2026Approve Virtual-Only Shareholder Meetings Until 2028CORPORATE GOVERNANCEISSUER8904.0000000AGAINST8904.000000AGAINSTS000047354BioNTech SE09075V102US09075V102605/15/2026Approve Creation of EUR 129.5 Million Pool of Authorized Capital with or without Exclusion of Preemptive RightsCAPITAL STRUCTUREISSUER8904.0000000FOR8904.000000FORS000047354BioNTech SE09075V102US09075V102605/15/2026Approve Affiliation Agreement with BioNTech Discovery GmbHEXTRAORDINARY TRANSACTIONSISSUER8904.0000000FOR8904.000000FORS000047354Krystal Biotech, Inc.501147102US501147102705/15/2026Election of Class III Directors: Krish S. KrishnanDIRECTOR ELECTIONSISSUER3182.0000000WITHHOLD3182.000000AGAINSTS000047354Krystal Biotech, Inc.501147102US501147102705/15/2026Election of Class III Directors: Christopher MasonDIRECTOR ELECTIONSISSUER3182.0000000WITHHOLD3182.000000AGAINSTS000047354Krystal Biotech, Inc.501147102US501147102705/15/2026To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER3182.0000000FOR3182.000000FORS000047354Krystal Biotech, Inc.501147102US501147102705/15/2026Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis.SECTION 14A SAY-ON-PAY VOTESISSUER3182.0000000FOR3182.000000FORS000047354Krystal Biotech, Inc.501147102US501147102705/15/2026Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis.SECTION 14A SAY-ON-PAY VOTESISSUER3182.0000000FOR3182.000000FOR4S000047354Krystal Biotech, Inc.501147102US501147102705/15/2026Approval of the Company's Non-Employee Director Compensation Policy.COMPENSATIONISSUER3182.0000000FOR3182.000000FORS000047354Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Wanda M. AustinDIRECTOR ELECTIONSISSUER2450.0000000FOR2450.000000FORS000047354Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. BradwayDIRECTOR ELECTIONSISSUER2450.0000000FOR2450.000000FORS000047354Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Michael V. DrakeDIRECTOR ELECTIONSISSUER2450.0000000FOR2450.000000FORS000047354Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Brian J. DrukerDIRECTOR ELECTIONSISSUER2450.0000000FOR2450.000000FORS000047354Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. EckertDIRECTOR ELECTIONSISSUER2450.0000000FOR2450.000000FORS000047354Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Greg C. GarlandDIRECTOR ELECTIONSISSUER2450.0000000FOR2450.000000FORS000047354Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Charles M. Holley, Jr.DIRECTOR ELECTIONSISSUER2450.0000000FOR2450.000000FORS000047354Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. S. Omar IshrakDIRECTOR ELECTIONSISSUER2450.0000000FOR2450.000000FORS000047354Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Tyler JacksDIRECTOR ELECTIONSISSUER2450.0000000FOR2450.000000FORS000047354Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Mary E. KlotmanDIRECTOR ELECTIONSISSUER2450.0000000FOR2450.000000FORS000047354Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Ellen J. KullmanDIRECTOR ELECTIONSISSUER2450.0000000FOR2450.000000FORS000047354Amgen Inc.031162100US031162100905/19/2026To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Amy E. MilesDIRECTOR ELECTIONSISSUER2450.0000000FOR2450.000000FORS000047354Amgen Inc.031162100US031162100905/19/2026Advisory vote to approve our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2450.0000000FOR2450.000000FORS000047354Amgen Inc.031162100US031162100905/19/2026Advisory vote to approve our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2450.0000000FOR2450.000000FOR4S000047354Amgen Inc.031162100US031162100905/19/2026To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER2450.0000000FOR2450.000000FORS000047354Amgen Inc.031162100US031162100905/19/2026Stockholder proposal to require an independent board chairman.CORPORATE GOVERNANCESECURITY HOLDER2450.0000000AGAINST2450.000000FORS000047354Phathom Pharmaceuticals, Inc.71722W107US71722W107105/19/2026To elect three class I directors to hold office until the 2029 Annual Meeting of Stockholders: Steven BastaDIRECTOR ELECTIONSISSUER53501.0000000WITHHOLD53501.000000AGAINSTS000047354Phathom Pharmaceuticals, Inc.71722W107US71722W107105/19/2026To elect three class I directors to hold office until the 2029 Annual Meeting of Stockholders: Theodore R. SchroederDIRECTOR ELECTIONSISSUER53501.0000000WITHHOLD53501.000000AGAINSTS000047354Phathom Pharmaceuticals, Inc.71722W107US71722W107105/19/2026To elect three class I directors to hold office until the 2029 Annual Meeting of Stockholders: Mark StenhouseDIRECTOR ELECTIONSISSUER53501.0000000WITHHOLD53501.000000AGAINSTS000047354Phathom Pharmaceuticals, Inc.71722W107US71722W107105/19/2026To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER53501.0000000FOR53501.000000FORS000047354Phathom Pharmaceuticals, Inc.71722W107US71722W107105/19/2026To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay").SECTION 14A SAY-ON-PAY VOTESISSUER53501.0000000FOR53501.000000FORS000047354Phathom Pharmaceuticals, Inc.71722W107US71722W107105/19/2026To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay").SECTION 14A SAY-ON-PAY VOTESISSUER53501.0000000FOR53501.000000FOR4S000047354Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Roy BaynesDIRECTOR ELECTIONSISSUER22364.0000000FOR22364.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Suzanne BruhnDIRECTOR ELECTIONSISSUER22364.0000000FOR22364.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Timothy CoughlinDIRECTOR ELECTIONSISSUER22364.0000000FOR22364.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Eric DubeDIRECTOR ELECTIONSISSUER22364.0000000FOR22364.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Gary LyonsDIRECTOR ELECTIONSISSUER22364.0000000FOR22364.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Jeffrey MecklerDIRECTOR ELECTIONSISSUER22364.0000000FOR22364.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: John OrwinDIRECTOR ELECTIONSISSUER22364.0000000FOR22364.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Sandra PooleDIRECTOR ELECTIONSISSUER22364.0000000FOR22364.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Ron SquarerDIRECTOR ELECTIONSISSUER22364.0000000FOR22364.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Ruth Williams-BrinkleyDIRECTOR ELECTIONSISSUER22364.0000000FOR22364.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares.COMPENSATIONISSUER22364.0000000FOR22364.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER22364.0000000FOR22364.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER22364.0000000FOR22364.000000FOR4S000047354Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER22364.0000000ONE YEAR22364.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER22364.0000000ONE YEAR22364.000000FOR4S000047354Travere Therapeutics, Inc.89422G107US89422G107605/19/2026To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER22364.0000000FOR22364.000000FORS000047354Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/20/2026To elect the following nominees as Class I directors of Alnylam: Stuart A. ArbuckleDIRECTOR ELECTIONSISSUER1958.0000000FOR1958.000000FORS000047354Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/20/2026To elect the following nominees as Class I directors of Alnylam: Yvonne L. Greenstreet, M.D.DIRECTOR ELECTIONSISSUER1958.0000000FOR1958.000000FORS000047354Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/20/2026To elect the following nominees as Class I directors of Alnylam: Elliott Sigal, M.D., Ph.D.DIRECTOR ELECTIONSISSUER1958.0000000FOR1958.000000FORS000047354Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/20/2026To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1958.0000000FOR1958.000000FORS000047354Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/20/2026To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1958.0000000FOR1958.000000FOR4S000047354Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/20/2026To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1958.0000000FOR1958.000000FORS000047354Geron Corporation374163103US374163103605/20/2026To elect the three nominees for director named below to hold office as Class III members of the Board of Directors until the 2029 annual meeting of stockholders: Susan M. Molineaux, Ph.D.DIRECTOR ELECTIONSISSUER572782.0000000FOR572782.000000FORS000047354Geron Corporation374163103US374163103605/20/2026To elect the three nominees for director named below to hold office as Class III members of the Board of Directors until the 2029 annual meeting of stockholders: Patricia S. AndrewsDIRECTOR ELECTIONSISSUER572782.0000000FOR572782.000000FORS000047354Geron Corporation374163103US374163103605/20/2026To elect the three nominees for director named below to hold office as Class III members of the Board of Directors until the 2029 annual meeting of stockholders: Constantine ChinoporosDIRECTOR ELECTIONSISSUER572782.0000000FOR572782.000000FORS000047354Geron Corporation374163103US374163103605/20/2026To approve the amendment and restatement of the Company's 2018 Equity Incentive Plan to increase the aggregate number of shares of common stock available for issuance thereunder by 4,500,000 shares and to make certain other changes thereto as described further in the Proxy Statement.COMPENSATIONISSUER572782.0000000FOR572782.000000FORS000047354Geron Corporation374163103US374163103605/20/2026To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER572782.0000000FOR572782.000000FORS000047354Geron Corporation374163103US374163103605/20/2026To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER572782.0000000FOR572782.000000FOR4S000047354Geron Corporation374163103US374163103605/20/2026To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER572782.0000000FOR572782.000000FORS000047354Nuvation Bio Inc.67080N101US67080N101905/21/2026Election of Directors: Robert BazemoreDIRECTOR ELECTIONSISSUER92405.0000000WITHHOLD92405.000000AGAINSTS000047354Nuvation Bio Inc.67080N101US67080N101905/21/2026Election of Directors: Robert Mashal, M.D.DIRECTOR ELECTIONSISSUER92405.0000000WITHHOLD92405.000000AGAINSTS000047354Nuvation Bio Inc.67080N101US67080N101905/21/2026Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER92405.0000000FOR92405.000000FORS000047354Nuvation Bio Inc.67080N101US67080N101905/21/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER92405.0000000FOR92405.000000FORS000047354Nuvation Bio Inc.67080N101US67080N101905/21/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER92405.0000000FOR92405.000000FOR4S000047354Exelixis, Inc.30161Q104US30161Q104005/26/2026To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Mary C. Beckerle, Ph.D.DIRECTOR ELECTIONSISSUER20651.0000000FOR20651.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/26/2026To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: S. Gail Eckhardt, M.D.DIRECTOR ELECTIONSISSUER20651.0000000FOR20651.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/26/2026To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Maria C. Freire, Ph.D.DIRECTOR ELECTIONSISSUER20651.0000000FOR20651.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/26/2026To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Tomas J. HeymanDIRECTOR ELECTIONSISSUER20651.0000000FOR20651.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/26/2026To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: David E. JohnsonDIRECTOR ELECTIONSISSUER20651.0000000FOR20651.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/26/2026To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Michael M. Morrissey, Ph.D.DIRECTOR ELECTIONSISSUER20651.0000000FOR20651.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/26/2026To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Robert L. Oliver, Jr.DIRECTOR ELECTIONSISSUER20651.0000000FOR20651.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/26/2026To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Stelios Papadopoulos, Ph.D.DIRECTOR ELECTIONSISSUER20651.0000000FOR20651.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/26/2026To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: George Poste, DVM, Ph.D., FRSDIRECTOR ELECTIONSISSUER20651.0000000FOR20651.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/26/2026To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Julie Anne SmithDIRECTOR ELECTIONSISSUER20651.0000000FOR20651.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/26/2026To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Jack L. WyszomierskiDIRECTOR ELECTIONSISSUER20651.0000000FOR20651.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/26/2026To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Exelixis' independent registered public accounting firm for the fiscal year ending January 1, 2027.AUDIT-RELATEDISSUER20651.0000000FOR20651.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/26/2026To amend and restate the Exelixis, Inc. 2017 Equity Incentive Plan to, among other things, increase the number of shares authorized for issuance by 2,000,000 shares.COMPENSATIONISSUER20651.0000000FOR20651.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/26/2026To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER20651.0000000FOR20651.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/26/2026To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER20651.0000000FOR20651.000000FOR4S000047354Immunocore Holdings Plc45258D105US45258D105405/27/2026To re-appoint Siddharth Kaul as a director who retires in accordance with the articles of association.DIRECTOR ELECTIONSISSUER3945.00000018995.000000FOR3945.000000FORS000047354Immunocore Holdings Plc45258D105US45258D105405/27/2026To re-appoint William Pao, M.D., Ph.D. as a director who retires in accordance with the articles of association.DIRECTOR ELECTIONSISSUER3945.00000018995.000000FOR3945.000000FORS000047354Immunocore Holdings Plc45258D105US45258D105405/27/2026To re-appoint Kristine Peterson as a director who retires in accordance with the articles of association.DIRECTOR ELECTIONSISSUER3945.00000018995.000000AGAINST3945.000000AGAINSTS000047354Immunocore Holdings Plc45258D105US45258D105405/27/2026To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER3945.00000018995.000000AGAINST3945.000000AGAINSTS000047354Immunocore Holdings Plc45258D105US45258D105405/27/2026To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER3945.00000018995.000000AGAINST3945.000000AGAINST4S000047354Immunocore Holdings Plc45258D105US45258D105405/27/2026To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending 31 December 2026.AUDIT-RELATEDISSUER3945.00000018995.000000FOR3945.000000FORS000047354Immunocore Holdings Plc45258D105US45258D105405/27/2026To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of our next annual general meeting of shareholders.AUDIT-RELATEDISSUER3945.00000018995.000000FOR3945.000000FORS000047354Immunocore Holdings Plc45258D105US45258D105405/27/2026To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending 31 December 2026.AUDIT-RELATEDISSUER3945.00000018995.000000FOR3945.000000FORS000047354Immunocore Holdings Plc45258D105US45258D105405/27/2026To receive and adopt the U.K. statutory annual accounts and reports for the year ended 31 December 2025.CORPORATE GOVERNANCEISSUER3945.00000018995.000000FOR3945.000000FORS000047354Immunocore Holdings Plc45258D105US45258D105405/27/2026To approve our directors' remuneration report for the year ended December 31, 2025, which is set forth as Annex A to the attached proxy statement and on pages 26 to 56 of the 2025 U.K. Annual Report (excluding the directors' remuneration policy set out on 26 to 56 2025 U.K. Annual Report (excluding the directors' remuneration policy set out on A7 to A18 of Annex A).COMPENSATIONISSUER3945.00000018995.000000AGAINST3945.000000AGAINSTS000047354Immunocore Holdings Plc45258D105US45258D105405/27/2026To authorize the Company to make political donations/incur political expenditure.OTHER SOCIAL ISSUESISSUER3945.00000018995.000000FOR3945.000000FORS000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/27/2026The election of the Board of Directors' three nominees for Class III directors named below to the Board of Directors to serve for a term of three years: Kevin C. Gorman, Ph.D.DIRECTOR ELECTIONSISSUER5524.0000000FOR5524.000000FORS000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/27/2026The election of the Board of Directors' three nominees for Class III directors named below to the Board of Directors to serve for a term of three years: Gary A. LyonsDIRECTOR ELECTIONSISSUER5524.0000000FOR5524.000000FORS000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/27/2026The election of the Board of Directors' three nominees for Class III directors named below to the Board of Directors to serve for a term of three years: Johanna MercierDIRECTOR ELECTIONSISSUER5524.0000000FOR5524.000000FORS000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/27/2026Advisory vote on the compensation paid to the Company's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER5524.0000000FOR5524.000000FORS000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/27/2026Advisory vote on the compensation paid to the Company's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER5524.0000000FOR5524.000000FOR4S000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/27/2026To approve an amendment of the Company's 2025 Equity Incentive Plan to increase the aggregate number of shares of common stock reserved for issuance thereunder by 4,000,000 shares; andCOMPENSATIONISSUER5524.0000000FOR5524.000000FORS000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/27/2026To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER5524.0000000FOR5524.000000FORS000047354Esperion Therapeutics, Inc.29664W105US29664W105305/28/2026Election of Class I Directors: J. Martin CarrollDIRECTOR ELECTIONSISSUER219293.0000000FOR219293.000000FORS000047354Esperion Therapeutics, Inc.29664W105US29664W105305/28/2026Election of Class I Directors: Sheldon L. KoenigDIRECTOR ELECTIONSISSUER219293.0000000FOR219293.000000FORS000047354Esperion Therapeutics, Inc.29664W105US29664W105305/28/2026To approve the non-binding advisory resolution on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER219293.0000000FOR219293.000000FORS000047354Esperion Therapeutics, Inc.29664W105US29664W105305/28/2026To approve the non-binding advisory resolution on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER219293.0000000FOR219293.000000FOR4S000047354Esperion Therapeutics, Inc.29664W105US29664W105305/28/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER219293.0000000FOR219293.000000FORS000047354Esperion Therapeutics, Inc.29664W105US29664W105305/28/2026To approve an amendment to the Esperion Therapeutics, Inc. 2022 Stock Option and Incentive Plan.COMPENSATIONISSUER219293.0000000FOR219293.000000FORS000047354Acadia Pharmaceuticals Inc.004225108US004225108405/29/2026To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: James M. DalyDIRECTOR ELECTIONSISSUER33499.0000000FOR33499.000000FORS000047354Acadia Pharmaceuticals Inc.004225108US004225108405/29/2026To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Edmund P. Harrigan, M.D.DIRECTOR ELECTIONSISSUER33499.0000000FOR33499.000000FORS000047354Acadia Pharmaceuticals Inc.004225108US004225108405/29/2026To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Adora Ndu, Pharm.D., J.D.DIRECTOR ELECTIONSISSUER33499.0000000FOR33499.000000FORS000047354Acadia Pharmaceuticals Inc.004225108US004225108405/29/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER33499.0000000FOR33499.000000FORS000047354Acadia Pharmaceuticals Inc.004225108US004225108405/29/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER33499.0000000FOR33499.000000FOR4S000047354Acadia Pharmaceuticals Inc.004225108US004225108405/29/2026To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER33499.0000000FOR33499.000000FORS000047354Acadia Pharmaceuticals Inc.004225108US004225108405/29/2026To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares.COMPENSATIONISSUER33499.0000000FOR33499.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Stephen R. BiggarDIRECTOR ELECTIONSISSUER20300.0000000AGAINST20300.000000AGAINSTS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: G. Bradley ColeDIRECTOR ELECTIONSISSUER20300.0000000FOR20300.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Barry D. QuartDIRECTOR ELECTIONSISSUER20300.0000000FOR20300.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To approve the appointment of PricewaterhouseCoopers LLP ("PwC") as the Company's UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders.AUDIT-RELATEDISSUER20300.0000000FOR20300.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To ratify the appointment of PwC as the Company's US independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER20300.0000000FOR20300.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To authorize the Company's Board of Directors, through its Audit Committee, to determine PwC's remuneration in its capacity as our UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders.AUDIT-RELATEDISSUER20300.0000000FOR20300.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To receive the Company's UK statutory annual accounts and report for the period ended December 31, 2025.CORPORATE GOVERNANCEISSUER20300.0000000FOR20300.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To approve, on an advisory (non-binding) basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2025.COMPENSATIONISSUER20300.0000000FOR20300.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To approve the Company's UK Statutory Directors' Remuneration Policy.COMPENSATIONISSUER20300.0000000FOR20300.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER20300.0000000FOR20300.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0705/29/2026To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER20300.0000000FOR20300.000000FOR4S000047354ADMA Biologics, Inc.000899104US000899104606/02/2026To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Alison C. FingerDIRECTOR ELECTIONSISSUER42683.0000000FOR42683.000000FORS000047354ADMA Biologics, Inc.000899104US000899104606/02/2026To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eduardo Rene SalasDIRECTOR ELECTIONSISSUER42683.0000000FOR42683.000000FORS000047354ADMA Biologics, Inc.000899104US000899104606/02/2026To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER42683.0000000FOR42683.000000FORS000047354ADMA Biologics, Inc.000899104US000899104606/02/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER42683.0000000FOR42683.000000FORS000047354ADMA Biologics, Inc.000899104US000899104606/02/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER42683.0000000FOR42683.000000FOR4S000047354BioMarin Pharmaceutical Inc.09061G101US09061G101306/02/2026Election of Directors: Elizabeth M. AndersonDIRECTOR ELECTIONSISSUER15836.0000000FOR15836.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101306/02/2026Election of Directors: Barbara W. BodemDIRECTOR ELECTIONSISSUER15836.0000000FOR15836.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101306/02/2026Election of Directors: Ian T. ClarkDIRECTOR ELECTIONSISSUER15836.0000000FOR15836.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101306/02/2026Election of Directors: Athena CountouriotisDIRECTOR ELECTIONSISSUER15836.0000000FOR15836.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101306/02/2026Election of Directors: Willard DereDIRECTOR ELECTIONSISSUER15836.0000000FOR15836.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101306/02/2026Election of Directors: Mark J. EnyedyDIRECTOR ELECTIONSISSUER15836.0000000FOR15836.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101306/02/2026Election of Directors: Alexander HardyDIRECTOR ELECTIONSISSUER15836.0000000FOR15836.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101306/02/2026Election of Directors: Maykin HoDIRECTOR ELECTIONSISSUER15836.0000000FOR15836.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101306/02/2026Election of Directors: Robert J. HombachDIRECTOR ELECTIONSISSUER15836.0000000FOR15836.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101306/02/2026Election of Directors: Timothy P. WalbertDIRECTOR ELECTIONSISSUER15836.0000000FOR15836.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101306/02/2026To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER15836.0000000FOR15836.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101306/02/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER15836.0000000FOR15836.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101306/02/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER15836.0000000FOR15836.000000FOR4S000047354BioMarin Pharmaceutical Inc.09061G101US09061G101306/02/2026To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended.COMPENSATIONISSUER15836.0000000FOR15836.000000FORS000047354PTC Therapeutics, Inc.69366J200US69366J200606/02/2026Election of Four Class I Directors: Jessica ChutterDIRECTOR ELECTIONSISSUER11160.0000000FOR11160.000000FORS000047354PTC Therapeutics, Inc.69366J200US69366J200606/02/2026Election of Four Class I Directors: Matthew B. Klein, M.D., M.S., F.A.C.S.DIRECTOR ELECTIONSISSUER11160.0000000FOR11160.000000FORS000047354PTC Therapeutics, Inc.69366J200US69366J200606/02/2026Election of Four Class I Directors: Stephanie S. Okey, M.S.DIRECTOR ELECTIONSISSUER11160.0000000FOR11160.000000FORS000047354PTC Therapeutics, Inc.69366J200US69366J200606/02/2026Election of Four Class I Directors: Jerome B. Zeldis, M.D., Ph.D.DIRECTOR ELECTIONSISSUER11160.0000000FOR11160.000000FORS000047354PTC Therapeutics, Inc.69366J200US69366J200606/02/2026Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER11160.0000000FOR11160.000000FORS000047354PTC Therapeutics, Inc.69366J200US69366J200606/02/2026Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER11160.0000000FOR11160.000000FORS000047354PTC Therapeutics, Inc.69366J200US69366J200606/02/2026Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER11160.0000000FOR11160.000000FOR4S000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102206/03/2026Election of Directors: Kevin TangDIRECTOR ELECTIONSISSUER57386.0000000FOR57386.000000FORS000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102206/03/2026Election of Directors: Jeffrey A. BaileyDIRECTOR ELECTIONSISSUER57386.0000000FOR57386.000000FORS000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102206/03/2026Election of Directors: Kathy GoetzDIRECTOR ELECTIONSISSUER57386.0000000FOR57386.000000FORS000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102206/03/2026Election of Directors: Craig JohnsonDIRECTOR ELECTIONSISSUER57386.0000000FOR57386.000000FORS000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102206/03/2026Election of Directors: Tina S. NovaDIRECTOR ELECTIONSISSUER57386.0000000FOR57386.000000FORS000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102206/03/2026Appointment of Auditors To approve the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the close of the 2027 annual general meeting of shareholders or until a successor is appointed.AUDIT-RELATEDISSUER57386.0000000FOR57386.000000FORS000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102206/03/2026Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, the Company's executive compensation set forth in the Company's Proxy Statement/Circular.SECTION 14A SAY-ON-PAY VOTESISSUER57386.0000000FOR57386.000000FORS000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102206/03/2026Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, the Company's executive compensation set forth in the Company's Proxy Statement/Circular.SECTION 14A SAY-ON-PAY VOTESISSUER57386.0000000FOR57386.000000FOR4S000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Approval of the Swiss management report, the consolidated financial statements and the statutory financial statements of the Company for the year ended December 31, 2025.CORPORATE GOVERNANCEISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Approval of the appropriation of financial results.CAPITAL STRUCTUREISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Discharge of the members of the Board of Directors and the Executive Committee.CORPORATE GOVERNANCEISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of the members to the Board of Directors and the Chairman: Re-election of Samarth Kulkarni, Ph.D., as member and ChairmanDIRECTOR ELECTIONSISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of Ali Behbahani, M.D.DIRECTOR ELECTIONSISSUER16046.0000000AGAINST16046.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of Maria Fardis, Ph.D.DIRECTOR ELECTIONSISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of H. Edward Fleming, Jr., M.D.DIRECTOR ELECTIONSISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of Simeon J. George, M.D.DIRECTOR ELECTIONSISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of John T. GreeneDIRECTOR ELECTIONSISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of Katherine A. High, M.D.DIRECTOR ELECTIONSISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of Sandesh Mahatme, LL.M.DIRECTOR ELECTIONSISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of Briggs W. Morrison, M.D.DIRECTOR ELECTIONSISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of Christian Rommel, Ph.D.DIRECTOR ELECTIONSISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of Douglas A. Treco, Ph.D.DIRECTOR ELECTIONSISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of the members of the Compensation Committee: Re-election of Ali Behbahani, M.D.DIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER16046.0000000AGAINST16046.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of H. Edward Fleming, Jr., M.D.DIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of John T. GreeneDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of Briggs W. Morrison, M.D.DIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2025 Compensation Report: Binding vote on maximum non-performance-related compensation for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders.COMPENSATIONISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Binding vote on maximum equity for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders.COMPENSATIONISSUER16046.0000000AGAINST16046.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027.COMPENSATIONISSUER16046.0000000AGAINST16046.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026.COMPENSATIONISSUER16046.0000000AGAINST16046.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders.COMPENSATIONISSUER16046.0000000AGAINST16046.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Non-binding advisory vote on the 2025 Compensation Report.COMPENSATIONISSUER16046.0000000AGAINST16046.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements.SECTION 14A SAY-ON-PAY VOTESISSUER16046.0000000AGAINST16046.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements.SECTION 14A SAY-ON-PAY VOTESISSUER16046.0000000AGAINST16046.000000AGAINST4S000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Approval of an increase to the Company's capital band.CAPITAL STRUCTUREISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Approval of an increase to the conditional share capital for the conversion of bonds and similar debt instruments.CAPITAL STRUCTUREISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Approval of the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan.COMPENSATIONISSUER16046.0000000AGAINST16046.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of the independent voting rights representative.CORPORATE GOVERNANCEISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Re-election of the auditors.AUDIT-RELATEDISSUER16046.0000000FOR16046.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/04/2026Transact any other business that may properly come before the 2026 Annual General Meeting or any adjournment or postponement thereof.CORPORATE GOVERNANCEISSUER16046.0000000AGAINST16046.000000AGAINSTS000047354Ionis Pharmaceuticals, Inc.462222100US462222100406/04/2026Election of Directors: Spencer R. BerthelsenDIRECTOR ELECTIONSISSUER10445.0000000FOR10445.000000FORS000047354Ionis Pharmaceuticals, Inc.462222100US462222100406/04/2026Election of Directors: Joan E. HermanDIRECTOR ELECTIONSISSUER10445.0000000FOR10445.000000FORS000047354Ionis Pharmaceuticals, Inc.462222100US462222100406/04/2026To make an advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER10445.0000000FOR10445.000000FORS000047354Ionis Pharmaceuticals, Inc.462222100US462222100406/04/2026To make an advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER10445.0000000FOR10445.000000FOR4S000047354Ionis Pharmaceuticals, Inc.462222100US462222100406/04/2026To approve an amendment of the Amended and Restated Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 9,500,000 shares to an aggregate of 52,000,000 shares.COMPENSATIONISSUER10445.0000000FOR10445.000000FORS000047354Ionis Pharmaceuticals, Inc.462222100US462222100406/04/2026To approve an amendment of the Amended and Restated 2000 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for purchase under such plan by 750,000 shares and remove the termination date of the plan.COMPENSATIONISSUER10445.0000000FOR10445.000000FORS000047354Ionis Pharmaceuticals, Inc.462222100US462222100406/04/2026To ratify the Audit Committee's selection of Ernst & Young LLP as independent auditors for the 2026 fiscal year.AUDIT-RELATEDISSUER10445.0000000FOR10445.000000FORS000047354Kura Oncology, Inc.50127T109US50127T109706/04/2026Election of three Class III directors for three-year terms: Diane ParksDIRECTOR ELECTIONSISSUER82610.0000000WITHHOLD82610.000000AGAINSTS000047354Kura Oncology, Inc.50127T109US50127T109706/04/2026Election of three Class III directors for three-year terms: Mary T. SzelaDIRECTOR ELECTIONSISSUER82610.0000000WITHHOLD82610.000000AGAINSTS000047354Kura Oncology, Inc.50127T109US50127T109706/04/2026Election of three Class III directors for three-year terms: Michael J. Vasconcelles, M.D.DIRECTOR ELECTIONSISSUER82610.0000000FOR82610.000000FORS000047354Kura Oncology, Inc.50127T109US50127T109706/04/2026Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER82610.0000000FOR82610.000000FORS000047354Kura Oncology, Inc.50127T109US50127T109706/04/2026Approval, on an advisory basis, of the compensation of our named executive officers ("Say-on-Pay"), as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER82610.0000000FOR82610.000000FORS000047354Kura Oncology, Inc.50127T109US50127T109706/04/2026Approval, on an advisory basis, of the compensation of our named executive officers ("Say-on-Pay"), as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER82610.0000000FOR82610.000000FOR4S000047354Kura Oncology, Inc.50127T109US50127T109706/04/2026Indication, on an advisory basis, of the preferred frequency of holding future Say-on-Pay votes on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER82610.0000000ONE YEAR82610.000000FORS000047354Kura Oncology, Inc.50127T109US50127T109706/04/2026Indication, on an advisory basis, of the preferred frequency of holding future Say-on-Pay votes on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER82610.0000000ONE YEAR82610.000000FOR4S000047354Kura Oncology, Inc.50127T109US50127T109706/04/2026Approval of an amendment to our Amended and Restated 2014 Equity Incentive Plan.COMPENSATIONISSUER82610.0000000AGAINST82610.000000AGAINSTS000047354Kura Oncology, Inc.50127T109US50127T109706/04/2026Approval of an amendment to our 2015 Employee Stock Purchase Plan.COMPENSATIONISSUER82610.0000000FOR82610.000000FORS000047354Sarepta Therapeutics, Inc.803607100US803607100406/04/2026To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Douglas S. IngramDIRECTOR ELECTIONSISSUER39213.0000000FOR39213.000000FORS000047354Sarepta Therapeutics, Inc.803607100US803607100406/04/2026To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Hans Wigzell, M.D., Ph.D.DIRECTOR ELECTIONSISSUER39213.0000000FOR39213.000000FORS000047354Sarepta Therapeutics, Inc.803607100US803607100406/04/2026To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Kathryn J. Boor, Ph.D.DIRECTOR ELECTIONSISSUER39213.0000000FOR39213.000000FORS000047354Sarepta Therapeutics, Inc.803607100US803607100406/04/2026To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Michael ChambersDIRECTOR ELECTIONSISSUER39213.0000000FOR39213.000000FORS000047354Sarepta Therapeutics, Inc.803607100US803607100406/04/2026To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Deirdre ConnellyDIRECTOR ELECTIONSISSUER39213.0000000FOR39213.000000FORS000047354Sarepta Therapeutics, Inc.803607100US803607100406/04/2026Advisory vote to approve, on a non-binding basis, named executive officer compensationSECTION 14A SAY-ON-PAY VOTESISSUER39213.0000000AGAINST39213.000000AGAINSTS000047354Sarepta Therapeutics, Inc.803607100US803607100406/04/2026Advisory vote to approve, on a non-binding basis, named executive officer compensationSECTION 14A SAY-ON-PAY VOTESISSUER39213.0000000AGAINST39213.000000AGAINST4S000047354Sarepta Therapeutics, Inc.803607100US803607100406/04/2026Approve the Company's 2026 Equity Incentive PlanCOMPENSATIONISSUER39213.0000000FOR39213.000000FORS000047354Sarepta Therapeutics, Inc.803607100US803607100406/04/2026Approve the Company's 2026 Employee Stock Purchase PlanCOMPENSATIONISSUER39213.0000000FOR39213.000000FORS000047354Sarepta Therapeutics, Inc.803607100US803607100406/04/2026Ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the current year ending December 31, 2026AUDIT-RELATEDISSUER39213.0000000FOR39213.000000FORS000047354Arcutis Biotherapeutics, Inc.03969K108US03969K108806/05/2026Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Patrick J. HeronDIRECTOR ELECTIONSISSUER29092.0000000WITHHOLD29092.000000AGAINSTS000047354Arcutis Biotherapeutics, Inc.03969K108US03969K108806/05/2026Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Neha KrishnamohanDIRECTOR ELECTIONSISSUER29092.0000000WITHHOLD29092.000000AGAINSTS000047354Arcutis Biotherapeutics, Inc.03969K108US03969K108806/05/2026Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Todd Franklin WatanabeDIRECTOR ELECTIONSISSUER29092.0000000WITHHOLD29092.000000AGAINSTS000047354Arcutis Biotherapeutics, Inc.03969K108US03969K108806/05/2026To ratify the selection, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER29092.0000000FOR29092.000000FORS000047354Arcutis Biotherapeutics, Inc.03969K108US03969K108806/05/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER29092.0000000FOR29092.000000FORS000047354Arcutis Biotherapeutics, Inc.03969K108US03969K108806/05/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER29092.0000000FOR29092.000000FOR4S000047354Axsome Therapeutics, Inc.05464T104US05464T104306/05/2026Election of Directors: Mark SaadDIRECTOR ELECTIONSISSUER6139.0000000WITHHOLD6139.000000AGAINSTS000047354Axsome Therapeutics, Inc.05464T104US05464T104306/05/2026Election of Directors: Susan Mahony, Ph.D., MBADIRECTOR ELECTIONSISSUER6139.0000000WITHHOLD6139.000000AGAINSTS000047354Axsome Therapeutics, Inc.05464T104US05464T104306/05/2026To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER6139.0000000FOR6139.000000FORS000047354Axsome Therapeutics, Inc.05464T104US05464T104306/05/2026To approve, by non-binding advisory vote, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6139.0000000FOR6139.000000FORS000047354Axsome Therapeutics, Inc.05464T104US05464T104306/05/2026To approve, by non-binding advisory vote, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6139.0000000FOR6139.000000FOR4S000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/05/2026Election of Directors: Jason M. AryehDIRECTOR ELECTIONSISSUER4797.0000000FOR4797.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/05/2026Election of Directors: Todd C. DavisDIRECTOR ELECTIONSISSUER4797.0000000FOR4797.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/05/2026Election of Directors: Nancy R. Gray, Ph.D.DIRECTOR ELECTIONSISSUER4797.0000000FOR4797.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/05/2026Election of Directors: Jason HaasDIRECTOR ELECTIONSISSUER4797.0000000FOR4797.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/05/2026Election of Directors: John W. Kozarich, Ph.D.DIRECTOR ELECTIONSISSUER4797.0000000FOR4797.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/05/2026Election of Directors: John L. LaMattina, Ph.D.DIRECTOR ELECTIONSISSUER4797.0000000FOR4797.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/05/2026Election of Directors: Stephen L. Sabba, M.D.DIRECTOR ELECTIONSISSUER4797.0000000FOR4797.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/05/2026Election of Directors: Martine Zimmermann, Pharm.D.DIRECTOR ELECTIONSISSUER4797.0000000FOR4797.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/05/2026Ratification of Ernst & Young LLP as Ligand's independent registered accounting firmAUDIT-RELATEDISSUER4797.0000000FOR4797.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/05/2026Approval, on an advisory basis, of the compensation of the named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER4797.0000000FOR4797.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/05/2026Approval, on an advisory basis, of the compensation of the named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER4797.0000000FOR4797.000000FOR4S000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/05/2026Approval of an amendment and restatement of Ligand's 2002 Stock Incentive PlanCOMPENSATIONISSUER4797.0000000FOR4797.000000FORS000047354Incyte Corporation45337C102US45337C102706/08/2026Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Julian C. BakerDIRECTOR ELECTIONSISSUER9532.0000000FOR9532.000000FORS000047354Incyte Corporation45337C102US45337C102706/08/2026Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Jean-Jacques BienaimeDIRECTOR ELECTIONSISSUER9532.0000000FOR9532.000000FORS000047354Incyte Corporation45337C102US45337C102706/08/2026Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Otis W. BrawleyDIRECTOR ELECTIONSISSUER9532.0000000FOR9532.000000FORS000047354Incyte Corporation45337C102US45337C102706/08/2026Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Paul J. ClancyDIRECTOR ELECTIONSISSUER9532.0000000FOR9532.000000FORS000047354Incyte Corporation45337C102US45337C102706/08/2026Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Jacqualyn A. FouseDIRECTOR ELECTIONSISSUER9532.0000000FOR9532.000000FORS000047354Incyte Corporation45337C102US45337C102706/08/2026Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Edmund P. HarriganDIRECTOR ELECTIONSISSUER9532.0000000FOR9532.000000FORS000047354Incyte Corporation45337C102US45337C102706/08/2026Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Katherine A. HighDIRECTOR ELECTIONSISSUER9532.0000000FOR9532.000000FORS000047354Incyte Corporation45337C102US45337C102706/08/2026Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: William J. MueryDIRECTOR ELECTIONSISSUER9532.0000000FOR9532.000000FORS000047354Incyte Corporation45337C102US45337C102706/08/2026Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER9532.0000000FOR9532.000000FORS000047354Incyte Corporation45337C102US45337C102706/08/2026Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER9532.0000000FOR9532.000000FOR4S000047354Incyte Corporation45337C102US45337C102706/08/2026Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER9532.0000000FOR9532.000000FORS000047354Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. FreireDIRECTOR ELECTIONSISSUER5223.0000000FOR5223.000000FORS000047354Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: William A. HawkinsDIRECTOR ELECTIONSISSUER5223.0000000FOR5223.000000FORS000047354Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. LangerDIRECTOR ELECTIONSISSUER5223.0000000FOR5223.000000FORS000047354Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. MantasDIRECTOR ELECTIONSISSUER5223.0000000FOR5223.000000FORS000047354Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Lloyd MinorDIRECTOR ELECTIONSISSUER5223.0000000FOR5223.000000FORS000047354Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Menelas PangalosDIRECTOR ELECTIONSISSUER5223.0000000FOR5223.000000FORS000047354Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Monish PatolawalaDIRECTOR ELECTIONSISSUER5223.0000000FOR5223.000000FORS000047354Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. RowinskyDIRECTOR ELECTIONSISSUER5223.0000000FOR5223.000000FORS000047354Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. SherwinDIRECTOR ELECTIONSISSUER5223.0000000FOR5223.000000FORS000047354Biogen Inc.09062X103US09062X103706/09/2026Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. ViehbacherDIRECTOR ELECTIONSISSUER5223.0000000FOR5223.000000FORS000047354Biogen Inc.09062X103US09062X103706/09/2026To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER5223.0000000FOR5223.000000FORS000047354Biogen Inc.09062X103US09062X103706/09/2026Say on Pay - To hold an advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER5223.0000000FOR5223.000000FORS000047354Biogen Inc.09062X103US09062X103706/09/2026Say on Pay - To hold an advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER5223.0000000FOR5223.000000FOR4S000047354ImmunityBio, Inc.45256X103US45256X103706/09/2026Election of Directors: Patrick Soon-Shiong, M.D.DIRECTOR ELECTIONSISSUER667.000000357080.000000WITHHOLD667.000000AGAINSTS000047354ImmunityBio, Inc.45256X103US45256X103706/09/2026Election of Directors: Cheryl L. CohenDIRECTOR ELECTIONSISSUER667.000000357080.000000FOR667.000000FORS000047354ImmunityBio, Inc.45256X103US45256X103706/09/2026Election of Directors: Richard AdcockDIRECTOR ELECTIONSISSUER667.000000357080.000000FOR667.000000FORS000047354ImmunityBio, Inc.45256X103US45256X103706/09/2026Election of Directors: Michael D. BlaszykDIRECTOR ELECTIONSISSUER667.000000357080.000000WITHHOLD667.000000AGAINSTS000047354ImmunityBio, Inc.45256X103US45256X103706/09/2026Election of Directors: Wesley ClarkDIRECTOR ELECTIONSISSUER667.000000357080.000000FOR667.000000FORS000047354ImmunityBio, Inc.45256X103US45256X103706/09/2026Election of Directors: Linda Maxwell, M.D.DIRECTOR ELECTIONSISSUER667.000000357080.000000WITHHOLD667.000000AGAINSTS000047354ImmunityBio, Inc.45256X103US45256X103706/09/2026Election of Directors: Christobel SeleckyDIRECTOR ELECTIONSISSUER667.000000357080.000000WITHHOLD667.000000AGAINSTS000047354ImmunityBio, Inc.45256X103US45256X103706/09/2026Election of Directors: Barry J. Simon, M.D.DIRECTOR ELECTIONSISSUER667.000000357080.000000FOR667.000000FORS000047354ImmunityBio, Inc.45256X103US45256X103706/09/2026Election of Directors: Bruce WendelDIRECTOR ELECTIONSISSUER667.000000357080.000000FOR667.000000FORS000047354ImmunityBio, Inc.45256X103US45256X103706/09/2026To ratify the selection of Deloitte & Touche LLP as ImmunityBio's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER667.000000357080.000000FOR667.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2026To elect six directors named in the proxy statement accompanying this notice to serve until the 2027 Annual Meeting of Stockholders: Iain Dukes, D. Phil.DIRECTOR ELECTIONSISSUER413436.0000000FOR413436.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2026To elect six directors named in the proxy statement accompanying this notice to serve until the 2027 Annual Meeting of Stockholders: Athena Countouriotis, M.D.DIRECTOR ELECTIONSISSUER413436.0000000FOR413436.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2026To elect six directors named in the proxy statement accompanying this notice to serve until the 2027 Annual Meeting of Stockholders: Ryan MaynardDIRECTOR ELECTIONSISSUER413436.0000000FOR413436.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2026To elect six directors named in the proxy statement accompanying this notice to serve until the 2027 Annual Meeting of Stockholders: Wayne P. RothbaumDIRECTOR ELECTIONSISSUER413436.0000000FOR413436.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2026To elect six directors named in the proxy statement accompanying this notice to serve until the 2027 Annual Meeting of Stockholders: Frederick G. Vogt, Ph.D., J.D.DIRECTOR ELECTIONSISSUER413436.0000000FOR413436.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2026To elect six directors named in the proxy statement accompanying this notice to serve until the 2027 Annual Meeting of Stockholders: Michael Weiser, M.D., Ph.D.DIRECTOR ELECTIONSISSUER413436.0000000FOR413436.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2026To approve, by non-binding advisory vote, the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER413436.0000000AGAINST413436.000000AGAINSTS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2026To approve, by non-binding advisory vote, the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER413436.0000000AGAINST413436.000000AGAINST4S000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2026To approve, by non-binding advisory vote, the frequency of our future votes on the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER413436.0000000ONE YEAR413436.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2026To approve, by non-binding advisory vote, the frequency of our future votes on the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER413436.0000000ONE YEAR413436.000000FOR4S000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER413436.0000000FOR413436.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2026To approve an amendment to our 2020 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder by 1,000,000 shares;COMPENSATIONISSUER413436.0000000FOR413436.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2026To approve an amendment to our Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 500,000,000 shares to 650,000,000 shares; andCAPITAL STRUCTUREISSUER413436.0000000FOR413436.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2026To approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 6.CORPORATE GOVERNANCEISSUER413436.0000000FOR413436.000000FORS000047354Syndax Pharmaceuticals, Inc.87164F105US87164F105706/10/2026Election of Directors: Pierre LegaultDIRECTOR ELECTIONSISSUER44650.0000000WITHHOLD44650.000000AGAINSTS000047354Syndax Pharmaceuticals, Inc.87164F105US87164F105706/10/2026Election of Directors: Michael A. MetzgerDIRECTOR ELECTIONSISSUER44650.0000000FOR44650.000000FORS000047354Syndax Pharmaceuticals, Inc.87164F105US87164F105706/10/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2026 proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER44650.0000000FOR44650.000000FORS000047354Syndax Pharmaceuticals, Inc.87164F105US87164F105706/10/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2026 proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER44650.0000000FOR44650.000000FOR4S000047354Syndax Pharmaceuticals, Inc.87164F105US87164F105706/10/2026To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER44650.0000000FOR44650.000000FORS000047354Syndax Pharmaceuticals, Inc.87164F105US87164F105706/10/2026To approve the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan.COMPENSATIONISSUER44650.0000000AGAINST44650.000000AGAINSTS000047354Syndax Pharmaceuticals, Inc.87164F105US87164F105706/10/2026To approve the Syndax Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan.COMPENSATIONISSUER44650.0000000FOR44650.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the audited Swiss statutory standalone financial statements and the audited Swiss statutory consolidated financial statements of the Company for fiscal year 2025 be and are hereby approved.CORPORATE GOVERNANCEISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the appropriation of the accumulated loss for fiscal year 2025 be and is hereby approved.CAPITAL STRUCTUREISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the members of the Board of Directors and the Executive Management Team be and are hereby discharged from liability for activities during the applicable period under Swiss law.CORPORATE GOVERNANCEISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Dr. Olivier Brandicourt be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Dr. Margaret Dugan be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Mr. Anthony C. Hooper be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Mr. John V. Oyler be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Dr. Alessandro Riva be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER3915.0000000AGAINST3915.000000AGAINSTS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Ms. Shalini Sharp be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Dr. Xiaodong Wang be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Dr. Felix J. Baker be and is hereby elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Ms. Elizabeth F. Mooney be and is hereby elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Dr. Charles L. Sawyers be and is hereby elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Mr. John V. Oyler be and is hereby re-elected to serve as Chairman of the Board of Directors of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSISSUER3915.0000000AGAINST3915.000000AGAINSTS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Dr. Margaret Dugan be and is hereby re-elected to serve as a member of the Compensation Committee of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Ms. Elizabeth F. Mooney be and is hereby elected to serve as a member of the Compensation Committee of the Company for a term extending until completion of the 2027 annual general meeting.DIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT Schweiger Advokatur/Notariat be and is hereby elected to serve as the Independent Voting Representative for a one-year term ending at the closing of the 2027 annual general meeting of shareholders, including any extraordinary general meeting of shareholders prior to the 2027 annual general meeting of shareholders.CORPORATE GOVERNANCEISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the appointment of Ernst & Young LLP, Ernst & Young and Ernst & Young Hua Ming LLP as the Company's independent auditors for the fiscal year ending December 31, 2026 be and is hereby ratified, and Ernst & Young AG be and is hereby re-elected as the Company's statutory auditor for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the Board of Directors is hereby authorized to fix the auditors' compensation for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, for the fiscal year ended December 31, 2025 be and is hereby approved.SECTION 14A SAY-ON-PAY VOTESISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, for the fiscal year ended December 31, 2025 be and is hereby approved.SECTION 14A SAY-ON-PAY VOTESISSUER3915.0000000FOR3915.000000FOR4S000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT, the maximum aggregate compensation for the Board of Directors for the period between the 2026 annual general meeting and the 2027 annual general meeting, be and is hereby approved.COMPENSATIONISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT, the maximum aggregate compensation for the Executive Management Team for fiscal year 2027 be and is hereby approved.COMPENSATIONISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT, on an advisory basis, the Swiss Statutory Compensation Report for the fiscal year ended December 31, 2025 be and is hereby approved.COMPENSATIONISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT, on an advisory basis, the Swiss Statutory Non-Financial Matters Report for the fiscal year ended December 31, 2025 be and is hereby approved.CORPORATE GOVERNANCEENVIRONMENT OR CLIMATEHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the Fifth Amended and Restated 2016 Share Option and Incentive Plan be and is hereby approved.COMPENSATIONISSUER3915.0000000AGAINST3915.000000AGAINSTS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the consultant sublimit in the Fifth Amended and Restated 2016 Share Option and Incentive Plan be and is hereby approvedCOMPENSATIONISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the Sixth Amended and Restated 2018 Employee Share Purchase Plan be and is hereby approved.COMPENSATIONISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the granting of a share issue mandate to the Board of Directors to issue, allot or deal with unissued ordinary shares and/or American Depositary Shares ("ADSs") (including any sale or transfer of treasury shares out of treasury) not exceeding 20% of the total number of issued shares of the Company (excluding treasury shares) as of the date of passing of this resolution up to the next annual general meeting of shareholders of the Company be and is hereby approved.CAPITAL STRUCTUREISSUER3915.0000000AGAINST3915.000000AGAINSTS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the granting of a share repurchase mandate to the Board of Directors to repurchase an amount of ordinary shares (excluding the Company's ordinary shares listed on the Science and Technology Innovation Board of Shanghai Stock Exchange and traded in RMB ("RMB shares")) and/or ADSs, not exceeding 10% of the total number of issued ordinary shares (excluding RMB shares and treasury shares) of the Company as of the date of passing of this resolution up to the next annual general meeting of shareholders of the Company be and is hereby approved.CAPITAL STRUCTUREISSUER3915.0000000FOR3915.000000FORS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the Company and its underwriters be and are hereby authorized, in their sole discretion, to allocate to Amgen Inc. ("Amgen"), up to a maximum amount of shares in order to maintain the same shareholding percentage of Amgen (based on the then-outstanding share capital of the Company) before and after the allocation of the corresponding securities issued pursuant to an offering conducted pursuant to the general mandate set forth in Resolution 17 for a period of five years, which period will be subject to an extension on a rolling basis each year.CAPITAL STRUCTUREISSUER3915.0000000AGAINST3915.000000AGAINSTS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026THAT the adjournment of the Annual Meeting by the chairman, if necessary, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to approve any of the proposals described above, be and is hereby approved.CORPORATE GOVERNANCEISSUER3915.0000000AGAINST3915.000000AGAINSTS000047354BeOne Medicines Ltd.07725L102US07725L102606/11/2026If new or modified agenda items (other than those in the invitation to the Annual Meeting and the 2026 Proxy Statement of the Company) or new or modified proposals or motions with respect to the agenda items listed in the invitation to the Annual Meeting and the 2026 Proxy Statement of the Company are presented at the Annual Meeting, I instruct the Independent Voting Representative to vote in favor of the recommendations of the Board (For), against the proposals (Against) or abstain (Abstain) as follows:CORPORATE GOVERNANCEISSUER3915.0000000AGAINST3915.000000AGAINSTS000047354BioCryst Pharmaceuticals, Inc.09058V103US09058V103506/11/2026Election of Directors (each to serve until the 2029 Annual Meeting of Stockholders): Theresa M. HeggieDIRECTOR ELECTIONSISSUER111529.0000000FOR111529.000000FORS000047354BioCryst Pharmaceuticals, Inc.09058V103US09058V103506/11/2026Election of Directors (each to serve until the 2029 Annual Meeting of Stockholders): Amy E. Mckee, M.D.DIRECTOR ELECTIONSISSUER111529.0000000FOR111529.000000FORS000047354BioCryst Pharmaceuticals, Inc.09058V103US09058V103506/11/2026Election of Directors (each to serve until the 2029 Annual Meeting of Stockholders): Jon P. StonehouseDIRECTOR ELECTIONSISSUER111529.0000000FOR111529.000000FORS000047354BioCryst Pharmaceuticals, Inc.09058V103US09058V103506/11/2026To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for 2026.AUDIT-RELATEDISSUER111529.0000000FOR111529.000000FORS000047354BioCryst Pharmaceuticals, Inc.09058V103US09058V103506/11/2026To hold a non-binding, advisory vote regarding executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER111529.0000000AGAINST111529.000000AGAINSTS000047354BioCryst Pharmaceuticals, Inc.09058V103US09058V103506/11/2026To hold a non-binding, advisory vote regarding executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER111529.0000000AGAINST111529.000000AGAINST4S000047354BioCryst Pharmaceuticals, Inc.09058V103US09058V103506/11/2026To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan.COMPENSATIONISSUER111529.0000000AGAINST111529.000000AGAINSTS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/11/2026Election of Directors: Laurence CharneyDIRECTOR ELECTIONSISSUER29012.0000000WITHHOLD29012.000000AGAINSTS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/11/2026Election of Directors: Yann EchelardDIRECTOR ELECTIONSISSUER29012.0000000WITHHOLD29012.000000AGAINSTS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/11/2026Election of Directors: Kenneth HobermanDIRECTOR ELECTIONSISSUER29012.0000000WITHHOLD29012.000000AGAINSTS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/11/2026Election of Directors: Daniel HumeDIRECTOR ELECTIONSISSUER29012.0000000WITHHOLD29012.000000AGAINSTS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/11/2026Election of Directors: Sagar Lonial, MDDIRECTOR ELECTIONSISSUER29012.0000000WITHHOLD29012.000000AGAINSTS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/11/2026Election of Directors: Michael S. WeissDIRECTOR ELECTIONSISSUER29012.0000000WITHHOLD29012.000000AGAINSTS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/11/2026To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER29012.0000000FOR29012.000000FORS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/11/2026An advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER29012.0000000AGAINST29012.000000AGAINSTS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/11/2026An advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER29012.0000000AGAINST29012.000000AGAINST4S000047354LENZ Therapeutics, Inc.52635N103US52635N103706/12/2026To elect three Class II directors to hold office until our 2029 annual meeting of stockholders, each until their respective successors are elected and qualified: Evert SchimmelpenninkDIRECTOR ELECTIONSISSUER400.00000049741.000000FOR400.000000FORS000047354LENZ Therapeutics, Inc.52635N103US52635N103706/12/2026To elect three Class II directors to hold office until our 2029 annual meeting of stockholders, each until their respective successors are elected and qualified: Jeff GeorgeDIRECTOR ELECTIONSISSUER400.00000049741.000000WITHHOLD400.000000AGAINSTS000047354LENZ Therapeutics, Inc.52635N103US52635N103706/12/2026To elect three Class II directors to hold office until our 2029 annual meeting of stockholders, each until their respective successors are elected and qualified: Shelley ThunenDIRECTOR ELECTIONSISSUER400.00000049741.000000FOR400.000000FORS000047354LENZ Therapeutics, Inc.52635N103US52635N103706/12/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER400.00000049741.000000FOR400.000000FORS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/12/2026Election of Directors: Joseph L. Goldstein, M.D.DIRECTOR ELECTIONSISSUER1226.0000000AGAINST1226.000000AGAINSTS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/12/2026Election of Directors: Christine A. PoonDIRECTOR ELECTIONSISSUER1226.0000000AGAINST1226.000000AGAINSTS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/12/2026Election of Directors: David P. Schenkein, M.D.DIRECTOR ELECTIONSISSUER1226.0000000FOR1226.000000FORS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/12/2026Election of Directors: Craig B. Thompson, M.D.DIRECTOR ELECTIONSISSUER1226.0000000AGAINST1226.000000AGAINSTS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/12/2026Election of Directors: Huda Y. Zoghbi, M.D.DIRECTOR ELECTIONSISSUER1226.0000000FOR1226.000000FORS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/12/2026Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1226.0000000FOR1226.000000FORS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/12/2026Proposal to approve, on an advisory basis, compensation of the Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER1226.0000000FOR1226.000000FORS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/12/2026Proposal to approve, on an advisory basis, compensation of the Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER1226.0000000FOR1226.000000FOR4S000047354Theravance Biopharma, Inc.G8807B106KYG8807B106806/12/2026Elect the following directors to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Laurie Smaldone AlsupDIRECTOR ELECTIONSISSUER1.00000046463.000000FOR1.000000FORS000047354Theravance Biopharma, Inc.G8807B106KYG8807B106806/12/2026Elect the following directors to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Susannah GrayDIRECTOR ELECTIONSISSUER1.00000046463.000000FOR1.000000FORS000047354Theravance Biopharma, Inc.G8807B106KYG8807B106806/12/2026Elect the following directors to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Dean J. MitchellDIRECTOR ELECTIONSISSUER1.00000046463.000000FOR1.000000FORS000047354Theravance Biopharma, Inc.G8807B106KYG8807B106806/12/2026Elect the following directors to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Donal O'ConnorDIRECTOR ELECTIONSISSUER1.00000046463.000000FOR1.000000FORS000047354Theravance Biopharma, Inc.G8807B106KYG8807B106806/12/2026Elect the following directors to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Deepika R. PakianathanDIRECTOR ELECTIONSISSUER1.00000046463.000000FOR1.000000FORS000047354Theravance Biopharma, Inc.G8807B106KYG8807B106806/12/2026Elect the following directors to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Rick E WinninghamDIRECTOR ELECTIONSISSUER1.00000046463.000000FOR1.000000FORS000047354Theravance Biopharma, Inc.G8807B106KYG8807B106806/12/2026Ratify the appointment of Ernst & Young LLP as Theravance Biopharma, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1.00000046463.000000FOR1.000000FORS000047354Theravance Biopharma, Inc.G8807B106KYG8807B106806/12/2026Approve the non-binding advisory resolution regarding the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000046463.000000FOR1.000000FORS000047354Theravance Biopharma, Inc.G8807B106KYG8807B106806/12/2026Approve the non-binding advisory resolution regarding the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000046463.000000FOR1.000000FOR4S000047354Mirum Pharmaceuticals, Inc.604749101US604749101306/15/2026To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSciDIRECTOR ELECTIONSISSUER13991.0000000WITHHOLD13991.000000AGAINSTS000047354Mirum Pharmaceuticals, Inc.604749101US604749101306/15/2026To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: William FaireyDIRECTOR ELECTIONSISSUER13991.0000000WITHHOLD13991.000000AGAINSTS000047354Mirum Pharmaceuticals, Inc.604749101US604749101306/15/2026To elect the Board's three Class III nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Timothy WalbertDIRECTOR ELECTIONSISSUER13991.0000000WITHHOLD13991.000000AGAINSTS000047354Mirum Pharmaceuticals, Inc.604749101US604749101306/15/2026To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER13991.0000000FOR13991.000000FORS000047354Mirum Pharmaceuticals, Inc.604749101US604749101306/15/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER13991.0000000FOR13991.000000FORS000047354Mirum Pharmaceuticals, Inc.604749101US604749101306/15/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER13991.0000000FOR13991.000000FOR4S000047354Ardelyx, Inc.039697107US039697107106/16/2026To elect three Class III directors to hold office until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, subject to his or her earlier death, resignation or removal: Robert BazemoreDIRECTOR ELECTIONSISSUER46997.00000099469.000000FOR46997.000000FORS000047354Ardelyx, Inc.039697107US039697107106/16/2026To elect three Class III directors to hold office until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, subject to his or her earlier death, resignation or removal: Muna Bhanji, R.Ph.DIRECTOR ELECTIONSISSUER46997.00000099469.000000WITHHOLD46997.000000AGAINSTS000047354Ardelyx, Inc.039697107US039697107106/16/2026To elect three Class III directors to hold office until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, subject to his or her earlier death, resignation or removal: Richard RodgersDIRECTOR ELECTIONSISSUER46997.00000099469.000000FOR46997.000000FORS000047354Ardelyx, Inc.039697107US039697107106/16/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay");SECTION 14A SAY-ON-PAY VOTESISSUER46997.00000099469.000000FOR46997.000000FORS000047354Ardelyx, Inc.039697107US039697107106/16/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay");SECTION 14A SAY-ON-PAY VOTESISSUER46997.00000099469.000000FOR46997.000000FOR4S000047354Ardelyx, Inc.039697107US039697107106/16/2026To approve, on a non-binding, advisory basis, whether a Say-on-Pay vote should occur every one (1) year, every two (2) years or every three (3) years;SECTION 14A SAY-ON-PAY VOTESISSUER46997.00000099469.000000ONE YEAR46997.000000FORS000047354Ardelyx, Inc.039697107US039697107106/16/2026To approve, on a non-binding, advisory basis, whether a Say-on-Pay vote should occur every one (1) year, every two (2) years or every three (3) years;SECTION 14A SAY-ON-PAY VOTESISSUER46997.00000099469.000000ONE YEAR46997.000000FOR4S000047354Ardelyx, Inc.039697107US039697107106/16/2026To ratify the appointment, by the Audit and Compliance Committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026; andAUDIT-RELATEDISSUER46997.00000099469.000000FOR46997.000000FORS000047354Ardelyx, Inc.039697107US039697107106/16/2026To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares.COMPENSATIONISSUER46997.00000099469.000000AGAINST46997.000000AGAINSTS000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/17/2026Re-election of Class I directors: Julian BakerDIRECTOR ELECTIONSISSUER952.000000703.000000FOR952.000000FORS000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/17/2026Re-election of Class I directors: Daniel BrennanDIRECTOR ELECTIONSISSUER952.000000703.000000FOR952.000000FORS000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/17/2026Re-election of Class I directors: James DalyDIRECTOR ELECTIONSISSUER952.000000703.000000FOR952.000000FORS000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/17/2026Advisory vote to approve executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER952.000000703.000000FOR952.000000FORS000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/17/2026Advisory vote to approve executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER952.000000703.000000FOR952.000000FOR4S000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/17/2026To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026AUDIT-RELATEDISSUER952.000000703.000000FOR952.000000FORS000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/17/2026Approval of Madrigal Pharmaceuticals, Inc. 2026 Stock PlanCOMPENSATIONISSUER952.000000703.000000FOR952.000000FORS000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/17/2026Approval of Madrigal Pharmaceuticals, Inc. 2026 Employee Stock Purchase PlanCOMPENSATIONISSUER952.000000703.000000FOR952.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/17/2026THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Samantha (Ying) DuDIRECTOR ELECTIONSISSUER29014.00000022171.000000FOR29014.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/17/2026THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: John D. DiekmanDIRECTOR ELECTIONSISSUER29014.00000022171.000000FOR29014.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/17/2026THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Richard GaynorDIRECTOR ELECTIONSISSUER29014.00000022171.000000FOR29014.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/17/2026THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Nisa LeungDIRECTOR ELECTIONSISSUER29014.00000022171.000000FOR29014.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/17/2026THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: William LisDIRECTOR ELECTIONSISSUER29014.00000022171.000000FOR29014.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/17/2026THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Scott MorrisonDIRECTOR ELECTIONSISSUER29014.00000022171.000000FOR29014.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/17/2026THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Leon O. Moulder, Jr.DIRECTOR ELECTIONSISSUER29014.00000022171.000000FOR29014.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/17/2026THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Michel VounatsosDIRECTOR ELECTIONSISSUER29014.00000022171.000000FOR29014.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/17/2026THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Peter WirthDIRECTOR ELECTIONSISSUER29014.00000022171.000000FOR29014.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/17/2026THAT, the appointment of KPMG LLP and KPMG as the Company's independent registered public accounting firms and auditors to audit the Company's consolidated financial statements to be filed with the U.S. Securities and Exchange Commission and The Stock Exchange of Hong Kong Limited for the year ending December 31, 2026, respectively, is hereby approved.AUDIT-RELATEDISSUER29014.00000022171.000000FOR29014.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/17/2026THAT, the authority of the Board of Directors to fix auditor compensation for 2026, is hereby approved.AUDIT-RELATEDISSUER29014.00000022171.000000FOR29014.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/17/2026THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved.SECTION 14A SAY-ON-PAY VOTESISSUER29014.00000022171.000000AGAINST29014.000000AGAINSTS000047354Zai Lab Limited98887Q104US98887Q104006/17/2026THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved.SECTION 14A SAY-ON-PAY VOTESISSUER29014.00000022171.000000AGAINST29014.000000AGAINST4S000047354Zai Lab Limited98887Q104US98887Q104006/17/2026THAT, a general mandate to the Board of Directors to allot and issue ordinary shares and/or ADSs and/or resell treasury shares of up to 10% of the total number of issued ordinary shares of the Company (excluding treasury shares) as of the date of the Annual Meeting until the 2027 annual general meeting of shareholders is hereby approved.CAPITAL STRUCTUREISSUER29014.00000022171.000000FOR29014.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/17/2026THAT, a general mandate to repurchase ordinary shares and/or ADSs of up to 10% of the total number of issued ordinary shares of the Company (excluding treasury shares) as of the date of the Annual Meeting until the 2027 annual general meeting of shareholders, is hereby approved.CAPITAL STRUCTUREISSUER29014.00000022171.000000FOR29014.000000FORS000047354Agios Pharmaceuticals, Inc.00847X104US00847X104606/18/2026To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Rahul Ballal, Ph.D.DIRECTOR ELECTIONSISSUER33353.0000000FOR33353.000000FORS000047354Agios Pharmaceuticals, Inc.00847X104US00847X104606/18/2026To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Brian GoffDIRECTOR ELECTIONSISSUER33353.0000000FOR33353.000000FORS000047354Agios Pharmaceuticals, Inc.00847X104US00847X104606/18/2026To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Cynthia SmithDIRECTOR ELECTIONSISSUER33353.0000000FOR33353.000000FORS000047354Agios Pharmaceuticals, Inc.00847X104US00847X104606/18/2026To vote, on an advisory basis, to approve the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER33353.0000000FOR33353.000000FORS000047354Agios Pharmaceuticals, Inc.00847X104US00847X104606/18/2026To vote, on an advisory basis, to approve the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER33353.0000000FOR33353.000000FOR4S000047354Agios Pharmaceuticals, Inc.00847X104US00847X104606/18/2026To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares.COMPENSATIONISSUER33353.0000000FOR33353.000000FORS000047354Agios Pharmaceuticals, Inc.00847X104US00847X104606/18/2026To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER33353.0000000FOR33353.000000FORS000047354Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/18/2026To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Caren DeardorfDIRECTOR ELECTIONSISSUER18014.0000000WITHHOLD18014.000000AGAINSTS000047354Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/18/2026To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Weston Nichols, Ph.D.DIRECTOR ELECTIONSISSUER18014.0000000FOR18014.000000FORS000047354Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/18/2026To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Stephanie S. Okey, M.S.DIRECTOR ELECTIONSISSUER18014.0000000WITHHOLD18014.000000AGAINSTS000047354Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/18/2026To ratify the selection of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER18014.0000000FOR18014.000000FORS000047354Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/18/2026To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; andSECTION 14A SAY-ON-PAY VOTESISSUER18014.0000000FOR18014.000000FORS000047354Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/18/2026To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; andSECTION 14A SAY-ON-PAY VOTESISSUER18014.0000000FOR18014.000000FOR4S000047354Novavax, Inc.670002401US670002401006/18/2026Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: John C. JacobsDIRECTOR ELECTIONSISSUER5604.000000138440.000000FOR5604.000000FORS000047354Novavax, Inc.670002401US670002401006/18/2026Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Gregg H. Alton, J.D.DIRECTOR ELECTIONSISSUER5604.000000138440.000000FOR5604.000000FORS000047354Novavax, Inc.670002401US670002401006/18/2026Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Richard J. RodgersDIRECTOR ELECTIONSISSUER5604.000000138440.000000FOR5604.000000FORS000047354Novavax, Inc.670002401US670002401006/18/2026The approval, on an advisory basis, of the compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER5604.000000138440.000000AGAINST5604.000000AGAINSTS000047354Novavax, Inc.670002401US670002401006/18/2026The approval, on an advisory basis, of the compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER5604.000000138440.000000AGAINST5604.000000AGAINST4S000047354Novavax, Inc.670002401US670002401006/18/2026Amendment and restatement of the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, to increase the number of shares of Common Stock available for issuance thereunder by 9,400,000 shares.COMPENSATIONISSUER5604.000000138440.000000FOR5604.000000FORS000047354Novavax, Inc.670002401US670002401006/18/2026Amendment and restatement of the Novavax, Inc. 2013 Employee Stock Purchase Plan, as amended (the "ESPP"), to increase the number of shares of Common Stock available for issuance under the ESPP by 1,000,000 shares, such that the number of shares available for issuance is the lesser of (a) 3,375,888 shares of Common Stock increased on January 1 of each year by 5% of the share pool and (b) 4,820,564 shares of Common Stock.COMPENSATIONISSUER5604.000000138440.000000FOR5604.000000FORS000047354Novavax, Inc.670002401US670002401006/18/2026Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER5604.000000138440.000000FOR5604.000000FORS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/22/2026To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly elected and qualified: James C. MomtazeeDIRECTOR ELECTIONSISSUER1359.00000011233.000000FOR1359.000000FORS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/22/2026To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly elected and qualified: Frank P. McCormick, Ph.D.DIRECTOR ELECTIONSISSUER1359.00000011233.000000FOR1359.000000FORS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/22/2026To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly elected and qualified: Hannah A. Valantine, M.D.DIRECTOR ELECTIONSISSUER1359.00000011233.000000WITHHOLD1359.000000AGAINSTS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/22/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER1359.00000011233.000000FOR1359.000000FORS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/22/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER1359.00000011233.000000FOR1359.000000FOR4S000047354BridgeBio Pharma, Inc.10806X102US10806X102806/22/2026To conduct a non-binding advisory vote on the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1359.00000011233.000000ONE YEAR1359.000000FORS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/22/2026To conduct a non-binding advisory vote on the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1359.00000011233.000000ONE YEAR1359.000000FOR4S000047354BridgeBio Pharma, Inc.10806X102US10806X102806/22/2026To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1359.00000011233.000000FOR1359.000000FORS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/22/2026To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares.COMPENSATIONISSUER1359.00000011233.000000AGAINST1359.000000AGAINSTS000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2026Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David W.J. McGirrDIRECTOR ELECTIONSISSUER8333.0000000WITHHOLD8333.000000AGAINSTS000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2026Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David P. Meeker, M.D.DIRECTOR ELECTIONSISSUER8333.0000000FOR8333.000000FORS000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2026Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER8333.0000000FOR8333.000000FORS000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2026Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER8333.0000000AGAINST8333.000000AGAINSTS000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2026Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER8333.0000000AGAINST8333.000000AGAINST4S000047354Tarsus Pharmaceuticals, Inc.87650L103US87650L103506/25/2026To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Wendy YarnoDIRECTOR ELECTIONSISSUER11632.0000000FOR11632.000000FORS000047354Tarsus Pharmaceuticals, Inc.87650L103US87650L103506/25/2026To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Andrew GoldbergDIRECTOR ELECTIONSISSUER11632.0000000WITHHOLD11632.000000AGAINSTS000047354Tarsus Pharmaceuticals, Inc.87650L103US87650L103506/25/2026To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Scott MorrisonDIRECTOR ELECTIONSISSUER11632.0000000FOR11632.000000FORS000047354Tarsus Pharmaceuticals, Inc.87650L103US87650L103506/25/2026To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: David E.I. PyottDIRECTOR ELECTIONSISSUER11632.0000000FOR11632.000000FORS000047354Tarsus Pharmaceuticals, Inc.87650L103US87650L103506/25/2026To hold an advisory vote to approve, on a non-binding basis, our named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER11632.0000000FOR11632.000000FORS000047354Tarsus Pharmaceuticals, Inc.87650L103US87650L103506/25/2026To hold an advisory vote to approve, on a non-binding basis, our named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER11632.0000000FOR11632.000000FOR4S000047354Tarsus Pharmaceuticals, Inc.87650L103US87650L103506/25/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER11632.0000000FOR11632.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2026Election of Directors: Christopher CauseyDIRECTOR ELECTIONSISSUER1914.0000000FOR1914.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2026Election of Directors: Richard GiltnerDIRECTOR ELECTIONSISSUER1914.0000000FOR1914.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2026Election of Directors: Ray KurzweilDIRECTOR ELECTIONSISSUER1914.0000000FOR1914.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2026Election of Directors: Jan MalcolmDIRECTOR ELECTIONSISSUER1914.0000000FOR1914.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2026Election of Directors: Linda MaxwellDIRECTOR ELECTIONSISSUER1914.0000000FOR1914.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2026Election of Directors: Nilda MesaDIRECTOR ELECTIONSISSUER1914.0000000FOR1914.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2026Election of Directors: Judy OlianDIRECTOR ELECTIONSISSUER1914.0000000FOR1914.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2026Election of Directors: Christopher PatuskyDIRECTOR ELECTIONSISSUER1914.0000000FOR1914.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2026Election of Directors: Martine RothblattDIRECTOR ELECTIONSISSUER1914.0000000FOR1914.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2026Election of Directors: Louis SullivanDIRECTOR ELECTIONSISSUER1914.0000000FOR1914.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2026Election of Directors: Tommy ThompsonDIRECTOR ELECTIONSISSUER1914.0000000FOR1914.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2026Election of Directors: Kevin TraceyDIRECTOR ELECTIONSISSUER1914.0000000FOR1914.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2026Advisory resolution to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1914.0000000FOR1914.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2026Advisory resolution to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1914.0000000FOR1914.000000FOR4S000047354United Therapeutics Corporation91307C102US91307C102706/26/2026Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan.COMPENSATIONISSUER1914.0000000AGAINST1914.000000AGAINSTS000047354United Therapeutics Corporation91307C102US91307C102706/26/2026Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER1914.0000000FOR1914.000000FORS000047354CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2026Election of Directors Wendy Montoya CloonanDIRECTOR ELECTIONSISSUER2225784.0000000.000000FOR2225784.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2026Election of Directors Barbara J. DuganierDIRECTOR ELECTIONSISSUER2225784.0000000.000000FOR2225784.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2026Election of Directors Laurie L. FitchDIRECTOR ELECTIONSISSUER2225784.0000000.000000FOR2225784.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2026Election of Directors Christopher H. FranklinDIRECTOR ELECTIONSISSUER2225784.0000000.000000FOR2225784.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2026Election of Directors Michael A. "Casey" HermanDIRECTOR ELECTIONSISSUER2225784.0000000.000000FOR2225784.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2026Election of Directors Raquelle W. LewisDIRECTOR ELECTIONSISSUER2225784.0000000.000000FOR2225784.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2026Election of Directors Thaddeus J. MalikDIRECTOR ELECTIONSISSUER2225784.0000000.000000FOR2225784.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2026Election of Directors Manuel B. MirandaDIRECTOR ELECTIONSISSUER2225784.0000000.000000FOR2225784.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2026Election of Directors Theodore F. PoundDIRECTOR ELECTIONSISSUER2225784.0000000.000000FOR2225784.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2026Election of Directors Dean L. SeaversDIRECTOR ELECTIONSISSUER2225784.0000000.000000FOR2225784.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2026Election of Directors Jason P. WellsDIRECTOR ELECTIONSISSUER2225784.0000000.000000FOR2225784.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2026Ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER2225784.0000000.000000FOR2225784.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2026Approve the advisory resolution on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2225784.0000000.000000FOR2225784.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2026Approve the advisory resolution on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2225784.0000000.000000FOR2225784.000000FOR2S000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2026Approve CenterPoint Energy, Inc.'s Amended and Restated Certificate of Formation to provide for limited officer exculpation and make certain other immaterial updates.CORPORATE GOVERNANCEISSUER2225784.0000000.000000FOR2225784.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/28/2026DIRECTOR: Alan ArmstrongDIRECTOR ELECTIONSISSUER518655.0000000.000000FOR518655.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/28/2026DIRECTOR: Yves de BalmannDIRECTOR ELECTIONSISSUER518655.0000000.000000FOR518655.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/28/2026DIRECTOR: Joseph DominguezDIRECTOR ELECTIONSISSUER518655.0000000.000000FOR518655.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/28/2026DIRECTOR: Bradley HalversonDIRECTOR ELECTIONSISSUER518655.0000000.000000FOR518655.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/28/2026DIRECTOR: Charles HarringtonDIRECTOR ELECTIONSISSUER518655.0000000.000000FOR518655.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/28/2026DIRECTOR: Julie HolzrichterDIRECTOR ELECTIONSISSUER518655.0000000.000000FOR518655.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/28/2026DIRECTOR: Dhiaa JamilDIRECTOR ELECTIONSISSUER518655.0000000.000000FOR518655.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/28/2026DIRECTOR: Ashish KhandpurDIRECTOR ELECTIONSISSUER518655.0000000.000000FOR518655.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/28/2026DIRECTOR: Robert LawlessDIRECTOR ELECTIONSISSUER518655.0000000.000000FOR518655.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/28/2026DIRECTOR: Eileen PatersonDIRECTOR ELECTIONSISSUER518655.0000000.000000FOR518655.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/28/2026DIRECTOR: John RichardsonDIRECTOR ELECTIONSISSUER518655.0000000.000000FOR518655.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/28/2026DIRECTOR: Nneka RimmerDIRECTOR ELECTIONSISSUER518655.0000000.000000FOR518655.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/28/2026To consider and act on an advisory vote regarding the approval of compensation paid to named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER518655.0000000.000000FOR518655.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/28/2026To consider and act on an advisory vote regarding the approval of compensation paid to named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER518655.0000000.000000FOR518655.000000FOR2S000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/28/2026To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026AUDIT-RELATEDISSUER518655.0000000.000000FOR518655.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/28/2026To consider a shareholder proposal (if properly presented) requesting a report assessing the bases for the company's diversity, equity and inclusion initiativesHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER518655.0000000.000000AGAINST518655.000000FORS000049397VISTRA CORP.92840M102US92840M102704/29/2026To elect the following 11 directors: Scott B. HelmDIRECTOR ELECTIONSISSUER950138.0000000.000000FOR950138.000000FORS000049397VISTRA CORP.92840M102US92840M102704/29/2026To elect the following 11 directors: Hilary E. AckermannDIRECTOR ELECTIONSISSUER950138.0000000.000000FOR950138.000000FORS000049397VISTRA CORP.92840M102US92840M102704/29/2026To elect the following 11 directors: Arcilia C. AcostaDIRECTOR ELECTIONSISSUER950138.0000000.000000FOR950138.000000FORS000049397VISTRA CORP.92840M102US92840M102704/29/2026To elect the following 11 directors: Gavin R. BaieraDIRECTOR ELECTIONSISSUER950138.0000000.000000FOR950138.000000FORS000049397VISTRA CORP.92840M102US92840M102704/29/2026To elect the following 11 directors: Paul M. BarbasDIRECTOR ELECTIONSISSUER950138.0000000.000000FOR950138.000000FORS000049397VISTRA CORP.92840M102US92840M102704/29/2026To elect the following 11 directors: James A. BurkeDIRECTOR ELECTIONSISSUER950138.0000000.000000FOR950138.000000FORS000049397VISTRA CORP.92840M102US92840M102704/29/2026To elect the following 11 directors: Lisa CrutchfieldDIRECTOR ELECTIONSISSUER950138.0000000.000000FOR950138.000000FORS000049397VISTRA CORP.92840M102US92840M102704/29/2026To elect the following 11 directors: Julie A. LagacyDIRECTOR ELECTIONSISSUER950138.0000000.000000FOR950138.000000FORS000049397VISTRA CORP.92840M102US92840M102704/29/2026To elect the following 11 directors: John W. (Bill) PitesaDIRECTOR ELECTIONSISSUER950138.0000000.000000FOR950138.000000FORS000049397VISTRA CORP.92840M102US92840M102704/29/2026To elect the following 11 directors: John R. (J. R.) SultDIRECTOR ELECTIONSISSUER950138.0000000.000000FOR950138.000000FORS000049397VISTRA CORP.92840M102US92840M102704/29/2026To elect the following 11 directors: Robert C. WaltersDIRECTOR ELECTIONSISSUER950138.0000000.000000FOR950138.000000FORS000049397VISTRA CORP.92840M102US92840M102704/29/2026To approve, on a non-binding advisory basis, the 2025 compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER950138.0000000.000000FOR950138.000000FORS000049397VISTRA CORP.92840M102US92840M102704/29/2026To approve, on a non-binding advisory basis, the 2025 compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER950138.0000000.000000FOR950138.000000FOR2S000049397VISTRA CORP.92840M102US92840M102704/29/2026To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER950138.0000000.000000FOR950138.000000FORS000049397NRG ENERGY, INC.629377508US629377508504/30/2026To elect ten directors. Antonio CarrilloDIRECTOR ELECTIONSISSUER424840.0000000.000000FOR424840.000000FORS000049397NRG ENERGY, INC.629377508US629377508504/30/2026To elect ten directors. Matthew Carter, Jr.DIRECTOR ELECTIONSISSUER424840.0000000.000000FOR424840.000000FORS000049397NRG ENERGY, INC.629377508US629377508504/30/2026To elect ten directors. Heather CoxDIRECTOR ELECTIONSISSUER424840.0000000.000000FOR424840.000000FORS000049397NRG ENERGY, INC.629377508US629377508504/30/2026To elect ten directors. Elisabeth B. DonohueDIRECTOR ELECTIONSISSUER424840.0000000.000000FOR424840.000000FORS000049397NRG ENERGY, INC.629377508US629377508504/30/2026To elect ten directors. Marwan FawazDIRECTOR ELECTIONSISSUER424840.0000000.000000FOR424840.000000FORS000049397NRG ENERGY, INC.629377508US629377508504/30/2026To elect ten directors. Robert J. GaudetteDIRECTOR ELECTIONSISSUER424840.0000000.000000FOR424840.000000FORS000049397NRG ENERGY, INC.629377508US629377508504/30/2026To elect ten directors. Sanjay KapoorDIRECTOR ELECTIONSISSUER424840.0000000.000000FOR424840.000000FORS000049397NRG ENERGY, INC.629377508US629377508504/30/2026To elect ten directors. Alexander PourbaixDIRECTOR ELECTIONSISSUER424840.0000000.000000FOR424840.000000FORS000049397NRG ENERGY, INC.629377508US629377508504/30/2026To elect ten directors. Alexandra PrunerDIRECTOR ELECTIONSISSUER424840.0000000.000000FOR424840.000000FORS000049397NRG ENERGY, INC.629377508US629377508504/30/2026To elect ten directors. Marcie C. ZlotnikDIRECTOR ELECTIONSISSUER424840.0000000.000000FOR424840.000000FORS000049397NRG ENERGY, INC.629377508US629377508504/30/2026To approve, on a non-binding advisory basis, NRG Energy, Inc.'s executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER424840.0000000.000000FOR424840.000000FORS000049397NRG ENERGY, INC.629377508US629377508504/30/2026To approve, on a non-binding advisory basis, NRG Energy, Inc.'s executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER424840.0000000.000000FOR424840.000000FOR2S000049397NRG ENERGY, INC.629377508US629377508504/30/2026To ratify the appointment of KPMG LLP as NRG Energy, Inc.'s independent registered public accounting firm for the 2026 fiscal year.AUDIT-RELATEDISSUER424840.0000000.000000FOR424840.000000FORS000049397NRG ENERGY, INC.629377508US629377508504/30/2026To approve the NRG Energy, Inc. 2026 Long-Term Incentive Plan.COMPENSATIONISSUER424840.0000000.000000FOR424840.000000FORS000049397NRG ENERGY, INC.629377508US629377508504/30/2026To vote on a stockholder proposal to give shareholders the ability to call for a special shareholder meeting, if properly presented at the meeting.CORPORATE GOVERNANCESECURITY HOLDER424840.0000000.000000AGAINST424840.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/05/2026DIRECTOR: Stephen SchaeferDIRECTOR ELECTIONSISSUER446224.0000000.000000FOR446224.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/05/2026DIRECTOR: Mark "Mac" McFarlandDIRECTOR ELECTIONSISSUER446224.0000000.000000FOR446224.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/05/2026DIRECTOR: Gizman AbbasDIRECTOR ELECTIONSISSUER446224.0000000.000000FOR446224.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/05/2026DIRECTOR: Anthony HortonDIRECTOR ELECTIONSISSUER446224.0000000.000000FOR446224.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/05/2026DIRECTOR: Karen HydeDIRECTOR ELECTIONSISSUER446224.0000000.000000FOR446224.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/05/2026DIRECTOR: Joseph NigroDIRECTOR ELECTIONSISSUER446224.0000000.000000FOR446224.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/05/2026DIRECTOR: C. Benson SchwartzsteinDIRECTOR ELECTIONSISSUER446224.0000000.000000FOR446224.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/05/2026To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER446224.0000000.000000FOR446224.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/05/2026To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER446224.0000000.000000FOR446224.000000FOR2S000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/05/2026To ratify the appointment of PricewaterhouseCoopers LLP as the Company's Independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER446224.0000000.000000FOR446224.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027 Warner L. BaxterDIRECTOR ELECTIONSISSUER137328.0000000.000000FOR137328.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027 Ave M. BieDIRECTOR ELECTIONSISSUER137328.0000000.000000FOR137328.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027 Danny L. CunninghamDIRECTOR ELECTIONSISSUER137328.0000000.000000FOR137328.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027 William M. Farrow IIIDIRECTOR ELECTIONSISSUER137328.0000000.000000FOR137328.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027 Cristina A. Garcia-ThomasDIRECTOR ELECTIONSISSUER137328.0000000.000000FOR137328.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027 Maria C. GreenDIRECTOR ELECTIONSISSUER137328.0000000.000000FOR137328.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027 Thomas K. LaneDIRECTOR ELECTIONSISSUER137328.0000000.000000FOR137328.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027 John D. LangeDIRECTOR ELECTIONSISSUER137328.0000000.000000FOR137328.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027 Scott J. LauberDIRECTOR ELECTIONSISSUER137328.0000000.000000FOR137328.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027 Ulice Payne, Jr.DIRECTOR ELECTIONSISSUER137328.0000000.000000FOR137328.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027 Mary Ellen StanekDIRECTOR ELECTIONSISSUER137328.0000000.000000FOR137328.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027 Glen E. TellockDIRECTOR ELECTIONSISSUER137328.0000000.000000FOR137328.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Ratification of Deloitte & Touche LLP as independent auditors for 2026AUDIT-RELATEDISSUER137328.0000000.000000FOR137328.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Advisory vote to approve executive compensation of the named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER137328.0000000.000000FOR137328.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Advisory vote to approve executive compensation of the named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER137328.0000000.000000FOR137328.000000FOR2S000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Amendments to the Restated Articles of Incorporation to eliminate supermajority voting requirementsCORPORATE GOVERNANCEISSUER137328.0000000.000000FOR137328.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Amendments to the Bylaws to eliminate supermajority voting requirementsCORPORATE GOVERNANCEISSUER137328.0000000.000000FOR137328.000000FORS000049397WEC ENERGY GROUP, INC.92939U106US92939U106005/07/2026Stockholder proposal to govern by majority voteCORPORATE GOVERNANCESECURITY HOLDER137328.0000000.000000AGAINST137328.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026ELECTION OF DIRECTORS Deborah H. ButlerDIRECTOR ELECTIONSISSUER660488.0000000.000000FOR660488.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026ELECTION OF DIRECTORS Ralph IzzoDIRECTOR ELECTIONSISSUER660488.0000000.000000FOR660488.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026ELECTION OF DIRECTORS Richard P. KeyesDIRECTOR ELECTIONSISSUER660488.0000000.000000FOR660488.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026ELECTION OF DIRECTORS Diane LeopoldDIRECTOR ELECTIONSISSUER660488.0000000.000000FOR660488.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026ELECTION OF DIRECTORS Garrick J. RochowDIRECTOR ELECTIONSISSUER660488.0000000.000000FOR660488.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026ELECTION OF DIRECTORS John G. RussellDIRECTOR ELECTIONSISSUER660488.0000000.000000FOR660488.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026ELECTION OF DIRECTORS Suzanne F. ShankDIRECTOR ELECTIONSISSUER660488.0000000.000000FOR660488.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026ELECTION OF DIRECTORS Myrna M. SotoDIRECTOR ELECTIONSISSUER660488.0000000.000000FOR660488.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026ELECTION OF DIRECTORS John G. SznewajsDIRECTOR ELECTIONSISSUER660488.0000000.000000FOR660488.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026ELECTION OF DIRECTORS Ronald J. TanskiDIRECTOR ELECTIONSISSUER660488.0000000.000000FOR660488.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026ELECTION OF DIRECTORS Laura H. WrightDIRECTOR ELECTIONSISSUER660488.0000000.000000FOR660488.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026Approve, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER660488.0000000.000000FOR660488.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026Approve, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER660488.0000000.000000FOR660488.000000FOR2S000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026Ratify the appointment of independent registered public accounting firm (PricewaterhouseCoopers LLP).AUDIT-RELATEDISSUER660488.0000000.000000FOR660488.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026Approve an Amendment to the Restated Articles of Incorporation Increasing the Number of Authorized Shares of Common Stock from 350 Million Shares to 700 Million Shares.CAPITAL STRUCTUREISSUER660488.0000000.000000FOR660488.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026Approve an Amendment to the Restated Articles of Incorporation to Allow Shareholders to Call a Special Meeting.CORPORATE GOVERNANCEISSUER660488.0000000.000000FOR660488.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/08/2026Vote on a Shareholder Proposal: Shareholder Right to Act by Written Consent.CORPORATE GOVERNANCESECURITY HOLDER660488.0000000.000000AGAINST660488.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/08/2026Election of Directors Gina F. AdamsDIRECTOR ELECTIONSISSUER675262.0000000.000000FOR675262.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/08/2026Election of Directors John H. BlackDIRECTOR ELECTIONSISSUER675262.0000000.000000FOR675262.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/08/2026Election of Directors John R. BurbankDIRECTOR ELECTIONSISSUER675262.0000000.000000FOR675262.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/08/2026Election of Directors James F. Caldwell, Jr.DIRECTOR ELECTIONSISSUER675262.0000000.000000FOR675262.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/08/2026Election of Directors Kirkland H. DonaldDIRECTOR ELECTIONSISSUER675262.0000000.000000FOR675262.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/08/2026Election of Directors Brian W. EllisDIRECTOR ELECTIONSISSUER675262.0000000.000000FOR675262.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/08/2026Election of Directors Philip L. FredericksonDIRECTOR ELECTIONSISSUER675262.0000000.000000FOR675262.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/08/2026Election of Directors M. Elise HylandDIRECTOR ELECTIONSISSUER675262.0000000.000000FOR675262.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/08/2026Election of Directors Stuart L. LevenickDIRECTOR ELECTIONSISSUER675262.0000000.000000FOR675262.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/08/2026Election of Directors Andrew S. MarshDIRECTOR ELECTIONSISSUER675262.0000000.000000FOR675262.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/08/2026Election of Directors Karen A. PuckettDIRECTOR ELECTIONSISSUER675262.0000000.000000FOR675262.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/08/2026Election of Directors R. Lewis RoppDIRECTOR ELECTIONSISSUER675262.0000000.000000FOR675262.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/08/2026Ratification of the Appointment of Deloitte & Touche LLP as Entergy's Independent Registered Public Accounting Firm for 2026.AUDIT-RELATEDISSUER675262.0000000.000000FOR675262.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/08/2026Advisory Vote to Approve Named Executive Officer Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER675262.0000000.000000FOR675262.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/08/2026Advisory Vote to Approve Named Executive Officer Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER675262.0000000.000000FOR675262.000000FOR2S000049397NISOURCE INC.65473P105US65473P105705/11/2026To elect twelve directors to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified. Peter A. AltabefDIRECTOR ELECTIONSISSUER1461055.0000000.000000FOR1461055.000000FORS000049397NISOURCE INC.65473P105US65473P105705/11/2026To elect twelve directors to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified. Sondra L. BarbourDIRECTOR ELECTIONSISSUER1461055.0000000.000000FOR1461055.000000FORS000049397NISOURCE INC.65473P105US65473P105705/11/2026To elect twelve directors to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified. Theodore H. Bunting, Jr.DIRECTOR ELECTIONSISSUER1461055.0000000.000000FOR1461055.000000FORS000049397NISOURCE INC.65473P105US65473P105705/11/2026To elect twelve directors to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified. Eric L. ButlerDIRECTOR ELECTIONSISSUER1461055.0000000.000000FOR1461055.000000FORS000049397NISOURCE INC.65473P105US65473P105705/11/2026To elect twelve directors to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified. Deborah A. HenrettaDIRECTOR ELECTIONSISSUER1461055.0000000.000000FOR1461055.000000FORS000049397NISOURCE INC.65473P105US65473P105705/11/2026To elect twelve directors to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified. Deborah A. P. HersmanDIRECTOR ELECTIONSISSUER1461055.0000000.000000FOR1461055.000000FORS000049397NISOURCE INC.65473P105US65473P105705/11/2026To elect twelve directors to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified. Michael E. JesanisDIRECTOR ELECTIONSISSUER1461055.0000000.000000FOR1461055.000000FORS000049397NISOURCE INC.65473P105US65473P105705/11/2026To elect twelve directors to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified. William D. JohnsonDIRECTOR ELECTIONSISSUER1461055.0000000.000000FOR1461055.000000FORS000049397NISOURCE INC.65473P105US65473P105705/11/2026To elect twelve directors to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified. Kevin T. KabatDIRECTOR ELECTIONSISSUER1461055.0000000.000000FOR1461055.000000FORS000049397NISOURCE INC.65473P105US65473P105705/11/2026To elect twelve directors to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified. Cassandra S. LeeDIRECTOR ELECTIONSISSUER1461055.0000000.000000FOR1461055.000000FORS000049397NISOURCE INC.65473P105US65473P105705/11/2026To elect twelve directors to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified. John McAvoyDIRECTOR ELECTIONSISSUER1461055.0000000.000000FOR1461055.000000FORS000049397NISOURCE INC.65473P105US65473P105705/11/2026To elect twelve directors to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified. Lloyd M. YatesDIRECTOR ELECTIONSISSUER1461055.0000000.000000FOR1461055.000000FORS000049397NISOURCE INC.65473P105US65473P105705/11/2026To approve the compensation of our named executive officers on an advisory basis.SECTION 14A SAY-ON-PAY VOTESISSUER1461055.0000000.000000FOR1461055.000000FORS000049397NISOURCE INC.65473P105US65473P105705/11/2026To approve the compensation of our named executive officers on an advisory basis.SECTION 14A SAY-ON-PAY VOTESISSUER1461055.0000000.000000FOR1461055.000000FOR2S000049397NISOURCE INC.65473P105US65473P105705/11/2026To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER1461055.0000000.000000FOR1461055.000000FORS000049397SEMPRA816851109US816851109005/12/2026Election of the following 11 director nominees: Andres ConesaDIRECTOR ELECTIONSISSUER752009.0000000.000000FOR752009.000000FORS000049397SEMPRA816851109US816851109005/12/2026Election of the following 11 director nominees: Pablo A. FerreroDIRECTOR ELECTIONSISSUER752009.0000000.000000FOR752009.000000FORS000049397SEMPRA816851109US816851109005/12/2026Election of the following 11 director nominees: Jennifer M. KirkDIRECTOR ELECTIONSISSUER752009.0000000.000000FOR752009.000000FORS000049397SEMPRA816851109US816851109005/12/2026Election of the following 11 director nominees: Richard J. MarkDIRECTOR ELECTIONSISSUER752009.0000000.000000FOR752009.000000FORS000049397SEMPRA816851109US816851109005/12/2026Election of the following 11 director nominees: Jeffrey W. MartinDIRECTOR ELECTIONSISSUER752009.0000000.000000FOR752009.000000FORS000049397SEMPRA816851109US816851109005/12/2026Election of the following 11 director nominees: Michael N. MearsDIRECTOR ELECTIONSISSUER752009.0000000.000000FOR752009.000000FORS000049397SEMPRA816851109US816851109005/12/2026Election of the following 11 director nominees: Kevin C. SagaraDIRECTOR ELECTIONSISSUER752009.0000000.000000FOR752009.000000FORS000049397SEMPRA816851109US816851109005/12/2026Election of the following 11 director nominees: Jack T. TaylorDIRECTOR ELECTIONSISSUER752009.0000000.000000FOR752009.000000FORS000049397SEMPRA816851109US816851109005/12/2026Election of the following 11 director nominees: Cynthia J. WarnerDIRECTOR ELECTIONSISSUER752009.0000000.000000FOR752009.000000FORS000049397SEMPRA816851109US816851109005/12/2026Election of the following 11 director nominees: Anya WeavingDIRECTOR ELECTIONSISSUER752009.0000000.000000FOR752009.000000FORS000049397SEMPRA816851109US816851109005/12/2026Election of the following 11 director nominees: James C. YardleyDIRECTOR ELECTIONSISSUER752009.0000000.000000FOR752009.000000FORS000049397SEMPRA816851109US816851109005/12/2026Ratification of appointment of independent registered public accounting firm.AUDIT-RELATEDISSUER752009.0000000.000000FOR752009.000000FORS000049397SEMPRA816851109US816851109005/12/2026Advisory approval of our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER752009.0000000.000000FOR752009.000000FORS000049397SEMPRA816851109US816851109005/12/2026Advisory approval of our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER752009.0000000.000000FOR752009.000000FOR2S000049397SEMPRA816851109US816851109005/12/2026Shareholder proposal requesting an independent board chairmanCORPORATE GOVERNANCESECURITY HOLDER752009.0000000.000000AGAINST752009.000000FORS000049397PPL CORPORATION69351T106US69351T106005/13/2026Election of directors: Arthur P. BeattieDIRECTOR ELECTIONSISSUER1572443.0000000.000000FOR1572443.000000FORS000049397PPL CORPORATION69351T106US69351T106005/13/2026Election of directors: Raja RajamannarDIRECTOR ELECTIONSISSUER1572443.0000000.000000FOR1572443.000000FORS000049397PPL CORPORATION69351T106US69351T106005/13/2026Election of directors: Heather B. RedmanDIRECTOR ELECTIONSISSUER1572443.0000000.000000FOR1572443.000000FORS000049397PPL CORPORATION69351T106US69351T106005/13/2026Election of directors: Craig A. RogersonDIRECTOR ELECTIONSISSUER1572443.0000000.000000FOR1572443.000000FORS000049397PPL CORPORATION69351T106US69351T106005/13/2026Election of directors: Vincent SorgiDIRECTOR ELECTIONSISSUER1572443.0000000.000000FOR1572443.000000FORS000049397PPL CORPORATION69351T106US69351T106005/13/2026Election of directors: Linda G. SullivanDIRECTOR ELECTIONSISSUER1572443.0000000.000000FOR1572443.000000FORS000049397PPL CORPORATION69351T106US69351T106005/13/2026Election of directors: Keith H. WilliamsonDIRECTOR ELECTIONSISSUER1572443.0000000.000000FOR1572443.000000FORS000049397PPL CORPORATION69351T106US69351T106005/13/2026Election of directors: Phoebe A. WoodDIRECTOR ELECTIONSISSUER1572443.0000000.000000FOR1572443.000000FORS000049397PPL CORPORATION69351T106US69351T106005/13/2026Election of directors: Armando Zagalo de LimaDIRECTOR ELECTIONSISSUER1572443.0000000.000000FOR1572443.000000FORS000049397PPL CORPORATION69351T106US69351T106005/13/2026Advisory vote to approve compensation of named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER1572443.0000000.000000FOR1572443.000000FORS000049397PPL CORPORATION69351T106US69351T106005/13/2026Advisory vote to approve compensation of named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER1572443.0000000.000000FOR1572443.000000FOR2S000049397PPL CORPORATION69351T106US69351T106005/13/2026Approval of the PPL Corporation Second Amended and Restated 2012 Stock Incentive PlanCOMPENSATIONISSUER1572443.0000000.000000FOR1572443.000000FORS000049397PPL CORPORATION69351T106US69351T106005/13/2026Ratification of the appointment of Independent Registered Public Accounting FirmAUDIT-RELATEDISSUER1572443.0000000.000000FOR1572443.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Elect 12 Directors: Janaki AkellaDIRECTOR ELECTIONSISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Elect 12 Directors: Shantella E. CooperDIRECTOR ELECTIONSISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Elect 12 Directors: Anthony F. Earley, Jr.DIRECTOR ELECTIONSISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Elect 12 Directors: James O. EtheredgeDIRECTOR ELECTIONSISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Elect 12 Directors: David J. GrainDIRECTOR ELECTIONSISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Elect 12 Directors: John D. JohnsDIRECTOR ELECTIONSISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Elect 12 Directors: David E. MeadorDIRECTOR ELECTIONSISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Elect 12 Directors: William G. Smith, Jr.DIRECTOR ELECTIONSISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Elect 12 Directors: Kristine L. SvinickiDIRECTOR ELECTIONSISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Elect 12 Directors: Lizanne ThomasDIRECTOR ELECTIONSISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Elect 12 Directors: John M. Turner, Jr.DIRECTOR ELECTIONSISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Elect 12 Directors: Christopher C. WomackDIRECTOR ELECTIONSISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Advisory vote to approve executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Advisory vote to approve executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER370369.0000000.000000FOR370369.000000FOR2S000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2026AUDIT-RELATEDISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Approve an amendment to the Restated Certificate of Incorporation to authorize additional common stockCAPITAL STRUCTUREISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Approve amendments to the Restated Certificate of Incorporation to authorize the issuance of preferred stockCAPITAL STRUCTUREISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Approve an amendment to the Restated Certificate of Incorporation to provide for officer exculpationCORPORATE GOVERNANCEISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Approve miscellaneous amendments to modernize, clarify and conform the Restated Certificate of IncorporationCORPORATE GOVERNANCEISSUER370369.0000000.000000FOR370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Stockholder proposal regarding independent board chairmanCORPORATE GOVERNANCESECURITY HOLDER370369.0000000.000000AGAINST370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Stockholder proposal regarding a report on data center costsOTHERCompany-Specific -- MiscellaneousSECURITY HOLDER370369.0000000.000000AGAINST370369.000000FORS000049397THE SOUTHERN COMPANY842587107US842587107105/13/2026Stockholder proposal regarding a report on climate due diligenceENVIRONMENT OR CLIMATESECURITY HOLDER370369.0000000.000000AGAINST370369.000000FORS000049397AMEREN CORPORATION023608102US023608102405/14/2026ITEM 1 COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR CYNTHIA J. BRINKLEYDIRECTOR ELECTIONSISSUER485476.0000000.000000FOR485476.000000FORS000049397AMEREN CORPORATION023608102US023608102405/14/2026ITEM 1 COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR WARD H. DICKSONDIRECTOR ELECTIONSISSUER485476.0000000.000000FOR485476.000000FORS000049397AMEREN CORPORATION023608102US023608102405/14/2026ITEM 1 COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR JAMIE L. ENGSTROMDIRECTOR ELECTIONSISSUER485476.0000000.000000FOR485476.000000FORS000049397AMEREN CORPORATION023608102US023608102405/14/2026ITEM 1 COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR ELLEN M. FITZSIMMONSDIRECTOR ELECTIONSISSUER485476.0000000.000000FOR485476.000000FORS000049397AMEREN CORPORATION023608102US023608102405/14/2026ITEM 1 COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR RAFAEL FLORESDIRECTOR ELECTIONSISSUER485476.0000000.000000FOR485476.000000FORS000049397AMEREN CORPORATION023608102US023608102405/14/2026ITEM 1 COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR RICHARD J. HARSHMANDIRECTOR ELECTIONSISSUER485476.0000000.000000FOR485476.000000FORS000049397AMEREN CORPORATION023608102US023608102405/14/2026ITEM 1 COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR CRAIG S. IVEYDIRECTOR ELECTIONSISSUER485476.0000000.000000FOR485476.000000FORS000049397AMEREN CORPORATION023608102US023608102405/14/2026ITEM 1 COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR STEVEN H. LIPSTEINDIRECTOR ELECTIONSISSUER485476.0000000.000000FOR485476.000000FORS000049397AMEREN CORPORATION023608102US023608102405/14/2026ITEM 1 COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR MARTIN J. LYONS, JR.DIRECTOR ELECTIONSISSUER485476.0000000.000000FOR485476.000000FORS000049397AMEREN CORPORATION023608102US023608102405/14/2026ITEM 1 COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR LEO S. MACKAY, JR.DIRECTOR ELECTIONSISSUER485476.0000000.000000FOR485476.000000FORS000049397AMEREN CORPORATION023608102US023608102405/14/2026ITEM 1 COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR TIMOTHY S. RAUSCHDIRECTOR ELECTIONSISSUER485476.0000000.000000FOR485476.000000FORS000049397AMEREN CORPORATION023608102US023608102405/14/2026ITEM 1 COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR STEVEN O. VONDRANDIRECTOR ELECTIONSISSUER485476.0000000.000000FOR485476.000000FORS000049397AMEREN CORPORATION023608102US023608102405/14/2026ITEM 2- COMPANY PROPOSAL - ADVISORY APPROVAL OF COMPENSATION OF THE NAMED EXECUTIVE OFFICERS DISCLOSED IN THE PROXY STATEMENT.SECTION 14A SAY-ON-PAY VOTESISSUER485476.0000000.000000FOR485476.000000FORS000049397AMEREN CORPORATION023608102US023608102405/14/2026ITEM 2- COMPANY PROPOSAL - ADVISORY APPROVAL OF COMPENSATION OF THE NAMED EXECUTIVE OFFICERS DISCLOSED IN THE PROXY STATEMENT.SECTION 14A SAY-ON-PAY VOTESISSUER485476.0000000.000000FOR485476.000000FOR2S000049397AMEREN CORPORATION023608102US023608102405/14/2026COMPANY PROPOSAL RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.AUDIT-RELATEDISSUER485476.0000000.000000FOR485476.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/14/2026DIRECTOR: Glynis A. BryanDIRECTOR ELECTIONSISSUER380936.0000000.000000FOR380936.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/14/2026DIRECTOR: Ronald Butler, Jr.DIRECTOR ELECTIONSISSUER380936.0000000.000000FOR380936.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/14/2026DIRECTOR: Gonzalo A. MelenaDIRECTOR ELECTIONSISSUER380936.0000000.000000FOR380936.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/14/2026DIRECTOR: Carol S. EicherDIRECTOR ELECTIONSISSUER380936.0000000.000000FOR380936.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/14/2026DIRECTOR: Susan T. FlanaganDIRECTOR ELECTIONSISSUER380936.0000000.000000FOR380936.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/14/2026DIRECTOR: Theodore N. GeislerDIRECTOR ELECTIONSISSUER380936.0000000.000000FOR380936.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/14/2026DIRECTOR: Paula J. SimsDIRECTOR ELECTIONSISSUER380936.0000000.000000FOR380936.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/14/2026DIRECTOR: William H. SpenceDIRECTOR ELECTIONSISSUER380936.0000000.000000FOR380936.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/14/2026DIRECTOR: Kristine L. SvinickiDIRECTOR ELECTIONSISSUER380936.0000000.000000FOR380936.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/14/2026DIRECTOR: James E. Trevathan, Jr.DIRECTOR ELECTIONSISSUER380936.0000000.000000FOR380936.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/14/2026To hold an advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER380936.0000000.000000FOR380936.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/14/2026To hold an advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER380936.0000000.000000FOR380936.000000FOR2S000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/14/2026To ratify the appointment of our independent accountant for the year ending December 31, 2026.AUDIT-RELATEDISSUER380936.0000000.000000FOR380936.000000FORS000049397ALLIANT ENERGY CORPORATION018802108US018802108505/20/2026Election of Directors Patrick AllenDIRECTOR ELECTIONSISSUER988318.0000000.000000FOR988318.000000FORS000049397ALLIANT ENERGY CORPORATION018802108US018802108505/20/2026Election of Directors Manu AsthanaDIRECTOR ELECTIONSISSUER988318.0000000.000000FOR988318.000000FORS000049397ALLIANT ENERGY CORPORATION018802108US018802108505/20/2026Election of Directors Ignacio CortinaDIRECTOR ELECTIONSISSUER988318.0000000.000000FOR988318.000000FORS000049397ALLIANT ENERGY CORPORATION018802108US018802108505/20/2026Election of Directors Michael GarciaDIRECTOR ELECTIONSISSUER988318.0000000.000000FOR988318.000000FORS000049397ALLIANT ENERGY CORPORATION018802108US018802108505/20/2026Advisory vote to approve the compensation of our named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER988318.0000000.000000FOR988318.000000FORS000049397ALLIANT ENERGY CORPORATION018802108US018802108505/20/2026Advisory vote to approve the compensation of our named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER988318.0000000.000000FOR988318.000000FOR2S000049397ALLIANT ENERGY CORPORATION018802108US018802108505/20/2026Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026AUDIT-RELATEDISSUER988318.0000000.000000FOR988318.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/20/2026Election of Directors Megan BurkhartDIRECTOR ELECTIONSISSUER1292533.0000000.000000FOR1292533.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/20/2026Election of Directors Lynn CaseyDIRECTOR ELECTIONSISSUER1292533.0000000.000000FOR1292533.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/20/2026Election of Directors Maria DemareeDIRECTOR ELECTIONSISSUER1292533.0000000.000000FOR1292533.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/20/2026Election of Directors Bob FrenzelDIRECTOR ELECTIONSISSUER1292533.0000000.000000FOR1292533.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/20/2026Election of Directors Netha JohnsonDIRECTOR ELECTIONSISSUER1292533.0000000.000000FOR1292533.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/20/2026Election of Directors Patricia KamplingDIRECTOR ELECTIONSISSUER1292533.0000000.000000FOR1292533.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/20/2026Election of Directors George KehlDIRECTOR ELECTIONSISSUER1292533.0000000.000000FOR1292533.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/20/2026Election of Directors Charles PardeeDIRECTOR ELECTIONSISSUER1292533.0000000.000000FOR1292533.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/20/2026Election of Directors Devin StockfishDIRECTOR ELECTIONSISSUER1292533.0000000.000000FOR1292533.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/20/2026Election of Directors Timothy WelshDIRECTOR ELECTIONSISSUER1292533.0000000.000000FOR1292533.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/20/2026Approval of Xcel Energy Inc.'s executive compensation in an advisory vote (say on pay vote)SECTION 14A SAY-ON-PAY VOTESISSUER1292533.0000000.000000FOR1292533.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/20/2026Approval of Xcel Energy Inc.'s executive compensation in an advisory vote (say on pay vote)SECTION 14A SAY-ON-PAY VOTESISSUER1292533.0000000.000000FOR1292533.000000FOR2S000049397XCEL ENERGY INC.98389B100US98389B100805/20/2026Ratification of the appointment of Deloitte & Touche LLP as Xcel Energy Inc.'s independent registered public accounting firm for 2026AUDIT-RELATEDISSUER1292533.0000000.000000FOR1292533.000000FORS000049397IDACORP, INC.451107106US451107106405/21/2026Elect ten directors nominated by the board of directors for one-year terms. Odette C. BolanoDIRECTOR ELECTIONSISSUER441908.0000000.000000FOR441908.000000FORS000049397IDACORP, INC.451107106US451107106405/21/2026Elect ten directors nominated by the board of directors for one-year terms. Annette G. ElgDIRECTOR ELECTIONSISSUER441908.0000000.000000FOR441908.000000FORS000049397IDACORP, INC.451107106US451107106405/21/2026Elect ten directors nominated by the board of directors for one-year terms. Lisa A. GrowDIRECTOR ELECTIONSISSUER441908.0000000.000000FOR441908.000000FORS000049397IDACORP, INC.451107106US451107106405/21/2026Elect ten directors nominated by the board of directors for one-year terms. Dennis L. JohnsonDIRECTOR ELECTIONSISSUER441908.0000000.000000FOR441908.000000FORS000049397IDACORP, INC.451107106US451107106405/21/2026Elect ten directors nominated by the board of directors for one-year terms. Nate R. JorgensenDIRECTOR ELECTIONSISSUER441908.0000000.000000FOR441908.000000FORS000049397IDACORP, INC.451107106US451107106405/21/2026Elect ten directors nominated by the board of directors for one-year terms. Michael J. KennedyDIRECTOR ELECTIONSISSUER441908.0000000.000000FOR441908.000000FORS000049397IDACORP, INC.451107106US451107106405/21/2026Elect ten directors nominated by the board of directors for one-year terms. Scott W. MadisonDIRECTOR ELECTIONSISSUER441908.0000000.000000FOR441908.000000FORS000049397IDACORP, INC.451107106US451107106405/21/2026Elect ten directors nominated by the board of directors for one-year terms. Sharon L. MillerDIRECTOR ELECTIONSISSUER441908.0000000.000000FOR441908.000000FORS000049397IDACORP, INC.451107106US451107106405/21/2026Elect ten directors nominated by the board of directors for one-year terms. Susan D. MorrisDIRECTOR ELECTIONSISSUER441908.0000000.000000FOR441908.000000FORS000049397IDACORP, INC.451107106US451107106405/21/2026Elect ten directors nominated by the board of directors for one-year terms. Dr. Mark T. PetersDIRECTOR ELECTIONSISSUER441908.0000000.000000FOR441908.000000FORS000049397IDACORP, INC.451107106US451107106405/21/2026Advisory resolution to approve our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER441908.0000000.000000FOR441908.000000FORS000049397IDACORP, INC.451107106US451107106405/21/2026Advisory resolution to approve our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER441908.0000000.000000FOR441908.000000FOR2S000049397IDACORP, INC.451107106US451107106405/21/2026Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER441908.0000000.000000FOR441908.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement. Nicole S. ArnaboldiDIRECTOR ELECTIONSISSUER747175.0000000.000000FOR747175.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement. James L. CamarenDIRECTOR ELECTIONSISSUER747175.0000000.000000FOR747175.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement. Naren K. GursahaneyDIRECTOR ELECTIONSISSUER747175.0000000.000000FOR747175.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement. Kirk S. HachigianDIRECTOR ELECTIONSISSUER747175.0000000.000000FOR747175.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement. Maria G. HenryDIRECTOR ELECTIONSISSUER747175.0000000.000000FOR747175.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement. John W. KetchumDIRECTOR ELECTIONSISSUER747175.0000000.000000FOR747175.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement. Amy B. LaneDIRECTOR ELECTIONSISSUER747175.0000000.000000FOR747175.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement. Geoffrey S. MarthaDIRECTOR ELECTIONSISSUER747175.0000000.000000FOR747175.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement. David L. PorgesDIRECTOR ELECTIONSISSUER747175.0000000.000000FOR747175.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement. Deborah L. "Dev" StahlkopfDIRECTOR ELECTIONSISSUER747175.0000000.000000FOR747175.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement. John A. StallDIRECTOR ELECTIONSISSUER747175.0000000.000000FOR747175.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement. Darryl L. WilsonDIRECTOR ELECTIONSISSUER747175.0000000.000000FOR747175.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026Ratification of appointment of Deloitte & Touche LLP as NextEra Energy's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER747175.0000000.000000FOR747175.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026Approval, by non-binding advisory vote, of NextEra Energy's compensation of its named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER747175.0000000.000000FOR747175.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026Approval, by non-binding advisory vote, of NextEra Energy's compensation of its named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER747175.0000000.000000FOR747175.000000FOR2S000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026A proposal entitled ''Paris Agreement Alignment'' requesting NextEra Energy publish a report describing if and how the Company plans to reduce its total contribution to climate change and align its operations and investments with the Paris Agreement's goal of maintaining global temperatures well below 2 degrees Celsius, and ideally, 1.5 degrees Celsius.ENVIRONMENT OR CLIMATESECURITY HOLDER747175.0000000.000000AGAINST747175.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/21/2026A proposal entitled ''Report on Net Zero Business Performance Risks'' requesting the Board of Directors of NextEra Energy prepare a report within the next year, evaluating the potential costs and benefits to NextEra Energy created by aggressive emission reduction policies.ENVIRONMENT OR CLIMATESECURITY HOLDER747175.0000000.000000AGAINST747175.000000FORS000049397National Grid plcGB00BDR05C0107/09/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Final DividendCAPITAL STRUCTUREISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Elect Paula Rosput ReynoldsDIRECTOR ELECTIONSISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Elect John PettigrewDIRECTOR ELECTIONSISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Elect Andy AggDIRECTOR ELECTIONSISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Elect Jacqui FergusonDIRECTOR ELECTIONSISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Elect Ian P. LivingstonDIRECTOR ELECTIONSISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Elect Iain J. MackayDIRECTOR ELECTIONSISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Elect Anne RobinsonDIRECTOR ELECTIONSISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Elect Earl L. ShippDIRECTOR ELECTIONSISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Elect Jonathan SilverDIRECTOR ELECTIONSISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Elect Antony WoodDIRECTOR ELECTIONSISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Elect Martha B. WyrschDIRECTOR ELECTIONSISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Appointment of AuditorAUDIT-RELATEDISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Remuneration PolicyCOMPENSATIONISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Remuneration ReportCOMPENSATIONISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Amendment to Borrowing LimitCAPITAL STRUCTUREISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Scrip DividendCAPITAL STRUCTUREISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Capitalisation of Accounts (Scrip Dividend Scheme)CAPITAL STRUCTUREISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment)CAPITAL STRUCTUREISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER10679.0000000.000000FOR10679.000000FORS000058304National Grid plcGB00BDR05C0107/09/2025Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER10679.0000000.000000FOR10679.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Remuneration ReportCOMPENSATIONISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Final DividendCAPITAL STRUCTUREISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Elect Louise CaseyDIRECTOR ELECTIONSISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Elect Michael CampbellDIRECTOR ELECTIONSISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Elect Sir Ian CheshireDIRECTOR ELECTIONSISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Elect Mark AllanDIRECTOR ELECTIONSISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Elect Vanessa SimmsDIRECTOR ELECTIONSISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Elect Moni ManningsDIRECTOR ELECTIONSISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Elect James BowlingDIRECTOR ELECTIONSISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Elect Christophe EvainDIRECTOR ELECTIONSISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Elect Miles W. RobertsDIRECTOR ELECTIONSISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Elect Manjiry TamhaneDIRECTOR ELECTIONSISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Appointment of AuditorAUDIT-RELATEDISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment)CAPITAL STRUCTUREISSUER16940.0000000.000000FOR16940.000000FORS000058304Land Securities Group plcGB00BYW0PQ6007/10/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER16940.0000000.000000FOR16940.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Remuneration ReportCOMPENSATIONISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Approval of Net Zero Transition PlanENVIRONMENT OR CLIMATEISSUER367.0000000.000000ABSTAIN367.000000AGAINSTS000058304Severn Trent plcGB00B1FH8J7207/10/2025Final DividendCAPITAL STRUCTUREISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Elect Tom DelayDIRECTOR ELECTIONSISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Elect Olivia (Liv) GarfieldDIRECTOR ELECTIONSISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Elect Nick HamptonDIRECTOR ELECTIONSISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Elect Christine HodgsonDIRECTOR ELECTIONSISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Elect Sarah C. LeggDIRECTOR ELECTIONSISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Elect Helen MilesDIRECTOR ELECTIONSISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Elect Sharmila NebhrajaniDIRECTOR ELECTIONSISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Elect Richard Mark TaylorDIRECTOR ELECTIONSISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Appointment of AuditorAUDIT-RELATEDISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment)CAPITAL STRUCTUREISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Adoption of New ArticlesCORPORATE GOVERNANCEISSUER367.0000000.000000FOR367.000000FORS000058304Severn Trent plcGB00B1FH8J7207/10/2025Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER367.0000000.000000FOR367.000000FORS000058304Industria de Diseno Textil S.A. - INDITEX, S.A.ES014839600707/15/2025Individual Accounts and ReportsCORPORATE GOVERNANCEISSUER1993.0000000.000000FOR1993.000000FORS000058304Industria de Diseno Textil S.A. - INDITEX, S.A.ES014839600707/15/2025Ratification of Board ActsCORPORATE GOVERNANCEISSUER1993.0000000.000000FOR1993.000000FORS000058304Industria de Diseno Textil S.A. - INDITEX, S.A.ES014839600707/15/2025Consolidated Accounts and ReportsCORPORATE GOVERNANCEISSUER1993.0000000.000000FOR1993.000000FORS000058304Industria de Diseno Textil S.A. - INDITEX, S.A.ES014839600707/15/2025Report on Non-Financial InformationCORPORATE GOVERNANCEISSUER1993.0000000.000000FOR1993.000000FORS000058304Industria de Diseno Textil S.A. - INDITEX, S.A.ES014839600707/15/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER1993.0000000.000000FOR1993.000000FORS000058304Industria de Diseno Textil S.A. - INDITEX, S.A.ES014839600707/15/2025Elect Roberto Cibeira MoreirasDIRECTOR ELECTIONSISSUER1993.0000000.000000FOR1993.000000FORS000058304Industria de Diseno Textil S.A. - INDITEX, S.A.ES014839600707/15/2025Appointment of AuditorAUDIT-RELATEDISSUER1993.0000000.000000FOR1993.000000FORS000058304Industria de Diseno Textil S.A. - INDITEX, S.A.ES014839600707/15/20252025-2029 Long-Term Incentive PlanCOMPENSATIONISSUER1993.0000000.000000FOR1993.000000FORS000058304Industria de Diseno Textil S.A. - INDITEX, S.A.ES014839600707/15/2025Remuneration ReportCOMPENSATIONISSUER1993.0000000.000000FOR1993.000000FORS000058304Industria de Diseno Textil S.A. - INDITEX, S.A.ES014839600707/15/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER1993.0000000.000000FOR1993.000000FORS000058304Stellantis N.VNL00150001Q907/18/2025Elect Antonio Filosa As Executive Director (Chief Executive Officer)DIRECTOR ELECTIONSISSUER3579.0000000.000000FOR3579.000000FORS000058304Link Real Estate Investment TrustHK082303277307/22/2025Elect Christopher John BrookeDIRECTOR ELECTIONSISSUER4466.0000000.000000FOR4466.000000FORS000058304Link Real Estate Investment TrustHK082303277307/22/2025Elect Melissa WU Mao ChinDIRECTOR ELECTIONSISSUER4466.0000000.000000FOR4466.000000FORS000058304Link Real Estate Investment TrustHK082303277307/22/2025Elect Jana Andonegui SehnalovaDIRECTOR ELECTIONSISSUER4466.0000000.000000FOR4466.000000FORS000058304Link Real Estate Investment TrustHK082303277307/22/2025Elect ENG-KWOK Seat MoeyDIRECTOR ELECTIONSISSUER4466.0000000.000000FOR4466.000000FORS000058304Link Real Estate Investment TrustHK082303277307/22/2025Elect Ann KUNG YEUNG Yun ChiDIRECTOR ELECTIONSISSUER4466.0000000.000000FOR4466.000000FORS000058304Link Real Estate Investment TrustHK082303277307/22/2025Authority to Repurchase UnitsCAPITAL STRUCTUREISSUER4466.0000000.000000FOR4466.000000FORS000058304CapitaLand Ascendas Real Estate Investment TrustSG1M7790691507/30/2025Acquisitions of 9 Tai Seng Drive and 5 Science Park DriveEXTRAORDINARY TRANSACTIONSISSUER5951.0000000.000000FOR5951.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403708/08/2025Elect Wiebe Draijer to the Supervisory BoardDIRECTOR ELECTIONSISSUER315.0000000.000000FOR315.000000FORS000058304Mediobanca - Banca Di Credito Finanziario SpaIT000006295708/21/2025Banca Generali OfferEXTRAORDINARY TRANSACTIONSISSUER3171.0000000.000000FOR3171.000000FORS000058304Lasertec CorporationJP397920000709/26/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER120.0000000.000000FOR120.000000FORS000058304Lasertec CorporationJP397920000709/26/2025Elect Osamu OkabayashiDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Lasertec CorporationJP397920000709/26/2025Elect Haruhiko KusunoseDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Lasertec CorporationJP397920000709/26/2025Elect Tetsuya SendodaDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Lasertec CorporationJP397920000709/26/2025Elect Atsushi TajimaDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Lasertec CorporationJP397920000709/26/2025Elect Koji MiharaDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Lasertec CorporationJP397920000709/26/2025Elect Yoshiko IwataDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Lasertec CorporationJP397920000709/26/2025Elect Miyuki IshiguroDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Lasertec CorporationJP397920000709/26/2025Elect Takashi YuriDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Lasertec CorporationJP397920000709/26/2025BonusCOMPENSATIONISSUER120.0000000.000000FOR120.000000FORS000058304Lasertec CorporationJP397920000709/26/2025Amendment to the Restricted Stock PlanCOMPENSATIONISSUER120.0000000.000000FOR120.000000FORS000058304Transurban GroupAU000000TCL610/08/2025Re-elect Marina S. GoDIRECTOR ELECTIONSISSUER14450.0000000.000000AGAINST14450.000000AGAINSTS000058304Transurban GroupAU000000TCL610/08/2025Re-elect Sarah E. RyanDIRECTOR ELECTIONSISSUER14450.0000000.000000FOR14450.000000FORS000058304Transurban GroupAU000000TCL610/08/2025Remuneration ReportCOMPENSATIONISSUER14450.0000000.000000FOR14450.000000FORS000058304Transurban GroupAU000000TCL610/08/2025Equity Grant (MD/CEO Michelle Jablko)COMPENSATIONISSUER14450.0000000.000000FOR14450.000000FORS000058304StocklandAU000000SGP010/16/2025Elect Chris LawtonDIRECTOR ELECTIONSISSUER38601.0000000.000000FOR38601.000000FORS000058304StocklandAU000000SGP010/16/2025Elect Penny WinnDIRECTOR ELECTIONSISSUER38601.0000000.000000FOR38601.000000FORS000058304StocklandAU000000SGP010/16/2025Remuneration ReportCOMPENSATIONISSUER38601.0000000.000000FOR38601.000000FORS000058304StocklandAU000000SGP010/16/2025Equity Grant (MD/CEO Tarun Gupta)COMPENSATIONISSUER38601.0000000.000000FOR38601.000000FORS000058304Unilever plcGB00B10RZP7810/21/2025Share ConsolidationCAPITAL STRUCTUREISSUER214.0000000.000000FOR214.000000FORS000058304Unilever plcGB00B10RZP7810/21/2025Amendments to Articles (Share Consolidation)CORPORATE GOVERNANCEISSUER214.0000000.000000FOR214.000000FORS000058304APA GroupAU000000APA110/22/2025Remuneration ReportCOMPENSATIONISSUER23429.0000000.000000FOR23429.000000FORS000058304APA GroupAU000000APA110/22/2025Approval of Climate Transition PlanENVIRONMENT OR CLIMATEISSUER23429.0000000.000000ABSTAIN23429.000000AGAINSTS000058304APA GroupAU000000APA110/22/2025Elect Varya DavidsonDIRECTOR ELECTIONSISSUER23429.0000000.000000FOR23429.000000FORS000058304APA GroupAU000000APA110/22/2025Re-elect James E. FazzinoDIRECTOR ELECTIONSISSUER23429.0000000.000000FOR23429.000000FORS000058304APA GroupAU000000APA110/22/2025Re-elect Rhoda Phillippo HarringtonDIRECTOR ELECTIONSISSUER23429.0000000.000000FOR23429.000000FORS000058304APA GroupAU000000APA110/22/2025Equity Grant (MD/CEO Adam Watson)COMPENSATIONISSUER23429.0000000.000000FOR23429.000000FORS000058304APA GroupAU000000APA110/22/2025Shareholder Proposal Regarding Facilitating Nonbinding Proposals (APA Infrastructure Trust)CORPORATE GOVERNANCESECURITY HOLDER23429.0000000.000000AGAINST23429.000000FORS000058304APA GroupAU000000APA110/22/2025Shareholder Proposal Regarding Facilitating Nonbinding Proposals (APA Investment Trust)CORPORATE GOVERNANCESECURITY HOLDER23429.0000000.000000AGAINST23429.000000FORS000058304APA GroupAU000000APA110/22/2025Shareholder Proposal Regarding Consistency of Capex with Climate CommitmentsENVIRONMENT OR CLIMATESECURITY HOLDER23429.0000000.000000AGAINST23429.000000FORS000058304APA GroupAU000000APA110/22/2025Shareholder Proposal Regarding Report on Supplier Code of Conduct Due DiligenceOTHER SOCIAL ISSUESSECURITY HOLDER23429.0000000.000000AGAINST23429.000000FORS000058304Sino Land Company LimitedHK008300050210/22/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER11425.0000000.000000FOR11425.000000FORS000058304Sino Land Company LimitedHK008300050210/22/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER11425.0000000.000000FOR11425.000000FORS000058304Sino Land Company LimitedHK008300050210/22/2025Elect Ringo CHAN Wing KwongDIRECTOR ELECTIONSISSUER11425.0000000.000000FOR11425.000000FORS000058304Sino Land Company LimitedHK008300050210/22/2025Elect Gordon LEE Ching KeungDIRECTOR ELECTIONSISSUER11425.0000000.000000FOR11425.000000FORS000058304Sino Land Company LimitedHK008300050210/22/2025Elect Victor TIN Sio UnDIRECTOR ELECTIONSISSUER11425.0000000.000000FOR11425.000000FORS000058304Sino Land Company LimitedHK008300050210/22/2025Elect Rock CHEN Chung-ninDIRECTOR ELECTIONSISSUER11425.0000000.000000AGAINST11425.000000AGAINSTS000058304Sino Land Company LimitedHK008300050210/22/2025Elect LIU Yee LeiDIRECTOR ELECTIONSISSUER11425.0000000.000000FOR11425.000000FORS000058304Sino Land Company LimitedHK008300050210/22/2025Directors' FeesCOMPENSATIONISSUER11425.0000000.000000FOR11425.000000FORS000058304Sino Land Company LimitedHK008300050210/22/2025Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER11425.0000000.000000FOR11425.000000FORS000058304Sino Land Company LimitedHK008300050210/22/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER11425.0000000.000000FOR11425.000000FORS000058304Sino Land Company LimitedHK008300050210/22/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER11425.0000000.000000AGAINST11425.000000AGAINSTS000058304Sino Land Company LimitedHK008300050210/22/2025Authority to Issue Repurchased SharesCAPITAL STRUCTUREISSUER11425.0000000.000000AGAINST11425.000000AGAINSTS000058304Sino Land Company LimitedHK008300050210/22/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER11425.0000000.000000FOR11425.000000FORS000058304BHP Group LimitedAU000000BHP410/23/2025Re-elect Xiaoqun Clever-StegDIRECTOR ELECTIONSISSUER2768.0000000.000000FOR2768.000000FORS000058304BHP Group LimitedAU000000BHP410/23/2025Re-elect Gary J. GoldbergDIRECTOR ELECTIONSISSUER2768.0000000.000000FOR2768.000000FORS000058304BHP Group LimitedAU000000BHP410/23/2025Re-elect Michelle A HinchliffeDIRECTOR ELECTIONSISSUER2768.0000000.000000FOR2768.000000FORS000058304BHP Group LimitedAU000000BHP410/23/2025Re-elect Donald R. LindsayDIRECTOR ELECTIONSISSUER2768.0000000.000000FOR2768.000000FORS000058304BHP Group LimitedAU000000BHP410/23/2025Re-elect Ross McEwanDIRECTOR ELECTIONSISSUER2768.0000000.000000FOR2768.000000FORS000058304BHP Group LimitedAU000000BHP410/23/2025Re-elect Christine E. O'ReillyDIRECTOR ELECTIONSISSUER2768.0000000.000000FOR2768.000000FORS000058304BHP Group LimitedAU000000BHP410/23/2025Re-elect Catherine TannaDIRECTOR ELECTIONSISSUER2768.0000000.000000FOR2768.000000FORS000058304BHP Group LimitedAU000000BHP410/23/2025Re-elect Dion J. WeislerDIRECTOR ELECTIONSISSUER2768.0000000.000000FOR2768.000000FORS000058304BHP Group LimitedAU000000BHP410/23/2025Remuneration ReportCOMPENSATIONISSUER2768.0000000.000000FOR2768.000000FORS000058304BHP Group LimitedAU000000BHP410/23/2025Equity Grant (CEO Mike Henry)COMPENSATIONISSUER2768.0000000.000000FOR2768.000000FORS000058304Mediobanca - Banca Di Credito Finanziario SpaIT000006295710/28/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER3171.0000000.000000FOR3171.000000FORS000058304Mediobanca - Banca Di Credito Finanziario SpaIT000006295710/28/2025Allocation of DividendsCAPITAL STRUCTUREISSUER3171.0000000.000000FOR3171.000000FORS000058304Mediobanca - Banca Di Credito Finanziario SpaIT000006295710/28/2025Remuneration PolicyCOMPENSATIONISSUER3171.0000000.000000FOR3171.000000FORS000058304Mediobanca - Banca Di Credito Finanziario SpaIT000006295710/28/2025Remuneration ReportCOMPENSATIONISSUER3171.0000000.000000FOR3171.000000FORS000058304Mediobanca - Banca Di Credito Finanziario SpaIT000006295710/28/20252025-26 Performance Share PlanCOMPENSATIONISSUER3171.0000000.000000FOR3171.000000FORS000058304Mediobanca - Banca Di Credito Finanziario SpaIT000006295710/28/2025Board SizeCORPORATE GOVERNANCEISSUER3171.0000000.000000FOR3171.000000FORS000058304Mediobanca - Banca Di Credito Finanziario SpaIT000006295710/28/2025List Presented by Banca Monte dei Paschi di SienaDIRECTOR ELECTIONSISSUER3171.0000000.000000FOR3171.000000NONES000058304Mediobanca - Banca Di Credito Finanziario SpaIT000006295710/28/2025Directors' FeesCOMPENSATIONISSUER3171.0000000.000000FOR3171.000000FORS000058304Mediobanca - Banca Di Credito Finanziario SpaIT000006295710/28/2025Shareholder Proposal Regarding Appointment of Auditor (FY2026-2034) and Appointment of Auditor for Sustainability Reporting (FY2026-2028) Subject to Early Termination of Auditor (EY)AUDIT-RELATEDSECURITY HOLDER3171.0000000.000000FOR3171.000000FORS000058304CAR Group Ltd.AU000000CAR310/31/2025Remuneration ReportCOMPENSATIONISSUER564.0000000.000000FOR564.000000FORS000058304CAR Group Ltd.AU000000CAR310/31/2025Re-elect David WiadrowskiDIRECTOR ELECTIONSISSUER564.0000000.000000AGAINST564.000000AGAINSTS000058304CAR Group Ltd.AU000000CAR310/31/2025Re-elect Patrick O'SullivanDIRECTOR ELECTIONSISSUER564.0000000.000000AGAINST564.000000AGAINSTS000058304CAR Group Ltd.AU000000CAR310/31/2025Equity Grant (MD/CEO William Elliott - FY25 STI)COMPENSATIONISSUER564.0000000.000000FOR564.000000FORS000058304CAR Group Ltd.AU000000CAR310/31/2025Equity Grant (MD/CEO William Elliott - FY26 LTI)COMPENSATIONISSUER564.0000000.000000FOR564.000000FORS000058304Fortescue LtdAU000000FMG410/31/2025Remuneration ReportCOMPENSATIONISSUER6819.0000000.000000FOR6819.000000FORS000058304Fortescue LtdAU000000FMG410/31/2025Re-elect Elizabeth GainesDIRECTOR ELECTIONSISSUER6819.0000000.000000FOR6819.000000FORS000058304Fortescue LtdAU000000FMG410/31/2025Re-elect Yifei LiDIRECTOR ELECTIONSISSUER6819.0000000.000000FOR6819.000000FORS000058304Fortescue LtdAU000000FMG410/31/2025Elect Noel QuinnDIRECTOR ELECTIONSISSUER6819.0000000.000000FOR6819.000000FORS000058304Fortescue LtdAU000000FMG410/31/2025Elect Yasmin BroughtonDIRECTOR ELECTIONSISSUER6819.0000000.000000FOR6819.000000FORS000058304Fortescue LtdAU000000FMG410/31/2025Equity Grant (CEO Metals and Operations Dino Otranto)COMPENSATIONISSUER6819.0000000.000000FOR6819.000000FORS000058304Fortescue LtdAU000000FMG410/31/2025Equity Grant (CEO Growth and Energy Agustin Pichot)COMPENSATIONISSUER6819.0000000.000000FOR6819.000000FORS000058304Fortescue LtdAU000000FMG410/31/2025Renew Proportional Takeover ProvisionsSHAREHOLDER RIGHTS AND DEFENSESISSUER6819.0000000.000000AGAINST6819.000000AGAINSTS000058304Vicinity CentresAU000000VCX711/06/2025REMUNERATION REPORTCOMPENSATIONISSUER42898.0000000.000000FOR42898.000000FORS000058304Vicinity CentresAU000000VCX711/06/2025Re-elect Trevor GerberDIRECTOR ELECTIONSISSUER42898.0000000.000000FOR42898.000000FORS000058304Vicinity CentresAU000000VCX711/06/2025Re-elect Tiffany L. FullerDIRECTOR ELECTIONSISSUER42898.0000000.000000FOR42898.000000FORS000058304Vicinity CentresAU000000VCX711/06/2025Re-elect Georgina A. LynchDIRECTOR ELECTIONSISSUER42898.0000000.000000FOR42898.000000FORS000058304Vicinity CentresAU000000VCX711/06/2025Re-elect Dion WerbeloffDIRECTOR ELECTIONSISSUER42898.0000000.000000FOR42898.000000FORS000058304Vicinity CentresAU000000VCX711/06/2025Equity Grant (MD/CEO Peter Huddle)COMPENSATIONISSUER42898.0000000.000000FOR42898.000000FORS000058304Vicinity CentresAU000000VCX711/06/2025Renew Proportional Takeover Provisions (Company Constitution)SHAREHOLDER RIGHTS AND DEFENSESISSUER42898.0000000.000000FOR42898.000000FORS000058304Vicinity CentresAU000000VCX711/06/2025Renew Proportional Takeover Provisions (Trust Constitution)SHAREHOLDER RIGHTS AND DEFENSESISSUER42898.0000000.000000FOR42898.000000FORS000058304Sonic Healthcare LimitedAU000000SHL711/20/2025Re-elect Christine BennettDIRECTOR ELECTIONSISSUER2235.0000000.000000FOR2235.000000FORS000058304Sonic Healthcare LimitedAU000000SHL711/20/2025Re-elect Katharine GilesDIRECTOR ELECTIONSISSUER2235.0000000.000000FOR2235.000000FORS000058304Sonic Healthcare LimitedAU000000SHL711/20/2025Elect Nicola M. Wakefield EvansDIRECTOR ELECTIONSISSUER2235.0000000.000000FOR2235.000000FORS000058304Sonic Healthcare LimitedAU000000SHL711/20/2025Remuneration ReportCOMPENSATIONISSUER2235.0000000.000000FOR2235.000000FORS000058304Sonic Healthcare LimitedAU000000SHL711/20/2025Equity Grant (Incoming MD/CEO Jim Newcombe)COMPENSATIONISSUER2235.0000000.000000FOR2235.000000FORS000058304Sonic Healthcare LimitedAU000000SHL711/20/2025Equity Grant (Finance Director and CFO Chris Wilks)COMPENSATIONISSUER2235.0000000.000000FOR2235.000000FORS000058304Mediobanca - Banca Di Credito Finanziario SpaIT000006295712/01/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER3171.0000000.000000FOR3171.000000FORS000058304Open Text CorporationCA683715106812/09/2025Elect P. Thomas JenkinsDIRECTOR ELECTIONSISSUER1424.0000000.000000FOR1424.000000FORS000058304Open Text CorporationCA683715106812/09/2025Elect Randy FowlieDIRECTOR ELECTIONSISSUER1424.0000000.000000FOR1424.000000FORS000058304Open Text CorporationCA683715106812/09/2025Elect David FraserDIRECTOR ELECTIONSISSUER1424.0000000.000000FOR1424.000000FORS000058304Open Text CorporationCA683715106812/09/2025Elect John HastingsDIRECTOR ELECTIONSISSUER1424.0000000.000000FOR1424.000000FORS000058304Open Text CorporationCA683715106812/09/2025Elect Robert HauDIRECTOR ELECTIONSISSUER1424.0000000.000000FOR1424.000000FORS000058304Open Text CorporationCA683715106812/09/2025Elect Goldy HyderDIRECTOR ELECTIONSISSUER1424.0000000.000000FOR1424.000000FORS000058304Open Text CorporationCA683715106812/09/2025Elect Kristen M. LudgateDIRECTOR ELECTIONSISSUER1424.0000000.000000FOR1424.000000FORS000058304Open Text CorporationCA683715106812/09/2025Elect Fletcher F. PrevinDIRECTOR ELECTIONSISSUER1424.0000000.000000FOR1424.000000FORS000058304Open Text CorporationCA683715106812/09/2025Elect Annette P. RippertDIRECTOR ELECTIONSISSUER1424.0000000.000000FOR1424.000000FORS000058304Open Text CorporationCA683715106812/09/2025Elect George D. SchindlerDIRECTOR ELECTIONSISSUER1424.0000000.000000FOR1424.000000FORS000058304Open Text CorporationCA683715106812/09/2025Elect Margaret StuartDIRECTOR ELECTIONSISSUER1424.0000000.000000FOR1424.000000FORS000058304Open Text CorporationCA683715106812/09/2025Elect Deborah WeinsteinDIRECTOR ELECTIONSISSUER1424.0000000.000000FOR1424.000000FORS000058304Open Text CorporationCA683715106812/09/2025Appointment of AuditorAUDIT-RELATEDISSUER1424.0000000.000000FOR1424.000000FORS000058304Open Text CorporationCA683715106812/09/2025Shareholder Rights Plan RenewalSHAREHOLDER RIGHTS AND DEFENSESISSUER1424.0000000.000000FOR1424.000000FORS000058304Open Text CorporationCA683715106812/09/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER1424.0000000.000000FOR1424.000000FORS000058304Open Text CorporationCA683715106812/09/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER1424.0000000.000000FOR1424.000000FOR3S000058304Reckitt Benckiser Group plcGB00B24CGK7701/27/2026Special DividendCAPITAL STRUCTUREISSUER1011.0000000.000000FOR1011.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7701/27/2026Share ConsolidationCAPITAL STRUCTUREISSUER1011.0000000.000000FOR1011.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7701/27/2026Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER1011.0000000.000000FOR1011.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7701/27/2026Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER1011.0000000.000000FOR1011.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7701/27/2026Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment)CAPITAL STRUCTUREISSUER1011.0000000.000000FOR1011.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7701/27/2026Authority to Repurchase SharesCAPITAL STRUCTUREISSUER1011.0000000.000000FOR1011.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Remuneration ReportCOMPENSATIONISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Final DividendCAPITAL STRUCTUREISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Elect Therese EsperdyDIRECTOR ELECTIONSISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Elect Susan M. ClarkDIRECTOR ELECTIONSISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Elect Ngozi EdozienDIRECTOR ELECTIONSISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Elect Andrew GilchristDIRECTOR ELECTIONSISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Elect Julie HamiltonDIRECTOR ELECTIONSISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Elect Alan JohnsonDIRECTOR ELECTIONSISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Elect Robert Kunze-ConcewitzDIRECTOR ELECTIONSISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Elect Lukas ParaviciniDIRECTOR ELECTIONSISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Elect Jon StantonDIRECTOR ELECTIONSISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Elect Abbe LuersmanDIRECTOR ELECTIONSISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Elect Murray McGowanDIRECTOR ELECTIONSISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Appointment of AuditorAUDIT-RELATEDISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Authority to Set Auditor's FeesAUDIT-RELATEDISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Authority to Repurchase SharesCAPITAL STRUCTUREISSUER3579.0000000.000000FOR3579.000000FORS000058304Imperial Brands plcGB000454492901/28/2026Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER3579.0000000.000000FOR3579.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892102/04/2026Amendments to Article 13; 14 (Remuneration of Key Personnel)CORPORATE GOVERNANCEISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892102/04/2026Amendments to Article 15; 17 (Submission of Lists by the Outgoing Board and Election Procedures)CORPORATE GOVERNANCEISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892102/04/2026Amendments to Article 15 (Co-Option of Directors)CORPORATE GOVERNANCEISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892102/04/2026Amendments to Article 15; 20 (Directors' Maximum Term Length)CORPORATE GOVERNANCEISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892102/04/2026Amendments to Article 17; 18; 21 (Board Chair and Vice Chair)CORPORATE GOVERNANCEISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892102/04/2026Amendments to Article 25 (Board of Statutory Auditors Election Procedures)CORPORATE GOVERNANCEISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892102/04/2026Amendments to Article 31 (Legal and Statutory Reserve)CORPORATE GOVERNANCEISSUER8728.0000000.000000FOR8728.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Remuneration ReportCOMPENSATIONISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Final DividendCAPITAL STRUCTUREISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Elect Jacqui CartinDIRECTOR ELECTIONSISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Elect Lori Mitchell-KellerDIRECTOR ELECTIONSISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Elect Andrew J. DuffDIRECTOR ELECTIONSISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Elect Steve HareDIRECTOR ELECTIONSISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Elect Dr. John BatesDIRECTOR ELECTIONSISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Elect Jonathan BewesDIRECTOR ELECTIONSISSUER834.0000000.000000AGAINST834.000000AGAINSTS000058304The Sage Group plcGB00B8C3BL0302/05/2026Elect Maggie Chan JonesDIRECTOR ELECTIONSISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Elect Annette CourtDIRECTOR ELECTIONSISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Elect Roisin DonnellyDIRECTOR ELECTIONSISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Elect Derek HardingDIRECTOR ELECTIONSISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Appointment of AuditorAUDIT-RELATEDISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Authority to Set Auditor's FeesAUDIT-RELATEDISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Increase in NED Fee CapCOMPENSATIONISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Approval of the Share Incentive PlanCOMPENSATIONISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Amendment to the Colleague Share Purchase PlanCOMPENSATIONISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Approval of the Save and Share PlanCOMPENSATIONISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment)CAPITAL STRUCTUREISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Authority to Repurchase SharesCAPITAL STRUCTUREISSUER834.0000000.000000FOR834.000000FORS000058304The Sage Group plcGB00B8C3BL0302/05/2026Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER834.0000000.000000FOR834.000000FORS000058304Siemens AGDE000723610102/12/2026Allocation of DividendsCAPITAL STRUCTUREISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Roland BuschCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Veronika BienertCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Peter KorteCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Cedrik NeikeCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Matthias RebelliusCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Ralf P. ThomasCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Judith WieseCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Jim Hagemann SnabeCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Birgit SteinbornCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Werner BrandtCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Tobias BaumlerCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Regina E. DuganCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Andrea FehrmannCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Bettina HallerCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Oliver HartmannCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Keryn Lee JamesCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Jurgen KernerCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Saskia KrausserCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Martina MerzCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Christian PfeifferCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Benoit PotierCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Hagen ReimerCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Kasper RorstedCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Ulf Mark SchneiderCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Nathalie von SiemensCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Dorothea SimonCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Mimon UhamouCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Grazia VittadiniCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Ratify Matthias ZachertCORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Appointment of AuditorAUDIT-RELATEDISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Remuneration ReportCOMPENSATIONISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Supervisory Board Remuneration PolicyCOMPENSATIONISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Amendments to Articles (Virtual AGM)CORPORATE GOVERNANCEISSUER308.0000000.000000FOR308.000000FORS000058304Siemens AGDE000723610102/12/2026Increase in Authorised Capital (Employee Participation)CAPITAL STRUCTUREISSUER308.0000000.000000FOR308.000000FORS000058304Banco Bpm SpAIT000521838002/23/2026Amendments to ArticlesCORPORATE GOVERNANCEISSUER8145.0000000.000000FOR8145.000000FORS000058304KONE OyjFI000901340303/05/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Ratification of Board and CEO ActsCORPORATE GOVERNANCEISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Remuneration ReportCOMPENSATIONISSUER755.0000000.000000AGAINST755.000000AGAINSTS000058304KONE OyjFI000901340303/05/2026Directors' FeesCOMPENSATIONISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Board SizeCORPORATE GOVERNANCEISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Elect Banmali AgrawalaDIRECTOR ELECTIONSISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Elect Matti AlahuhtaDIRECTOR ELECTIONSISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Elect Susan DuinhovenDIRECTOR ELECTIONSISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Elect Marika FredrikssonDIRECTOR ELECTIONSISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Elect Anna HerlinDIRECTOR ELECTIONSISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Elect Antti HerlinDIRECTOR ELECTIONSISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Elect Jussi HerlinDIRECTOR ELECTIONSISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Elect Timo IhamuotilaDIRECTOR ELECTIONSISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Authority to Set Auditor's FeesAUDIT-RELATEDISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Number of AuditorsAUDIT-RELATEDISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Appointment of AuditorAUDIT-RELATEDISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Authority to Set Sustainability Reporting Auditor's FeesAUDIT-RELATEDISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER755.0000000.000000FOR755.000000FORS000058304KONE OyjFI000901340303/05/2026Authority to Issue Shares w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER755.0000000.000000FOR755.000000FORS000058304Novartis AGCH001200526703/06/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Report on Non-Financial MattersCORPORATE GOVERNANCEISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Ratification of Board and Management ActsCORPORATE GOVERNANCEISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Allocation of DividendsCAPITAL STRUCTUREISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Cancellation of Shares and Reduction in Share CapitalCAPITAL STRUCTUREISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Board CompensationCOMPENSATIONISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Executive Compensation (Total)COMPENSATIONISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Compensation ReportCOMPENSATIONISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect Giovanni Caforio as Board ChairDIRECTOR ELECTIONSISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect Nancy C. AndrewsDIRECTOR ELECTIONSISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect Ton BuchnerDIRECTOR ELECTIONSISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect Patrice BulaDIRECTOR ELECTIONSISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect Elizabeth DohertyDIRECTOR ELECTIONSISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect Bridgette P. HellerDIRECTOR ELECTIONSISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect Frans van HoutenDIRECTOR ELECTIONSISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect Elizabeth McNallyDIRECTOR ELECTIONSISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect Simon MoroneyDIRECTOR ELECTIONSISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect Ana de Pro GonzaloDIRECTOR ELECTIONSISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect John D. YoungDIRECTOR ELECTIONSISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect Charles SwantonDIRECTOR ELECTIONSISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect Patrice Bula as Compensation Committee MemberCORPORATE GOVERNANCEISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect Bridgette P. Heller as Compensation Committee MemberCORPORATE GOVERNANCEISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect Simon Moroney as Compensation Committee MemberCORPORATE GOVERNANCEISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect John D. Young as Compensation Committee MemberCORPORATE GOVERNANCEISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Elect Elizabeth McNally as Compensation Committee MemberCORPORATE GOVERNANCEISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Appointment of AuditorAUDIT-RELATEDISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Appointment of Independent ProxyCORPORATE GOVERNANCEISSUER478.0000000.000000Takenoaction478.000000NONES000058304Novartis AGCH001200526703/06/2026Transaction of Other BusinessCORPORATE GOVERNANCEISSUER478.0000000.000000Takenoaction478.000000NONES000058304Bper Banca SpAIT000006612303/12/2026Merger by AbsorptionEXTRAORDINARY TRANSACTIONSISSUER9721.0000000.000000FOR9721.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER9278.0000000.000000FOR9278.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Report on Non-Financial InformationCORPORATE GOVERNANCEISSUER9278.0000000.000000FOR9278.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER9278.0000000.000000FOR9278.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Ratification of Board ActsCORPORATE GOVERNANCEISSUER9278.0000000.000000FOR9278.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Elect Sonia DulaDIRECTOR ELECTIONSISSUER9278.0000000.000000FOR9278.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Elect Raul Catarino Galamba de OliveiraDIRECTOR ELECTIONSISSUER9278.0000000.000000FOR9278.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Elect Ana Leonor Revenga ShanklinDIRECTOR ELECTIONSISSUER9278.0000000.000000FOR9278.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Elect Carlos Salazar LomelinDIRECTOR ELECTIONSISSUER9278.0000000.000000FOR9278.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Elect Jorge Montalbo TodoliDIRECTOR ELECTIONSISSUER9278.0000000.000000FOR9278.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Authority to Issue Contingent Convertible InstrumentsCAPITAL STRUCTUREISSUER9278.0000000.000000FOR9278.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Authority to Repurchase SharesCAPITAL STRUCTUREISSUER9278.0000000.000000FOR9278.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Authority to Cancel Treasury Shares and Reduce CapitalCAPITAL STRUCTUREISSUER9278.0000000.000000FOR9278.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Remuneration PolicyCOMPENSATIONISSUER9278.0000000.000000FOR9278.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Maximum Variable Pay RatioCOMPENSATIONISSUER9278.0000000.000000FOR9278.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Appointment of AuditorAUDIT-RELATEDISSUER9278.0000000.000000FOR9278.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER9278.0000000.000000FOR9278.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/19/2026Remuneration ReportCOMPENSATIONISSUER9278.0000000.000000FOR9278.000000FORS000058304Swedbank ABSE000024245503/24/2026Election of Presiding ChairCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026AgendaCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Compliance with the Rules of ConvocationCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Ratification of Goran BengtssonCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Ratification of Annika CreutzerCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Ratification of Kerstin HermanssonCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Ratification of Helena LiljedahlCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Ratification of Anna MossbergCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Ratification of Per Olof NymanCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Ratification of Biljana PehrssonCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Ratification of Goran PerssonCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Ratification of Biorn RieseCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Ratification of Hans EckerstromCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Ratification of Rasmus RoosCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Ratification of Jens Henriksson (CEO)CORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Ratification of Roger LjungCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Ratification of Ake SkoglundCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Ratification of Henrik JoelssonCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Ratification of Camilla LinderCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Board SizeCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Directors' and Auditors' FeesCOMPENSATIONISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Elect Goran BengtssonDIRECTOR ELECTIONSISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Elect Annika CreutzerDIRECTOR ELECTIONSISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Elect Kerstin HermanssonDIRECTOR ELECTIONSISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Elect Helena LiljedahlDIRECTOR ELECTIONSISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Elect Anna MossbergDIRECTOR ELECTIONSISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Elect Per Olof NymanDIRECTOR ELECTIONSISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Elect Biljana PehrssonDIRECTOR ELECTIONSISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Elect Goran PerssonDIRECTOR ELECTIONSISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Elect Biorn RieseDIRECTOR ELECTIONSISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Elect Rasmus RoosDIRECTOR ELECTIONSISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Elect Rikard JosefsonDIRECTOR ELECTIONSISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Elect Goran Persson as Chair of the Board of DirectorsCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Appointment of AuditorAUDIT-RELATEDISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Approval of Nomination Committee GuidelinesCORPORATE GOVERNANCEISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Authority to Repurchase Shares Related to Securities OperationsCAPITAL STRUCTUREISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Authority to Repurchase SharesCAPITAL STRUCTUREISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Authority to Issue Convertible Debt InstrumentsCAPITAL STRUCTUREISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Adoption of Share-Based Incentives (Eken 2026)COMPENSATIONISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Adoption of Share-Based Incentives (IP 2026)COMPENSATIONISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Transfer of Treasury Shares (Eken 2026 and IP 2026)CAPITAL STRUCTUREISSUER560.0000000.000000FOR560.000000FORS000058304Swedbank ABSE000024245503/24/2026Remuneration ReportCOMPENSATIONISSUER560.0000000.000000AGAINST560.000000AGAINSTS000058304JAPAN TOBACCO INC.JP372680000003/25/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER4430.0000000.000000FOR4430.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/25/2026Elect Shigeaki OkamotoDIRECTOR ELECTIONSISSUER4430.0000000.000000FOR4430.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/25/2026Elect Masamichi TerabatakeDIRECTOR ELECTIONSISSUER4430.0000000.000000FOR4430.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/25/2026Elect Takehiko TsutsuiDIRECTOR ELECTIONSISSUER4430.0000000.000000FOR4430.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/25/2026Elect Koji ShimayoshiDIRECTOR ELECTIONSISSUER4430.0000000.000000FOR4430.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/25/2026Elect Kei NakanoDIRECTOR ELECTIONSISSUER4430.0000000.000000FOR4430.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/25/2026Elect Masato KiteraDIRECTOR ELECTIONSISSUER4430.0000000.000000FOR4430.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/25/2026Elect Tetsuya ShojiDIRECTOR ELECTIONSISSUER4430.0000000.000000FOR4430.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/25/2026Elect Hiroko YamashinaDIRECTOR ELECTIONSISSUER4430.0000000.000000FOR4430.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/25/2026Elect Kenji AsakuraDIRECTOR ELECTIONSISSUER4430.0000000.000000FOR4430.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/25/2026Elect Yukiko UchidaDIRECTOR ELECTIONSISSUER4430.0000000.000000FOR4430.000000FORS000058304Swisscom AGCH000874251903/25/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Compensation ReportCOMPENSATIONISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Report on Non-Financial MattersCORPORATE GOVERNANCEISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Allocation of DividendsCAPITAL STRUCTUREISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Ratification of Board and Management ActsCORPORATE GOVERNANCEISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Elect Michael Rechsteiner as Board ChairDIRECTOR ELECTIONSISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Elect Roland AbtDIRECTOR ELECTIONSISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Elect Monique BourquinDIRECTOR ELECTIONSISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Elect Laura CioliDIRECTOR ELECTIONSISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Elect Philippe DeeckeDIRECTOR ELECTIONSISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Elect Guus DekkersDIRECTOR ELECTIONSISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Elect Sandra Lathion-ZweifelDIRECTOR ELECTIONSISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Elect Anna MossbergDIRECTOR ELECTIONSISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Elect Daniel MungerDIRECTOR ELECTIONSISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Elect Roland Abt as Compensation Committee MemberCORPORATE GOVERNANCEISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Elect Monique Bourquin as Compensation Committee MemberCORPORATE GOVERNANCEISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Elect Guus Dekkers as Compensation Committee MemberCORPORATE GOVERNANCEISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Elect Michael Rechsteiner as Compensation Committee MemberCORPORATE GOVERNANCEISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Elect Fritz Zurbrugg as Compensation Committee MemberCORPORATE GOVERNANCEISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Board CompensationCOMPENSATIONISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Executive Compensation (Total)COMPENSATIONISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Appointment of Independent ProxyCORPORATE GOVERNANCEISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Appointment of AuditorAUDIT-RELATEDISSUER192.0000000.000000Takenoaction192.000000NONES000058304Swisscom AGCH000874251903/25/2026Transaction of Other BusinessCORPORATE GOVERNANCEISSUER192.0000000.000000Takenoaction192.000000NONES000058304Yamaha Motor Co., Ltd.JP394280000803/25/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER1676.0000000.000000FOR1676.000000FORS000058304Yamaha Motor Co., Ltd.JP394280000803/25/2026Elect Katsuaki WatanabeDIRECTOR ELECTIONSISSUER1676.0000000.000000FOR1676.000000FORS000058304Yamaha Motor Co., Ltd.JP394280000803/25/2026Elect Motofumi ShitaraDIRECTOR ELECTIONSISSUER1676.0000000.000000FOR1676.000000FORS000058304Yamaha Motor Co., Ltd.JP394280000803/25/2026Elect Toshiaki IbataDIRECTOR ELECTIONSISSUER1676.0000000.000000FOR1676.000000FORS000058304Yamaha Motor Co., Ltd.JP394280000803/25/2026Elect Takuya KinoshitaDIRECTOR ELECTIONSISSUER1676.0000000.000000FOR1676.000000FORS000058304Yamaha Motor Co., Ltd.JP394280000803/25/2026Elect Kenichi MurakiDIRECTOR ELECTIONSISSUER1676.0000000.000000FOR1676.000000FORS000058304Yamaha Motor Co., Ltd.JP394280000803/25/2026Elect Jin Song MontesanoDIRECTOR ELECTIONSISSUER1676.0000000.000000FOR1676.000000FORS000058304Yamaha Motor Co., Ltd.JP394280000803/25/2026Elect Keiji MasuiDIRECTOR ELECTIONSISSUER1676.0000000.000000FOR1676.000000FORS000058304Yamaha Motor Co., Ltd.JP394280000803/25/2026Elect Sarah L. CasanovaDIRECTOR ELECTIONSISSUER1676.0000000.000000FOR1676.000000FORS000058304Yamaha Motor Co., Ltd.JP394280000803/25/2026Elect Naoki OnoDIRECTOR ELECTIONSISSUER1676.0000000.000000FOR1676.000000FORS000058304Yamaha Motor Co., Ltd.JP394280000803/25/2026Elect Junko Sunaga @ Junko InoueDIRECTOR ELECTIONSISSUER1676.0000000.000000FOR1676.000000FORS000058304Yamaha Motor Co., Ltd.JP394280000803/25/2026Elect Etsuko Kobayashi as Statutory AuditorCORPORATE GOVERNANCEISSUER1676.0000000.000000FOR1676.000000FORS000058304CaixaBank SAES014060901903/26/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER9578.0000000.000000FOR9578.000000FORS000058304CaixaBank SAES014060901903/26/2026Report on Non-Financial InformationCORPORATE GOVERNANCEISSUER9578.0000000.000000FOR9578.000000FORS000058304CaixaBank SAES014060901903/26/2026Ratification of Board ActsCORPORATE GOVERNANCEISSUER9578.0000000.000000FOR9578.000000FORS000058304CaixaBank SAES014060901903/26/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER9578.0000000.000000FOR9578.000000FORS000058304CaixaBank SAES014060901903/26/2026Appointment of AuditorAUDIT-RELATEDISSUER9578.0000000.000000FOR9578.000000FORS000058304CaixaBank SAES014060901903/26/2026Elect Tomas Muniesa AranteguiDIRECTOR ELECTIONSISSUER9578.0000000.000000FOR9578.000000FORS000058304CaixaBank SAES014060901903/26/2026Elect Eduardo Javier Sanchiz IrazuDIRECTOR ELECTIONSISSUER9578.0000000.000000FOR9578.000000FORS000058304CaixaBank SAES014060901903/26/2026Elect Ana Garcia FauDIRECTOR ELECTIONSISSUER9578.0000000.000000AGAINST9578.000000AGAINSTS000058304CaixaBank SAES014060901903/26/2026Ratify Co-Option and Elect Pablo Arturo Forero CalderonDIRECTOR ELECTIONSISSUER9578.0000000.000000FOR9578.000000FORS000058304CaixaBank SAES014060901903/26/2026Authority to Cancel Treasury Shares and Reduce Share CapitalCAPITAL STRUCTUREISSUER9578.0000000.000000FOR9578.000000FORS000058304CaixaBank SAES014060901903/26/2026Authority to Issue Contingent Convertible Instruments w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER9578.0000000.000000FOR9578.000000FORS000058304CaixaBank SAES014060901903/26/2026Directors' FeesCOMPENSATIONISSUER9578.0000000.000000FOR9578.000000FORS000058304CaixaBank SAES014060901903/26/2026Amendment to Remuneration PolicyCOMPENSATIONISSUER9578.0000000.000000FOR9578.000000FORS000058304CaixaBank SAES014060901903/26/2026Authority to Issue Shares Pursuant to Equity Remuneration PlanCAPITAL STRUCTUREISSUER9578.0000000.000000FOR9578.000000FORS000058304CaixaBank SAES014060901903/26/2026Maximum Variable Pay RatioCOMPENSATIONISSUER9578.0000000.000000FOR9578.000000FORS000058304CaixaBank SAES014060901903/26/2026Remuneration ReportCOMPENSATIONISSUER9578.0000000.000000FOR9578.000000FORS000058304CaixaBank SAES014060901903/26/2026Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER9578.0000000.000000FOR9578.000000FORS000058304Kesko OyjFI000900020203/26/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER1458.0000000.000000FOR1458.000000FORS000058304Kesko OyjFI000900020203/26/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER1458.0000000.000000FOR1458.000000FORS000058304Kesko OyjFI000900020203/26/2026Ratification of Board and CEO ActsCORPORATE GOVERNANCEISSUER1458.0000000.000000FOR1458.000000FORS000058304Kesko OyjFI000900020203/26/2026Remuneration ReportCOMPENSATIONISSUER1458.0000000.000000FOR1458.000000FORS000058304Kesko OyjFI000900020203/26/2026Directors' FeesCOMPENSATIONISSUER1458.0000000.000000FOR1458.000000FORS000058304Kesko OyjFI000900020203/26/2026Board SizeCORPORATE GOVERNANCEISSUER1458.0000000.000000FOR1458.000000FORS000058304Kesko OyjFI000900020203/26/2026Election of DirectorsDIRECTOR ELECTIONSISSUER1458.0000000.000000FOR1458.000000FORS000058304Kesko OyjFI000900020203/26/2026Authority to Set Auditor's FeesAUDIT-RELATEDISSUER1458.0000000.000000FOR1458.000000FORS000058304Kesko OyjFI000900020203/26/2026Appointment of AuditorAUDIT-RELATEDISSUER1458.0000000.000000FOR1458.000000FORS000058304Kesko OyjFI000900020203/26/2026Authority to Set Sustainability Reporting Auditor's FeesAUDIT-RELATEDISSUER1458.0000000.000000FOR1458.000000FORS000058304Kesko OyjFI000900020203/26/2026Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER1458.0000000.000000FOR1458.000000FORS000058304Kesko OyjFI000900020203/26/2026Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER1458.0000000.000000FOR1458.000000FORS000058304Kesko OyjFI000900020203/26/2026Authority to Issue Shares w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER1458.0000000.000000FOR1458.000000FORS000058304Kesko OyjFI000900020203/26/2026Charitable DonationsOTHER SOCIAL ISSUESISSUER1458.0000000.000000FOR1458.000000FORS000058304SGS SACH125674092403/26/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Report on Non-Financial MattersCORPORATE GOVERNANCEISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Compensation ReportCOMPENSATIONISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Ratification of Board and Management ActsCORPORATE GOVERNANCEISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Allocation of DividendsCAPITAL STRUCTUREISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Issuance of Shares without Preemptive RightsCAPITAL STRUCTUREISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Elect Sami AtiyaDIRECTOR ELECTIONSISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Elect Phyllis CheungDIRECTOR ELECTIONSISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Elect Ian GallienneDIRECTOR ELECTIONSISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Elect Tobias HartmannDIRECTOR ELECTIONSISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Elect Patrick KronDIRECTOR ELECTIONSISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Elect Geraldine PicaudDIRECTOR ELECTIONSISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Elect Kory SorensonDIRECTOR ELECTIONSISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Elect Janet S. VergisDIRECTOR ELECTIONSISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Elect Gilbert GhostineDIRECTOR ELECTIONSISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Elect Gilbert Ghostine as Board ChairCORPORATE GOVERNANCEISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Elect Sami Atiya as Compensation Committee MemberCORPORATE GOVERNANCEISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Elect Patrick Kron as Compensation Committee MemberCORPORATE GOVERNANCEISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Elect Kory Sorenson as Compensation Committee MemberCORPORATE GOVERNANCEISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Appointment of AuditorAUDIT-RELATEDISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Appointment of Independent ProxyCORPORATE GOVERNANCEISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Board CompensationCOMPENSATIONISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Executive Compensation (Fixed)COMPENSATIONISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Executive Compensation (Short-Term)COMPENSATIONISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Executive Compensation (Long-Term)COMPENSATIONISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Amendments to Articles (Editorial)CORPORATE GOVERNANCEISSUER304.0000000.000000Takenoaction304.000000NONES000058304SGS SACH125674092403/26/2026Transaction of Other BusinessCORPORATE GOVERNANCEISSUER304.0000000.000000Takenoaction304.000000NONES000058304CANON INC.JP324280000503/27/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER2218.0000000.000000FOR2218.000000FORS000058304CANON INC.JP324280000503/27/2026Elect Fujio MitaraiDIRECTOR ELECTIONSISSUER2218.0000000.000000FOR2218.000000FORS000058304CANON INC.JP324280000503/27/2026Elect Toshizo TanakaDIRECTOR ELECTIONSISSUER2218.0000000.000000FOR2218.000000FORS000058304CANON INC.JP324280000503/27/2026Elect Toshio HommaDIRECTOR ELECTIONSISSUER2218.0000000.000000FOR2218.000000FORS000058304CANON INC.JP324280000503/27/2026Elect Kazuto OgawaDIRECTOR ELECTIONSISSUER2218.0000000.000000FOR2218.000000FORS000058304CANON INC.JP324280000503/27/2026Elect Hiroaki TakeishiDIRECTOR ELECTIONSISSUER2218.0000000.000000FOR2218.000000FORS000058304CANON INC.JP324280000503/27/2026Elect Minoru AsadaDIRECTOR ELECTIONSISSUER2218.0000000.000000FOR2218.000000FORS000058304CANON INC.JP324280000503/27/2026Elect Yusuke KawamuraDIRECTOR ELECTIONSISSUER2218.0000000.000000FOR2218.000000FORS000058304CANON INC.JP324280000503/27/2026Elect Masayuki IkegamiDIRECTOR ELECTIONSISSUER2218.0000000.000000FOR2218.000000FORS000058304CANON INC.JP324280000503/27/2026Elect Masaki SuzukiDIRECTOR ELECTIONSISSUER2218.0000000.000000FOR2218.000000FORS000058304CANON INC.JP324280000503/27/2026Elect Akiko Ito @ Akiko NodaDIRECTOR ELECTIONSISSUER2218.0000000.000000FOR2218.000000FORS000058304CANON INC.JP324280000503/27/2026Elect Atsumi ArimaDIRECTOR ELECTIONSISSUER2218.0000000.000000FOR2218.000000FORS000058304CANON INC.JP324280000503/27/2026Elect Ikuko NaruseCORPORATE GOVERNANCEISSUER2218.0000000.000000FOR2218.000000FORS000058304CANON INC.JP324280000503/27/2026Elect Kaori Asakura @ Kaori YoshinoCORPORATE GOVERNANCEISSUER2218.0000000.000000FOR2218.000000FORS000058304CANON INC.JP324280000503/27/2026BonusCOMPENSATIONISSUER2218.0000000.000000FOR2218.000000FORS000058304OTSUKA CORPORATIONJP318820000403/27/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER4421.0000000.000000FOR4421.000000FORS000058304OTSUKA CORPORATIONJP318820000403/27/2026Amendments to ArticlesCORPORATE GOVERNANCEISSUER4421.0000000.000000FOR4421.000000FORS000058304OTSUKA CORPORATIONJP318820000403/27/2026Elect Yoko NakaiDIRECTOR ELECTIONSISSUER4421.0000000.000000AGAINST4421.000000AGAINSTS000058304OTSUKA CORPORATIONJP318820000403/27/2026Elect Emi WakatsukiDIRECTOR ELECTIONSISSUER4421.0000000.000000FOR4421.000000FORS000058304OTSUKA CORPORATIONJP318820000403/27/2026Performance Share UnitCOMPENSATIONISSUER4421.0000000.000000FOR4421.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/31/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER3627.0000000.000000FOR3627.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/31/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER3627.0000000.000000FOR3627.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/31/2026Directors' FeesCOMPENSATIONISSUER3627.0000000.000000FOR3627.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/31/2026Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER3627.0000000.000000FOR3627.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/31/2026Elect Peter SEAH Lim HuatDIRECTOR ELECTIONSISSUER3627.0000000.000000FOR3627.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/31/2026Elect Punita LalDIRECTOR ELECTIONSISSUER3627.0000000.000000FOR3627.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/31/2026Elect Anthony LIM Weng KinDIRECTOR ELECTIONSISSUER3627.0000000.000000FOR3627.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/31/2026Elect David HO Hing-YuenDIRECTOR ELECTIONSISSUER3627.0000000.000000FOR3627.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/31/2026Authority to Issue Shares w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER3627.0000000.000000FOR3627.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/31/2026Authority to issue shares pursuant to the DBSH Scrip Dividend SchemeCAPITAL STRUCTUREISSUER3627.0000000.000000FOR3627.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/31/2026Authority to Repurchase SharesCAPITAL STRUCTUREISSUER3627.0000000.000000FOR3627.000000FORS000058304Elisa OyjFI000900788404/01/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER1980.0000000.000000FOR1980.000000FORS000058304Elisa OyjFI000900788404/01/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER1980.0000000.000000FOR1980.000000FORS000058304Elisa OyjFI000900788404/01/2026Ratification of Board and CEO ActsCORPORATE GOVERNANCEISSUER1980.0000000.000000FOR1980.000000FORS000058304Elisa OyjFI000900788404/01/2026REMUNERATION REPORTCOMPENSATIONISSUER1980.0000000.000000FOR1980.000000FORS000058304Elisa OyjFI000900788404/01/2026Directors' FeesCOMPENSATIONISSUER1980.0000000.000000FOR1980.000000FORS000058304Elisa OyjFI000900788404/01/2026Board SizeCORPORATE GOVERNANCEISSUER1980.0000000.000000FOR1980.000000FORS000058304Elisa OyjFI000900788404/01/2026Election of DirectorsDIRECTOR ELECTIONSISSUER1980.0000000.000000FOR1980.000000FORS000058304Elisa OyjFI000900788404/01/2026Authority to Set Auditor's FeesAUDIT-RELATEDISSUER1980.0000000.000000FOR1980.000000FORS000058304Elisa OyjFI000900788404/01/2026Appointment of AuditorAUDIT-RELATEDISSUER1980.0000000.000000FOR1980.000000FORS000058304Elisa OyjFI000900788404/01/2026Authority to Set Sustainability Reporting Auditor's FeesAUDIT-RELATEDISSUER1980.0000000.000000FOR1980.000000FORS000058304Elisa OyjFI000900788404/01/2026Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER1980.0000000.000000FOR1980.000000FORS000058304Elisa OyjFI000900788404/01/2026Authority to Repurchase SharesCAPITAL STRUCTUREISSUER1980.0000000.000000FOR1980.000000FORS000058304Elisa OyjFI000900788404/01/2026Authority to Issue Shares w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER1980.0000000.000000FOR1980.000000FORS000058304Elisa OyjFI000900788404/01/2026Approval of Nomination Committee GuidelinesCORPORATE GOVERNANCEISSUER1980.0000000.000000FOR1980.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/08/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER287.0000000.000000FOR287.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/08/2026Allocation of DividendsCAPITAL STRUCTUREISSUER287.0000000.000000FOR287.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/08/2026Remuneration ReportCOMPENSATIONISSUER287.0000000.000000FOR287.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/08/2026Ratification of Management Board ActsCORPORATE GOVERNANCEISSUER287.0000000.000000FOR287.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/08/2026Ratification of Supervisory Board ActsCORPORATE GOVERNANCEISSUER287.0000000.000000FOR287.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/08/2026Elect Pauline van der Meer Mohr to the Supervisory BoardDIRECTOR ELECTIONSISSUER287.0000000.000000FOR287.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/08/2026Elect Neela Montgomery to the Supervisory BoardDIRECTOR ELECTIONSISSUER287.0000000.000000FOR287.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/08/2026Elect Jolanda Poots-Bijl to the Management BoardDIRECTOR ELECTIONSISSUER287.0000000.000000FOR287.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/08/2026Management Board Remuneration PolicyCOMPENSATIONISSUER287.0000000.000000FOR287.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/08/2026Supervisory Board Remuneration PolicyCOMPENSATIONISSUER287.0000000.000000FOR287.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/08/2026Appointment of AuditorAUDIT-RELATEDISSUER287.0000000.000000FOR287.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/08/2026Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER287.0000000.000000FOR287.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/08/2026Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER287.0000000.000000FOR287.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/08/2026Authority to Suppress Preemptive RightsCAPITAL STRUCTUREISSUER287.0000000.000000FOR287.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/08/2026Authority to Repurchase SharesCAPITAL STRUCTUREISSUER287.0000000.000000FOR287.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/08/2026Cancellation of sharesCAPITAL STRUCTUREISSUER287.0000000.000000FOR287.000000FORS000058304Volvo ABSE000011544604/08/2026Election of Presiding ChairCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026AgendaCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Compliance with the Rules of ConvocationCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Matti AlahuhtaCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Bo AnnvikCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Par BomanCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Jan CarlsonCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Eric ElzvikCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Martha Finn BrooksCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Kurt JofsCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Martin LundstedtCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Kathryn V. MarinelloCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Martina MerzCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Helena StjernholmCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Lars AskCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Urban SpannarCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Therese KoggdalCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Danny BilgerCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Camilla JohanssonCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Erik SvenssonCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Ratify Martin Lundstedt (CEO)CORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Board SizeCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Number of DeputiesCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Directors' FeesCOMPENSATIONISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Elect Bo AnnvikDIRECTOR ELECTIONSISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Elect Par BomanDIRECTOR ELECTIONSISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Elect Jan CarlsonDIRECTOR ELECTIONSISSUER4747.0000000.000000AGAINST4747.000000AGAINSTS000058304Volvo ABSE000011544604/08/2026Elect Eric A. ElzvikDIRECTOR ELECTIONSISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Elect Martha Finn BrooksDIRECTOR ELECTIONSISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Elect Kurt JofsDIRECTOR ELECTIONSISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Elect Martin LundstedtDIRECTOR ELECTIONSISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Elect Kathryn V. MarinelloDIRECTOR ELECTIONSISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Elect Martina MerzDIRECTOR ELECTIONSISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Elect Helena StjernholmDIRECTOR ELECTIONSISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Elect Par Boman as ChairCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Authority to Set Auditor's FeesAUDIT-RELATEDISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Appointment of AuditorAUDIT-RELATEDISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Elect Fredrik Persson to the Nomination CommitteeCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Elect Dick Bergqvist to the Nomination CommitteeCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Elect Carina Silberg to the Nomination CommitteeCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Elect Anders Algotsson to the Nomination CommitteeCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Elect the Chair of the Board to the Nomination CommitteeCORPORATE GOVERNANCEISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Remuneration ReportCOMPENSATIONISSUER4747.0000000.000000FOR4747.000000FORS000058304Volvo ABSE000011544604/08/2026Shareholder Proposal Regarding Review of Climate-Related Policy EngagementENVIRONMENT OR CLIMATESECURITY HOLDER4747.0000000.000000AGAINST4747.000000FORS000058304Zurich Insurance Group AGCH001107539404/08/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Compensation ReportCOMPENSATIONISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Report on Non-Financial MattersCORPORATE GOVERNANCEISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Allocation of DividendsCAPITAL STRUCTUREISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Ratification of Board and Management ActsCORPORATE GOVERNANCEISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Michel M. Lies as Board ChairDIRECTOR ELECTIONSISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Joan AmbleDIRECTOR ELECTIONSISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Catherine BessantDIRECTOR ELECTIONSISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Michael HalbherrDIRECTOR ELECTIONSISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Thomas JordanDIRECTOR ELECTIONSISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Sabine Keller-BusseDIRECTOR ELECTIONSISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Kishore MahbubaniDIRECTOR ELECTIONSISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Peter MaurerDIRECTOR ELECTIONSISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect John RafterDIRECTOR ELECTIONSISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Jasmin StaiblinDIRECTOR ELECTIONSISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Barry StoweDIRECTOR ELECTIONSISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Mary ForrestDIRECTOR ELECTIONSISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Michel M. Lies as Compensation Committee MemberCORPORATE GOVERNANCEISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Catherine Bessant as Compensation Committee MemberCORPORATE GOVERNANCEISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Sabine Keller-Busse as Compensation Committee MemberCORPORATE GOVERNANCEISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Kishore Mahbubani as Compensation Committee MemberCORPORATE GOVERNANCEISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Jasmin Staiblin as Compensation Committee MemberCORPORATE GOVERNANCEISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Elect Michael Halbherr as Compensation Committee MemberCORPORATE GOVERNANCEISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Appointment of Independent ProxyCORPORATE GOVERNANCEISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Appointment of AuditorAUDIT-RELATEDISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Board CompensationCOMPENSATIONISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Executive Compensation (Total)COMPENSATIONISSUER301.0000000.000000Takenoaction301.000000NONES000058304Zurich Insurance Group AGCH001107539404/08/2026Transaction of Other BusinessCORPORATE GOVERNANCEISSUER301.0000000.000000Takenoaction301.000000NONES000058304Royal Bank of CanadaCA780087102104/09/2026Elect Mirko BibicDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Elect Andrew A. ChisholmDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Elect Jacynthe CoteDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Elect Toos N. DaruvalaDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Elect Cynthia DevineDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Elect Roberta JamiesonDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Elect David I. McKayDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Elect Amanda NortonDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Elect Barry V. PerryDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Elect Maryann TurckeDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Elect Thierry VandalDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Elect Frank VetteseDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Elect Jeffery W. YabukiDIRECTOR ELECTIONSISSUER120.0000000.000000FOR120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Appointment of AuditorAUDIT-RELATEDISSUER120.0000000.000000FOR120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER120.0000000.000000FOR120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER120.0000000.000000FOR120.000000FOR3S000058304Royal Bank of CanadaCA780087102104/09/2026Shareholder Proposal Regarding Participation in Annual MeetingsCORPORATE GOVERNANCESECURITY HOLDER120.0000000.000000AGAINST120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Shareholder Proposal Regarding Board Youth RepresentationCORPORATE GOVERNANCESECURITY HOLDER120.0000000.000000AGAINST120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Shareholder Proposal Regarding Executive Compensation PolicyCOMPENSATIONSECURITY HOLDER120.0000000.000000AGAINST120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Shareholder Proposal Regarding Board Skill Diversification PolicyCORPORATE GOVERNANCESECURITY HOLDER120.0000000.000000AGAINST120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Shareholder Proposal Regarding Establishment of Advisory Committee on Systemic ImpactsENVIRONMENT OR CLIMATESECURITY HOLDER120.0000000.000000AGAINST120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Shareholder Proposal Regarding Report on Forced and Child Labour in Loan PortfoliosHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER120.0000000.000000AGAINST120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Shareholder Proposal Regarding Report on Use of Artificial IntelligenceOTHER SOCIAL ISSUESSECURITY HOLDER120.0000000.000000FOR120.000000AGAINSTS000058304Royal Bank of CanadaCA780087102104/09/2026Shareholder Proposal Regarding Disclosure of Country-by-Country ReportingCORPORATE GOVERNANCESECURITY HOLDER120.0000000.000000AGAINST120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Shareholder Proposal Regarding Say on ClimateENVIRONMENT OR CLIMATESECURITY HOLDER120.0000000.000000AGAINST120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Shareholder Proposal Regarding Reporting Circular Economy LoansENVIRONMENT OR CLIMATESECURITY HOLDER120.0000000.000000AGAINST120.000000FORS000058304Royal Bank of CanadaCA780087102104/09/2026Shareholder Proposal Regarding In-Person Shareholder MeetingsCORPORATE GOVERNANCESECURITY HOLDER120.0000000.000000AGAINST120.000000FORS000058304UPM-Kymmene OyjFI000900598704/09/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER3198.0000000.000000FOR3198.000000FORS000058304UPM-Kymmene OyjFI000900598704/09/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER3198.0000000.000000FOR3198.000000FORS000058304UPM-Kymmene OyjFI000900598704/09/2026Ratification of Board and CEO ActsCORPORATE GOVERNANCEISSUER3198.0000000.000000FOR3198.000000FORS000058304UPM-Kymmene OyjFI000900598704/09/2026Remuneration ReportCOMPENSATIONISSUER3198.0000000.000000FOR3198.000000FORS000058304UPM-Kymmene OyjFI000900598704/09/2026Remuneration PolicyCOMPENSATIONISSUER3198.0000000.000000AGAINST3198.000000AGAINSTS000058304UPM-Kymmene OyjFI000900598704/09/2026Directors' FeesCOMPENSATIONISSUER3198.0000000.000000FOR3198.000000FORS000058304UPM-Kymmene OyjFI000900598704/09/2026Board SizeCORPORATE GOVERNANCEISSUER3198.0000000.000000FOR3198.000000FORS000058304UPM-Kymmene OyjFI000900598704/09/2026Election of DirectorsDIRECTOR ELECTIONSISSUER3198.0000000.000000FOR3198.000000FORS000058304UPM-Kymmene OyjFI000900598704/09/2026Authority to Set Auditor's FeesAUDIT-RELATEDISSUER3198.0000000.000000FOR3198.000000FORS000058304UPM-Kymmene OyjFI000900598704/09/2026Authority to Set Sustainability Reporting Auditor's FeesAUDIT-RELATEDISSUER3198.0000000.000000FOR3198.000000FORS000058304UPM-Kymmene OyjFI000900598704/09/2026Appointment of AuditorAUDIT-RELATEDISSUER3198.0000000.000000FOR3198.000000FORS000058304UPM-Kymmene OyjFI000900598704/09/2026Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER3198.0000000.000000FOR3198.000000FORS000058304UPM-Kymmene OyjFI000900598704/09/2026Authority to Issue Shares w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER3198.0000000.000000FOR3198.000000FORS000058304UPM-Kymmene OyjFI000900598704/09/2026Authority to Repurchase SharesCAPITAL STRUCTUREISSUER3198.0000000.000000FOR3198.000000FORS000058304UPM-Kymmene OyjFI000900598704/09/2026Charitable DonationsOTHER SOCIAL ISSUESISSUER3198.0000000.000000FOR3198.000000FORS000058304Swiss Re LtdCH012688156104/10/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Compensation ReportCOMPENSATIONISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Report on Non-Financial MattersCORPORATE GOVERNANCEISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Allocation of DividendsCAPITAL STRUCTUREISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Ratification of Board ActsCORPORATE GOVERNANCEISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Elect Jacques de Vaucleroy as Board ChairDIRECTOR ELECTIONSISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Elect Karen GavanDIRECTOR ELECTIONSISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Elect Morten HubbeDIRECTOR ELECTIONSISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Elect Vanessa LauDIRECTOR ELECTIONSISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Elect Geraldine MatchettDIRECTOR ELECTIONSISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Elect Joachim OechslinDIRECTOR ELECTIONSISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Elect Deanna OngDIRECTOR ELECTIONSISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Elect George QuinnDIRECTOR ELECTIONSISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Elect Jay RalphDIRECTOR ELECTIONSISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Elect Jorg ReinhardtDIRECTOR ELECTIONSISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Elect Pia TischhauserDIRECTOR ELECTIONSISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Elect Jean-Jacques HenchozDIRECTOR ELECTIONSISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Elect Morten Hubbe as Compensation Committee MemberCORPORATE GOVERNANCEISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Elect Deanna Ong as Compensation Committee MemberCORPORATE GOVERNANCEISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Elect Jay Ralph as Compensation Committee MemberCORPORATE GOVERNANCEISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Elect Jorg Reinhardt as Compensation Committee MemberCORPORATE GOVERNANCEISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Appointment of Independent ProxyCORPORATE GOVERNANCEISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Appointment of AuditorAUDIT-RELATEDISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Board CompensationCOMPENSATIONISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Executive Compensation (Short-Term)COMPENSATIONISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Executive Compensation (Fixed and Long-term)COMPENSATIONISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Reduction in Par Value of SharesCAPITAL STRUCTUREISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Amendments to Articles (Share Capital Currency)CORPORATE GOVERNANCEISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Approval of a Capital BandCAPITAL STRUCTUREISSUER248.0000000.000000Takenoaction248.000000NONES000058304Swiss Re LtdCH012688156104/10/2026Transaction of Other BusinessCORPORATE GOVERNANCEISSUER248.0000000.000000Takenoaction248.000000NONES000058304The Bank of Nova ScotiaCA064149107504/14/2026Elect Nora A. AufreiterDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Elect Guillermo E. BabatzDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Elect W. Dave DowrichDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Elect Antonio GarzaDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Elect Michael B. MedlineDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Elect Lynn K. PattersonDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Elect Una M. PowerDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Elect Aaron W. RegentDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Elect Sandra StuartDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Elect L. Scott ThomsonDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Elect Steven C. Van WykDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Elect Benita M. WarmboldDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Appointment of AuditorAUDIT-RELATEDISSUER1877.0000000.000000FOR1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Amendment to By-Law Regarding Directors' CompensationCORPORATE GOVERNANCEISSUER1877.0000000.000000FOR1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Technical Amendments to By-lawCORPORATE GOVERNANCEISSUER1877.0000000.000000FOR1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER1877.0000000.000000FOR1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER1877.0000000.000000FOR1877.000000FOR3S000058304The Bank of Nova ScotiaCA064149107504/14/2026Shareholder Proposal Regarding Participation in Annual MeetingsCORPORATE GOVERNANCESECURITY HOLDER1877.0000000.000000AGAINST1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Shareholder Proposal Regarding Board Youth RepresentationCORPORATE GOVERNANCESECURITY HOLDER1877.0000000.000000AGAINST1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Shareholder Proposal Regarding Executive Compensation PolicyCOMPENSATIONSECURITY HOLDER1877.0000000.000000AGAINST1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Shareholder Proposal Regarding Board Skill Diversification PolicyCORPORATE GOVERNANCESECURITY HOLDER1877.0000000.000000AGAINST1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Shareholder Proposal Regarding Establishment of Advisory Committee on Systemic ImpactsENVIRONMENT OR CLIMATESECURITY HOLDER1877.0000000.000000AGAINST1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Shareholder Proposal Regarding Report on Use of Artificial IntelligenceOTHER SOCIAL ISSUESSECURITY HOLDER1877.0000000.000000FOR1877.000000AGAINSTS000058304The Bank of Nova ScotiaCA064149107504/14/2026Shareholder Proposal Regarding Disclosure of Country-by-Country ReportingCORPORATE GOVERNANCESECURITY HOLDER1877.0000000.000000AGAINST1877.000000FORS000058304The Bank of Nova ScotiaCA064149107504/14/2026Shareholder Proposal Regarding Say on ClimateENVIRONMENT OR CLIMATESECURITY HOLDER1877.0000000.000000AGAINST1877.000000FORS000058304Vinci SAFR000012548604/14/2026APPROVAL OF THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE 2025 FINANCIAL YEARCORPORATE GOVERNANCEISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026APPROVAL OF THE FINANCIAL STATEMENTS FOR THE 2025 FINANCIAL YEARCORPORATE GOVERNANCEISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026APPROPRIATION OF THE 2025 CORPORATE INCOMECAPITAL STRUCTUREISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026RENEWAL OF THE TERM OF OFFICE OF 'MR. XAVIER HUILLARD' AS A DIRECTOR FOR A PERIOD OF FOUR YEARSDIRECTOR ELECTIONSISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026RENEWAL OF THE TERM OF OFFICE OF 'MR. CLAUDE LARUELLE' AS DIRECTOR FOR A PERIOD OF FOUR YEARSDIRECTOR ELECTIONSISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026RENEWAL OF THE TERM OF OFFICE OF 'MR. RENE MEDORI' AS DIRECTOR FOR A PERIOD OF FOUR YEARSDIRECTOR ELECTIONSISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026RATIFICATION OF THE CO-OPTATION OF 'MR. FREDERIC NOUGAREDE' AS DIRECTOR REPRESENTING EMPLOYEE SHAREHOLDERSDIRECTOR ELECTIONSISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026DETERMINATION OF THE ANNUAL TOTAL AMOUNT OF REMUNERATION OF THE MEMBERS OF THE BOARD OF DIRECTORSCOMPENSATIONISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026RENEWAL OF THE DELEGATION OF POWERS TO THE BOARD OF DIRECTORS FOR THE PURCHASE BY THE COMPANY OF ITS OWN SHARESCAPITAL STRUCTUREISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026APPROVAL OF THE REMUNERATION POLICY FOR THE MEMBERS OF THE BOARD OF DIRECTORSCOMPENSATIONISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026APPROVAL OF THE REMUNERATION POLICY APPLICABLE TO THE CHAIRMAN OF THE BOARD OF DIRECTORSCOMPENSATIONISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026APPROVAL OF THE REMUNERATION POLICY APPLICABLE TO THE CHIEF EXECUTIVE OFFICERCOMPENSATIONISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026APPROVAL OF THE REMUNERATION REPORTCOMPENSATIONISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL COMPONENTS OF THE TOTAL REMUNERATION AND BENEFITS IN KIND PAID DURING THE 2025 FINANCIAL YEAR OR AWARDED IN RESPECT OF THE SAME FINANCIAL YEAR TO 'MR. XAVIER HUILLARD'COMPENSATIONISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL COMPONENTS OF THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND PAID DURING THE 2025 FINANCIAL YEAR OR AWARDED IN RESPECT OF THE SAME FINANCIAL YEAR TO 'MR. PIERRE ANJOLRAS'COMPENSATIONISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026RENEWAL OF THE AUTHORISATION GIVEN TO THE BOARD OF DIRECTORS TO REDUCE THE SHARE CAPITAL BY CANCELLING THE VINCI SHARES HELD BY THE COMPANYCAPITAL STRUCTUREISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS TO CARRY OUT CAPITAL INCREASES RESERVED FOR EMPLOYEES OF THE COMPANY AND VINCI GROUP COMPANIES IN THE CONTEXT OF SAVINGS PLANS WITH CANCELLATION OF PREFERENTIAL SUBSCRIPTION RIGHTSCOMPENSATIONISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026DELEGATION OF AUTHORITY GRANTED TO THE BOARD OF DIRECTORS TO CARRY OUT CAPITAL INCREASES RESERVED FOR A CATEGORY OF BENEFICIARIES IN ORDER TO OFFER EMPLOYEES OF CERTAIN FOREIGN SUBSIDIARIES ADVANTAGES COMPARABLE TO THOSE OFFERED TO EMPLOYEES SUBSCRIBING DIRECTLY OR INDIRECTLY (PLEASE SEE THE ATTACHED LINK FOR MORE DETAILS)COMPENSATIONISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026AMENDMENTS TO THE ARTICLES OF ASSOCIATIONCORPORATE GOVERNANCEISSUER765.0000000.000000FOR765.000000FORS000058304Vinci SAFR000012548604/14/2026POWERS FOR FORMALITIESCORPORATE GOVERNANCEISSUER765.0000000.000000FOR765.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Allocation of DividendsCAPITAL STRUCTUREISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Maximum Variable Pay RatioCOMPENSATIONISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Remuneration PolicyCOMPENSATIONISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Remuneration ReportCOMPENSATIONISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/20262026 Short-Term Incentive PlanCOMPENSATIONISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Board SizeCORPORATE GOVERNANCEISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Number of Vice ChairsCORPORATE GOVERNANCEISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026List Presented by Board of DirectorsDIRECTOR ELECTIONSISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026List Presented by Group of Institutional Investors representing 0.78% of Share CapitalDIRECTOR ELECTIONSISSUER8728.0000000.000000ABSTAIN8728.000000NONES000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026List Presented by PLT Holding Srl and PLT SpADIRECTOR ELECTIONSISSUER8728.0000000.000000ABSTAIN8728.000000NONES000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Nicola MaioneDIRECTOR ELECTIONSISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Fabrizio PalermoDIRECTOR ELECTIONSISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Corrado PasseraDIRECTOR ELECTIONSISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Carlo VivaldiDIRECTOR ELECTIONSISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Alessandro CaltagironeDIRECTOR ELECTIONSISSUER8728.0000000.000000AGAINST8728.000000AGAINSTS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Domenico LombardiDIRECTOR ELECTIONSISSUER8728.0000000.000000AGAINST8728.000000AGAINSTS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Paolo TestiDIRECTOR ELECTIONSISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Paolo BoccardelliDIRECTOR ELECTIONSISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Marcella PanucciDIRECTOR ELECTIONSISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Francesca Paramico RenzulliDIRECTOR ELECTIONSISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Elena De SimoneDIRECTOR ELECTIONSISSUER8728.0000000.000000AGAINST8728.000000AGAINSTS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Fabiana MassaDIRECTOR ELECTIONSISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Renato SalaDIRECTOR ELECTIONSISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Gianluca BrancadoroDIRECTOR ELECTIONSISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Paola LucantoniDIRECTOR ELECTIONSISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Antonella CentraDIRECTOR ELECTIONSISSUER8728.0000000.000000ABSTAIN8728.000000AGAINSTS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Gianmarco MontanariDIRECTOR ELECTIONSISSUER8728.0000000.000000ABSTAIN8728.000000AGAINSTS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Simonetta IarloriDIRECTOR ELECTIONSISSUER8728.0000000.000000ABSTAIN8728.000000AGAINSTS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Francesca PaceDIRECTOR ELECTIONSISSUER8728.0000000.000000ABSTAIN8728.000000AGAINSTS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Rosa CipriottiDIRECTOR ELECTIONSISSUER8728.0000000.000000ABSTAIN8728.000000AGAINSTS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Elect Nicola Maione as Chair of BoardCORPORATE GOVERNANCEISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Election of Vice Chair of the BoardCORPORATE GOVERNANCEISSUER8728.0000000.000000ABSTAIN8728.000000AGAINSTS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Election of Vice Chair of the BoardCORPORATE GOVERNANCEISSUER8728.0000000.000000ABSTAIN8728.000000AGAINSTS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Directors' FeesCOMPENSATIONISSUER8728.0000000.000000AGAINST8728.000000AGAINSTS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Chair's FeesCOMPENSATIONISSUER8728.0000000.000000AGAINST8728.000000AGAINSTS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026List Presented by Group of Institutional Investors Representing 0.78% of Share CapitalDIRECTOR ELECTIONSISSUER8728.0000000.000000FOR8728.000000NONES000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026List Presented by VM 2006 SrlDIRECTOR ELECTIONSISSUER8728.0000000.000000ABSTAIN8728.000000NONES000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026List Presented by PLT Holding Srl and PLT SpADIRECTOR ELECTIONSISSUER8728.0000000.000000ABSTAIN8728.000000NONES000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Statutory Auditors' FeesCOMPENSATIONISSUER8728.0000000.000000FOR8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Shareholder Proposal for Liability Action Against Nicola Maione (Chair)CORPORATE GOVERNANCESECURITY HOLDER8728.0000000.000000AGAINST8728.000000FORS000058304Banca Monte dei Paschi di Siena S.p.A.IT000550892104/15/2026Shareholder Proposal for Liability Action Against Luigi LovaglioCORPORATE GOVERNANCESECURITY HOLDER8728.0000000.000000AGAINST8728.000000FORS000058304Bank of MontrealCA063671101604/15/2026Elect George A. CopeDIRECTOR ELECTIONSISSUER702.0000000.000000FOR702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Elect Janice M. BabiakDIRECTOR ELECTIONSISSUER702.0000000.000000FOR702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Elect Craig W. BroderickDIRECTOR ELECTIONSISSUER702.0000000.000000FOR702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Elect Tammy L. BrownDIRECTOR ELECTIONSISSUER702.0000000.000000FOR702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Elect Hazel ClaxtonDIRECTOR ELECTIONSISSUER702.0000000.000000FOR702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Elect Diane L. CooperDIRECTOR ELECTIONSISSUER702.0000000.000000FOR702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Elect Stephen DentDIRECTOR ELECTIONSISSUER702.0000000.000000FOR702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Elect Martin S. EichenbaumDIRECTOR ELECTIONSISSUER702.0000000.000000FOR702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Elect David E. HarquailDIRECTOR ELECTIONSISSUER702.0000000.000000FOR702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Elect Eric R. La FlecheDIRECTOR ELECTIONSISSUER702.0000000.000000FOR702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Elect Brian McManusDIRECTOR ELECTIONSISSUER702.0000000.000000FOR702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Elect Lorraine MitchelmoreDIRECTOR ELECTIONSISSUER702.0000000.000000FOR702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Elect Madhu RanganathanDIRECTOR ELECTIONSISSUER702.0000000.000000FOR702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Elect Darryl WhiteDIRECTOR ELECTIONSISSUER702.0000000.000000FOR702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Appointment of AuditorAUDIT-RELATEDISSUER702.0000000.000000FOR702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER702.0000000.000000FOR702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER702.0000000.000000FOR702.000000FOR3S000058304Bank of MontrealCA063671101604/15/2026Shareholder Proposal Regarding Participation in Annual MeetingsCORPORATE GOVERNANCESECURITY HOLDER702.0000000.000000AGAINST702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Shareholder Proposal Regarding Board Youth RepresentationCORPORATE GOVERNANCESECURITY HOLDER702.0000000.000000AGAINST702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Shareholder Proposal Regarding Executive Compensation PolicyCOMPENSATIONSECURITY HOLDER702.0000000.000000AGAINST702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Shareholder Proposal Regarding Board Skill Diversification PolicyCORPORATE GOVERNANCESECURITY HOLDER702.0000000.000000AGAINST702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Shareholder Proposal Regarding Establishment of Advisory Committee on Systemic ImpactsENVIRONMENT OR CLIMATESECURITY HOLDER702.0000000.000000AGAINST702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Shareholder Proposal Regarding Report on Use of Artificial IntelligenceOTHER SOCIAL ISSUESSECURITY HOLDER702.0000000.000000FOR702.000000AGAINSTS000058304Bank of MontrealCA063671101604/15/2026Shareholder Proposal Regarding Disclosure of Country-by-Country ReportingCORPORATE GOVERNANCESECURITY HOLDER702.0000000.000000AGAINST702.000000FORS000058304Bank of MontrealCA063671101604/15/2026Shareholder Proposal Regarding Say on ClimateENVIRONMENT OR CLIMATESECURITY HOLDER702.0000000.000000AGAINST702.000000FORS000058304Koninklijke KPN N.V.NL000000908204/15/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER7956.0000000.000000FOR7956.000000FORS000058304Koninklijke KPN N.V.NL000000908204/15/2026Remuneration ReportCOMPENSATIONISSUER7956.0000000.000000FOR7956.000000FORS000058304Koninklijke KPN N.V.NL000000908204/15/2026Allocation of DividendsCAPITAL STRUCTUREISSUER7956.0000000.000000FOR7956.000000FORS000058304Koninklijke KPN N.V.NL000000908204/15/2026Ratification of Management Board ActsCORPORATE GOVERNANCEISSUER7956.0000000.000000FOR7956.000000FORS000058304Koninklijke KPN N.V.NL000000908204/15/2026Ratification of Supervisory Board ActsCORPORATE GOVERNANCEISSUER7956.0000000.000000FOR7956.000000FORS000058304Koninklijke KPN N.V.NL000000908204/15/2026Elect Kitty Koelemeijer to the Supervisory BoardDIRECTOR ELECTIONSISSUER7956.0000000.000000FOR7956.000000FORS000058304Koninklijke KPN N.V.NL000000908204/15/2026Authority to Repurchase SharesCAPITAL STRUCTUREISSUER7956.0000000.000000FOR7956.000000FORS000058304Koninklijke KPN N.V.NL000000908204/15/2026Cancellation of SharesCAPITAL STRUCTUREISSUER7956.0000000.000000FOR7956.000000FORS000058304Koninklijke KPN N.V.NL000000908204/15/2026Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER7956.0000000.000000FOR7956.000000FORS000058304Koninklijke KPN N.V.NL000000908204/15/2026Authority to Suppress Preemptive RightsCAPITAL STRUCTUREISSUER7956.0000000.000000FOR7956.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Allocation of DividendsCAPITAL STRUCTUREISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Remuneration PolicyCOMPENSATIONISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Remuneration ReportCOMPENSATIONISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/20262026 Short-Term Incentive PlanCOMPENSATIONISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Authority to Issue Shares to Service 2026 Short Term Incentive PlanCAPITAL STRUCTUREISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026List Presented by Board of DirectorsDIRECTOR ELECTIONSISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026List Presented by Delfinances SASDIRECTOR ELECTIONSISSUER8145.0000000.000000ABSTAIN8145.000000AGAINSTS000058304Banco Bpm SpAIT000521838004/16/2026List Presented by Group of Institutional Investors Representing 3.69% of Share CapitalDIRECTOR ELECTIONSISSUER8145.0000000.000000ABSTAIN8145.000000AGAINSTS000058304Banco Bpm SpAIT000521838004/16/2026Elect Massimo TononiDIRECTOR ELECTIONSISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Elect Giuseppe CastagnaDIRECTOR ELECTIONSISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Elect Maurizio ComoliDIRECTOR ELECTIONSISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Elect Marina MantelliDIRECTOR ELECTIONSISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Elect Luigia TauroDIRECTOR ELECTIONSISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Elect Alberto OlivetiDIRECTOR ELECTIONSISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Elect Costanza TorricelliDIRECTOR ELECTIONSISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Elect Eugenio RossettiDIRECTOR ELECTIONSISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Elect Giovanna ZanottiDIRECTOR ELECTIONSISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Elect Francesco Renato MeleDIRECTOR ELECTIONSISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Elect Silvia StefiniDIRECTOR ELECTIONSISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Elect Cecilia RossignoliDIRECTOR ELECTIONSISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Elect Elisa CorghiDIRECTOR ELECTIONSISSUER8145.0000000.000000ABSTAIN8145.000000AGAINSTS000058304Banco Bpm SpAIT000521838004/16/2026Elect Teresa Cristiana NaddeoDIRECTOR ELECTIONSISSUER8145.0000000.000000ABSTAIN8145.000000AGAINSTS000058304Banco Bpm SpAIT000521838004/16/2026Elect Milena Teresa MottaDIRECTOR ELECTIONSISSUER8145.0000000.000000ABSTAIN8145.000000AGAINSTS000058304Banco Bpm SpAIT000521838004/16/2026Elect Giorgio MionDIRECTOR ELECTIONSISSUER8145.0000000.000000ABSTAIN8145.000000AGAINSTS000058304Banco Bpm SpAIT000521838004/16/2026Elect Pietro GrassanoDIRECTOR ELECTIONSISSUER8145.0000000.000000ABSTAIN8145.000000AGAINSTS000058304Banco Bpm SpAIT000521838004/16/2026Elect Manuela SoffientiniDIRECTOR ELECTIONSISSUER8145.0000000.000000ABSTAIN8145.000000AGAINSTS000058304Banco Bpm SpAIT000521838004/16/2026Elect Savino CasamassimaDIRECTOR ELECTIONSISSUER8145.0000000.000000ABSTAIN8145.000000AGAINSTS000058304Banco Bpm SpAIT000521838004/16/2026Elect Marco BragadinDIRECTOR ELECTIONSISSUER8145.0000000.000000ABSTAIN8145.000000AGAINSTS000058304Banco Bpm SpAIT000521838004/16/2026List Presented by Delfinances SASDIRECTOR ELECTIONSISSUER8145.0000000.000000ABSTAIN8145.000000NONES000058304Banco Bpm SpAIT000521838004/16/2026List Presented by Group of Institutional Investors Representing 0.72% of Share CapitalDIRECTOR ELECTIONSISSUER8145.0000000.000000FOR8145.000000NONES000058304Banco Bpm SpAIT000521838004/16/2026List Presented by Group of ShareholdersDIRECTOR ELECTIONSISSUER8145.0000000.000000ABSTAIN8145.000000NONES000058304Banco Bpm SpAIT000521838004/16/2026Directors' FeesCOMPENSATIONISSUER8145.0000000.000000FOR8145.000000FORS000058304Banco Bpm SpAIT000521838004/16/2026Statutory Auditors' FeesCOMPENSATIONISSUER8145.0000000.000000FOR8145.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Elect Ammar Al-JoundiDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Elect Michelle L. CollinsDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Elect Harry CulhamDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Elect Marianne HarrisonDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Elect Kevin J. KellyDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Elect Christine E. LarsenDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Elect Mary Lou MaherDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Elect William F. MorneauDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Elect Mark W. PodlaslyDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Elect Francois L. PoirierDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Elect Katharine B. StevensonDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Elect Martine TurcotteDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Elect Barry L. ZubrowDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Appointment of AuditorAUDIT-RELATEDISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER837.0000000.000000FOR837.000000FOR3S000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Amendment to the Employee Stock Option PlanCOMPENSATIONISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Amendment to By-Law Regarding Directors' RemunerationCORPORATE GOVERNANCEISSUER837.0000000.000000FOR837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Shareholder Proposal Regarding Participation in Annual MeetingsCORPORATE GOVERNANCESECURITY HOLDER837.0000000.000000AGAINST837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Shareholder Proposal Regarding Board Youth RepresentationCORPORATE GOVERNANCESECURITY HOLDER837.0000000.000000AGAINST837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Shareholder Proposal Regarding Executive Compensation PolicyCOMPENSATIONSECURITY HOLDER837.0000000.000000AGAINST837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Shareholder Proposal Regarding Board Skill Diversification PolicyCORPORATE GOVERNANCESECURITY HOLDER837.0000000.000000AGAINST837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Shareholder Proposal Regarding Establishment of Advisory Committee on Systemic ImpactsENVIRONMENT OR CLIMATESECURITY HOLDER837.0000000.000000AGAINST837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Shareholder Proposal Regarding Disclosure of Country-by-Country ReportingCORPORATE GOVERNANCESECURITY HOLDER837.0000000.000000AGAINST837.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/16/2026Shareholder Proposal Regarding Say on ClimateENVIRONMENT OR CLIMATESECURITY HOLDER837.0000000.000000AGAINST837.000000FORS000058304CovivioFR000006457804/16/2026Accounts and Reports; Non Tax-Deductible ExpensesCORPORATE GOVERNANCEISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Consolidated Accounts and ReportsCORPORATE GOVERNANCEISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Special Auditors Report on Regulated AgreementsAUDIT-RELATEDISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/20262025 Remuneration ReportCOMPENSATIONISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/20262025 Remuneration of Jean-Luc Biamonti, ChairCOMPENSATIONISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/20262025 Remuneration of Christophe Kullmann, CEOCOMPENSATIONISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/20262025 Remuneration of Olivier Esteve, Deputy CEOCOMPENSATIONISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/20262026 Remuneration Policy (Chair)COMPENSATIONISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/20262026 Remuneration Policy (CEO)COMPENSATIONISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/20262026 Remuneration Policy (Deputy CEO)COMPENSATIONISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/20262026 Remuneration Policy (Board of Directors)COMPENSATIONISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Elect ACM Vie (Catherine Jean-Louis)DIRECTOR ELECTIONSISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Elect Romolo BardinDIRECTOR ELECTIONSISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Elect Alix d'OcagneDIRECTOR ELECTIONSISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Elect Daniela SchwarzerDIRECTOR ELECTIONSISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Authority to Increase Capital Through CapitalisationsCAPITAL STRUCTUREISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Authority to Cancel Shares and Reduce CapitalCAPITAL STRUCTUREISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Authority to Issue Shares and Convertible Debt w/ Preemptive RightsCAPITAL STRUCTUREISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Authority to Issue Shares and Convertible Debt w/o Preemptive RightsCAPITAL STRUCTUREISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Authority to Issue Shares and Convertible Debt w/o Preemptive Rights (Qualified Investors)CAPITAL STRUCTUREISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026GreenshoeCAPITAL STRUCTUREISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Authority to Increase Capital in Case of Exchange OffersCAPITAL STRUCTUREISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Authority to Increase Capital in Consideration for Contributions In KindCAPITAL STRUCTUREISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Employee Stock Purchase PlanCOMPENSATIONISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Amendments to Articles Regarding the Record DateCORPORATE GOVERNANCEISSUER724.0000000.000000FOR724.000000FORS000058304CovivioFR000006457804/16/2026Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER724.0000000.000000FOR724.000000FORS000058304Mercedes-Benz Group AGDE000710000004/16/2026Resolution on the appropriation of distributable profitCAPITAL STRUCTUREISSUER472.0000000.000000FOR472.000000FORS000058304Mercedes-Benz Group AGDE000710000004/16/2026Resolution on ratification of Board of Management members actions in financial year 2025CORPORATE GOVERNANCEISSUER472.0000000.000000ABSTAIN472.000000AGAINSTS000058304Mercedes-Benz Group AGDE000710000004/16/2026Resolution on ratification of Supervisory Board members actions in financial year 2025CORPORATE GOVERNANCEISSUER472.0000000.000000FOR472.000000FORS000058304Mercedes-Benz Group AGDE000710000004/16/2026Resolution on the appointment of the auditor for the annual financial statements, the auditor for the consolidated financial statements, the auditor for the review of the interim financial reports, and the auditor for the sustainability report - Auditor for the annual financial statements, auditor for the consolidated financial statements and auditor for the review of the interim financial reports for financial year 2026 (PricewaterhouseCoopers GmbH Wirtschaftsprfungsgesellschaft)AUDIT-RELATEDISSUER472.0000000.000000FOR472.000000FORS000058304Mercedes-Benz Group AGDE000710000004/16/2026Resolution on the appointment of the auditor for the annual financial statements, the auditor for the consolidated financial statements, the auditor for the review of the interim financial reports, and the auditor for the sustainability report - Auditor for the review of interim financial reports for financial year 2027 in the period until the next Annual General Meeting in financial year 2027 (PricewaterhouseCoopers GmbH Wirtschaftsprfungsgesellschaft)AUDIT-RELATEDISSUER472.0000000.000000FOR472.000000FORS000058304Mercedes-Benz Group AGDE000710000004/16/2026Resolution on the appointment of the auditor for the annual financial statements, the auditor for the consolidated financial statements, the auditor for the review of the interim financial reports, and the auditor for the sustainability report - Auditor for the sustainability report for financial year 2026 (PricewaterhouseCoopers GmbH Wirtschaftsprfungsgesellschaft)AUDIT-RELATEDISSUER472.0000000.000000FOR472.000000FORS000058304Mercedes-Benz Group AGDE000710000004/16/2026Resolution on the approval of the remuneration report for financial year 2025COMPENSATIONISSUER472.0000000.000000FOR472.000000FORS000058304Mercedes-Benz Group AGDE000710000004/16/2026Resolution on elections to the Supervisory Board - Dr-Ing Dipl-Wirt-Ing Katharina BeumelburgDIRECTOR ELECTIONSISSUER472.0000000.000000FOR472.000000FORS000058304Mercedes-Benz Group AGDE000710000004/16/2026Resolution on elections to the Supervisory Board - Dr Rashmi MisraDIRECTOR ELECTIONSISSUER472.0000000.000000FOR472.000000FORS000058304Mercedes-Benz Group AGDE000710000004/16/2026Resolution on elections to the Supervisory Board - Marco GobbettiDIRECTOR ELECTIONSISSUER472.0000000.000000FOR472.000000FORS000058304Mercedes-Benz Group AGDE000710000004/16/2026With regard to motions and election proposals by shareholders that are not to be made accessible prior to the Annual General Meeting and which are only submitted or amended during the Annual General Meeting, I/we vote as follows or I/we issue the following instruction, unless I/we vote or issue instructions differently elsewhereCORPORATE GOVERNANCESECURITY HOLDER472.0000000.000000AGAINST472.000000NONES000058304Nestle S.A.CH003886335004/16/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Compensation ReportCOMPENSATIONISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Report on Non-Financial MattersCORPORATE GOVERNANCEISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Ratification of Board and Management ActsCORPORATE GOVERNANCEISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Allocation of DividendsCAPITAL STRUCTUREISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Pablo Isla as Board ChairDIRECTOR ELECTIONSISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Dick BoerDIRECTOR ELECTIONSISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Marie-Gabrielle Ineichen-FleischDIRECTOR ELECTIONSISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Renato FassbindDIRECTOR ELECTIONSISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Patrick AebischerDIRECTOR ELECTIONSISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Dinesh PaliwalDIRECTOR ELECTIONSISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Lindiwe Majele SibandaDIRECTOR ELECTIONSISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Chris LeongDIRECTOR ELECTIONSISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Luca MaestriDIRECTOR ELECTIONSISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Rainer BlairDIRECTOR ELECTIONSISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Geraldine MatchettDIRECTOR ELECTIONSISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Fatima D. FranciscoDIRECTOR ELECTIONSISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Thomas JordanDIRECTOR ELECTIONSISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Dinesh PaliwalCORPORATE GOVERNANCEISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Dick BoerCORPORATE GOVERNANCEISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Patrick AebischerCORPORATE GOVERNANCEISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Marie-Gabrielle Ineichen-FleischCORPORATE GOVERNANCEISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Renato FassbindCORPORATE GOVERNANCEISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Elect Luca MaestriCORPORATE GOVERNANCEISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Appointment of AuditorAUDIT-RELATEDISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Appointment of Independent ProxyCORPORATE GOVERNANCEISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Board CompensationCOMPENSATIONISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Executive Compensation (Total)COMPENSATIONISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304Nestle S.A.CH003886335004/16/2026Transaction of Other BusinessCORPORATE GOVERNANCEISSUER1500.0000000.000000Takenoaction1500.000000NONES000058304ageas SA/NVBE097426493004/22/2026Increase in Authorised CapitalCAPITAL STRUCTUREISSUER359.0000000.000000FOR359.000000FORS000058304ageas SA/NVBE097426493004/22/2026Authority to Repurchase SharesCAPITAL STRUCTUREISSUER359.0000000.000000FOR359.000000FORS000058304ASML Holding N.V.NL001027321504/22/2026Remuneration ReportCOMPENSATIONISSUER16.0000000.000000FOR16.000000FORS000058304ASML Holding N.V.NL001027321504/22/2026Accounts and ReportsCORPORATE GOVERNANCEISSUER16.0000000.000000FOR16.000000FORS000058304ASML Holding N.V.NL001027321504/22/2026Allocation of DividendsCAPITAL STRUCTUREISSUER16.0000000.000000FOR16.000000FORS000058304ASML Holding N.V.NL001027321504/22/2026Ratification of Management Board ActsCORPORATE GOVERNANCEISSUER16.0000000.000000FOR16.000000FORS000058304ASML Holding N.V.NL001027321504/22/2026Ratification of Supervisory Board ActsCORPORATE GOVERNANCEISSUER16.0000000.000000FOR16.000000FORS000058304ASML Holding N.V.NL001027321504/22/2026Long-Term Incentive Plan; Authority to Issue SharesCOMPENSATIONISSUER16.0000000.000000FOR16.000000FORS000058304ASML Holding N.V.NL001027321504/22/2026Elect Terri L. Kelly to the Supervisory BoardDIRECTOR ELECTIONSISSUER16.0000000.000000FOR16.000000FORS000058304ASML Holding N.V.NL001027321504/22/2026Elect An Steegen to the Supervisory BoardDIRECTOR ELECTIONSISSUER16.0000000.000000FOR16.000000FORS000058304ASML Holding N.V.NL001027321504/22/2026Elect Benjamin Loh to the Supervisory BoardDIRECTOR ELECTIONSISSUER16.0000000.000000FOR16.000000FORS000058304ASML Holding N.V.NL001027321504/22/2026Appointment of AuditorAUDIT-RELATEDISSUER16.0000000.000000FOR16.000000FORS000058304ASML Holding N.V.NL001027321504/22/2026Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER16.0000000.000000FOR16.000000FORS000058304ASML Holding N.V.NL001027321504/22/2026Authority to Issue Shares w/ Preemptive Rights (5% for General Purposes; 5% for M&A Purposes)CAPITAL STRUCTUREISSUER16.0000000.000000FOR16.000000FORS000058304ASML Holding N.V.NL001027321504/22/2026Authority to Suppress Preemptive Rights (5% for General Purposes; 5% for M&A Purposes)CAPITAL STRUCTUREISSUER16.0000000.000000FOR16.000000FORS000058304ASML Holding N.V.NL001027321504/22/2026Authority to Repurchase SharesCAPITAL STRUCTUREISSUER16.0000000.000000FOR16.000000FORS000058304ASML Holding N.V.NL001027321504/22/2026Cancellation of SharesCAPITAL STRUCTUREISSUER16.0000000.000000FOR16.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER5874.0000000.000000FOR5874.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2026Amendments to ArticlesCORPORATE GOVERNANCEISSUER5874.0000000.000000FOR5874.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2026Elect Yoshihiro NakaiDIRECTOR ELECTIONSISSUER5874.0000000.000000FOR5874.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2026Elect Satoshi TanakaDIRECTOR ELECTIONSISSUER5874.0000000.000000AGAINST5874.000000AGAINSTS000058304Sekisui House, Ltd.JP342060000304/23/2026Elect Toru IshiiDIRECTOR ELECTIONSISSUER5874.0000000.000000FOR5874.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2026Elect Yasushi OmuraDIRECTOR ELECTIONSISSUER5874.0000000.000000FOR5874.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2026Elect Masaru NomaDIRECTOR ELECTIONSISSUER5874.0000000.000000FOR5874.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2026Elect Yukiko YoshimaruDIRECTOR ELECTIONSISSUER5874.0000000.000000FOR5874.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2026Elect Toshifumi KitazawaDIRECTOR ELECTIONSISSUER5874.0000000.000000FOR5874.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2026Elect Yoshimi NakajimaDIRECTOR ELECTIONSISSUER5874.0000000.000000FOR5874.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2026Elect Shinichi AbeDIRECTOR ELECTIONSISSUER5874.0000000.000000FOR5874.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2026Elect Yukiko Kuroda @ Yukiko MatsumotoDIRECTOR ELECTIONSISSUER5874.0000000.000000FOR5874.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2026Elect Takashi OginoCORPORATE GOVERNANCEISSUER5874.0000000.000000FOR5874.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2026Elect Nobuo HanadaCORPORATE GOVERNANCEISSUER5874.0000000.000000FOR5874.000000FORS000058304Enbridge Inc.CA29250N105005/06/2026Elect Mayank M. AsharDIRECTOR ELECTIONSISSUER4675.0000000.000000FOR4675.000000FORS000058304Enbridge Inc.CA29250N105005/06/2026Elect Gaurdie E. Banister Jr.DIRECTOR ELECTIONSISSUER4675.0000000.000000FOR4675.000000FORS000058304Enbridge Inc.CA29250N105005/06/2026Elect Susan M. CunninghamDIRECTOR ELECTIONSISSUER4675.0000000.000000FOR4675.000000FORS000058304Enbridge Inc.CA29250N105005/06/2026Elect Gregory L. EbelDIRECTOR ELECTIONSISSUER4675.0000000.000000FOR4675.000000FORS000058304Enbridge Inc.CA29250N105005/06/2026Elect Jason B. FewDIRECTOR ELECTIONSISSUER4675.0000000.000000FOR4675.000000FORS000058304Enbridge Inc.CA29250N105005/06/2026Elect Douglas L. FosheeDIRECTOR ELECTIONSISSUER4675.0000000.000000FOR4675.000000FORS000058304Enbridge Inc.CA29250N105005/06/2026Elect Theresa B.Y. JangDIRECTOR ELECTIONSISSUER4675.0000000.000000FOR4675.000000FORS000058304Enbridge Inc.CA29250N105005/06/2026Elect Teresa S. MaddenDIRECTOR ELECTIONSISSUER4675.0000000.000000FOR4675.000000FORS000058304Enbridge Inc.CA29250N105005/06/2026Elect Manjit MinhasDIRECTOR ELECTIONSISSUER4675.0000000.000000FOR4675.000000FORS000058304Enbridge Inc.CA29250N105005/06/2026Elect Stephen S. PolozDIRECTOR ELECTIONSISSUER4675.0000000.000000FOR4675.000000FORS000058304Enbridge Inc.CA29250N105005/06/2026Elect S. Jane RoweDIRECTOR ELECTIONSISSUER4675.0000000.000000FOR4675.000000FORS000058304Enbridge Inc.CA29250N105005/06/2026Elect Steven W. WilliamsDIRECTOR ELECTIONSISSUER4675.0000000.000000FOR4675.000000FORS000058304Enbridge Inc.CA29250N105005/06/2026Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER4675.0000000.000000FOR4675.000000FORS000058304Enbridge Inc.CA29250N105005/06/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER4675.0000000.000000FOR4675.000000FORS000058304Enbridge Inc.CA29250N105005/06/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER4675.0000000.000000FOR4675.000000FOR3S000058304Enbridge Inc.CA29250N105005/06/2026Shareholder Rights Plan RenewalSHAREHOLDER RIGHTS AND DEFENSESISSUER4675.0000000.000000FOR4675.000000FORS000058304BCE Inc.CA05534B760405/07/2026Elect Mirko BibicDIRECTOR ELECTIONSISSUER589.0000000.000000FOR589.000000FORS000058304BCE Inc.CA05534B760405/07/2026Elect Robert P. DexterDIRECTOR ELECTIONSISSUER589.0000000.000000FOR589.000000FORS000058304BCE Inc.CA05534B760405/07/2026Elect Katherine LeeDIRECTOR ELECTIONSISSUER589.0000000.000000FOR589.000000FORS000058304BCE Inc.CA05534B760405/07/2026Elect Monique F. LerouxDIRECTOR ELECTIONSISSUER589.0000000.000000FOR589.000000FORS000058304BCE Inc.CA05534B760405/07/2026Elect Sheila A. MurrayDIRECTOR ELECTIONSISSUER589.0000000.000000FOR589.000000FORS000058304BCE Inc.CA05534B760405/07/2026Elect Louis P. PagnuttiDIRECTOR ELECTIONSISSUER589.0000000.000000FOR589.000000FORS000058304BCE Inc.CA05534B760405/07/2026Elect Calin RovinescuDIRECTOR ELECTIONSISSUER589.0000000.000000FOR589.000000FORS000058304BCE Inc.CA05534B760405/07/2026Elect Karen H. SheriffDIRECTOR ELECTIONSISSUER589.0000000.000000FOR589.000000FORS000058304BCE Inc.CA05534B760405/07/2026Elect Jennifer ToryDIRECTOR ELECTIONSISSUER589.0000000.000000FOR589.000000FORS000058304BCE Inc.CA05534B760405/07/2026Elect Louis VachonDIRECTOR ELECTIONSISSUER589.0000000.000000FOR589.000000FORS000058304BCE Inc.CA05534B760405/07/2026Elect Steve WeedDIRECTOR ELECTIONSISSUER589.0000000.000000FOR589.000000FORS000058304BCE Inc.CA05534B760405/07/2026Elect Johan WiberghDIRECTOR ELECTIONSISSUER589.0000000.000000FOR589.000000FORS000058304BCE Inc.CA05534B760405/07/2026Elect Cornell WrightDIRECTOR ELECTIONSISSUER589.0000000.000000FOR589.000000FORS000058304BCE Inc.CA05534B760405/07/2026Appointment of AuditorAUDIT-RELATEDISSUER589.0000000.000000FOR589.000000FORS000058304BCE Inc.CA05534B760405/07/2026ADVISORY VOTE ON EXECUTIVE COMPENSATIONSECTION 14A SAY-ON-PAY VOTESISSUER589.0000000.000000FOR589.000000FORS000058304BCE Inc.CA05534B760405/07/2026ADVISORY VOTE ON EXECUTIVE COMPENSATIONSECTION 14A SAY-ON-PAY VOTESISSUER589.0000000.000000FOR589.000000FOR3S000058304BCE Inc.CA05534B760405/07/2026Shareholder Proposal Regarding Participation in Annual MeetingsCORPORATE GOVERNANCESECURITY HOLDER589.0000000.000000AGAINST589.000000FORS000058304Canadian Natural Resources LimitedCA136385101705/07/2026Elect Shelley A.M. BrownDIRECTOR ELECTIONSISSUER1934.0000000.000000FOR1934.000000FORS000058304Canadian Natural Resources LimitedCA136385101705/07/2026Elect M. Elizabeth CannonDIRECTOR ELECTIONSISSUER1934.0000000.000000FOR1934.000000FORS000058304Canadian Natural Resources LimitedCA136385101705/07/2026Elect N. Murray EdwardsDIRECTOR ELECTIONSISSUER1934.0000000.000000FOR1934.000000FORS000058304Canadian Natural Resources LimitedCA136385101705/07/2026Elect Christopher L. FongDIRECTOR ELECTIONSISSUER1934.0000000.000000FOR1934.000000FORS000058304Canadian Natural Resources LimitedCA136385101705/07/2026Elect Gordon D. GiffinDIRECTOR ELECTIONSISSUER1934.0000000.000000FOR1934.000000FORS000058304Canadian Natural Resources LimitedCA136385101705/07/2026Elect Christine M. HealyDIRECTOR ELECTIONSISSUER1934.0000000.000000FOR1934.000000FORS000058304Canadian Natural Resources LimitedCA136385101705/07/2026Elect Grant E. IsaacDIRECTOR ELECTIONSISSUER1934.0000000.000000FOR1934.000000FORS000058304Canadian Natural Resources LimitedCA136385101705/07/2026Elect Steve W. LautDIRECTOR ELECTIONSISSUER1934.0000000.000000FOR1934.000000FORS000058304Canadian Natural Resources LimitedCA136385101705/07/2026Elect Frank J. McKennaDIRECTOR ELECTIONSISSUER1934.0000000.000000FOR1934.000000FORS000058304Canadian Natural Resources LimitedCA136385101705/07/2026Elect Scott G. StauthDIRECTOR ELECTIONSISSUER1934.0000000.000000FOR1934.000000FORS000058304Canadian Natural Resources LimitedCA136385101705/07/2026Elect David A. TuerDIRECTOR ELECTIONSISSUER1934.0000000.000000FOR1934.000000FORS000058304Canadian Natural Resources LimitedCA136385101705/07/2026Elect Annette VerschurenDIRECTOR ELECTIONSISSUER1934.0000000.000000FOR1934.000000FORS000058304Canadian Natural Resources LimitedCA136385101705/07/2026Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER1934.0000000.000000FOR1934.000000FORS000058304Canadian Natural Resources LimitedCA136385101705/07/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER1934.0000000.000000FOR1934.000000FORS000058304Canadian Natural Resources LimitedCA136385101705/07/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER1934.0000000.000000FOR1934.000000FOR3S000058304TC Energy CorporationCA87807B107605/07/2026Elect Scott B. BonhamDIRECTOR ELECTIONSISSUER2035.0000000.000000FOR2035.000000FORS000058304TC Energy CorporationCA87807B107605/07/2026Elect Cheryl F. CampbellDIRECTOR ELECTIONSISSUER2035.0000000.000000FOR2035.000000FORS000058304TC Energy CorporationCA87807B107605/07/2026Elect Michael R. CulbertDIRECTOR ELECTIONSISSUER2035.0000000.000000FOR2035.000000FORS000058304TC Energy CorporationCA87807B107605/07/2026Elect William D. JohnsonDIRECTOR ELECTIONSISSUER2035.0000000.000000FOR2035.000000FORS000058304TC Energy CorporationCA87807B107605/07/2026Elect Susan C. JonesDIRECTOR ELECTIONSISSUER2035.0000000.000000FOR2035.000000FORS000058304TC Energy CorporationCA87807B107605/07/2026Elect John E. LoweDIRECTOR ELECTIONSISSUER2035.0000000.000000FOR2035.000000FORS000058304TC Energy CorporationCA87807B107605/07/2026Elect Dawn Madahbee LeachDIRECTOR ELECTIONSISSUER2035.0000000.000000FOR2035.000000FORS000058304TC Energy CorporationCA87807B107605/07/2026Elect Francois L. PoirierDIRECTOR ELECTIONSISSUER2035.0000000.000000FOR2035.000000FORS000058304TC Energy CorporationCA87807B107605/07/2026Elect Una M. PowerDIRECTOR ELECTIONSISSUER2035.0000000.000000FOR2035.000000FORS000058304TC Energy CorporationCA87807B107605/07/2026Elect Mary Pat SalomoneDIRECTOR ELECTIONSISSUER2035.0000000.000000FOR2035.000000FORS000058304TC Energy CorporationCA87807B107605/07/2026Elect Siim A. VanaseljaDIRECTOR ELECTIONSISSUER2035.0000000.000000AGAINST2035.000000AGAINSTS000058304TC Energy CorporationCA87807B107605/07/2026Elect Thierry VandalDIRECTOR ELECTIONSISSUER2035.0000000.000000FOR2035.000000FORS000058304TC Energy CorporationCA87807B107605/07/2026Elect Dheeraj D VermaDIRECTOR ELECTIONSISSUER2035.0000000.000000FOR2035.000000FORS000058304TC Energy CorporationCA87807B107605/07/2026Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER2035.0000000.000000FOR2035.000000FORS000058304TC Energy CorporationCA87807B107605/07/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER2035.0000000.000000FOR2035.000000FORS000058304TC Energy CorporationCA87807B107605/07/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER2035.0000000.000000FOR2035.000000FOR3S000058304IGM Financial Inc.CA449586106005/08/2026Elect Marc A. BibeauDIRECTOR ELECTIONSISSUER368.0000000.000000FOR368.000000FORS000058304IGM Financial Inc.CA449586106005/08/2026Elect Andra S. BolotinDIRECTOR ELECTIONSISSUER368.0000000.000000FOR368.000000FORS000058304IGM Financial Inc.CA449586106005/08/2026Elect Betsey ChungDIRECTOR ELECTIONSISSUER368.0000000.000000FOR368.000000FORS000058304IGM Financial Inc.CA449586106005/08/2026Elect Marcel R. CoutuDIRECTOR ELECTIONSISSUER368.0000000.000000FOR368.000000FORS000058304IGM Financial Inc.CA449586106005/08/2026Elect Andre DesmaraisDIRECTOR ELECTIONSISSUER368.0000000.000000FOR368.000000FORS000058304IGM Financial Inc.CA449586106005/08/2026Elect Paul Desmarais, Jr.DIRECTOR ELECTIONSISSUER368.0000000.000000AGAINST368.000000AGAINSTS000058304IGM Financial Inc.CA449586106005/08/2026Elect Gary A. DoerDIRECTOR ELECTIONSISSUER368.0000000.000000FOR368.000000FORS000058304IGM Financial Inc.CA449586106005/08/2026Elect Claude GenereuxDIRECTOR ELECTIONSISSUER368.0000000.000000AGAINST368.000000AGAINSTS000058304IGM Financial Inc.CA449586106005/08/2026Elect Sharon L. HodgsonDIRECTOR ELECTIONSISSUER368.0000000.000000FOR368.000000FORS000058304IGM Financial Inc.CA449586106005/08/2026Elect Jake P. LawrenceDIRECTOR ELECTIONSISSUER368.0000000.000000FOR368.000000FORS000058304IGM Financial Inc.CA449586106005/08/2026Elect Sharon MacLeodDIRECTOR ELECTIONSISSUER368.0000000.000000FOR368.000000FORS000058304IGM Financial Inc.CA449586106005/08/2026Elect Susan J. McArthurDIRECTOR ELECTIONSISSUER368.0000000.000000FOR368.000000FORS000058304IGM Financial Inc.CA449586106005/08/2026Elect Damon MurchisonDIRECTOR ELECTIONSISSUER368.0000000.000000FOR368.000000FORS000058304IGM Financial Inc.CA449586106005/08/2026Elect R. Jeffrey OrrDIRECTOR ELECTIONSISSUER368.0000000.000000FOR368.000000FORS000058304IGM Financial Inc.CA449586106005/08/2026Elect James O' SullivanDIRECTOR ELECTIONSISSUER368.0000000.000000AGAINST368.000000AGAINSTS000058304IGM Financial Inc.CA449586106005/08/2026Elect Elizabeth D. WilsonDIRECTOR ELECTIONSISSUER368.0000000.000000FOR368.000000FORS000058304IGM Financial Inc.CA449586106005/08/2026Appointment of AuditorAUDIT-RELATEDISSUER368.0000000.000000FOR368.000000FORS000058304IGM Financial Inc.CA449586106005/08/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER368.0000000.000000FOR368.000000FORS000058304IGM Financial Inc.CA449586106005/08/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER368.0000000.000000FOR368.000000FOR3S000058304Pembina Pipeline CorporationCA706327103405/08/2026Elect J. Scott BurrowsDIRECTOR ELECTIONSISSUER3603.0000000.000000FOR3603.000000FORS000058304Pembina Pipeline CorporationCA706327103405/08/2026Elect Cynthia B. CarrollDIRECTOR ELECTIONSISSUER3603.0000000.000000FOR3603.000000FORS000058304Pembina Pipeline CorporationCA706327103405/08/2026Elect Alister CowanDIRECTOR ELECTIONSISSUER3603.0000000.000000FOR3603.000000FORS000058304Pembina Pipeline CorporationCA706327103405/08/2026Elect Ana DutraDIRECTOR ELECTIONSISSUER3603.0000000.000000FOR3603.000000FORS000058304Pembina Pipeline CorporationCA706327103405/08/2026Elect Maureen E. HoweDIRECTOR ELECTIONSISSUER3603.0000000.000000FOR3603.000000FORS000058304Pembina Pipeline CorporationCA706327103405/08/2026Elect David M.B. LeGresleyDIRECTOR ELECTIONSISSUER3603.0000000.000000FOR3603.000000FORS000058304Pembina Pipeline CorporationCA706327103405/08/2026Elect Andy J. MahDIRECTOR ELECTIONSISSUER3603.0000000.000000FOR3603.000000FORS000058304Pembina Pipeline CorporationCA706327103405/08/2026Elect Leslie A. O'DonoghueDIRECTOR ELECTIONSISSUER3603.0000000.000000FOR3603.000000FORS000058304Pembina Pipeline CorporationCA706327103405/08/2026Elect Bruce D. RubinDIRECTOR ELECTIONSISSUER3603.0000000.000000FOR3603.000000FORS000058304Pembina Pipeline CorporationCA706327103405/08/2026Elect Henry W. SykesDIRECTOR ELECTIONSISSUER3603.0000000.000000FOR3603.000000FORS000058304Pembina Pipeline CorporationCA706327103405/08/2026Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER3603.0000000.000000FOR3603.000000FORS000058304Pembina Pipeline CorporationCA706327103405/08/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER3603.0000000.000000FOR3603.000000FORS000058304Pembina Pipeline CorporationCA706327103405/08/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER3603.0000000.000000FOR3603.000000FOR3S000058304TELUS CorporationCA87971M996905/08/2026Elect Raymond T. ChanDIRECTOR ELECTIONSISSUER9550.0000000.000000FOR9550.000000FORS000058304TELUS CorporationCA87971M996905/08/2026Elect Hazel ClaxtonDIRECTOR ELECTIONSISSUER9550.0000000.000000FOR9550.000000FORS000058304TELUS CorporationCA87971M996905/08/2026Elect Lisa de WildeDIRECTOR ELECTIONSISSUER9550.0000000.000000FOR9550.000000FORS000058304TELUS CorporationCA87971M996905/08/2026Elect Victor G. DodigDIRECTOR ELECTIONSISSUER9550.0000000.000000FOR9550.000000FORS000058304TELUS CorporationCA87971M996905/08/2026Elect Darren EntwistleDIRECTOR ELECTIONSISSUER9550.0000000.000000FOR9550.000000FORS000058304TELUS CorporationCA87971M996905/08/2026Elect Martha Hall FindlayDIRECTOR ELECTIONSISSUER9550.0000000.000000FOR9550.000000FORS000058304TELUS CorporationCA87971M996905/08/2026Elect Thomas E. FlynnDIRECTOR ELECTIONSISSUER9550.0000000.000000FOR9550.000000FORS000058304TELUS CorporationCA87971M996905/08/2026Elect Mary Jo HaddadDIRECTOR ELECTIONSISSUER9550.0000000.000000FOR9550.000000FORS000058304TELUS CorporationCA87971M996905/08/2026Elect Christine MageeDIRECTOR ELECTIONSISSUER9550.0000000.000000FOR9550.000000FORS000058304TELUS CorporationCA87971M996905/08/2026Elect John P. ManleyDIRECTOR ELECTIONSISSUER9550.0000000.000000FOR9550.000000FORS000058304TELUS CorporationCA87971M996905/08/2026Elect David MowatDIRECTOR ELECTIONSISSUER9550.0000000.000000FOR9550.000000FORS000058304TELUS CorporationCA87971M996905/08/2026Elect Marc ParentDIRECTOR ELECTIONSISSUER9550.0000000.000000FOR9550.000000FORS000058304TELUS CorporationCA87971M996905/08/2026Elect Denise PickettDIRECTOR ELECTIONSISSUER9550.0000000.000000FOR9550.000000FORS000058304TELUS CorporationCA87971M996905/08/2026Elect W. Sean WillyDIRECTOR ELECTIONSISSUER9550.0000000.000000FOR9550.000000FORS000058304TELUS CorporationCA87971M996905/08/2026Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER9550.0000000.000000FOR9550.000000FORS000058304TELUS CorporationCA87971M996905/08/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER9550.0000000.000000FOR9550.000000FORS000058304TELUS CorporationCA87971M996905/08/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER9550.0000000.000000FOR9550.000000FOR3S000058304TELUS CorporationCA87971M996905/08/2026Amendment to the Restricted Share Unit PlanCOMPENSATIONISSUER9550.0000000.000000FOR9550.000000FORS000058304Manulife Financial CorporationCA56501R106405/14/2026Elect Nicole S. ArnaboldiDIRECTOR ELECTIONSISSUER5085.0000000.000000FOR5085.000000FORS000058304Manulife Financial CorporationCA56501R106405/14/2026Elect Guy L.T. BainbridgeDIRECTOR ELECTIONSISSUER5085.0000000.000000FOR5085.000000FORS000058304Manulife Financial CorporationCA56501R106405/14/2026Elect Nancy J. CarrollDIRECTOR ELECTIONSISSUER5085.0000000.000000FOR5085.000000FORS000058304Manulife Financial CorporationCA56501R106405/14/2026Elect Julie E. DicksonDIRECTOR ELECTIONSISSUER5085.0000000.000000FOR5085.000000FORS000058304Manulife Financial CorporationCA56501R106405/14/2026Elect J. Michael DurlandDIRECTOR ELECTIONSISSUER5085.0000000.000000FOR5085.000000FORS000058304Manulife Financial CorporationCA56501R106405/14/2026Elect Donald P. KanakDIRECTOR ELECTIONSISSUER5085.0000000.000000FOR5085.000000FORS000058304Manulife Financial CorporationCA56501R106405/14/2026Elect Donald R. LindsayDIRECTOR ELECTIONSISSUER5085.0000000.000000FOR5085.000000FORS000058304Manulife Financial CorporationCA56501R106405/14/2026Elect Anna ManningDIRECTOR ELECTIONSISSUER5085.0000000.000000FOR5085.000000FORS000058304Manulife Financial CorporationCA56501R106405/14/2026Elect John MontalbanoDIRECTOR ELECTIONSISSUER5085.0000000.000000FOR5085.000000FORS000058304Manulife Financial CorporationCA56501R106405/14/2026Elect May TanDIRECTOR ELECTIONSISSUER5085.0000000.000000FOR5085.000000FORS000058304Manulife Financial CorporationCA56501R106405/14/2026Elect Leagh E. TurnerDIRECTOR ELECTIONSISSUER5085.0000000.000000FOR5085.000000FORS000058304Manulife Financial CorporationCA56501R106405/14/2026Elect Philip J. WitheringtonDIRECTOR ELECTIONSISSUER5085.0000000.000000FOR5085.000000FORS000058304Manulife Financial CorporationCA56501R106405/14/2026Elect John WongDIRECTOR ELECTIONSISSUER5085.0000000.000000FOR5085.000000FORS000058304Manulife Financial CorporationCA56501R106405/14/2026Appointment of AuditorAUDIT-RELATEDISSUER5085.0000000.000000FOR5085.000000FORS000058304Manulife Financial CorporationCA56501R106405/14/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER5085.0000000.000000FOR5085.000000FORS000058304Manulife Financial CorporationCA56501R106405/14/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER5085.0000000.000000FOR5085.000000FOR3S000058304Emera IncorporatedCA290876101805/21/2026Elect Scott C. BalfourDIRECTOR ELECTIONSISSUER844.0000000.000000FOR844.000000FORS000058304Emera IncorporatedCA290876101805/21/2026Elect Jim V. BertramDIRECTOR ELECTIONSISSUER844.0000000.000000FOR844.000000FORS000058304Emera IncorporatedCA290876101805/21/2026Elect Isabelle CourvilleDIRECTOR ELECTIONSISSUER844.0000000.000000FOR844.000000FORS000058304Emera IncorporatedCA290876101805/21/2026Elect Henry E. DemoneDIRECTOR ELECTIONSISSUER844.0000000.000000FOR844.000000FORS000058304Emera IncorporatedCA290876101805/21/2026Elect Paula Y. Gold-WilliamsDIRECTOR ELECTIONSISSUER844.0000000.000000FOR844.000000FORS000058304Emera IncorporatedCA290876101805/21/2026Elect Kent M. HarveyDIRECTOR ELECTIONSISSUER844.0000000.000000FOR844.000000FORS000058304Emera IncorporatedCA290876101805/21/2026Elect Lynn LoewenDIRECTOR ELECTIONSISSUER844.0000000.000000FOR844.000000FORS000058304Emera IncorporatedCA290876101805/21/2026Elect Ian E. RobertsonDIRECTOR ELECTIONSISSUER844.0000000.000000FOR844.000000FORS000058304Emera IncorporatedCA290876101805/21/2026Elect Karen H. SheriffDIRECTOR ELECTIONSISSUER844.0000000.000000FOR844.000000FORS000058304Emera IncorporatedCA290876101805/21/2026Elect Jochen E. TilkDIRECTOR ELECTIONSISSUER844.0000000.000000FOR844.000000FORS000058304Emera IncorporatedCA290876101805/21/2026Elect Carla M. TullyDIRECTOR ELECTIONSISSUER844.0000000.000000FOR844.000000FORS000058304Emera IncorporatedCA290876101805/21/2026Appointment of AuditorAUDIT-RELATEDISSUER844.0000000.000000FOR844.000000FORS000058304Emera IncorporatedCA290876101805/21/2026Authority to Set Auditor's FeesAUDIT-RELATEDISSUER844.0000000.000000FOR844.000000FORS000058304Emera IncorporatedCA290876101805/21/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER844.0000000.000000FOR844.000000FORS000058304Emera IncorporatedCA290876101805/21/2026Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER844.0000000.000000FOR844.000000FOR3S000058304Emera IncorporatedCA290876101805/21/2026Amendment to the Employee Share Purchase PlanCOMPENSATIONISSUER844.0000000.000000FOR844.000000FORS000058304Emera IncorporatedCA290876101805/21/2026Stock Option Plan RenewalCOMPENSATIONISSUER844.0000000.000000FOR844.000000FORS000058304MITSUI & CO., LTD.JP389360000106/17/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER2431.0000000.000000FOR2431.000000FORS000058304MITSUI & CO., LTD.JP389360000106/17/2026Elect Tatsuo YasunagaDIRECTOR ELECTIONSISSUER2431.0000000.000000FOR2431.000000FORS000058304MITSUI & CO., LTD.JP389360000106/17/2026Elect Kenichi HoriDIRECTOR ELECTIONSISSUER2431.0000000.000000FOR2431.000000FORS000058304MITSUI & CO., LTD.JP389360000106/17/2026Elect Kazumasa NakaiDIRECTOR ELECTIONSISSUER2431.0000000.000000FOR2431.000000FORS000058304MITSUI & CO., LTD.JP389360000106/17/2026Elect Tetsuya FukudaDIRECTOR ELECTIONSISSUER2431.0000000.000000FOR2431.000000FORS000058304MITSUI & CO., LTD.JP389360000106/17/2026Elect Makoto TanakaDIRECTOR ELECTIONSISSUER2431.0000000.000000FOR2431.000000FORS000058304MITSUI & CO., LTD.JP389360000106/17/2026Elect Masaya InamuroDIRECTOR ELECTIONSISSUER2431.0000000.000000FOR2431.000000FORS000058304MITSUI & CO., LTD.JP389360000106/17/2026Elect Samuel WalshDIRECTOR ELECTIONSISSUER2431.0000000.000000FOR2431.000000FORS000058304MITSUI & CO., LTD.JP389360000106/17/2026Elect Takeshi UchiyamadaDIRECTOR ELECTIONSISSUER2431.0000000.000000FOR2431.000000FORS000058304MITSUI & CO., LTD.JP389360000106/17/2026Elect Masako EgawaDIRECTOR ELECTIONSISSUER2431.0000000.000000FOR2431.000000FORS000058304MITSUI & CO., LTD.JP389360000106/17/2026Elect Fujiyo IshiguroDIRECTOR ELECTIONSISSUER2431.0000000.000000FOR2431.000000FORS000058304MITSUI & CO., LTD.JP389360000106/17/2026Elect Sarah L. CasanovaDIRECTOR ELECTIONSISSUER2431.0000000.000000FOR2431.000000FORS000058304MITSUI & CO., LTD.JP389360000106/17/2026Elect Jessica Tan Soon NeoDIRECTOR ELECTIONSISSUER2431.0000000.000000FOR2431.000000FORS000058304MITSUI & CO., LTD.JP389360000106/17/2026Elect Tetsuya ShigetaCORPORATE GOVERNANCEISSUER2431.0000000.000000FOR2431.000000FORS000058304MITSUI & CO., LTD.JP389360000106/17/2026Elect Yuko TamaiCORPORATE GOVERNANCEISSUER2431.0000000.000000FOR2431.000000FORS000058304MITSUI & CO., LTD.JP389360000106/17/2026Amendment to the Restricted Stock PlanCOMPENSATIONISSUER2431.0000000.000000FOR2431.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/17/2026Elect Akio ToyodaDIRECTOR ELECTIONSISSUER11850.0000000.000000FOR11850.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/17/2026Elect Kenta KonDIRECTOR ELECTIONSISSUER11850.0000000.000000FOR11850.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/17/2026Elect Hiroki NakajimaDIRECTOR ELECTIONSISSUER11850.0000000.000000FOR11850.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/17/2026Elect Yoichi MiyazakiDIRECTOR ELECTIONSISSUER11850.0000000.000000FOR11850.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/17/2026Elect Shigeaki OkamotoDIRECTOR ELECTIONSISSUER11850.0000000.000000FOR11850.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/17/2026Elect Kumi Fujisawa @ Kumi TsunodaDIRECTOR ELECTIONSISSUER11850.0000000.000000FOR11850.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2026Elect Kenji YasukawaDIRECTOR ELECTIONSISSUER4414.0000000.000000FOR4414.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2026Elect Naoki OkamuraDIRECTOR ELECTIONSISSUER4414.0000000.000000FOR4414.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2026Elect Katsuyoshi SugitaDIRECTOR ELECTIONSISSUER4414.0000000.000000FOR4414.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2026Elect Masahiro MiyazakiDIRECTOR ELECTIONSISSUER4414.0000000.000000FOR4414.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2026Elect Yoichi OnoDIRECTOR ELECTIONSISSUER4414.0000000.000000FOR4414.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2026Elect Andreas BuschDIRECTOR ELECTIONSISSUER4414.0000000.000000FOR4414.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2026Elect Mark J. EnyedyDIRECTOR ELECTIONSISSUER4414.0000000.000000FOR4414.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2026Elect Rika HirotaDIRECTOR ELECTIONSISSUER4414.0000000.000000FOR4414.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2026Elect Tomoko AramakiDIRECTOR ELECTIONSISSUER4414.0000000.000000FOR4414.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2026Elect Shigeki TakaharaDIRECTOR ELECTIONSISSUER4414.0000000.000000FOR4414.000000FORS000058304Kawasaki Kisen Kaisha, Ltd.JP322380000806/19/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER1072.0000000.000000FOR1072.000000FORS000058304Kawasaki Kisen Kaisha, Ltd.JP322380000806/19/2026Elect Yukikazu MyochinDIRECTOR ELECTIONSISSUER1072.0000000.000000FOR1072.000000FORS000058304Kawasaki Kisen Kaisha, Ltd.JP322380000806/19/2026Elect Takenori IgarashiDIRECTOR ELECTIONSISSUER1072.0000000.000000FOR1072.000000FORS000058304Kawasaki Kisen Kaisha, Ltd.JP322380000806/19/2026Elect Kunihiko AraiDIRECTOR ELECTIONSISSUER1072.0000000.000000FOR1072.000000FORS000058304Kawasaki Kisen Kaisha, Ltd.JP322380000806/19/2026Elect Keiji YamadaDIRECTOR ELECTIONSISSUER1072.0000000.000000FOR1072.000000FORS000058304Kawasaki Kisen Kaisha, Ltd.JP322380000806/19/2026Elect Ryuhei UchidaDIRECTOR ELECTIONSISSUER1072.0000000.000000FOR1072.000000FORS000058304Kawasaki Kisen Kaisha, Ltd.JP322380000806/19/2026Elect Koji KotakaDIRECTOR ELECTIONSISSUER1072.0000000.000000FOR1072.000000FORS000058304Kawasaki Kisen Kaisha, Ltd.JP322380000806/19/2026Elect Hiroyuki MakiDIRECTOR ELECTIONSISSUER1072.0000000.000000FOR1072.000000FORS000058304Kawasaki Kisen Kaisha, Ltd.JP322380000806/19/2026Elect Takako Masai @ Takako NishidaDIRECTOR ELECTIONSISSUER1072.0000000.000000FOR1072.000000FORS000058304Kawasaki Kisen Kaisha, Ltd.JP322380000806/19/2026Elect Atsumi HarasawaDIRECTOR ELECTIONSISSUER1072.0000000.000000FOR1072.000000FORS000058304Kawasaki Kisen Kaisha, Ltd.JP322380000806/19/2026Elect Shinsuke KuboDIRECTOR ELECTIONSISSUER1072.0000000.000000FOR1072.000000FORS000058304Marubeni CorporationJP387760000106/19/2026Amendments to ArticlesCORPORATE GOVERNANCEISSUER2477.0000000.000000FOR2477.000000FORS000058304Marubeni CorporationJP387760000106/19/2026Elect Masumi KakinokiDIRECTOR ELECTIONSISSUER2477.0000000.000000FOR2477.000000FORS000058304Marubeni CorporationJP387760000106/19/2026Elect Masayuki OmotoDIRECTOR ELECTIONSISSUER2477.0000000.000000FOR2477.000000FORS000058304Marubeni CorporationJP387760000106/19/2026Elect Kenichiro OikawaDIRECTOR ELECTIONSISSUER2477.0000000.000000FOR2477.000000FORS000058304Marubeni CorporationJP387760000106/19/2026Elect Shigeki IshizukaDIRECTOR ELECTIONSISSUER2477.0000000.000000FOR2477.000000FORS000058304Marubeni CorporationJP387760000106/19/2026Elect Hisayoshi AndoDIRECTOR ELECTIONSISSUER2477.0000000.000000FOR2477.000000FORS000058304Marubeni CorporationJP387760000106/19/2026Elect Soichiro MinamiDIRECTOR ELECTIONSISSUER2477.0000000.000000FOR2477.000000FORS000058304Marubeni CorporationJP387760000106/19/2026Elect Keiji KojimaDIRECTOR ELECTIONSISSUER2477.0000000.000000FOR2477.000000FORS000058304Marubeni CorporationJP387760000106/19/2026Elect Yumiko KajiwaraDIRECTOR ELECTIONSISSUER2477.0000000.000000FOR2477.000000FORS000058304Marubeni CorporationJP387760000106/19/2026Elect Miki Iwamura @ Miki OkuDIRECTOR ELECTIONSISSUER2477.0000000.000000FOR2477.000000FORS000058304Marubeni CorporationJP387760000106/19/2026Elect Chijyo TajimaDIRECTOR ELECTIONSISSUER2477.0000000.000000FOR2477.000000FORS000058304Marubeni CorporationJP387760000106/19/2026Elect Takao AndoDIRECTOR ELECTIONSISSUER2477.0000000.000000FOR2477.000000FORS000058304Marubeni CorporationJP387760000106/19/2026Elect Kana OdawaraDIRECTOR ELECTIONSISSUER2477.0000000.000000FOR2477.000000FORS000058304Marubeni CorporationJP387760000106/19/2026Elect Hiroko MiyazakiDIRECTOR ELECTIONSISSUER2477.0000000.000000FOR2477.000000FORS000058304Marubeni CorporationJP387760000106/19/2026Elect Yasuo FukamiDIRECTOR ELECTIONSISSUER2477.0000000.000000FOR2477.000000FORS000058304Marubeni CorporationJP387760000106/19/2026Elect Ulrike SchaedeDIRECTOR ELECTIONSISSUER2477.0000000.000000FOR2477.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER595.0000000.000000FOR595.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Elect Takehiko KakiuchiDIRECTOR ELECTIONSISSUER595.0000000.000000FOR595.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Elect Katsuya NakanishiDIRECTOR ELECTIONSISSUER595.0000000.000000FOR595.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Elect Yoshiyuki NojimaDIRECTOR ELECTIONSISSUER595.0000000.000000FOR595.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Elect Kenji KobayashiDIRECTOR ELECTIONSISSUER595.0000000.000000FOR595.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Elect Juro BabaDIRECTOR ELECTIONSISSUER595.0000000.000000FOR595.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Elect Yoshihiro ShimazuDIRECTOR ELECTIONSISSUER595.0000000.000000FOR595.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Elect Tsuneyoshi TatsuokaDIRECTOR ELECTIONSISSUER595.0000000.000000FOR595.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Elect Shunichi MiyanagaDIRECTOR ELECTIONSISSUER595.0000000.000000FOR595.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Elect Mari Sagiya @ Mari ItayaDIRECTOR ELECTIONSISSUER595.0000000.000000FOR595.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Elect Mana Nakazora @ Mana MiwaDIRECTOR ELECTIONSISSUER595.0000000.000000FOR595.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Elect Mitsumasa IchoDIRECTOR ELECTIONSISSUER595.0000000.000000FOR595.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Elect Yuzo NouchiDIRECTOR ELECTIONSISSUER595.0000000.000000FOR595.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Elect Sakie AkiyamaDIRECTOR ELECTIONSISSUER595.0000000.000000FOR595.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Elect Tetsuya MogiDIRECTOR ELECTIONSISSUER595.0000000.000000FOR595.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Elect Keiko KanekoDIRECTOR ELECTIONSISSUER595.0000000.000000FOR595.000000FORS000058304Mitsubishi CorporationJP389840000106/19/2026Elect Mari Sagiya @ Mari Itaya as Alternate Audit Committee DirectorDIRECTOR ELECTIONSISSUER595.0000000.000000FOR595.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/19/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER2356.0000000.000000FOR2356.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/19/2026Elect Masayuki HyodoDIRECTOR ELECTIONSISSUER2356.0000000.000000FOR2356.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/19/2026Elect Toshikazu NambuDIRECTOR ELECTIONSISSUER2356.0000000.000000FOR2356.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/19/2026Elect Shingo UenoDIRECTOR ELECTIONSISSUER2356.0000000.000000FOR2356.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/19/2026Elect Reiji MorookaDIRECTOR ELECTIONSISSUER2356.0000000.000000FOR2356.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/19/2026Elect Yasuhiro YoshidaDIRECTOR ELECTIONSISSUER2356.0000000.000000FOR2356.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/19/2026Elect Takashi MitachiDIRECTOR ELECTIONSISSUER2356.0000000.000000FOR2356.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/19/2026Elect Takahisa TakaharaDIRECTOR ELECTIONSISSUER2356.0000000.000000AGAINST2356.000000AGAINSTS000058304SUMITOMO CORPORATIONJP340460000306/19/2026Elect Haruyasu AsakuraDIRECTOR ELECTIONSISSUER2356.0000000.000000FOR2356.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/19/2026Elect Nana OtsukiDIRECTOR ELECTIONSISSUER2356.0000000.000000FOR2356.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/19/2026Elect Yasuko GotohDIRECTOR ELECTIONSISSUER2356.0000000.000000FOR2356.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/19/2026Elect Mitsuhiro Takeda as Audit Committee DirectorDIRECTOR ELECTIONSISSUER2356.0000000.000000FOR2356.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/22/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER3118.0000000.000000FOR3118.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/22/2026Amendments to ArticlesCORPORATE GOVERNANCEISSUER3118.0000000.000000FOR3118.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/22/2026Elect Noriyuki HaraDIRECTOR ELECTIONSISSUER3118.0000000.000000FOR3118.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/22/2026Elect Yasuzo KanasugiDIRECTOR ELECTIONSISSUER3118.0000000.000000FOR3118.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/22/2026Elect Shinichiro FunabikiDIRECTOR ELECTIONSISSUER3118.0000000.000000FOR3118.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/22/2026Elect Shigeo KudoDIRECTOR ELECTIONSISSUER3118.0000000.000000FOR3118.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/22/2026Elect Keisuke NiiroDIRECTOR ELECTIONSISSUER3118.0000000.000000FOR3118.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/22/2026Elect Rochelle KoppDIRECTOR ELECTIONSISSUER3118.0000000.000000FOR3118.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/22/2026Elect Akemi IshiwataDIRECTOR ELECTIONSISSUER3118.0000000.000000FOR3118.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/22/2026Elect Jun SuzukiDIRECTOR ELECTIONSISSUER3118.0000000.000000FOR3118.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/22/2026Elect Atsuko OkajimaDIRECTOR ELECTIONSISSUER3118.0000000.000000FOR3118.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/22/2026Elect Jiro SeguchiDIRECTOR ELECTIONSISSUER3118.0000000.000000FOR3118.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/22/2026Non-Audit Committee Directors' FeesCOMPENSATIONISSUER3118.0000000.000000FOR3118.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/22/2026Audit Committee Directors' FeesCOMPENSATIONISSUER3118.0000000.000000FOR3118.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/22/2026Amendment to the Restricted Stock PlanCOMPENSATIONISSUER3118.0000000.000000FOR3118.000000FORS000058304KOMATSU LTD.JP330420000306/23/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER3458.0000000.000000FOR3458.000000FORS000058304KOMATSU LTD.JP330420000306/23/2026Elect Hiroyuki OgawaDIRECTOR ELECTIONSISSUER3458.0000000.000000FOR3458.000000FORS000058304KOMATSU LTD.JP330420000306/23/2026Elect Takuya ImayoshiDIRECTOR ELECTIONSISSUER3458.0000000.000000FOR3458.000000FORS000058304KOMATSU LTD.JP330420000306/23/2026Elect Taisuke KusabaDIRECTOR ELECTIONSISSUER3458.0000000.000000FOR3458.000000FORS000058304KOMATSU LTD.JP330420000306/23/2026Elect Mitsuko YokomotoDIRECTOR ELECTIONSISSUER3458.0000000.000000FOR3458.000000FORS000058304KOMATSU LTD.JP330420000306/23/2026Elect Takeshi KunibeDIRECTOR ELECTIONSISSUER3458.0000000.000000FOR3458.000000FORS000058304KOMATSU LTD.JP330420000306/23/2026Elect Naoko SaikiDIRECTOR ELECTIONSISSUER3458.0000000.000000FOR3458.000000FORS000058304KOMATSU LTD.JP330420000306/23/2026Elect Michitaka SawadaDIRECTOR ELECTIONSISSUER3458.0000000.000000FOR3458.000000FORS000058304KOMATSU LTD.JP330420000306/23/2026Elect Thomas M. ClarkDIRECTOR ELECTIONSISSUER3458.0000000.000000FOR3458.000000FORS000058304KOMATSU LTD.JP330420000306/23/2026Elect Tatsuro Kosaka as Statutory AuditorCORPORATE GOVERNANCEISSUER3458.0000000.000000FOR3458.000000FORS000058304Tokyo Electron LimitedJP357140000506/23/2026Elect Toshiki KawaiDIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/23/2026Elect Kazushi TaharaDIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/23/2026Elect Hiroshi IshidaDIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/23/2026Elect Shinichi HayashiDIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/23/2026Elect Michio SasakiDIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/23/2026Elect Joseph A. Kraft Jr.DIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/23/2026Elect Yukari SuzukiDIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/23/2026Elect Yukihiro ShinoharaDIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/23/2026Elect Jenifer S. RogersDIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/23/2026Adoption of Special Provisions for Share-Based Compensation for California ResidentsCOMPENSATIONISSUER389.0000000.000000FOR389.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/23/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER2562.0000000.000000FOR2562.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/23/2026Elect Nobuhiko MurakamiDIRECTOR ELECTIONSISSUER2562.0000000.000000AGAINST2562.000000AGAINSTS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/23/2026Elect Ichiro KashitaniDIRECTOR ELECTIONSISSUER2562.0000000.000000FOR2562.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/23/2026Elect Toshimitsu ImaiDIRECTOR ELECTIONSISSUER2562.0000000.000000FOR2562.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/23/2026Elect Hideyuki IwamotoDIRECTOR ELECTIONSISSUER2562.0000000.000000FOR2562.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/23/2026Elect Tatsuya WatanukiDIRECTOR ELECTIONSISSUER2562.0000000.000000FOR2562.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/23/2026Elect Didier LeroyDIRECTOR ELECTIONSISSUER2562.0000000.000000FOR2562.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/23/2026Elect Yukari InoueDIRECTOR ELECTIONSISSUER2562.0000000.000000FOR2562.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/23/2026Elect Chieko MatsudaDIRECTOR ELECTIONSISSUER2562.0000000.000000FOR2562.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/23/2026Elect Goro YamaguchiDIRECTOR ELECTIONSISSUER2562.0000000.000000FOR2562.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/23/2026Elect Yuki IsogaiDIRECTOR ELECTIONSISSUER2562.0000000.000000FOR2562.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/23/2026Elect Kentaro HayashiCORPORATE GOVERNANCEISSUER2562.0000000.000000FOR2562.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/23/2026Elect Kazuya KawashimaCORPORATE GOVERNANCEISSUER2562.0000000.000000FOR2562.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/23/2026Elect Tsutomu TakahashiCORPORATE GOVERNANCEISSUER2562.0000000.000000FOR2562.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER63.0000000.000000FOR63.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2026Elect Kazuma SekiyaDIRECTOR ELECTIONSISSUER63.0000000.000000FOR63.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2026Elect Noboru YoshinagaDIRECTOR ELECTIONSISSUER63.0000000.000000FOR63.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2026Elect Takao TamuraDIRECTOR ELECTIONSISSUER63.0000000.000000FOR63.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2026Elect Kazuyoshi TokimaruDIRECTOR ELECTIONSISSUER63.0000000.000000FOR63.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2026Elect Noriko OkiDIRECTOR ELECTIONSISSUER63.0000000.000000FOR63.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2026Elect Akiko MatsuoDIRECTOR ELECTIONSISSUER63.0000000.000000FOR63.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2026Elect Etsuko Kobayashi @ Etsuko MasamuneDIRECTOR ELECTIONSISSUER63.0000000.000000FOR63.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2026Elect Christina L. AhmadjianDIRECTOR ELECTIONSISSUER63.0000000.000000FOR63.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2026Elect Atsushi MurakamiDIRECTOR ELECTIONSISSUER63.0000000.000000FOR63.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2026Elect Hideshi SanoDIRECTOR ELECTIONSISSUER63.0000000.000000FOR63.000000FORS000058304SUBARU CORPORATIONJP381480000306/24/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER696.0000000.000000FOR696.000000FORS000058304SUBARU CORPORATIONJP381480000306/24/2026Amendments to ArticlesCORPORATE GOVERNANCEISSUER696.0000000.000000FOR696.000000FORS000058304SUBARU CORPORATIONJP381480000306/24/2026Elect Fumiaki HayataDIRECTOR ELECTIONSISSUER696.0000000.000000FOR696.000000FORS000058304SUBARU CORPORATIONJP381480000306/24/2026Elect Atsushi OsakiDIRECTOR ELECTIONSISSUER696.0000000.000000FOR696.000000FORS000058304SUBARU CORPORATIONJP381480000306/24/2026Elect Tetsuo FujinukiDIRECTOR ELECTIONSISSUER696.0000000.000000FOR696.000000FORS000058304SUBARU CORPORATIONJP381480000306/24/2026Elect Shinsuke TodaDIRECTOR ELECTIONSISSUER696.0000000.000000FOR696.000000FORS000058304SUBARU CORPORATIONJP381480000306/24/2026Elect Fuminao HachiumaDIRECTOR ELECTIONSISSUER696.0000000.000000FOR696.000000FORS000058304SUBARU CORPORATIONJP381480000306/24/2026Elect Shigeru YamashitaDIRECTOR ELECTIONSISSUER696.0000000.000000FOR696.000000FORS000058304SUBARU CORPORATIONJP381480000306/24/2026Elect Kayako Omura @ Kayako MiyazawaDIRECTOR ELECTIONSISSUER696.0000000.000000FOR696.000000FORS000058304SUBARU CORPORATIONJP381480000306/24/2026Elect Jinya ShojiDIRECTOR ELECTIONSISSUER696.0000000.000000FOR696.000000FORS000058304SUBARU CORPORATIONJP381480000306/24/2026Elect Yuri FurusawaDIRECTOR ELECTIONSISSUER696.0000000.000000FOR696.000000FORS000058304SUBARU CORPORATIONJP381480000306/24/2026Elect Yasumasa MasudaDIRECTOR ELECTIONSISSUER696.0000000.000000FOR696.000000FORS000058304SUBARU CORPORATIONJP381480000306/24/2026Elect Yukiko MitsuhashiDIRECTOR ELECTIONSISSUER696.0000000.000000FOR696.000000FORS000058304SUBARU CORPORATIONJP381480000306/24/2026Non-Audit Committee Directors' FeesCOMPENSATIONISSUER696.0000000.000000FOR696.000000FORS000058304SUBARU CORPORATIONJP381480000306/24/2026Audit Committee Directors' FeesCOMPENSATIONISSUER696.0000000.000000FOR696.000000FORS000058304SUBARU CORPORATIONJP381480000306/24/2026Approval of the Restricted Stock PlanCOMPENSATIONISSUER696.0000000.000000FOR696.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/24/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER3271.0000000.000000FOR3271.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/24/2026Elect Julie KimDIRECTOR ELECTIONSISSUER3271.0000000.000000FOR3271.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/24/2026Elect Milano FurutaDIRECTOR ELECTIONSISSUER3271.0000000.000000FOR3271.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/24/2026Elect Andrew PlumpDIRECTOR ELECTIONSISSUER3271.0000000.000000FOR3271.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/24/2026Elect Masami IijimaDIRECTOR ELECTIONSISSUER3271.0000000.000000AGAINST3271.000000AGAINSTS000058304Takeda Pharmaceutical Company LimitedJP346300000406/24/2026Elect Steven GillisDIRECTOR ELECTIONSISSUER3271.0000000.000000FOR3271.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/24/2026Elect John M. MaraganoreDIRECTOR ELECTIONSISSUER3271.0000000.000000FOR3271.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/24/2026Elect Miki TsusakaDIRECTOR ELECTIONSISSUER3271.0000000.000000FOR3271.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/24/2026Elect Paul StoffelsDIRECTOR ELECTIONSISSUER3271.0000000.000000FOR3271.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/24/2026Elect Kimberly A. ReedDIRECTOR ELECTIONSISSUER3271.0000000.000000FOR3271.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/24/2026Elect Bruce D. BroussardDIRECTOR ELECTIONSISSUER3271.0000000.000000AGAINST3271.000000AGAINSTS000058304Takeda Pharmaceutical Company LimitedJP346300000406/24/2026Elect Koichiro KimuraDIRECTOR ELECTIONSISSUER3271.0000000.000000FOR3271.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/24/2026Elect Paul Stoffels as Alternate Audit Committee DirectorDIRECTOR ELECTIONSISSUER3271.0000000.000000FOR3271.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/24/2026BonusCOMPENSATIONISSUER3271.0000000.000000FOR3271.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER6555.0000000.000000FOR6555.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2026Amendments to ArticlesCORPORATE GOVERNANCEISSUER6555.0000000.000000FOR6555.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2026Elect Kei TakeuchiDIRECTOR ELECTIONSISSUER6555.0000000.000000FOR6555.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2026Elect Yoshihiro MoriDIRECTOR ELECTIONSISSUER6555.0000000.000000FOR6555.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2026Elect Tsukasa OkamotoDIRECTOR ELECTIONSISSUER6555.0000000.000000FOR6555.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2026Elect Yutaka AmanoDIRECTOR ELECTIONSISSUER6555.0000000.000000FOR6555.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2026Elect Yoshimasa TanakaDIRECTOR ELECTIONSISSUER6555.0000000.000000FOR6555.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2026Elect Yutaka TakahashiDIRECTOR ELECTIONSISSUER6555.0000000.000000FOR6555.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2026Elect Atsushi IritaniDIRECTOR ELECTIONSISSUER6555.0000000.000000FOR6555.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2026Elect Junko OwadaDIRECTOR ELECTIONSISSUER6555.0000000.000000FOR6555.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2026Elect Koichi AbeDIRECTOR ELECTIONSISSUER6555.0000000.000000FOR6555.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2026Elect Kyoko AsakawaDIRECTOR ELECTIONSISSUER6555.0000000.000000FOR6555.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/26/2026Elect Toshihiro MibeDIRECTOR ELECTIONSISSUER11938.0000000.000000FOR11938.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/26/2026Elect Noriya KaiharaDIRECTOR ELECTIONSISSUER11938.0000000.000000FOR11938.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/26/2026Elect Mahito ShikamaDIRECTOR ELECTIONSISSUER11938.0000000.000000FOR11938.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/26/2026Elect Asako SuzukiDIRECTOR ELECTIONSISSUER11938.0000000.000000FOR11938.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/26/2026Elect Jiro MorisawaDIRECTOR ELECTIONSISSUER11938.0000000.000000FOR11938.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/26/2026Elect Kunihiko SakaiDIRECTOR ELECTIONSISSUER11938.0000000.000000FOR11938.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/26/2026Elect Fumiya KokubuDIRECTOR ELECTIONSISSUER11938.0000000.000000FOR11938.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/26/2026Elect Yoichiro OgawaDIRECTOR ELECTIONSISSUER11938.0000000.000000FOR11938.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/26/2026Elect Kazuhiro HigashiDIRECTOR ELECTIONSISSUER11938.0000000.000000FOR11938.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/26/2026Elect Ryoko NagataDIRECTOR ELECTIONSISSUER11938.0000000.000000FOR11938.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/26/2026Elect Mika AgatsumaDIRECTOR ELECTIONSISSUER11938.0000000.000000FOR11938.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/26/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER4479.0000000.000000FOR4479.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/26/2026Elect Satoko Kuwabara @ Satoko OtaDIRECTOR ELECTIONSISSUER4479.0000000.000000FOR4479.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/26/2026Elect Mari Elka PangestuDIRECTOR ELECTIONSISSUER4479.0000000.000000FOR4479.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/26/2026Elect Hiroshi ShimizuDIRECTOR ELECTIONSISSUER4479.0000000.000000FOR4479.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/26/2026Elect David SneiderDIRECTOR ELECTIONSISSUER4479.0000000.000000FOR4479.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/26/2026Elect Miyuki SuzukiDIRECTOR ELECTIONSISSUER4479.0000000.000000FOR4479.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/26/2026Elect Koichi TsujiDIRECTOR ELECTIONSISSUER4479.0000000.000000FOR4479.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/26/2026Elect Teruhisa UedaDIRECTOR ELECTIONSISSUER4479.0000000.000000FOR4479.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/26/2026Elect Kenichiro YoshidaDIRECTOR ELECTIONSISSUER4479.0000000.000000FOR4479.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/26/2026Elect Takayuki YasudaDIRECTOR ELECTIONSISSUER4479.0000000.000000FOR4479.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/26/2026Elect Norio KanieDIRECTOR ELECTIONSISSUER4479.0000000.000000FOR4479.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/26/2026Elect Hironori KamezawaDIRECTOR ELECTIONSISSUER4479.0000000.000000FOR4479.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/26/2026Elect Junichi HanzawaDIRECTOR ELECTIONSISSUER4479.0000000.000000FOR4479.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/26/2026Elect Hiroshi KubotaDIRECTOR ELECTIONSISSUER4479.0000000.000000FOR4479.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/26/2026Elect Masakazu OsawaDIRECTOR ELECTIONSISSUER4479.0000000.000000FOR4479.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/26/2026Elect Hiroyuki SekiDIRECTOR ELECTIONSISSUER4479.0000000.000000FOR4479.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/26/2026Elect Takashi TsukiokaDIRECTOR ELECTIONSISSUER1033.0000000.000000FOR1033.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/26/2026Elect Kotaro OnoDIRECTOR ELECTIONSISSUER1033.0000000.000000FOR1033.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/26/2026Elect Hiromichi ShinoharaDIRECTOR ELECTIONSISSUER1033.0000000.000000FOR1033.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/26/2026Elect Yumiko NodaDIRECTOR ELECTIONSISSUER1033.0000000.000000FOR1033.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/26/2026Elect Takakazu UchidaDIRECTOR ELECTIONSISSUER1033.0000000.000000FOR1033.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/26/2026Elect Masahiko TezukaDIRECTOR ELECTIONSISSUER1033.0000000.000000FOR1033.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/26/2026Elect Yuki Ikuno @ Yuki KanzakiDIRECTOR ELECTIONSISSUER1033.0000000.000000FOR1033.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/26/2026Elect Keiji KojimaDIRECTOR ELECTIONSISSUER1033.0000000.000000FOR1033.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/26/2026Elect Hidekatsu TakeDIRECTOR ELECTIONSISSUER1033.0000000.000000FOR1033.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/26/2026Elect Makoto HitomiDIRECTOR ELECTIONSISSUER1033.0000000.000000FOR1033.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/26/2026Elect Masahiro KiharaDIRECTOR ELECTIONSISSUER1033.0000000.000000FOR1033.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/26/2026Elect Fusae AkamatsuDIRECTOR ELECTIONSISSUER1033.0000000.000000FOR1033.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/26/2026Elect Shiro ShiraishiDIRECTOR ELECTIONSISSUER1033.0000000.000000FOR1033.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/26/2026Elect Makoto SamejimaDIRECTOR ELECTIONSISSUER1033.0000000.000000FOR1033.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/26/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER272.0000000.000000FOR272.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/26/2026Elect Toshio HiroeDIRECTOR ELECTIONSISSUER272.0000000.000000FOR272.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/26/2026Elect Masato GotoDIRECTOR ELECTIONSISSUER272.0000000.000000FOR272.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/26/2026Elect Yoichi KondoDIRECTOR ELECTIONSISSUER272.0000000.000000FOR272.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/26/2026Elect Yoshihisa IshikawaDIRECTOR ELECTIONSISSUER272.0000000.000000FOR272.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/26/2026Elect Hiroko Okudaira @ Hiroko KimuraDIRECTOR ELECTIONSISSUER272.0000000.000000FOR272.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/26/2026Elect Seiji NaraharaDIRECTOR ELECTIONSISSUER272.0000000.000000FOR272.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/26/2026Elect Fumikazu SatoDIRECTOR ELECTIONSISSUER272.0000000.000000FOR272.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/26/2026Elect Nobuo KawahashiDIRECTOR ELECTIONSISSUER272.0000000.000000FOR272.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/26/2026Elect Akihiko Miyagawa as Statutory AuditorCORPORATE GOVERNANCEISSUER272.0000000.000000AGAINST272.000000AGAINSTS000058304SCREEN Holdings Co., Ltd.JP349460000406/26/2026Elect Tomoyuki Ito as Alternate Statutory AuditorDIRECTOR ELECTIONSISSUER272.0000000.000000FOR272.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/26/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER3228.0000000.000000FOR3228.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/26/2026Increase in Authorized Share CapitalCAPITAL STRUCTUREISSUER3228.0000000.000000FOR3228.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/26/2026Elect Makoto TakashimaDIRECTOR ELECTIONSISSUER3228.0000000.000000FOR3228.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/26/2026Elect Toru NakashimaDIRECTOR ELECTIONSISSUER3228.0000000.000000FOR3228.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/26/2026Elect Teiko KudoDIRECTOR ELECTIONSISSUER3228.0000000.000000FOR3228.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/26/2026Elect Kazuyuki AnchiDIRECTOR ELECTIONSISSUER3228.0000000.000000FOR3228.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/26/2026Elect Takeshi MikamiDIRECTOR ELECTIONSISSUER3228.0000000.000000FOR3228.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/26/2026Elect Honami MatsugasakiDIRECTOR ELECTIONSISSUER3228.0000000.000000FOR3228.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/26/2026Elect Sonosuke KadonagaDIRECTOR ELECTIONSISSUER3228.0000000.000000FOR3228.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/26/2026Elect Jun SawadaDIRECTOR ELECTIONSISSUER3228.0000000.000000AGAINST3228.000000AGAINSTS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/26/2026Elect Yoriko GotoDIRECTOR ELECTIONSISSUER3228.0000000.000000FOR3228.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/26/2026Elect Isao TeshirogiDIRECTOR ELECTIONSISSUER3228.0000000.000000AGAINST3228.000000AGAINSTS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/26/2026Elect Norimitsu TakashimaDIRECTOR ELECTIONSISSUER3228.0000000.000000FOR3228.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/26/2026Elect Charles D. Lake IIDIRECTOR ELECTIONSISSUER3228.0000000.000000FOR3228.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/26/2026Elect Jenifer S. RogersDIRECTOR ELECTIONSISSUER3228.0000000.000000FOR3228.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/26/2026Shareholder Proposal Regarding Acquisition of Shares by Resolution of General Meeting of ShareholdersCAPITAL STRUCTURESECURITY HOLDER3228.0000000.000000AGAINST3228.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/29/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER1739.0000000.000000FOR1739.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/29/2026Elect Norio NakajimaDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/29/2026Elect Hiroshi IwatsuboDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/29/2026Elect Masanori MinamideDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/29/2026Elect Hiroshi IzumitaniDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/29/2026Elect Takaki MurataDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/29/2026Elect Yuko YasudaDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/29/2026Elect Takashi NishijimaDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/29/2026Elect Hiroyuki InaDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/29/2026Elect Kaori KitasumiDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/29/2026Elect Seiichi EnomotoDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/29/2026Elect Mayo Mita @ Mayo NakatsukaDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/29/2026Elect Asako YamagamiDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/29/2026Appointment of AuditorAUDIT-RELATEDISSUER1739.0000000.000000FOR1739.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/29/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER1730.0000000.000000FOR1730.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/29/2026Elect Takeo ObayashiDIRECTOR ELECTIONSISSUER1730.0000000.000000FOR1730.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/29/2026Elect Toshimi SatoDIRECTOR ELECTIONSISSUER1730.0000000.000000FOR1730.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/29/2026Elect Yoshihito SasakiDIRECTOR ELECTIONSISSUER1730.0000000.000000FOR1730.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/29/2026Elect Yasuo MoritaDIRECTOR ELECTIONSISSUER1730.0000000.000000FOR1730.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/29/2026Elect Masako OriiDIRECTOR ELECTIONSISSUER1730.0000000.000000FOR1730.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/29/2026Elect Hiroyuki KatoDIRECTOR ELECTIONSISSUER1730.0000000.000000FOR1730.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/29/2026Elect Yukiko Kuroda @ Yukiko MatsumotoDIRECTOR ELECTIONSISSUER1730.0000000.000000FOR1730.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/29/2026Elect Hiroyuki ShimeDIRECTOR ELECTIONSISSUER1730.0000000.000000FOR1730.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/29/2026Elect Yoshihiro IkegawaDIRECTOR ELECTIONSISSUER1730.0000000.000000FOR1730.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/29/2026Elect Midori Tomita @ Midori NagashimaDIRECTOR ELECTIONSISSUER1730.0000000.000000FOR1730.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/29/2026Elect Yoshiaki TakataCORPORATE GOVERNANCEISSUER1730.0000000.000000FOR1730.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/29/2026Elect Yohei UedaCORPORATE GOVERNANCEISSUER1730.0000000.000000FOR1730.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/29/2026Elect Sachiko TsujinoCORPORATE GOVERNANCEISSUER1730.0000000.000000FOR1730.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/29/2026Amendment to the Equity Compensation PlanCOMPENSATIONISSUER1730.0000000.000000FOR1730.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/29/2026Statutory Auditors' FeesCOMPENSATIONISSUER1730.0000000.000000FOR1730.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Authority to Reduce Capital ReserveCAPITAL STRUCTUREISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Amendments to ArticlesCORPORATE GOVERNANCEISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Satoru KomiyaDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Masahiro KoikeDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Kichiichiro YamamotoDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Hiroaki ShirotaDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Nobuhiro EndoDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Shinya KatanozakaDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Emi OsonoDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Robert Alan FeldmanDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Yoichi MoriwakiDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Mika NabeshimaDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Junko ShimizuDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Saima HasanDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Akira HarashimaDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Kenji OkadaDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Kosei ShindoDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Haruka Matsuyama @ Haruka KatoDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Nana OtsukiDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Elect Junko Shimizu as Alternate Audit Committee DirectorDIRECTOR ELECTIONSISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Non-Audit Committee Directors' FeesCOMPENSATIONISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Audit Committee Directors' FeesCOMPENSATIONISSUER1704.0000000.000000FOR1704.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/29/2026Amendment to Trust Type Equity PlanCOMPENSATIONISSUER1704.0000000.000000FOR1704.000000FORS000058304Eagle Point Institutional Income Fund269819207US269819207507/07/2025Election of Trustees: Scott W. Appleby Class I trusteeOTHERPreferred share-related matterISSUER124739.0000000.000000FOR124739.000000FORS000059080Eagle Point Institutional Income Fund269819207US269819207507/07/2025Election of Trustees: Jeffrey L. Weiss Class I trusteeOTHERPreferred share-related matterISSUER124739.0000000.000000FOR124739.000000FORS000059080RiverNorth Opportunities Fund, Inc.76881Y208US76881Y208109/22/2025To elect two Class II Directors and one Class III Director to the Board of Directors: J. Wayne Hutchens (Class II)OTHERPreferred share-related matterISSUER127803.0000000.000000FOR127803.000000FORS000059080RiverNorth Opportunities Fund, Inc.76881Y208US76881Y208109/22/2025To elect two Class II Directors and one Class III Director to the Board of Directors: Jerry R. Raio (Class II)OTHERPreferred share-related matterISSUER127803.0000000.000000FOR127803.000000FORS000059080RiverNorth Opportunities Fund, Inc.76881Y208US76881Y208109/22/2025To elect two Class II Directors and one Class III Director to the Board of Directors: David M. Swanson (Class III)OTHERPreferred share-related matterISSUER127803.0000000.000000FOR127803.000000FORS000059080Oxford Lane Capital Corp.691543805US691543805410/24/2025To vote on the election of one director of the Company to be elected by the holders of the Company's outstanding common stock, par value $0.01 per share, and outstanding preferred stock, par value $0.01 per share ("Preferred Stock"), voting together as a single class, with such director to serve for a term of three years, or until his successor is duly elected and qualified: Jonathan H. CohenOTHERPreferred share-related matterISSUER22874.0000000.000000FOR22874.000000FORS000059080Oxford Lane Capital Corp.691543805US691543805410/24/2025To vote on the election of one director of the Company to be elected by the holders of the Company's outstanding Preferred Stock, voting as a single class, with such director to serve for a term of three years, or until his successor is duly elected and qualified: Mark J. AshenfelterOTHERPreferred share-related matterISSUER22874.0000000.000000FOR22874.000000FORS000059080Pearl Diver Credit Company Inc.70476Q209US70476Q209312/04/2025Election of Directors: Martin Mellish (Class II Director)OTHERPreferred share-related matterISSUER48251.0000000.000000FOR48251.000000FORS000059080Pearl Diver Credit Company Inc.70476Q209US70476Q209312/04/2025Election of Directors: Gary Wilder (Class II Director)OTHERPreferred share-related matterISSUER48251.0000000.000000FOR48251.000000FORS000059080Sound Point Meridian Capital, Inc.83617A207US83617A207812/17/2025Election of Directors: Mr. Douglas T. HealyOTHERPreferred share-related matterISSUER252882.0000000.000000FOR252882.000000FORS000059080Sound Point Meridian Capital, Inc.83617A207US83617A207812/17/2025Election of Directors: Mr. Ujjaval DesaiOTHERPreferred share-related matterISSUER252882.0000000.000000FOR252882.000000FORS000059080Prospect Capital Corporation74348T565US74348T565301/15/2026To elect two Class III directors of the Company to serve until the Annual Meeting of Stockholders in 2028 or, in each case, until his successor is duly elected and qualifies: John F. Barry IIIOTHERPreferred share-related matterISSUER1006876.0000000.000000FOR1006876.000000FORS000059080Prospect Capital Corporation74348T565US74348T565301/15/2026To elect two Class III directors of the Company to serve until the Annual Meeting of Stockholders in 2028 or, in each case, until his successor is duly elected and qualifies: Eugene S. StarkOTHERPreferred share-related matterISSUER1006876.0000000.000000FOR1006876.000000FORS000059080Eagle Point Credit Company Inc.269809877US269809877703/12/2026To approve a change in Eagle Point Credit Company Inc.'s legal form from a Delaware corporation to a Delaware statutory trust (the "Proposal"); andOTHERPreferred share-related matterISSUER64847.0000000.000000FOR64847.000000FORS000059080Liberty Broadband Corporation530307503US530307503105/11/2026Election of Directors: John C. MaloneDIRECTOR ELECTIONSISSUER170316.0000000.000000FOR170316.000000FORS000059080Liberty Broadband Corporation530307503US530307503105/11/2026Election of Directors: Gregg L. EnglesDIRECTOR ELECTIONSISSUER170316.0000000.000000FOR170316.000000FORS000059080Liberty Broadband Corporation530307503US530307503105/11/2026Election of Directors: John E. Welsh IIIDIRECTOR ELECTIONSISSUER170316.0000000.000000FOR170316.000000FORS000059080Liberty Broadband Corporation530307503US530307503105/11/2026The auditor ratification proposal, to ratify the selection of KPMG LLP as our independent auditors for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER170316.0000000.000000FOR170316.000000FORS000059080Eagle Point Income Company Inc269817409US269817409905/12/2026Election of Directors: Kevin F. McDonaldOTHERPreferred share-related matterISSUER24.0000000.000000FOR24.000000FORS000059080Eagle Point Income Company Inc269817409US269817409905/12/2026Election of Directors: Thomas P. MajewskiOTHERPreferred share-related matterISSUER24.0000000.000000FOR24.000000FORS000059080Eagle Point Income Company Inc.269817409US269817409905/20/2026To approve a change in the Company's legal form from a Delaware corporation to a Delaware statutory trust; andINVESTMENT COMPANY MATTERSISSUER23299.0000000.000000FOR23299.000000FORS000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement: Nicole S. ArnaboldiDIRECTOR ELECTIONSISSUER40.0000000.000000FOR40.000000FORS000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement: James L. CamarenDIRECTOR ELECTIONSISSUER40.0000000.000000FOR40.000000FORS000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement: Naren K. GursahaneyDIRECTOR ELECTIONSISSUER40.0000000.000000FOR40.000000FORS000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement: Kirk S. HachigianDIRECTOR ELECTIONSISSUER40.0000000.000000FOR40.000000FORS000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement: Maria G. HenryDIRECTOR ELECTIONSISSUER40.0000000.000000FOR40.000000FORS000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement: John W. KetchumDIRECTOR ELECTIONSISSUER40.0000000.000000FOR40.000000FORS000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement: Amy B. LaneDIRECTOR ELECTIONSISSUER40.0000000.000000FOR40.000000FORS000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement: Geoffrey S. MarthaDIRECTOR ELECTIONSISSUER40.0000000.000000FOR40.000000FORS000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement: David L. PorgesDIRECTOR ELECTIONSISSUER40.0000000.000000FOR40.000000FORS000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement: Deborah L. "Dev" StahlkopfDIRECTOR ELECTIONSISSUER40.0000000.000000FOR40.000000FORS000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement: John A. StallDIRECTOR ELECTIONSISSUER40.0000000.000000FOR40.000000FORS000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026Election as Directors of the nominees specified in the proxy statement: Darryl L. WilsonDIRECTOR ELECTIONSISSUER40.0000000.000000FOR40.000000FORS000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026Ratification of appointment of Deloitte & Touche LLP as NextEra Energy's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER40.0000000.000000FOR40.000000FORS000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026Approval, by non-binding advisory vote, of NextEra Energy's compensation of its named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER40.0000000.000000FOR40.000000FORS000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026Approval, by non-binding advisory vote, of NextEra Energy's compensation of its named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER40.0000000.000000FOR40.000000FOR1S000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026A proposal entitled "Paris Agreement Alignment" requesting NextEra Energy publish a report describing if and how the Company plans to reduce its total contribution to climate change and align its operations and investments with the Paris Agreement's goal of maintaining global temperatures well below 2 degrees Celsius, and ideally, 1.5 degrees Celsius.ENVIRONMENT OR CLIMATESECURITY HOLDER40.0000000.000000AGAINST40.000000FORS000059080NextEra Energy, Inc.65339F101US65339F101205/21/2026A proposal entitled "Report on Net Zero Business Performance Risks" requesting the Board of Directors of NextEra Energy prepare a report within the next year, evaluating the potential costs and benefits to NextEra Energy created by aggressive emission reduction policies.ENVIRONMENT OR CLIMATESECURITY HOLDER40.0000000.000000AGAINST40.000000FORS000059080Strategy Inc594972853US594972853006/08/2026To approve and adopt an amendment and restatement of the Certificate of Designations of the Company's Variable Rate Series A Perpetual Stretch Preferred Stock to provide for two scheduled dividend payment dates per month, instead of one.OTHERPreferred share-related matterISSUER397728.0000000.000000FOR397728.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/29/2026Ratify Ernst & Young LLP as AuditorsAUDIT-RELATEDISSUER31094.0000000.000000FOR31094.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/29/2026Elect Director Brett C. CarterDIRECTOR ELECTIONSISSUER31094.0000000.000000FOR31094.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/29/2026Elect Director Amee ChandeDIRECTOR ELECTIONSISSUER31094.0000000.000000FOR31094.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/29/2026Elect Director D. Randall (Randy) LaneyDIRECTOR ELECTIONSISSUER31094.0000000.000000FOR31094.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/29/2026Elect Director David LevensonDIRECTOR ELECTIONSISSUER31094.0000000.000000FOR31094.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/29/2026Elect Director Christopher F. LopezDIRECTOR ELECTIONSISSUER31094.0000000.000000FOR31094.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/29/2026Elect Director Gavin MolinelliDIRECTOR ELECTIONSISSUER31094.0000000.000000FOR31094.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/29/2026Elect Director Dilek SamilDIRECTOR ELECTIONSISSUER31094.0000000.000000FOR31094.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/29/2026Elect Director DeAnn WalkerDIRECTOR ELECTIONSISSUER31094.0000000.000000FOR31094.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/29/2026Elect Director Roderick WestDIRECTOR ELECTIONSISSUER31094.0000000.000000FOR31094.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/29/2026Amend Share Unit PlanCOMPENSATIONISSUER31094.0000000.000000FOR31094.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/29/2026Advisory Vote on Executive Compensation ApproachCOMPENSATIONISSUER31094.0000000.000000FOR31094.000000FORS000059080BlackRock Debt Strategies Fund, Inc.09255R202US09255R202207/11/2025To Elect Board Member Nominees: Robert FairbairnDIRECTOR ELECTIONSISSUER85729.0000000FOR85729.000000FORS000064727BlackRock Debt Strategies Fund, Inc.09255R202US09255R202207/11/2025To Elect Board Member Nominees: J. Phillip HollomanDIRECTOR ELECTIONSISSUER85729.0000000FOR85729.000000FORS000064727BlackRock Debt Strategies Fund, Inc.09255R202US09255R202207/11/2025To Elect Board Member Nominees: Arthur P. SteinmetzDIRECTOR ELECTIONSISSUER85729.0000000FOR85729.000000FORS000064727BlackRock Floating Rate Income Strategies Fund, Inc.09255X100US09255X100007/11/2025To Elect Board Member Nominees: Robert FairbairnDIRECTOR ELECTIONSISSUER71967.0000000FOR71967.000000FORS000064727BlackRock Floating Rate Income Strategies Fund, Inc.09255X100US09255X100007/11/2025To Elect Board Member Nominees: J. Phillip HollomanDIRECTOR ELECTIONSISSUER71967.0000000FOR71967.000000FORS000064727BlackRock Floating Rate Income Strategies Fund, Inc.09255X100US09255X100007/11/2025To Elect Board Member Nominees: Arthur P. SteinmetzDIRECTOR ELECTIONSISSUER71967.0000000FOR71967.000000FORS000064727BlackRock Floating Rate Income Trust091941104US091941104307/11/2025To Elect Board Member Nominees: Cynthia L. EganDIRECTOR ELECTIONSISSUER73334.0000000FOR73334.000000FORS000064727BlackRock Floating Rate Income Trust091941104US091941104307/11/2025To Elect Board Member Nominees: Robert FairbairnDIRECTOR ELECTIONSISSUER73334.0000000FOR73334.000000FORS000064727BlackRock Floating Rate Income Trust091941104US091941104307/11/2025To Elect Board Member Nominees: Stayce D. HarrisDIRECTOR ELECTIONSISSUER73334.0000000FOR73334.000000FORS000064727BlackRock Income Trust, Inc.09247F209US09247F209207/11/2025To Elect Board Member Nominees: Cynthia L. EganDIRECTOR ELECTIONSISSUER76704.0000000FOR76704.000000FORS000064727BlackRock Income Trust, Inc.09247F209US09247F209207/11/2025To Elect Board Member Nominees: Robert FairbairnDIRECTOR ELECTIONSISSUER76704.0000000FOR76704.000000FORS000064727BlackRock Income Trust, Inc.09247F209US09247F209207/11/2025To Elect Board Member Nominees: Stayce D. HarrisDIRECTOR ELECTIONSISSUER76704.0000000FOR76704.000000FORS000064727BlackRock Limited Duration Income Trust09249W101US09249W101807/11/2025To Elect Board Member Nominees: Cynthia L. EganDIRECTOR ELECTIONSISSUER29363.00000029900.000000FOR29363.000000FORS000064727BlackRock Limited Duration Income Trust09249W101US09249W101807/11/2025To Elect Board Member Nominees: Robert FairbairnDIRECTOR ELECTIONSISSUER29363.00000029900.000000FOR29363.000000FORS000064727BlackRock Limited Duration Income Trust09249W101US09249W101807/11/2025To Elect Board Member Nominees: Stayce D. HarrisDIRECTOR ELECTIONSISSUER29363.00000029900.000000FOR29363.000000FORS000064727BlackRock Technology and Private Equity Term Trust09260Q108US09260Q108507/11/2025To Elect Board Member Nominees: Cynthia L. EganDIRECTOR ELECTIONSISSUER133661.0000000FOR133661.000000FORS000064727BlackRock Technology and Private Equity Term Trust09260Q108US09260Q108507/11/2025To Elect Board Member Nominees: Lorenzo A. FloresDIRECTOR ELECTIONSISSUER133661.0000000FOR133661.000000FORS000064727BlackRock Technology and Private Equity Term Trust09260Q108US09260Q108507/11/2025To Elect Board Member Nominees: Stayce D. HarrisDIRECTOR ELECTIONSISSUER133661.0000000FOR133661.000000FORS000064727BlackRock Technology and Private Equity Term Trust09260Q108US09260Q108507/11/2025To Elect Board Member Nominees: Catherine A. LynchDIRECTOR ELECTIONSISSUER133661.0000000FOR133661.000000FORS000064727BlackRock Technology and Private Equity Term Trust09260Q108US09260Q108507/11/2025To Elect Board Member Nominees: R. Glenn HubbardDIRECTOR ELECTIONSISSUER133661.0000000FOR133661.000000FORS000064727BlackRock Technology and Private Equity Term Trust09260Q108US09260Q108507/11/2025To Elect Board Member Nominees: W. Carl KesterDIRECTOR ELECTIONSISSUER133661.0000000FOR133661.000000FORS000064727BlackRock Technology and Private Equity Term Trust09260Q108US09260Q108507/11/2025To Elect Board Member Nominees: John M. PerlowskiDIRECTOR ELECTIONSISSUER133661.0000000FOR133661.000000FORS000064727BlackRock Technology and Private Equity Term Trust09260Q108US09260Q108507/11/2025To Elect Board Member Nominees: Robert FairbairnDIRECTOR ELECTIONSISSUER133661.0000000FOR133661.000000FORS000064727BlackRock Technology and Private Equity Term Trust09260Q108US09260Q108507/11/2025To Elect Board Member Nominees: J. Phillip HollomanDIRECTOR ELECTIONSISSUER133661.0000000FOR133661.000000FORS000064727BlackRock Technology and Private Equity Term Trust09260Q108US09260Q108507/11/2025To Elect Board Member Nominees: Arthur P. SteinmetzDIRECTOR ELECTIONSISSUER133661.0000000FOR133661.000000FORS000064727Bain Capital Specialty Finance, Inc.05684B107US05684B107007/15/2025To elect two Class III Directors of the Company who will serve for a three-year term expiring at the 2028 annual meeting of stockholders or until their respective successor is duly elected and qualified: David G. FubiniDIRECTOR ELECTIONSISSUER45310.0000000AGAINST45310.000000AGAINSTS000064727Bain Capital Specialty Finance, Inc.05684B107US05684B107007/15/2025To elect two Class III Directors of the Company who will serve for a three-year term expiring at the 2028 annual meeting of stockholders or until their respective successor is duly elected and qualified: Jeffrey B. HawkinsDIRECTOR ELECTIONSISSUER45310.0000000FOR45310.000000FORS000064727Bain Capital Specialty Finance, Inc.05684B107US05684B107007/15/2025To approve a proposal to renew the Company's authorization, with the approval of the Company's Board of Directors, to sell shares of the Company's common stock (during the next 12 months following such stockholder authorization), at a price below the then-current net asset value per share, subject to certain limitations described in the accompanying Proxy Statement;CAPITAL STRUCTUREISSUER45310.0000000FOR45310.000000FORS000064727Bain Capital Specialty Finance, Inc.05684B107US05684B107007/15/2025To approve the adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies.CORPORATE GOVERNANCEISSUER45310.0000000AGAINST45310.000000AGAINSTS000064727Capital Southwest Corporation140501107US140501107307/24/2025To elect six directors to serve until the 2026 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified: Christine S. BattistDIRECTOR ELECTIONSISSUER39571.0000000FOR39571.000000FORS000064727Capital Southwest Corporation140501107US140501107307/24/2025To elect six directors to serve until the 2026 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified: David R. BrooksDIRECTOR ELECTIONSISSUER39571.0000000FOR39571.000000FORS000064727Capital Southwest Corporation140501107US140501107307/24/2025To elect six directors to serve until the 2026 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified: Jack D. FurstDIRECTOR ELECTIONSISSUER39571.0000000FOR39571.000000FORS000064727Capital Southwest Corporation140501107US140501107307/24/2025To elect six directors to serve until the 2026 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified: Ramona L. Rogers-WindsorDIRECTOR ELECTIONSISSUER39571.0000000FOR39571.000000FORS000064727Capital Southwest Corporation140501107US140501107307/24/2025To elect six directors to serve until the 2026 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified: Michael S. SarnerDIRECTOR ELECTIONSISSUER39571.0000000FOR39571.000000FORS000064727Capital Southwest Corporation140501107US140501107307/24/2025To elect six directors to serve until the 2026 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified: William R. ThomasDIRECTOR ELECTIONSISSUER39571.0000000FOR39571.000000FORS000064727Capital Southwest Corporation140501107US140501107307/24/2025To approve, on an advisory basis, the compensation of Capital Southwest Corporation's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER39571.0000000AGAINST39571.000000AGAINSTS000064727Capital Southwest Corporation140501107US140501107307/24/2025To approve, on an advisory basis, the compensation of Capital Southwest Corporation's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER39571.0000000AGAINST39571.000000AGAINST4S000064727Capital Southwest Corporation140501107US140501107307/24/2025Approve an amendment to the Capital Southwest Corporation 2021 Employee Restricted Stock Award Plan.COMPENSATIONISSUER39571.0000000FOR39571.000000FORS000064727Capital Southwest Corporation140501107US140501107307/24/2025To ratify the appointment of RSM US LLP as Capital Southwest Corporation's independent registered public accounting firm for the fiscal year ending March 31, 2026.AUDIT-RELATEDISSUER39571.0000000FOR39571.000000FORS000064727CION Investment Corporation17259U204US17259U204207/28/2025To elect three directors of the Company, who will each serve for a term of three years expiring in 2028, or until their successors are duly elected and qualified (the "Class I Director Proposal"): Edward J. EstradaDIRECTOR ELECTIONSISSUER80860.0000000WITHHOLD80860.000000AGAINSTS000064727CION Investment Corporation17259U204US17259U204207/28/2025To elect three directors of the Company, who will each serve for a term of three years expiring in 2028, or until their successors are duly elected and qualified (the "Class I Director Proposal"): Peter I. FinlayDIRECTOR ELECTIONSISSUER80860.0000000WITHHOLD80860.000000AGAINSTS000064727CION Investment Corporation17259U204US17259U204207/28/2025To elect three directors of the Company, who will each serve for a term of three years expiring in 2028, or until their successors are duly elected and qualified (the "Class I Director Proposal"): Earl V. HedinDIRECTOR ELECTIONSISSUER80860.0000000WITHHOLD80860.000000AGAINSTS000064727CION Investment Corporation17259U204US17259U204207/28/2025To ratify the selection of RSM US LLP to serve as the Company's independent registered public accounting firm for the year ending December 31, 2025 (the "Auditors Proposal").AUDIT-RELATEDISSUER80860.0000000FOR80860.000000FORS000064727OFS Capital Corporation67103B100US67103B100807/30/2025To authorize flexibility for the Company, with approval of its Board of Directors, to sell or otherwise issue shares of its common stock (during the next 12 months) at a price below the Company's then current net asset value per share in one or more offerings, subject to certain limitations set forth in the proxy statement for the Special Meeting of Stockholders (including that the cumulative number of shares sold pursuant to such authority does not exceed 25% of the Company's then-outstanding common stock immediately prior to each such sale).CAPITAL STRUCTUREISSUER71776.0000000FOR71776.000000FORS000064727WhiteHorse Finance, Inc.96524V106US96524V106107/30/2025Election of Directors: G. Stacy SmithDIRECTOR ELECTIONSISSUER51556.0000006700.000000FOR51556.000000FORS000064727WhiteHorse Finance, Inc.96524V106US96524V106107/30/2025Election of Directors: John P. VolpeDIRECTOR ELECTIONSISSUER51556.0000006700.000000FOR51556.000000FORS000064727WhiteHorse Finance, Inc.96524V106US96524V106107/30/2025To ratify the selection of Crowe LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER51556.0000006700.000000FOR51556.000000FORS000064727Eaton Vance Senior Floating-Rate Trust27828Q105US27828Q105808/07/2025Election of four Class I Trustees: Cynthia E. FrostDIRECTOR ELECTIONSISSUER70300.0000000FOR70300.000000FORS000064727Eaton Vance Senior Floating-Rate Trust27828Q105US27828Q105808/07/2025Election of four Class I Trustees: Valerie A. MosleyDIRECTOR ELECTIONSISSUER70300.0000000FOR70300.000000FORS000064727Eaton Vance Senior Floating-Rate Trust27828Q105US27828Q105808/07/2025Election of four Class I Trustees: Scott E. WennerholmDIRECTOR ELECTIONSISSUER70300.0000000FOR70300.000000FORS000064727Eaton Vance Senior Floating-Rate Trust27828Q105US27828Q105808/07/2025Election of four Class I Trustees: Nancy Wiser StefaniDIRECTOR ELECTIONSISSUER70300.0000000FOR70300.000000FORS000064727Gladstone Investment Corporation376546107US376546107008/07/2025Election of Directors to hold office until the 2028 Annual Meeting of Stockholders: David GladstoneDIRECTOR ELECTIONSISSUER501.00000053267.000000FOR501.000000FORS000064727Gladstone Investment Corporation376546107US376546107008/07/2025Election of Directors to hold office until the 2028 Annual Meeting of Stockholders: John H. OutlandDIRECTOR ELECTIONSISSUER501.00000053267.000000FOR501.000000FORS000064727Gladstone Investment Corporation376546107US376546107008/07/2025To ratify our Audit Committee's selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending March 31, 2026.AUDIT-RELATEDISSUER501.00000053267.000000FOR501.000000FORS000064727Ares Capital Corporation04010L103US04010L103508/08/2025To authorize the Company, with the approval of its board of directors, to sell or otherwise issue shares of its common stock at a price below its then current net asset value per share subject to the limitations set forth in the proxy statement for the special meeting of stockholders (including, without limitation, that the number of shares issued does not exceed 25% of the Company's then outstanding common stock). If approved, the authorization would be effective for common stock issued during a twelve-month period expiring on the anniversary of the date of this Special Meeting.CAPITAL STRUCTUREISSUER1.00000033593.000000FOR1.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/12/2025Election of Trustees by Common Shareholders and Preferred Shareholders voting together as a single class: Cynthia HostetlerDIRECTOR ELECTIONSISSUER274790.0000000FOR274790.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/12/2025Election of Trustees by Common Shareholders and Preferred Shareholders voting together as a single class: Eli JonesDIRECTOR ELECTIONSISSUER274790.0000000FOR274790.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/12/2025Election of Trustees by Common Shareholders and Preferred Shareholders voting together as a single class: Daniel S. VandivortDIRECTOR ELECTIONSISSUER274790.0000000FOR274790.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/12/2025Election of Trustees by Common Shareholders and Preferred Shareholders voting together as a single class: James "Jim" LiddyDIRECTOR ELECTIONSISSUER274790.0000000FOR274790.000000FORS000064727OFS Credit Company, Inc.67111Q107US67111Q107608/14/2025The election of the following person (except as marked to the contrary) who will serve as a Class I director of OFS Credit Company, Inc. until 2028, or until his successor is elected and qualified. Nominee: Class I Director: Bilal RashidDIRECTOR ELECTIONSISSUER159838.000000190400.000000FOR159838.000000FORS000064727OFS Credit Company, Inc.67111Q107US67111Q107608/14/2025The ratification of the selection of KPMG LLP as our independent registered public accounting firm for the year ending October 31, 2025.AUDIT-RELATEDISSUER159838.000000190400.000000FOR159838.000000FORS000064727FS KKR Capital Corp.302635206US302635206808/15/2025Election of Class C Directors: Class C Directors: Barbara AdamsDIRECTOR ELECTIONSISSUER19578.00000027600.000000FOR19578.000000FORS000064727FS KKR Capital Corp.302635206US302635206808/15/2025Election of Class C Directors: Class C Directors: Michael C. FormanDIRECTOR ELECTIONSISSUER19578.00000027600.000000FOR19578.000000FORS000064727FS KKR Capital Corp.302635206US302635206808/15/2025Election of Class C Directors: Class C Directors: Jerel A. HopkinsDIRECTOR ELECTIONSISSUER19578.00000027600.000000WITHHOLD19578.000000AGAINSTS000064727FS KKR Capital Corp.302635206US302635206808/15/2025To approve a proposal to allow the Company in future offerings to sell its shares below net asset value per share in order to provide flexibility for future sales.CAPITAL STRUCTUREISSUER19578.00000027600.000000FOR19578.000000FORS000064727Oxford Square Capital Corp.69181V107US69181V107008/20/2025To elect one director to serve until the 2028 Annual Meeting of Stockholders or until his respective successor is duly elected and qualified: Barry A. OsherowDIRECTOR ELECTIONSISSUER71388.000000149100.000000WITHHOLD71388.000000AGAINSTS000064727Oxford Square Capital Corp.69181V107US69181V107008/20/2025To ratify the selection of PricewaterhouseCoopers LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER71388.000000149100.000000FOR71388.000000FORS000064727Pioneer Floating Rate Fund, Inc.72369J102US72369J102508/20/2025To approve the liquidation and dissolution of the Fund pursuant to the Plan of Liquidation and Dissolution as described in the Joint Proxy Statement.EXTRAORDINARY TRANSACTIONSISSUER79711.0000000FOR79711.000000FORS000064727Carlyle Credit Income Fund92535C104US92535C104509/04/2025To elect to the Board of Trustees two Class I Trustees to serve a three (3) year term expiring in 2028; Class I Trustees: Mark Garbin (Class I Nominee)DIRECTOR ELECTIONSISSUER181994.0000000FOR181994.000000FORS000064727Carlyle Credit Income Fund92535C104US92535C104509/04/2025To elect to the Board of Trustees two Class I Trustees to serve a three (3) year term expiring in 2028; Class I Trustees: Nishil Mehta (Class I Nominee)DIRECTOR ELECTIONSISSUER181994.0000000FOR181994.000000FORS000064727First Trust Senior Floating Rate Income Fund II33740U257US33740U257409/04/2025Election of Three Class III Trustees and One Class II Trustee: James A. Bowen (Class III Nominee)DIRECTOR ELECTIONSISSUER81640.0000000FOR81640.000000FORS000064727First Trust Senior Floating Rate Income Fund II33740U257US33740U257409/04/2025Election of Three Class III Trustees and One Class II Trustee: Robert F. Keith (Class III Nominee)DIRECTOR ELECTIONSISSUER81640.0000000FOR81640.000000FORS000064727First Trust Senior Floating Rate Income Fund II33740U257US33740U257409/04/2025Election of Three Class III Trustees and One Class II Trustee: Bronwyn Wright (Class III Nominee)DIRECTOR ELECTIONSISSUER81640.0000000WITHHOLD81640.000000AGAINSTS000064727First Trust Senior Floating Rate Income Fund II33740U257US33740U257409/04/2025Election of Three Class III Trustees and One Class II Trustee: Thomas J. Driscoll (Class II Nominee)DIRECTOR ELECTIONSISSUER81640.0000000FOR81640.000000FORS000064727Blackstone Secured Lending Fund09261X102US09261X102809/25/2025Elect three Class I Trustee nominees listed in the Proxy: Vikrant SawhneyDIRECTOR ELECTIONSISSUER8666.00000013000.000000FOR8666.000000FORS000064727Blackstone Secured Lending Fund09261X102US09261X102809/25/2025Elect three Class I Trustee nominees listed in the Proxy: James F. ClarkDIRECTOR ELECTIONSISSUER8666.00000013000.000000WITHHOLD8666.000000AGAINSTS000064727Blackstone Secured Lending Fund09261X102US09261X102809/25/2025Elect three Class I Trustee nominees listed in the Proxy: Vicki L. FullerDIRECTOR ELECTIONSISSUER8666.00000013000.000000WITHHOLD8666.000000AGAINSTS000064727Blackstone Secured Lending Fund09261X102US09261X102809/25/2025Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER8666.00000013000.000000FOR8666.000000FORS000064727Saratoga Investment Corp.80349A208US80349A208709/25/2025The election of the following persons as directors, who will each serve as a director of Saratoga Investment Corp.'s (the "Company") board of directors until 2028, or until their respective successor is duly elected and qualified: Steven M. LooneyDIRECTOR ELECTIONSISSUER36200.000000100.000000WITHHOLD36200.000000AGAINSTS000064727Saratoga Investment Corp.80349A208US80349A208709/25/2025The election of the following persons as directors, who will each serve as a director of Saratoga Investment Corp.'s (the "Company") board of directors until 2028, or until their respective successor is duly elected and qualified: Charles S. Whitman IIIDIRECTOR ELECTIONSISSUER36200.000000100.000000WITHHOLD36200.000000AGAINSTS000064727Saratoga Investment Corp.80349A208US80349A208709/25/2025To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending February 28, 2026.AUDIT-RELATEDISSUER36200.000000100.000000FOR36200.000000FORS000064727Eaton Vance Senior Income Trust27826S103US27826S103310/08/2025Election of three Class III Trustees: Alan C. BowserDIRECTOR ELECTIONSISSUER135425.0000007400.000000FOR135425.000000FORS000064727Eaton Vance Senior Income Trust27826S103US27826S103310/08/2025Election of three Class III Trustees: George J. GormanDIRECTOR ELECTIONSISSUER135425.0000007400.000000FOR135425.000000FORS000064727Eaton Vance Senior Income Trust27826S103US27826S103310/08/2025Election of three Class III Trustees: Marcus L. SmithDIRECTOR ELECTIONSISSUER135425.0000007400.000000FOR135425.000000FORS000064727SLR Investment Corp.83413U100US83413U100711/19/2025The election of each of the following persons (except as marked to the contrary) as a director of SLR Investment Corp., who will each serve as a director of SLR Investment Corp. until 2028, or until their respective successors are duly elected and qualified: Andrea C. RobertsDIRECTOR ELECTIONSISSUER44758.0000000WITHHOLD44758.000000AGAINSTS000064727SLR Investment Corp.83413U100US83413U100711/19/2025The election of each of the following persons (except as marked to the contrary) as a director of SLR Investment Corp., who will each serve as a director of SLR Investment Corp. until 2028, or until their respective successors are duly elected and qualified: David S. WachterDIRECTOR ELECTIONSISSUER44758.0000000WITHHOLD44758.000000AGAINSTS000064727SLR Investment Corp.83413U100US83413U100711/19/2025The ratification of the selection of KPMG LLP as SLR Investment Corp.'s independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER44758.0000000FOR44758.000000FORS000064727Prospect Capital Corporation74348T102US74348T102512/16/2025To elect one Class III director of the Company to serve until the Annual Meeting of Stockholders in 2028 and until his successor is duly elected and qualifies: John F. Barry IIIDIRECTOR ELECTIONSISSUER660086.0000000AGAINST660086.000000AGAINSTS000064727Sound Point Meridian Capital, Inc.83617A108US83617A108812/17/2025Election of Director: Douglas T. HealyDIRECTOR ELECTIONSISSUER27088.0000000WITHHOLD27088.000000AGAINSTS000064727Golub Capital BDC, Inc.38173M102US38173M102702/02/2026Election of Directors - To elect two Class I directors of the Company who will each serve until the 2029 Annual Meeting of Stockholders of the Company or until their successor is duly elected and qualified: David B. GolubDIRECTOR ELECTIONSISSUER1.00000048999.000000FOR1.000000FORS000064727Golub Capital BDC, Inc.38173M102US38173M102702/02/2026Election of Directors - To elect two Class I directors of the Company who will each serve until the 2029 Annual Meeting of Stockholders of the Company or until their successor is duly elected and qualified: Anita J. RivalDIRECTOR ELECTIONSISSUER1.00000048999.000000FOR1.000000FORS000064727Golub Capital BDC, Inc.38173M102US38173M102702/02/2026To ratify the selection of Ernst & Young LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2026.AUDIT-RELATEDISSUER1.00000048999.000000FOR1.000000FORS000064727PennantPark Floating Rate Capital Ltd.70806A106US70806A106002/03/2026Election of Directors: Arthur H. PennDIRECTOR ELECTIONSISSUER53501.00000031554.000000AGAINST53501.000000AGAINSTS000064727PennantPark Floating Rate Capital Ltd.70806A106US70806A106002/03/2026Election of Directors: Jose A. Briones, Jr.DIRECTOR ELECTIONSISSUER53501.00000031554.000000AGAINST53501.000000AGAINSTS000064727PennantPark Floating Rate Capital Ltd.70806A106US70806A106002/03/2026To ratify the selection of RSM US LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2026.AUDIT-RELATEDISSUER53501.00000031554.000000FOR53501.000000FORS000064727PennantPark Investment Corporation708062104US708062104502/03/2026Election of Directors: Samuel KatzDIRECTOR ELECTIONSISSUER1042.000000130398.000000AGAINST1042.000000AGAINSTS000064727PennantPark Investment Corporation708062104US708062104502/03/2026Election of Directors: Marshall BrozostDIRECTOR ELECTIONSISSUER1042.000000130398.000000AGAINST1042.000000AGAINSTS000064727PennantPark Investment Corporation708062104US708062104502/03/2026To ratify the selection of RSM US LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2026.AUDIT-RELATEDISSUER1042.000000130398.000000FOR1042.000000FORS000064727Gladstone Capital Corporation376535878US376535878902/05/2026To ratify our Audit Committee's selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending September 30, 2026.AUDIT-RELATEDISSUER30310.0000000FOR30310.000000FORS000064727Oaktree Specialty Lending Corporation67401P405US67401P405403/03/2026To authorize the Company, with the approval of the Board of Directors, to sell or otherwise issue shares of its common stock at a price below its then current net asset value per share, provided that the number of shares issued does not exceed 25% of its then outstanding common stock.CAPITAL STRUCTUREISSUER64479.0000000FOR64479.000000FORS000064727Oaktree Specialty Lending Corporation67401P405US67401P405403/03/2026To elect two directors of the Company, who will each serve until the Company's 2029 Annual Meeting of Stockholders and until his successor is duly elected and qualifies: John FrankDIRECTOR ELECTIONSISSUER63129.0000000FOR63129.000000FORS000064727Oaktree Specialty Lending Corporation67401P405US67401P405403/03/2026To elect two directors of the Company, who will each serve until the Company's 2029 Annual Meeting of Stockholders and until his successor is duly elected and qualifies: Bruce ZimmermanDIRECTOR ELECTIONSISSUER63129.0000000FOR63129.000000FORS000064727Oaktree Specialty Lending Corporation67401P405US67401P405403/03/2026To ratify the appointment of Ernst & Young LLP as the Independent Registered Public Accounting Firm for the Company for the fiscal year ending September 30, 2026.AUDIT-RELATEDISSUER63129.0000000FOR63129.000000FORS000064727Eaton Vance Floating-Rate Income Trust278279104US278279104803/11/2026Election of three Class I Trustees: Cynthia E. FrostDIRECTOR ELECTIONSISSUER52944.0000000FOR52944.000000FORS000064727Eaton Vance Floating-Rate Income Trust278279104US278279104803/11/2026Election of three Class I Trustees: Nancy Wiser StefaniDIRECTOR ELECTIONSISSUER52944.0000000FOR52944.000000FORS000064727Eaton Vance Floating-Rate Income Trust278279104US278279104803/11/2026Election of three Class I Trustees: Scott E. WennerholmDIRECTOR ELECTIONSISSUER52944.0000000FOR52944.000000FORS000064727Eagle Point Credit Company Inc.269808101US269808101303/12/2026To approve a change in Eagle Point Credit Company Inc.'s legal form from a Delaware corporation to a Delaware statutory trust (the "Proposal"); andINVESTMENT COMPANY MATTERSISSUER1.000000302121.000000AGAINST1.000000AGAINSTS000064727Horizon Technology Finance Corporation44045A102US44045A102503/13/2026to approve the issuance of shares of HRZN common stock, par value $0.001 per share ("HRZN Common Stock"), pursuant to the Agreement and Plan of Merger, dated as of August 7, 2025 (the "Merger Agreement"), by and among HRZN, Monroe Capital Corporation, a Maryland corporation ("MRCC"), HMMS, Inc., a Maryland corporation and wholly owned subsidiary of HRZN ("Merger Sub"), Monroe Capital BDC Advisors, LLC, a Delaware limited liability company and investment adviser to MRCC ("MC Advisors"), and Horizon Technology Finance Management LLC, a Delaware limited liability company and investment adviser to HRZN ("HRZN Advisor") (such proposal is referred to herein as the "Merger Stock Issuance Proposal"),EXTRAORDINARY TRANSACTIONSISSUER21162.000000142853.000000FOR21162.000000FORS000064727Horizon Technology Finance Corporation44045A102US44045A102503/13/2026to approve the election of one Class I director of HRZN who will serve until the 2026 annual meeting of stockholders or until his successor is duly elected and qualified (such proposal is referred to herein as the "Director Election Proposal"): Thomas J. AllisonDIRECTOR ELECTIONSISSUER21162.000000142853.000000FOR21162.000000FORS000064727Monroe Capital Corporation610335101US610335101003/13/2026To approve the Asset Purchase Agreement, dated as of August 7, 2025 (the "Asset Purchase Agreement"), by and among Monroe Capital Corporation (the "Company"), Monroe Capital BDC Advisors, LLC ("MC Advisors") and Monroe Capital Income Plus Corporation ("MCIP"), and the transactions contemplated thereby, including the sale of all of MRCC's investment assets, as well as liabilities with respect to such assets, to MCIP for the price, and on the terms, set forth in the Asset Purchase Agreement (the "Asset Sale Proposal").EXTRAORDINARY TRANSACTIONSISSUER66909.0000000AGAINST66909.000000AGAINSTS000064727Monroe Capital Corporation610335101US610335101003/13/2026To approve the merger of HMMS, Inc. ("Merger Sub"), a Maryland corporation and wholly owned subsidiary of Horizon Technology Finance Corporation ("HRZN"), a Delaware corporation, with and into the Company, with the Company continuing as the surviving company and as a wholly-owned subsidiary of HRZN, pursuant to the Agreement and Plan of Merger, dated as of August 7, 2025, by and among the Company, HRZN, Merger Sub, MC Advisors and Horizon Technology Finance Management LLC, a Delaware limited liability company (the "Merger Proposal").EXTRAORDINARY TRANSACTIONSISSUER66909.0000000AGAINST66909.000000AGAINSTS000064727KKR Income Opportunities Fund48249T106US48249T106003/18/2026To elect one (1) Class III Trustee to the Board of Trustees of the Fund to serve a three (3) year term expiring in 2029 and until his successor is duly elected and qualifies: Jeffrey L. ZlotDIRECTOR ELECTIONSISSUER48006.0000009600.000000FOR48006.000000FORS000064727Nuveen Credit Strategies Income Fund67073D102US67073D102804/16/2026Election of Board Members: Class II: Joseph A. BoatengDIRECTOR ELECTIONSISSUER79895.00000055800.000000FOR79895.000000FORS000064727Nuveen Credit Strategies Income Fund67073D102US67073D102804/16/2026Election of Board Members: Class II: Amy B. R. LancellottaDIRECTOR ELECTIONSISSUER79895.00000055800.000000FOR79895.000000FORS000064727Nuveen Credit Strategies Income Fund67073D102US67073D102804/16/2026Election of Board Members: Class II: John K. NelsonDIRECTOR ELECTIONSISSUER79895.00000055800.000000FOR79895.000000FORS000064727Nuveen Credit Strategies Income Fund67073D102US67073D102804/16/2026Election of Board Members: Class II: Terence J. TothDIRECTOR ELECTIONSISSUER79895.00000055800.000000FOR79895.000000FORS000064727Nuveen Floating Rate Income Fund67072T108US67072T108804/16/2026Election of Board Members: Class II: Joseph A. BoatengDIRECTOR ELECTIONSISSUER88296.0000000FOR88296.000000FORS000064727Nuveen Floating Rate Income Fund67072T108US67072T108804/16/2026Election of Board Members: Class II: Amy B. R. LancellottaDIRECTOR ELECTIONSISSUER88296.0000000FOR88296.000000FORS000064727Nuveen Floating Rate Income Fund67072T108US67072T108804/16/2026Election of Board Members: Class II: John K. NelsonDIRECTOR ELECTIONSISSUER88296.0000000FOR88296.000000FORS000064727Nuveen Floating Rate Income Fund67072T108US67072T108804/16/2026Election of Board Members: Class II: Terence J. TothDIRECTOR ELECTIONSISSUER88296.0000000FOR88296.000000FORS000064727Blackstone Senior Floating Rate 2027 Term Fund09256U105US09256U105104/22/2026Election of one Nominee for Trustee: Jane SiebelsDIRECTOR ELECTIONSISSUER35960.0000000FOR35960.000000FORS000064727TriplePoint Venture Growth BDC Corp.89677Y100US89677Y100104/29/2026To elect three Class III directors of the Company who will each serve until the 2029 annual meeting of the Company's stockholders, or until their respective successors are duly elected and qualitied: James P. LabeDIRECTOR ELECTIONSISSUER65413.0000003100.000000FOR65413.000000FORS000064727TriplePoint Venture Growth BDC Corp.89677Y100US89677Y100104/29/2026To elect three Class III directors of the Company who will each serve until the 2029 annual meeting of the Company's stockholders, or until their respective successors are duly elected and qualitied: Cynthia M. FornelliDIRECTOR ELECTIONSISSUER65413.0000003100.000000WITHHOLD65413.000000AGAINSTS000064727TriplePoint Venture Growth BDC Corp.89677Y100US89677Y100104/29/2026To elect three Class III directors of the Company who will each serve until the 2029 annual meeting of the Company's stockholders, or until their respective successors are duly elected and qualitied: Katherine J. ParkDIRECTOR ELECTIONSISSUER65413.0000003100.000000WITHHOLD65413.000000AGAINSTS000064727TriplePoint Venture Growth BDC Corp.89677Y100US89677Y100104/29/2026To ratity the selection of Deloitte & Touche LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER65413.0000003100.000000FOR65413.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/04/2026Election of Directors: J. Kevin GriffinDIRECTOR ELECTIONSISSUER1.0000005379.000000FOR1.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/04/2026Election of Directors: John E. JacksonDIRECTOR ELECTIONSISSUER1.0000005379.000000FOR1.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/04/2026Election of Directors: Brian E. LaneDIRECTOR ELECTIONSISSUER1.0000005379.000000FOR1.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/04/2026Election of Directors: Dunia A. ShiveDIRECTOR ELECTIONSISSUER1.0000005379.000000FOR1.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/04/2026Election of Directors: Stephen B. SolcherDIRECTOR ELECTIONSISSUER1.0000005379.000000FOR1.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/04/2026Election of Directors: Vincent D. FosterDIRECTOR ELECTIONSISSUER1.0000005379.000000FOR1.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/04/2026Election of Directors: Dwayne L. HyzakDIRECTOR ELECTIONSISSUER1.0000005379.000000FOR1.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/04/2026Proposal to ratify our appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER1.0000005379.000000FOR1.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/04/2026Advisory non-binding approval of executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000005379.000000FOR1.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/04/2026Advisory non-binding approval of executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000005379.000000FOR1.000000FOR4S000064727Ares Capital Corporation04010L103US04010L103505/07/2026Election of Directors: Ann Torre BatesDIRECTOR ELECTIONSISSUER1.00000026167.000000FOR1.000000FORS000064727Ares Capital Corporation04010L103US04010L103505/07/2026Election of Directors: Steven B. McKeeverDIRECTOR ELECTIONSISSUER1.00000026167.000000AGAINST1.000000AGAINSTS000064727Ares Capital Corporation04010L103US04010L103505/07/2026Election of Directors: Michael J AroughetiDIRECTOR ELECTIONSISSUER1.00000026167.000000FOR1.000000FORS000064727Ares Capital Corporation04010L103US04010L103505/07/2026To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER1.00000026167.000000FOR1.000000FORS000064727Barings BDC, Inc.06759L103US06759L103505/07/2026The election of the following three persons as Class II Directors who will serve as directors of Barings BDC, Inc. until the 2029 Annual Meeting and until their successors have been duly elected and qualified: Steve ByersDIRECTOR ELECTIONSISSUER55991.0000000AGAINST55991.000000AGAINSTS000064727Barings BDC, Inc.06759L103US06759L103505/07/2026The election of the following three persons as Class II Directors who will serve as directors of Barings BDC, Inc. until the 2029 Annual Meeting and until their successors have been duly elected and qualified: Valerie Lancaster-BealDIRECTOR ELECTIONSISSUER55991.0000000AGAINST55991.000000AGAINSTS000064727Barings BDC, Inc.06759L103US06759L103505/07/2026The election of the following three persons as Class II Directors who will serve as directors of Barings BDC, Inc. until the 2029 Annual Meeting and until their successors have been duly elected and qualified: John A. SwitzerDIRECTOR ELECTIONSISSUER55991.0000000AGAINST55991.000000AGAINSTS000064727XAI Octagon Floating Rate & Alternative Income Trust98400T304US98400T304105/07/2026Election of Class III Trustees to be elected by the holders of Common Shares and Preferred Shares, voting together as a single class, to serve until the Trust's 2029 annual meeting of shareholders or until their respective successors shall have been elected and qualified: Scott Craven JonesDIRECTOR ELECTIONSISSUER55758.0000000FOR55758.000000FORS000064727XAI Octagon Floating Rate & Alternative Income Trust98400T304US98400T304105/07/2026Election of Class III Trustees to be elected by the holders of Common Shares and Preferred Shares, voting together as a single class, to serve until the Trust's 2029 annual meeting of shareholders or until their respective successors shall have been elected and qualified: William T. MeyersDIRECTOR ELECTIONSISSUER55758.0000000FOR55758.000000FORS000064727Eagle Point Credit Company Inc269808101US269808101305/12/2026Election of Director: Kevin F. McDonaldDIRECTOR ELECTIONSISSUER168005.000000299809.000000FOR168005.000000FORS000064727New Mountain Finance Corporation647551100US647551100105/12/2026The election of the following persons (except as marked to the contrary) as directors, who will each serve as a director of New Mountain Finance Corporation until 2029, or until their respective successors are duly elected and qualify: Rome G. Arnold IIIDIRECTOR ELECTIONSISSUER89471.0000000FOR89471.000000FORS000064727New Mountain Finance Corporation647551100US647551100105/12/2026The election of the following persons (except as marked to the contrary) as directors, who will each serve as a director of New Mountain Finance Corporation until 2029, or until their respective successors are duly elected and qualify: Daniel B. HebertDIRECTOR ELECTIONSISSUER89471.0000000FOR89471.000000FORS000064727New Mountain Finance Corporation647551100US647551100105/12/2026The election of the following persons (except as marked to the contrary) as directors, who will each serve as a director of New Mountain Finance Corporation until 2029, or until their respective successors are duly elected and qualify: Steven B. KlinskyDIRECTOR ELECTIONSISSUER89471.0000000FOR89471.000000FORS000064727New Mountain Finance Corporation647551100US647551100105/12/2026To ratify the appointment of Deloitte & Touche LLP to serve as New Mountain Finance Corporation's Independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER89471.0000000FOR89471.000000FORS000064727Crescent Capital BDC, Inc.225655109US225655109205/15/2026To elect two Class II Directors of the Corporation, to serve until the 2029 Annual Meeting and until their respective successors are duly elected and qualify: Susan Yun LeeDIRECTOR ELECTIONSISSUER44918.0000000FOR44918.000000FORS000064727Crescent Capital BDC, Inc.225655109US225655109205/15/2026To elect two Class II Directors of the Corporation, to serve until the 2029 Annual Meeting and until their respective successors are duly elected and qualify: Michael S. SegalDIRECTOR ELECTIONSISSUER44918.0000000FOR44918.000000FORS000064727Crescent Capital BDC, Inc.225655109US225655109205/15/2026To ratify the selection of Ernst & Young LLP as the Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026, as more particularly described in the accompanying Proxy Statement.AUDIT-RELATEDISSUER44918.0000000FOR44918.000000FORS000064727Bain Capital Specialty Finance, Inc.05684B107US05684B107005/21/2026To elect three Class I Directors of the Company who will serve for a three-year term expiring at the Company's 2029 annual meeting of stockholders or until their respective successor is duly elected and qualified: Amy ButteDIRECTOR ELECTIONSISSUER32899.00000010500.000000AGAINST32899.000000AGAINSTS000064727Bain Capital Specialty Finance, Inc.05684B107US05684B107005/21/2026To elect three Class I Directors of the Company who will serve for a three-year term expiring at the Company's 2029 annual meeting of stockholders or until their respective successor is duly elected and qualified: Thomas A. HoughDIRECTOR ELECTIONSISSUER32899.00000010500.000000FOR32899.000000FORS000064727Bain Capital Specialty Finance, Inc.05684B107US05684B107005/21/2026To elect three Class I Directors of the Company who will serve for a three-year term expiring at the Company's 2029 annual meeting of stockholders or until their respective successor is duly elected and qualified: Clare S. RicherDIRECTOR ELECTIONSISSUER32899.00000010500.000000FOR32899.000000FORS000064727Bain Capital Specialty Finance, Inc.05684B107US05684B107005/21/2026To ratify the selection of PricewaterhouseCoopers LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER32899.00000010500.000000FOR32899.000000FORS000064727Nuveen Churchill Direct Lending Corp.67090S108US67090S108705/21/2026The election of the following persons as directors, who will each serve as a director of Nuveen Churchill Direct Lending Corp. 's board of directors until 2029, or until their respective successor is duly elected and qualified. Class III directors (term ending at the Annual Meeting): Kenneth KencelDIRECTOR ELECTIONSISSUER28533.00000029.000000FOR28533.000000FORS000064727Nuveen Churchill Direct Lending Corp.67090S108US67090S108705/21/2026The election of the following persons as directors, who will each serve as a director of Nuveen Churchill Direct Lending Corp. 's board of directors until 2029, or until their respective successor is duly elected and qualified. Class III directors (term ending at the Annual Meeting): Stephen PotterDIRECTOR ELECTIONSISSUER28533.00000029.000000WITHHOLD28533.000000AGAINSTS000064727Sixth Street Specialty Lending, Inc.83012A109US83012A109705/21/2026Election of Directors: Hurley DoddyDIRECTOR ELECTIONSISSUER3115.00000023514.000000FOR3115.000000FORS000064727Sixth Street Specialty Lending, Inc.83012A109US83012A109705/21/2026Election of Directors: Michael FishmanDIRECTOR ELECTIONSISSUER3115.00000023514.000000FOR3115.000000FORS000064727Sixth Street Specialty Lending, Inc.83012A109US83012A109705/21/2026Election of Directors: Robert StanleyDIRECTOR ELECTIONSISSUER3115.00000023514.000000FOR3115.000000FORS000064727Sixth Street Specialty Lending, Inc.83012A109US83012A109705/21/2026To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER3115.00000023514.000000FOR3115.000000FORS000064727BlackRock TCP Capital Corp.09259E108US09259E108205/27/2026To elect all six Director nominees to the Board of Directors of the Company to serve until the 2027 Annual Meeting of Stockholders of the Company, or until his or her successor is duly elected and qualifies: John R. BaronDIRECTOR ELECTIONSISSUER237415.0000009900.000000FOR237415.000000FORS000064727BlackRock TCP Capital Corp.09259E108US09259E108205/27/2026To elect all six Director nominees to the Board of Directors of the Company to serve until the 2027 Annual Meeting of Stockholders of the Company, or until his or her successor is duly elected and qualifies: Eric J. DrautDIRECTOR ELECTIONSISSUER237415.0000009900.000000FOR237415.000000FORS000064727BlackRock TCP Capital Corp.09259E108US09259E108205/27/2026To elect all six Director nominees to the Board of Directors of the Company to serve until the 2027 Annual Meeting of Stockholders of the Company, or until his or her successor is duly elected and qualifies: Karen L. LeetsDIRECTOR ELECTIONSISSUER237415.0000009900.000000FOR237415.000000FORS000064727BlackRock TCP Capital Corp.09259E108US09259E108205/27/2026To elect all six Director nominees to the Board of Directors of the Company to serve until the 2027 Annual Meeting of Stockholders of the Company, or until his or her successor is duly elected and qualifies: Andrea L. PetroDIRECTOR ELECTIONSISSUER237415.0000009900.000000FOR237415.000000FORS000064727BlackRock TCP Capital Corp.09259E108US09259E108205/27/2026To elect all six Director nominees to the Board of Directors of the Company to serve until the 2027 Annual Meeting of Stockholders of the Company, or until his or her successor is duly elected and qualifies: Maureen K. UsiferDIRECTOR ELECTIONSISSUER237415.0000009900.000000FOR237415.000000FORS000064727BlackRock TCP Capital Corp.09259E108US09259E108205/27/2026To elect all six Director nominees to the Board of Directors of the Company to serve until the 2027 Annual Meeting of Stockholders of the Company, or until his or her successor is duly elected and qualifies: Philip TsengDIRECTOR ELECTIONSISSUER237415.0000009900.000000FOR237415.000000FORS000064727Goldman Sachs BDC, Inc.38147U107US38147U107905/27/2026To elect two Class III directors of the Company, who will serve until the 2029 annual meeting of stockholders or until his or her successor is duly elected and qualified: Timothy J. LeachDIRECTOR ELECTIONSISSUER1.00000088737.000000FOR1.000000FORS000064727Goldman Sachs BDC, Inc.38147U107US38147U107905/27/2026To elect two Class III directors of the Company, who will serve until the 2029 annual meeting of stockholders or until his or her successor is duly elected and qualified: Kaysie UniackeDIRECTOR ELECTIONSISSUER1.00000088737.000000FOR1.000000FORS000064727Goldman Sachs BDC, Inc.38147U107US38147U107905/27/2026To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1.00000088737.000000FOR1.000000FORS000064727Morgan Stanley Direct Lending Fund61774A103US61774A103406/01/2026To elect two Directors of the Company, each to serve for a three-year term until his successor has been elected and qualified or until his earlier resignation, removal, death or incapacity: David N. MillerDIRECTOR ELECTIONSISSUER28899.0000000FOR28899.000000FORS000064727Morgan Stanley Direct Lending Fund61774A103US61774A103406/01/2026To elect two Directors of the Company, each to serve for a three-year term until his successor has been elected and qualified or until his earlier resignation, removal, death or incapacity: Kevin ShannonDIRECTOR ELECTIONSISSUER28899.0000000AGAINST28899.000000AGAINSTS000064727Morgan Stanley Direct Lending Fund61774A103US61774A103406/01/2026To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER28899.0000000FOR28899.000000FORS000064727Ares Dynamic Credit Allocation Fund, Inc.04014F102US04014F102106/04/2026To consider and vote upon the election of one Class I director, to serve for a term expiring on the date on which the Annual Meeting of Stockholders is held in 2029 and until his successor is duly elected and qualifies: Jeffrey PerlowitzDIRECTOR ELECTIONSISSUER34335.0000000FOR34335.000000FORS000064727Carlyle Secured Lending, Inc.872280102US872280102906/09/2026To approve a proposal to authorize the Company, with the approval of the Company's Board of Directors, to sell or otherwise issue shares of the Company's common stock, during the next 12 months following stockholder approval, at a price below the then-current net asset value per share, subject to certain limitations described in the proxy statement.CAPITAL STRUCTUREISSUER52318.0000004600.000000FOR52318.000000FORS000064727Carlyle Secured Lending, Inc.872280102US872280102906/09/2026Election of Directors - To elect two Class I directors, to serve for a three-year term, until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal: Linda Pace (Class I Nominee)DIRECTOR ELECTIONSISSUER52318.0000004600.000000FOR52318.000000FORS000064727Carlyle Secured Lending, Inc.872280102US872280102906/09/2026Election of Directors - To elect two Class I directors, to serve for a three-year term, until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal: William H. Wright II (Class I Nominee)DIRECTOR ELECTIONSISSUER52318.0000004600.000000WITHHOLD52318.000000AGAINSTS000064727Carlyle Secured Lending, Inc.872280102US872280102906/09/2026To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER52318.0000004600.000000FOR52318.000000FORS000064727OFS Capital Corporation67103B100US67103B100806/10/2026The election of the following two persons (except as marked to the contrary) as directors who will serve as Class II directors of OFS Capital Corporation until 2029, or until their successors are elected and qualified. Nominees: Class II Directors: Romita ShettyDIRECTOR ELECTIONSISSUER94652.0000000FOR94652.000000FORS000064727OFS Capital Corporation67103B100US67103B100806/10/2026The election of the following two persons (except as marked to the contrary) as directors who will serve as Class II directors of OFS Capital Corporation until 2029, or until their successors are elected and qualified. Nominees: Class II Directors: Bilal RashidDIRECTOR ELECTIONSISSUER94652.0000000FOR94652.000000FORS000064727OFS Capital Corporation67103B100US67103B100806/10/2026The ratification of the selection of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER94652.0000000FOR94652.000000FORS000064727Stellus Capital Investment Corporation858568108US858568108806/16/2026To elect one director of the Company nominated by the Company's Board of Directors and named in this proxy statement who will serve for three years or until his successor is elected and qualified: Bruce R. BilgerDIRECTOR ELECTIONSISSUER61973.0000000WITHHOLD61973.000000AGAINSTS000064727Stellus Capital Investment Corporation858568108US858568108806/16/2026To approve a new investment advisory agreement between the Company and Stellus Capital Management, LLC;INVESTMENT COMPANY MATTERSISSUER61973.0000000FOR61973.000000FORS000064727Stellus Capital Investment Corporation858568108US858568108806/16/2026To approve the adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies; andCORPORATE GOVERNANCEISSUER61973.0000000AGAINST61973.000000AGAINSTS000064727Hercules Capital, Inc.427096508US427096508406/18/2026Election of an independent director: Robert P. BadavasDIRECTOR ELECTIONSISSUER35399.0000000AGAINST35399.000000AGAINSTS000064727Hercules Capital, Inc.427096508US427096508406/18/2026Advisory vote to approve the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER35399.0000000FOR35399.000000FORS000064727Hercules Capital, Inc.427096508US427096508406/18/2026Advisory vote to approve the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER35399.0000000FOR35399.000000FOR4S000064727Hercules Capital, Inc.427096508US427096508406/18/2026Advisory vote on the frequency of the advisory vote to approve the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER35399.0000000ONE YEAR35399.000000FORS000064727Hercules Capital, Inc.427096508US427096508406/18/2026Advisory vote on the frequency of the advisory vote to approve the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER35399.0000000ONE YEAR35399.000000FOR4S000064727Hercules Capital, Inc.427096508US427096508406/18/2026Approval of the amendment and restatement of the Hercules Capital, Inc. Amended and Restated 2018 Equity Incentive Plan.COMPENSATIONISSUER35399.0000000FOR35399.000000FORS000064727Hercules Capital, Inc.427096508US427096508406/18/2026Approval of the amendment and restatement of the Hercules Capital, Inc. 2018 Non-Employee Director Plan.COMPENSATIONISSUER35399.0000000FOR35399.000000FORS000064727Hercules Capital, Inc.427096508US427096508406/18/2026Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER35399.0000000FOR35399.000000FORS000064727MidCap Financial Investment Corporation03761U502US03761U502006/18/2026Election of Directors: Emanuel PearlmanDIRECTOR ELECTIONSISSUER259.00000047800.000000WITHHOLD259.000000AGAINSTS000064727MidCap Financial Investment Corporation03761U502US03761U502006/18/2026Election of Directors: Tanner PowellDIRECTOR ELECTIONSISSUER259.00000047800.000000FOR259.000000FORS000064727MidCap Financial Investment Corporation03761U502US03761U502006/18/2026To ratify the selection of Deloitte & Touche LLP as MidCap Financial Investment Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER259.00000047800.000000FOR259.000000FORS000064727Sixth Street Specialty Lending, Inc.83012A109US83012A109706/18/2026To approve a proposal to authorize the Company to sell or otherwise issue shares of its common stock at a price below its then-current net asset value per share in one or more offerings, in each case subject to the approval of its Board of Directors and subject to the conditions set forth in the accompanying proxy statement.CAPITAL STRUCTUREISSUER3115.00000023514.000000FOR3115.000000FORS000064727Runway Growth Finance Corp.78163D100US78163D100006/23/2026To elect two Class I directors who will each serve for a term of three years and until their successors are elected and qualified: Alexander DukaDIRECTOR ELECTIONSISSUER13606.00000070700.000000WITHHOLD13606.000000AGAINSTS000064727Runway Growth Finance Corp.78163D100US78163D100006/23/2026To elect two Class I directors who will each serve for a term of three years and until their successors are elected and qualified: Gary KovacsDIRECTOR ELECTIONSISSUER13606.00000070700.000000WITHHOLD13606.000000AGAINSTS000064727Runway Growth Finance Corp.78163D100US78163D100006/23/2026To ratify the selection of Deloitte & Touche LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER13606.00000070700.000000AGAINST13606.000000AGAINSTS000064727Fidus Investment Corporation316500107US316500107006/24/2026The election for each of the Class III Directors until the 2029 annual meeting of stockholders or their respective successor has been duly elected and qualified: Edward H. RossDIRECTOR ELECTIONSISSUER28443.0000002000.000000FOR28443.000000FORS000064727Fidus Investment Corporation316500107US316500107006/24/2026The election for each of the Class III Directors until the 2029 annual meeting of stockholders or their respective successor has been duly elected and qualified: Raymond L. Anstiss, Jr.DIRECTOR ELECTIONSISSUER28443.0000002000.000000WITHHOLD28443.000000AGAINSTS000064727Fidus Investment Corporation316500107US316500107006/24/2026To authorize the Company, subject to the approval of the Company's Board of Directors, to sell or otherwise issue shares of its common stock during the next year at a price below the Company's then current net asset value per share, subject to certain conditions as set forth in the proxy statement (including that the cumulative number of shares sold pursuant to such authority does not exceed 25% of its then outstanding common stock immediately prior to each such sale).CAPITAL STRUCTUREISSUER28443.0000002000.000000FOR28443.000000FORS000064727BCP Investment Corporation73688F201US73688F201106/25/2026To elect as directors three nominees, each for a term of three years and until his or her successor is duly elected and qualified: Jennifer Kwon ChouDIRECTOR ELECTIONSISSUER28578.0000000FOR28578.000000FORS000064727BCP Investment Corporation73688F201US73688F201106/25/2026To elect as directors three nominees, each for a term of three years and until his or her successor is duly elected and qualified: Joseph MoreaDIRECTOR ELECTIONSISSUER28578.0000000FOR28578.000000FORS000064727BCP Investment Corporation73688F201US73688F201106/25/2026To elect as directors three nominees, each for a term of three years and until his or her successor is duly elected and qualified: Robert WarshauerDIRECTOR ELECTIONSISSUER28578.0000000FOR28578.000000FORS000064727BCP Investment Corporation73688F201US73688F201106/25/2026To ratify the selection of Deloitte & Touche LLP as the independent registered public accountant of the Company for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER28578.0000000FOR28578.000000FORS000064727CION Investment Corporation17259U204US17259U204206/25/2026To elect two directors of the Company, who will each serve for a term of three years expiring in 2029, or until their successors are duly elected and qualified (the "Class II Director Proposal"): Robert A. BreakstoneDIRECTOR ELECTIONSISSUER77829.0000000WITHHOLD77829.000000AGAINSTS000064727CION Investment Corporation17259U204US17259U204206/25/2026To elect two directors of the Company, who will each serve for a term of three years expiring in 2029, or until their successors are duly elected and qualified (the "Class II Director Proposal"): Catherine K. ChoiDIRECTOR ELECTIONSISSUER77829.0000000WITHHOLD77829.000000AGAINSTS000064727CION Investment Corporation17259U204US17259U204206/25/2026To ratify the selection of RSM US LLP to serve as the Company's independent registered public accounting firm for the year ending December 31, 2026 (the "Auditors Proposal").AUDIT-RELATEDISSUER77829.0000000FOR77829.000000FORS000064727First Trust Senior Floating Rate Income Fund II33740U257US33740U257406/25/2026Approve Reorganization of Funds between First Trust Senior Floating Rate Income Fund II and First Trust Exchange-Traded Fund VIII, on behalf of First Trust Flexible Income ETFINVESTMENT COMPANY MATTERSISSUER67293.0000000FOR67293.000000FORS000064727Horizon Technology Finance Corporation44045A102US44045A102506/26/2026Election of Directors: Kimberley A. O'ConnorDIRECTOR ELECTIONSISSUER120885.00000055693.000000WITHHOLD120885.000000AGAINSTS000064727Horizon Technology Finance Corporation44045A102US44045A102506/26/2026Election of Directors: Thomas J. AllisonDIRECTOR ELECTIONSISSUER120885.00000055693.000000FOR120885.000000FORS000064727Horizon Technology Finance Corporation44045A102US44045A102506/26/2026To ratify the selection of Grant Thornton LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER120885.00000055693.000000FOR120885.000000FORS000064727National Grid Plc636274409US636274409507/09/2025Accept Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Approve Final DividendCAPITAL STRUCTUREISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Re-elect Paula Reynolds as DirectorDIRECTOR ELECTIONSISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Re-elect John Pettigrew as DirectorDIRECTOR ELECTIONSISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Re-elect Andy Agg as DirectorDIRECTOR ELECTIONSISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Re-elect Jacqui Ferguson as DirectorDIRECTOR ELECTIONSISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Re-elect Ian Livingston as DirectorDIRECTOR ELECTIONSISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Re-elect Iain Mackay as DirectorDIRECTOR ELECTIONSISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Re-elect Anne Robinson as DirectorDIRECTOR ELECTIONSISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Re-elect Earl Shipp as DirectorDIRECTOR ELECTIONSISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Re-elect Jonathan Silver as DirectorDIRECTOR ELECTIONSISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Re-elect Tony Wood as DirectorDIRECTOR ELECTIONSISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Re-elect Martha Wyrsch as DirectorDIRECTOR ELECTIONSISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Reappoint Deloitte LLP as AuditorsAUDIT-RELATEDISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Authorise the Audit & Risk Committee to Fix Remuneration of AuditorsAUDIT-RELATEDISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Approve Remuneration PolicyCOMPENSATIONISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Approve Remuneration ReportCOMPENSATIONISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Authorise UK Political Donations and ExpenditureOTHER SOCIAL ISSUESISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Approve Increase in Borrowing LimitCAPITAL STRUCTUREOTHERDebt RelatedISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Approve Scrip Dividend SchemeCAPITAL STRUCTUREISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Authorise Directors to Capitalise the Appropriate Nominal Amounts of New Shares of the Company Allotted Pursuant to the Company's Scrip Dividend SchemeCAPITAL STRUCTUREISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Authorise Issue of EquityCAPITAL STRUCTUREISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Authorise Issue of Equity without Pre-emptive RightsCAPITAL STRUCTUREISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital InvestmentCAPITAL STRUCTUREISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Authorise Market Purchase of Ordinary SharesCAPITAL STRUCTUREISSUER1.0000002465.000000FOR1.000000FORS000064728National Grid Plc636274409US636274409507/09/2025Authorise the Company to Call General Meeting with Two Weeks' NoticeCORPORATE GOVERNANCEISSUER1.0000002465.000000FOR1.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/22/2025Election of Directors: Dr. Bobbie ByrneDIRECTOR ELECTIONSISSUER9911.0000000FOR9911.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/22/2025Election of Directors: Christine M. CournoyerDIRECTOR ELECTIONSISSUER9911.0000000FOR9911.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/22/2025Election of Directors: Randy HyunDIRECTOR ELECTIONSISSUER9911.0000000FOR9911.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/22/2025Election of Directors: Vincent D. KellyDIRECTOR ELECTIONSISSUER9911.0000000FOR9911.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/22/2025Election of Directors: Brett ShockleyDIRECTOR ELECTIONSISSUER9911.0000000FOR9911.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/22/2025Election of Directors: Todd SteinDIRECTOR ELECTIONSISSUER9911.0000000FOR9911.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/22/2025Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER9911.0000000FOR9911.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/22/2025Advisory vote to approve named executive officer compensation for 2024.SECTION 14A SAY-ON-PAY VOTESISSUER9911.0000000FOR9911.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/22/2025Advisory vote to approve named executive officer compensation for 2024.SECTION 14A SAY-ON-PAY VOTESISSUER9911.0000000FOR9911.000000FOR4S000064728GeoPark LimitedG38327105BMG38327105008/06/2025Elect Director Sylvia Escovar GomezDIRECTOR ELECTIONSISSUER6576.00000013770.000000FOR6576.000000FORS000064728GeoPark LimitedG38327105BMG38327105008/06/2025Elect Director James F. ParkDIRECTOR ELECTIONSISSUER6576.00000013770.000000FOR6576.000000FORS000064728GeoPark LimitedG38327105BMG38327105008/06/2025Elect Director Robert A. BedingfieldDIRECTOR ELECTIONSISSUER6576.00000013770.000000FOR6576.000000FORS000064728GeoPark LimitedG38327105BMG38327105008/06/2025Elect Director Brian F. MaxtedDIRECTOR ELECTIONSISSUER6576.00000013770.000000FOR6576.000000FORS000064728GeoPark LimitedG38327105BMG38327105008/06/2025Elect Director Carlos E. MacellariDIRECTOR ELECTIONSISSUER6576.00000013770.000000FOR6576.000000FORS000064728GeoPark LimitedG38327105BMG38327105008/06/2025Elect Director Constantin PapadimitriouDIRECTOR ELECTIONSISSUER6576.00000013770.000000FOR6576.000000FORS000064728GeoPark LimitedG38327105BMG38327105008/06/2025Elect Director Marcela Vaca TorresDIRECTOR ELECTIONSISSUER6576.00000013770.000000FOR6576.000000FORS000064728GeoPark LimitedG38327105BMG38327105008/06/2025Elect Director Somit VarmaDIRECTOR ELECTIONSISSUER6576.00000013770.000000FOR6576.000000FORS000064728GeoPark LimitedG38327105BMG38327105008/06/2025Elect Director Felipe BayonDIRECTOR ELECTIONSISSUER6576.00000013770.000000FOR6576.000000FORS000064728GeoPark LimitedG38327105BMG38327105008/06/2025Ratify Ernst & Young Audit S.A.S. as AuditorsAUDIT-RELATEDISSUER6576.00000013770.000000FOR6576.000000FORS000064728GeoPark LimitedG38327105BMG38327105008/06/2025Authorise the Audit Committee to Fix Remuneration of AuditorsAUDIT-RELATEDISSUER6576.00000013770.000000FOR6576.000000FORS000064728Cosan SA22113B103US22113B103510/23/2025Approve Increase in Authorized Capital and Amend Article 6 AccordinglyCAPITAL STRUCTUREISSUER4731.00000032400.000000FOR4731.000000FORS000064728Cosan SA22113B103US22113B103510/23/2025Waive Mandatory Offer RequirementSHAREHOLDER RIGHTS AND DEFENSESISSUER4731.00000032400.000000FOR4731.000000FORS000064728Cosan SA22113B103US22113B103510/23/2025Authorize Executives to Ratify and Execute Approved ResolutionsCORPORATE GOVERNANCEISSUER4731.00000032400.000000FOR4731.000000FORS000064728Cosan SA22113B103US22113B103510/23/2025Consolidate BylawsCORPORATE GOVERNANCEISSUER4731.00000032400.000000FOR4731.000000FORS000064728Ecopetrol SA279158109US279158109111/11/2025Approve Meeting AgendaCORPORATE GOVERNANCEISSUER16.00000019147.000000FOR16.000000FORS000064728Ecopetrol SA279158109US279158109111/11/2025Elect Chairman of MeetingCORPORATE GOVERNANCEISSUER16.00000019147.000000FOR16.000000FORS000064728Ecopetrol SA279158109US279158109111/11/2025Appoint Committee in Charge of Scrutinizing Elections and PollingCORPORATE GOVERNANCEISSUER16.00000019147.000000FOR16.000000FORS000064728Ecopetrol SA279158109US279158109111/11/2025Elect Meeting Approval CommitteeCORPORATE GOVERNANCEISSUER16.00000019147.000000FOR16.000000FORS000064728Ecopetrol SA279158109US279158109111/11/2025Amend ArticlesCORPORATE GOVERNANCEISSUER16.00000019147.000000AGAINST16.000000AGAINSTS000064728Berry Corporation (bry)08579X101US08579X101912/15/2025The Merger Agreement Proposal: To adopt the Agreement and Plan of Merger, dated September 14, 2025, by and among California Resources Corporation ("CRC"), Dornoch Merger Sub, LLC ("Merger Sub"), and Berry Corporation (bry) ("Berry") (as it may be amended from time to time), providing for the merger of Merger Sub with and into Berry, with Berry surviving as a direct, wholly-owned subsidiary of CRC (the "Merger").EXTRAORDINARY TRANSACTIONSISSUER44499.0000000FOR44499.000000FORS000064728Berry Corporation (bry)08579X101US08579X101912/15/2025The Advisory Compensation Proposal: To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Berry's named executive officers that is based on or otherwise relates to the Merger.SECTION 14A SAY-ON-PAY VOTESISSUER44499.0000000FOR44499.000000FORS000064728Berry Corporation (bry)08579X101US08579X101912/15/2025The Advisory Compensation Proposal: To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Berry's named executive officers that is based on or otherwise relates to the Merger.SECTION 14A SAY-ON-PAY VOTESISSUER44499.0000000FOR44499.000000FOR4S000064728Berry Corporation (bry)08579X101US08579X101912/15/2025The Adjournment Proposal: To approve one or more adjournments of the special meeting of the stockholders of Berry, if necessary or appropriate, to permit solicitation of additional votes or proxies if there are not sufficient votes to approve the Merger Agreement Proposal.CORPORATE GOVERNANCEISSUER44499.0000000FOR44499.000000FORS000064728Ituran Location & Control Ltd.M6158M104IL001081868512/16/2025Appoint Fahn Kanne & co. as AuditorsAUDIT-RELATEDISSUER4849.0000000FOR4849.000000FORS000064728Ituran Location & Control Ltd.M6158M104IL001081868512/16/2025Reelect Eyal Sheratzky as DirectorDIRECTOR ELECTIONSISSUER4849.0000000FOR4849.000000FORS000064728Ituran Location & Control Ltd.M6158M104IL001081868512/16/2025Reelect Efraim Sheratzky as DirectorDIRECTOR ELECTIONSISSUER4849.0000000FOR4849.000000FORS000064728Ituran Location & Control Ltd.M6158M104IL001081868512/16/2025Reelect Tal Sheratzky-Jaffa as DirectorDIRECTOR ELECTIONSISSUER4849.0000000FOR4849.000000FORS000064728Ituran Location & Control Ltd.M6158M104IL001081868512/16/2025Reelect Yoav Kahane as DirectorDIRECTOR ELECTIONSISSUER4849.0000000FOR4849.000000FORS000064728Ituran Location & Control Ltd.M6158M104IL001081868512/16/2025Approve Renewal Compensation Policy for the Directors and Officers of the CompanyCOMPENSATIONISSUER4849.0000000FOR4849.000000FORS000064728Ituran Location & Control Ltd.M6158M104IL001081868512/16/2025Reelect Riki Segev as External DirectorDIRECTOR ELECTIONSISSUER4849.0000000FOR4849.000000FORS000064728Ituran Location & Control Ltd.M6158M104IL001081868512/16/2025Vote FOR if you are a controlling shareholder or have a personal interest in one or several resolutions, as indicated in the proxy card; otherwise, vote AGAINST. You may not abstain. If you vote FOR, please provide an explanation to your account managerOTHERProcedural matterISSUER4849.0000000AGAINST4849.000000NONES000064728Permian Basin Royalty Trust714236106US714236106912/16/2025Approval of SoftVest Advisors, LLC or another appropriate party taking all appropriate actions to effect the judicial reformation or modification of the Permian Basin Royalty Trust Indenture dated November 1, 1980, as later restated and amended (the "Trust Indenture") to allow for the approval of any amendment to the Trust Indenture by a simple majority of votes cast by Unitholders at a special meeting at which a quorum is present.CORPORATE GOVERNANCESECURITY HOLDER5197.0000004400.000000FOR5197.000000NONES000064728Permian Basin Royalty Trust714236106US714236106912/16/2025Approval of the adjournment of the Special Meeting, if necessary or appropriate, to permit solicitation of additional proxies in favor of the above proposal.CORPORATE GOVERNANCEISSUER5197.0000004400.000000FOR5197.000000NONES000064728New Jersey Resources Corporation646025106US646025106801/21/2026Election of the following five Directors that were named in the Proxy Statement; each for a term expiring in 2029: Jane M. KennyDIRECTOR ELECTIONSISSUER3708.0000000FOR3708.000000FORS000064728New Jersey Resources Corporation646025106US646025106801/21/2026Election of the following five Directors that were named in the Proxy Statement; each for a term expiring in 2029: Amy B. MansueDIRECTOR ELECTIONSISSUER3708.0000000FOR3708.000000FORS000064728New Jersey Resources Corporation646025106US646025106801/21/2026Election of the following five Directors that were named in the Proxy Statement; each for a term expiring in 2029: Sharon C. TaylorDIRECTOR ELECTIONSISSUER3708.0000000FOR3708.000000FORS000064728New Jersey Resources Corporation646025106US646025106801/21/2026Election of the following five Directors that were named in the Proxy Statement; each for a term expiring in 2029: Stephen D. WesthovenDIRECTOR ELECTIONSISSUER3708.0000000FOR3708.000000FORS000064728New Jersey Resources Corporation646025106US646025106801/21/2026Election of the following five Directors that were named in the Proxy Statement; each for a term expiring in 2029: William T. YardleyDIRECTOR ELECTIONSISSUER3708.0000000FOR3708.000000FORS000064728New Jersey Resources Corporation646025106US646025106801/21/2026To approve a non-binding advisory resolution approving the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3708.0000000FOR3708.000000FORS000064728New Jersey Resources Corporation646025106US646025106801/21/2026To approve a non-binding advisory resolution approving the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3708.0000000FOR3708.000000FOR4S000064728New Jersey Resources Corporation646025106US646025106801/21/2026To approve the 2026 Stock Award and Incentive Plan.COMPENSATIONISSUER3708.0000000FOR3708.000000FORS000064728New Jersey Resources Corporation646025106US646025106801/21/2026To ratify the appointment by the Audit Committee of Deloitte & Touche LLP as our independent registered public accounting firm of the fiscal year ending September 30, 2026.AUDIT-RELATEDISSUER3708.0000000FOR3708.000000FORS000064728Civitas Resources, Inc.17888H103US17888H103201/27/2026To adopt the Agreement and Plan of Merger, dated as of November 2, 2025, by and among SM Energy Company, a Delaware corporation ("SM Energy"), Cars Merger Sub, Inc., a Delaware corporation and direct wholly owned subsidiary of SM Energy, and Civitas Resources, Inc. ("Civitas"), as it may be amended from time to time, a copy of which is included as Annex A to the joint proxy statement/prospectus; andEXTRAORDINARY TRANSACTIONSISSUER5296.0000000FOR5296.000000FORS000064728Civitas Resources, Inc.17888H103US17888H103201/27/2026To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Civitas' named executive officers in connection with the mergers (as defined in the joint proxy statement/prospectus).SECTION 14A SAY-ON-PAY VOTESISSUER5296.0000000FOR5296.000000FORS000064728Civitas Resources, Inc.17888H103US17888H103201/27/2026To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Civitas' named executive officers in connection with the mergers (as defined in the joint proxy statement/prospectus).SECTION 14A SAY-ON-PAY VOTESISSUER5296.0000000FOR5296.000000FOR4S000064728Cabot Corporation127055101US127055101303/12/2026Election of Directors: Sean D. KeohaneDIRECTOR ELECTIONSISSUER2475.0000000FOR2475.000000FORS000064728Cabot Corporation127055101US127055101303/12/2026Election of Directors: Raffiq NathooDIRECTOR ELECTIONSISSUER2475.0000000FOR2475.000000FORS000064728Cabot Corporation127055101US127055101303/12/2026Election of Directors: Thierry VanlanckerDIRECTOR ELECTIONSISSUER2475.0000000FOR2475.000000FORS000064728Cabot Corporation127055101US127055101303/12/2026To approve, in an advisory vote, Cabot's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2475.0000000FOR2475.000000FORS000064728Cabot Corporation127055101US127055101303/12/2026To approve, in an advisory vote, Cabot's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2475.0000000FOR2475.000000FOR4S000064728Cabot Corporation127055101US127055101303/12/2026To ratify the appointment of Deloitte & Touche LLP as Cabot's independent registered public accounting firm for the fiscal year ending September 30, 2026.AUDIT-RELATEDISSUER2475.0000000FOR2475.000000FORS000064728Ituran Location & Control Ltd.M6158M104IL001081868503/31/2026Approve Amended Compensation Policy for the Directors and Officers of the CompanyCOMPENSATIONISSUER3735.0000000FOR3735.000000FORS000064728Ituran Location & Control Ltd.M6158M104IL001081868503/31/2026Vote FOR if you are a controlling shareholder or have a personal interest in one or several resolutions, as indicated in the proxy card; otherwise, vote AGAINST. You may not abstain. If you vote FOR, please provide an explanation to your account managerOTHERProcedural matterISSUER3735.0000000AGAINST3735.000000NONES000064728KT Corp.48268K101US48268K101603/31/2026Approve Financial Statements and Allocation of IncomeCAPITAL STRUCTURECORPORATE GOVERNANCEISSUER8891.0000000FOR8891.000000FORS000064728KT Corp.48268K101US48268K101603/31/2026Amend Articles of Incorporation (Business Objectives)CORPORATE GOVERNANCEISSUER8891.0000000FOR8891.000000FORS000064728KT Corp.48268K101US48268K101603/31/2026Amend Articles of Incorporation (Public Notice)CORPORATE GOVERNANCEISSUER8891.0000000FOR8891.000000FORS000064728KT Corp.48268K101US48268K101603/31/2026Amend Articles of Incorporation (Fiduciary Duty)CORPORATE GOVERNANCEISSUER8891.0000000FOR8891.000000FORS000064728KT Corp.48268K101US48268K101603/31/2026Amend Articles of Incorporation (Director Title Change)CORPORATE GOVERNANCEISSUER8891.0000000FOR8891.000000FORS000064728KT Corp.48268K101US48268K101603/31/2026Amend Articles of Incorporation (Electronic Shareholder Meeting)CORPORATE GOVERNANCEISSUER8891.0000000FOR8891.000000FORS000064728KT Corp.48268K101US48268K101603/31/2026Amend Articles of Incorporation (Separate Election of Audit Committee Member)CORPORATE GOVERNANCEISSUER8891.0000000FOR8891.000000FORS000064728KT Corp.48268K101US48268K101603/31/2026Amend Articles of Incorporation (Treasury Shares)CORPORATE GOVERNANCEISSUER8891.0000000FOR8891.000000FORS000064728KT Corp.48268K101US48268K101603/31/2026Amend Articles of IncorporationCORPORATE GOVERNANCEISSUER8891.0000000FOR8891.000000FORS000064728KT Corp.48268K101US48268K101603/31/2026Elect Kim Young-han as Outside DirectorDIRECTOR ELECTIONSISSUER8891.0000000FOR8891.000000FORS000064728KT Corp.48268K101US48268K101603/31/2026Elect Kwon Myeong-suk as Outside Director to Serve as an Audit Committee MemberDIRECTOR ELECTIONSISSUER8891.0000000FOR8891.000000FORS000064728KT Corp.48268K101US48268K101603/31/2026Elect Seo Jin-seok as Outside Director to Serve as an Audit Committee MemberDIRECTOR ELECTIONSISSUER8891.0000000FOR8891.000000FORS000064728KT Corp.48268K101US48268K101603/31/2026Approve Total Remuneration of Inside Directors and Outside DirectorsCOMPENSATIONISSUER8891.0000000FOR8891.000000FORS000064728KT Corp.48268K101US48268K101603/31/2026Approval of the Plan for Holding and Disposition of Treasury SharesOTHERCompany-specific matterISSUER8891.0000000FOR8891.000000FORS000064728KT Corp.48268K101US48268K101603/31/2026Elect Park Yoon-young as CEODIRECTOR ELECTIONSISSUER8891.0000000FOR8891.000000FORS000064728KT Corp.48268K101US48268K101603/31/2026Elect Park Hyeon-jin as Inside DirectorDIRECTOR ELECTIONSISSUER8891.0000000FOR8891.000000FORS000064728KT Corp.48268K101US48268K101603/31/2026Approve Management ContractOTHERCompany-specific matterISSUER8891.0000000FOR8891.000000FORS000064728TIM SA88706T108US88706T108803/31/2026Accept Financial Statements and Statutory Reports for Fiscal Year Ended Dec. 31, 2025CORPORATE GOVERNANCEISSUER8106.0000000FOR8106.000000FORS000064728TIM SA88706T108US88706T108803/31/2026Approve Allocation of Income and DividendsCAPITAL STRUCTUREISSUER8106.0000000FOR8106.000000FORS000064728TIM SA88706T108US88706T108803/31/2026Approve Classification of Denisio Augusto Liberato Delfino as Independent DirectorDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER8106.0000000FOR8106.000000FORS000064728TIM SA88706T108US88706T108803/31/2026Ratify Denisio Augusto Liberato Delfino as Independent Director and Camillo Greco as DirectorDIRECTOR ELECTIONSISSUER8106.0000000AGAINST8106.000000AGAINSTS000064728TIM SA88706T108US88706T108803/31/2026Fix Number of Fiscal Council Members at ThreeCORPORATE GOVERNANCEISSUER8106.0000000FOR8106.000000FORS000064728TIM SA88706T108US88706T108803/31/2026Elect Fiscal Council MembersCOMPENSATIONCORPORATE GOVERNANCEISSUER8106.0000000FOR8106.000000FORS000064728TIM SA88706T108US88706T108803/31/2026Approve Remuneration of Company's Management, Committees' Members, and Fiscal CouncilCOMPENSATIONISSUER8106.0000000AGAINST8106.000000AGAINSTS000064728TIM SA88706T108US88706T108803/31/2026Approve Prolonging of Cooperation and Support Agreement between Telecom Italia S.p.A and TIM S.A.CORPORATE GOVERNANCEISSUER8106.0000000FOR8106.000000FORS000064728TIM SA88706T108US88706T108803/31/2026Amend Article 5 to Reflect Changes in CapitalCAPITAL STRUCTURECORPORATE GOVERNANCEISSUER8106.0000000FOR8106.000000FORS000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/01/2026Approve Listing of Company Shares on Novo Mercado Segment of B3CAPITAL STRUCTUREISSUER18373.0000000FOR18373.000000FORS000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/01/2026Approve Conversion of All Class A1 Preferred Shares (PNA1) into Common Shares at Ratio 1.1 Common Shares for One PNA1CAPITAL STRUCTUREISSUER18373.0000000FOR18373.000000FORS000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/01/2026Approve Conversion of All Class B1 Preferred Shares (PNB1) into Common Shares at Ratio 1.1 Common Shares for One PNB1CAPITAL STRUCTUREISSUER18373.0000000FOR18373.000000FORS000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/01/2026Amend Articles and Consolidate Bylaws (Subject to the Approval and Effectiveness of the Preferred Shares Conversion and to the Prior Consent of ANEEL)CORPORATE GOVERNANCEISSUER18373.0000000FOR18373.000000FORS000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/01/2026Amend Articles and Consolidate Bylaws (Subject to the Approval and Effectiveness of the PNB1 Conversion, the Non-Approval of the PNA1 Conversion at the PNA1 Shareholder's Meeting, and the Prior Consent of ANEEL)CORPORATE GOVERNANCEISSUER18373.0000000FOR18373.000000FORS000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/01/2026Authorize Board to Implement the Listing of Company Shares on Novo Mercado Segment of B3CORPORATE GOVERNANCEISSUER18373.0000000FOR18373.000000FORS000064728SLB Limited806857108AN806857108604/08/2026Election of Directors: Peter ColemanDIRECTOR ELECTIONSISSUER4242.0000000FOR4242.000000FORS000064728SLB Limited806857108AN806857108604/08/2026Election of Directors: Patrick de La ChevardiereDIRECTOR ELECTIONSISSUER4242.0000000FOR4242.000000FORS000064728SLB Limited806857108AN806857108604/08/2026Election of Directors: Miguel GaluccioDIRECTOR ELECTIONSISSUER4242.0000000FOR4242.000000FORS000064728SLB Limited806857108AN806857108604/08/2026Election of Directors: Jim HackettDIRECTOR ELECTIONSISSUER4242.0000000FOR4242.000000FORS000064728SLB Limited806857108AN806857108604/08/2026Election of Directors: Olivier Le PeuchDIRECTOR ELECTIONSISSUER4242.0000000FOR4242.000000FORS000064728SLB Limited806857108AN806857108604/08/2026Election of Directors: Samuel LeupoldDIRECTOR ELECTIONSISSUER4242.0000000FOR4242.000000FORS000064728SLB Limited806857108AN806857108604/08/2026Election of Directors: Maria Moraeus HanssenDIRECTOR ELECTIONSISSUER4242.0000000FOR4242.000000FORS000064728SLB Limited806857108AN806857108604/08/2026Election of Directors: Vanitha NarayananDIRECTOR ELECTIONSISSUER4242.0000000FOR4242.000000FORS000064728SLB Limited806857108AN806857108604/08/2026Election of Directors: Jeff SheetsDIRECTOR ELECTIONSISSUER4242.0000000FOR4242.000000FORS000064728SLB Limited806857108AN806857108604/08/2026Advisory approval of our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER4242.0000000FOR4242.000000FORS000064728SLB Limited806857108AN806857108604/08/2026Advisory approval of our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER4242.0000000FOR4242.000000FOR4S000064728SLB Limited806857108AN806857108604/08/2026Approval of our consolidated balance sheet at December 31, 2025; our consolidated statement of income for the year ended December 31, 2025; and the declarations of dividends by our Board of Directors in 2025, as reflected in our Annual Report on Form 10-K for the fiscal year ended December 31 2025.CAPITAL STRUCTURECORPORATE GOVERNANCEISSUER4242.0000000FOR4242.000000FORS000064728SLB Limited806857108AN806857108604/08/2026Ratification of the appointment of PricewaterhouseCoopers LLP as our independent auditors for 2026.AUDIT-RELATEDISSUER4242.0000000FOR4242.000000FORS000064728SLB Limited806857108AN806857108604/08/2026Approval of an amendment and restatement of the 2017 SLB Omnibus Stock Incentive Plan.COMPENSATIONISSUER4242.0000000FOR4242.000000FORS000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/15/2026Accept Financial Statements and Statutory Reports for Fiscal Year Ended Dec. 31, 2025CORPORATE GOVERNANCEISSUER18373.0000000FOR18373.000000FORS000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/15/2026Approve Allocation of Income and DividendsCAPITAL STRUCTUREISSUER18373.0000000FOR18373.000000FORS000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/15/2026Elect Jose Raimundo dos Santos as Fiscal Council Member and Paulo Roberto Bellentani Brandao as AlternateDIRECTOR ELECTIONSSECURITY HOLDER18373.0000000FOR18373.000000NONES000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/15/2026Elect Cristina Fontes Doherty as Fiscal Council Member and Catia Yuassa Tokoro as AlternateDIRECTOR ELECTIONSSECURITY HOLDER18373.0000000FOR18373.000000NONES000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/15/2026Elect Jose Reinaldo Magalhaes as Fiscal Council Member and Anderson Carlos Koch as AlternateDIRECTOR ELECTIONSSECURITY HOLDER18373.0000000ABSTAIN18373.000000NONES000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/15/2026Elect Carlos Eduardo Teixeira Taveiros as Fiscal Council Member and Rochana Grossi Freire as AlternateDIRECTOR ELECTIONSSECURITY HOLDER18373.0000000FOR18373.000000NONES000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/15/2026Approve Remuneration of Company's Management, External Advisory Committee Members, and Fiscal CouncilCOMPENSATIONISSUER18373.0000000FOR18373.000000FORS000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/15/2026Change Company Name to AXIA Energia S.A. and Amend Bylaws AccordinglyCORPORATE GOVERNANCEISSUER18373.0000000FOR18373.000000FORS000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/15/2026Amend ArticlesCORPORATE GOVERNANCEISSUER18373.0000000FOR18373.000000FORS000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/15/2026Consolidate BylawsCORPORATE GOVERNANCEISSUER18373.0000000FOR18373.000000FORS000064728Centrais Eletricas Brasileiras SA15234Q207US15234Q207504/15/2026Approve Performance Share PlanCOMPENSATIONISSUER18373.0000000AGAINST18373.000000AGAINSTS000064728Getty Realty Corp.374297109US374297109204/21/2026Election of Directors: Christopher J. ConstantDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Getty Realty Corp.374297109US374297109204/21/2026Election of Directors: Milton CooperDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Getty Realty Corp.374297109US374297109204/21/2026Election of Directors: Philip E. CovielloDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Getty Realty Corp.374297109US374297109204/21/2026Election of Directors: Evelyn Leon InfurnaDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Getty Realty Corp.374297109US374297109204/21/2026Election of Directors: Mary Lou MalanoskiDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Getty Realty Corp.374297109US374297109204/21/2026Election of Directors: Howard B. SafenowitzDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Getty Realty Corp.374297109US374297109204/21/2026ADVISORY (NON-BINDING) VOTE ON NAMED EXECUTIVE COMPENSATION (SAY-ON-PAY).SECTION 14A SAY-ON-PAY VOTESISSUER5768.0000000FOR5768.000000FORS000064728Getty Realty Corp.374297109US374297109204/21/2026ADVISORY (NON-BINDING) VOTE ON NAMED EXECUTIVE COMPENSATION (SAY-ON-PAY).SECTION 14A SAY-ON-PAY VOTESISSUER5768.0000000FOR5768.000000FOR4S000064728Getty Realty Corp.374297109US374297109204/21/2026RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.AUDIT-RELATEDISSUER5768.0000000FOR5768.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/22/2026ELECTIONS OF DIRECTORS: Brian T. FinneganDIRECTOR ELECTIONSISSUER6235.0000000FOR6235.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/22/2026ELECTIONS OF DIRECTORS: Sheryl M. CroslandDIRECTOR ELECTIONSISSUER6235.0000000FOR6235.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/22/2026ELECTIONS OF DIRECTORS: Michael BermanDIRECTOR ELECTIONSISSUER6235.0000000FOR6235.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/22/2026ELECTIONS OF DIRECTORS: Julie BowermanDIRECTOR ELECTIONSISSUER6235.0000000FOR6235.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/22/2026ELECTIONS OF DIRECTORS: Thomas W. DicksonDIRECTOR ELECTIONSISSUER6235.0000000FOR6235.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/22/2026ELECTIONS OF DIRECTORS: Daniel B. HurwitzDIRECTOR ELECTIONSISSUER6235.0000000FOR6235.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/22/2026ELECTIONS OF DIRECTORS: Sandra A.J. LawrenceDIRECTOR ELECTIONSISSUER6235.0000000FOR6235.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/22/2026ELECTIONS OF DIRECTORS: William D. RahmDIRECTOR ELECTIONSISSUER6235.0000000FOR6235.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/22/2026ELECTIONS OF DIRECTORS: JP SuarezDIRECTOR ELECTIONSISSUER6235.0000000FOR6235.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/22/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER6235.0000000FOR6235.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/22/2026To approve, on a non-binding advisory basis, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6235.0000000FOR6235.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/22/2026To approve, on a non-binding advisory basis, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6235.0000000FOR6235.000000FOR4S000064728Brixmor Property Group Inc.11120U105US11120U105104/22/2026To determine, on a non-binding advisory basis, the frequency of future non-binding advisory votes to approve the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6235.0000000ONE YEAR6235.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/22/2026To determine, on a non-binding advisory basis, the frequency of future non-binding advisory votes to approve the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6235.0000000ONE YEAR6235.000000FOR4S000064728BP Plc055622104US055622104404/23/2026Accept Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Approve Remuneration ReportCOMPENSATIONISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Approve Remuneration PolicyCOMPENSATIONISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Elect Albert Manifold as DirectorDIRECTOR ELECTIONSISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Elect Meg O'Neill as DirectorDIRECTOR ELECTIONSISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Re-elect Kate Thomson as DirectorDIRECTOR ELECTIONSISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Re-elect Dame Amanda Blanc as DirectorDIRECTOR ELECTIONSISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Re-elect Tushar Morzaria as DirectorDIRECTOR ELECTIONSISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Re-elect Ian Tyler as DirectorDIRECTOR ELECTIONSISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Re-elect Satish Pai as DirectorDIRECTOR ELECTIONSISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Re-elect Johannes Teyssen as DirectorDIRECTOR ELECTIONSISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Re-elect Hina Nagarajan as DirectorDIRECTOR ELECTIONSISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Elect Dave Hager as DirectorDIRECTOR ELECTIONSISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Reappoint Deloitte LLP as AuditorsAUDIT-RELATEDISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Authorise the Audit Committee to Fix Remuneration of AuditorsAUDIT-RELATEDISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Authorise UK Political Donations and ExpenditureOTHER SOCIAL ISSUESISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Authorise Issue of EquityCAPITAL STRUCTUREISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Authorise Issue of Equity without Pre-emptive RightsCAPITAL STRUCTUREISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital InvestmentCAPITAL STRUCTUREISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Authorise Market Purchase of Ordinary SharesCAPITAL STRUCTUREISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Authorise the Company to Call General Meeting with Two Weeks' NoticeCORPORATE GOVERNANCEISSUER4763.0000000FOR4763.000000FORS000064728BP Plc055622104US055622104404/23/2026Adopt New Articles of AssociationCORPORATE GOVERNANCEISSUER4763.0000000AGAINST4763.000000AGAINSTS000064728BP Plc055622104US055622104404/23/2026Approve Revocation of Resolution 25 (2015) and Resolution 22 (2019)OTHERCompany-specific matterISSUER4763.0000000AGAINST4763.000000AGAINSTS000064728BP Plc055622104US055622104404/23/2026Approve Shareholder Requisitioned ResolutionCORPORATE GOVERNANCEOTHERCompany-specific matterSECURITY HOLDER4763.0000000AGAINST4763.000000FORS000064728Edison International281020107US281020107704/23/2026Election of Directors: Jeanne Beliveau-DunnDIRECTOR ELECTIONSISSUER2682.0000000FOR2682.000000FORS000064728Edison International281020107US281020107704/23/2026Election of Directors: Michael C. CamunezDIRECTOR ELECTIONSISSUER2682.0000000FOR2682.000000FORS000064728Edison International281020107US281020107704/23/2026Election of Directors: Jennifer M. GranholmDIRECTOR ELECTIONSISSUER2682.0000000FOR2682.000000FORS000064728Edison International281020107US281020107704/23/2026Election of Directors: James T. MorrisDIRECTOR ELECTIONSISSUER2682.0000000FOR2682.000000FORS000064728Edison International281020107US281020107704/23/2026Election of Directors: Timothy T. O'TooleDIRECTOR ELECTIONSISSUER2682.0000000FOR2682.000000FORS000064728Edison International281020107US281020107704/23/2026Election of Directors: Pedro J. PizarroDIRECTOR ELECTIONSISSUER2682.0000000FOR2682.000000FORS000064728Edison International281020107US281020107704/23/2026Election of Directors: Marcy L. ReedDIRECTOR ELECTIONSISSUER2682.0000000FOR2682.000000FORS000064728Edison International281020107US281020107704/23/2026Election of Directors: Carey A. SmithDIRECTOR ELECTIONSISSUER2682.0000000FOR2682.000000FORS000064728Edison International281020107US281020107704/23/2026Election of Directors: Linda G. StuntzDIRECTOR ELECTIONSISSUER2682.0000000FOR2682.000000FORS000064728Edison International281020107US281020107704/23/2026Election of Directors: Peter J. TaylorDIRECTOR ELECTIONSISSUER2682.0000000FOR2682.000000FORS000064728Edison International281020107US281020107704/23/2026Election of Directors: Keith TrentDIRECTOR ELECTIONSISSUER2682.0000000FOR2682.000000FORS000064728Edison International281020107US281020107704/23/2026Ratification of the Independent Registered Public Accounting FirmAUDIT-RELATEDISSUER2682.0000000FOR2682.000000FORS000064728Edison International281020107US281020107704/23/2026Advisory Vote to Approve Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER2682.0000000FOR2682.000000FORS000064728Edison International281020107US281020107704/23/2026Advisory Vote to Approve Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER2682.0000000FOR2682.000000FOR4S000064728Edison International281020107US281020107704/23/2026Shareholder Proposal Regarding Retention of EquityCOMPENSATIONSECURITY HOLDER2682.0000000FOR2682.000000AGAINSTS000064728Park Hotels & Resorts Inc.700517105US700517105004/24/2026Election of Directors: Thomas J. Baltimore, Jr.DIRECTOR ELECTIONSISSUER15069.0000000FOR15069.000000FORS000064728Park Hotels & Resorts Inc.700517105US700517105004/24/2026Election of Directors: Patricia M. BedientDIRECTOR ELECTIONSISSUER15069.0000000FOR15069.000000FORS000064728Park Hotels & Resorts Inc.700517105US700517105004/24/2026Election of Directors: Thomas D. EckertDIRECTOR ELECTIONSISSUER15069.0000000FOR15069.000000FORS000064728Park Hotels & Resorts Inc.700517105US700517105004/24/2026Election of Directors: Geoffrey M. GarrettDIRECTOR ELECTIONSISSUER15069.0000000FOR15069.000000FORS000064728Park Hotels & Resorts Inc.700517105US700517105004/24/2026Election of Directors: Christie B. KellyDIRECTOR ELECTIONSISSUER15069.0000000FOR15069.000000FORS000064728Park Hotels & Resorts Inc.700517105US700517105004/24/2026Election of Directors: Terri D. McClementsDIRECTOR ELECTIONSISSUER15069.0000000FOR15069.000000FORS000064728Park Hotels & Resorts Inc.700517105US700517105004/24/2026Election of Directors: Thomas A. NatelliDIRECTOR ELECTIONSISSUER15069.0000000FOR15069.000000FORS000064728Park Hotels & Resorts Inc.700517105US700517105004/24/2026Election of Directors: Timothy J. NaughtonDIRECTOR ELECTIONSISSUER15069.0000000FOR15069.000000FORS000064728Park Hotels & Resorts Inc.700517105US700517105004/24/2026Election of Directors: Stephen I. SadoveDIRECTOR ELECTIONSISSUER15069.0000000FOR15069.000000FORS000064728Park Hotels & Resorts Inc.700517105US700517105004/24/2026To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER15069.0000000FOR15069.000000FORS000064728Park Hotels & Resorts Inc.700517105US700517105004/24/2026To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER15069.0000000FOR15069.000000FOR4S000064728Park Hotels & Resorts Inc.700517105US700517105004/24/2026To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER15069.0000000FOR15069.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/28/2026Election of Directors: Bill FehrmanDIRECTOR ELECTIONSISSUER1419.0000000FOR1419.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/28/2026Election of Directors: Ben FowkeDIRECTOR ELECTIONSISSUER1419.0000000FOR1419.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/28/2026Election of Directors: Art A. GarciaDIRECTOR ELECTIONSISSUER1419.0000000FOR1419.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/28/2026Election of Directors: Sandra Beach LinDIRECTOR ELECTIONSISSUER1419.0000000FOR1419.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/28/2026Election of Directors: Margaret M. McCarthyDIRECTOR ELECTIONSISSUER1419.0000000FOR1419.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/28/2026Election of Directors: Daryl RobertsDIRECTOR ELECTIONSISSUER1419.0000000FOR1419.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/28/2026Election of Directors: Joseph G. SauvageDIRECTOR ELECTIONSISSUER1419.0000000FOR1419.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/28/2026Election of Directors: Daniel G. StoddardDIRECTOR ELECTIONSISSUER1419.0000000FOR1419.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/28/2026Election of Directors: Sara Martinez TuckerDIRECTOR ELECTIONSISSUER1419.0000000FOR1419.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/28/2026Election of Directors: Lewis Von ThaerDIRECTOR ELECTIONSISSUER1419.0000000FOR1419.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/28/2026Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER1419.0000000FOR1419.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/28/2026Amendment of the Company's Restated Certificate of Incorporation to increase the number of authorized shares of common stock.CAPITAL STRUCTUREISSUER1419.0000000FOR1419.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/28/2026Approval of the AEP Employee Stock Purchase Plan.COMPENSATIONISSUER1419.0000000FOR1419.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/28/2026Approval, on an advisory basis, of the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1419.0000000FOR1419.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/28/2026Approval, on an advisory basis, of the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1419.0000000FOR1419.000000FOR4S000064728Enel Chile SA29278D105US29278D105404/28/2026Approve Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER41164.0000000FOR41164.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2026Approve Allocation of Income and Dividends of USD 0.003 per ShareCAPITAL STRUCTUREISSUER41164.0000000FOR41164.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2026Approve Remuneration of DirectorsCOMPENSATIONISSUER41164.0000000FOR41164.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2026Approve Remuneration and Budget of Directors' CommitteeCOMPENSATIONISSUER41164.0000000FOR41164.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2026Appoint AuditorsAUDIT-RELATEDISSUER41164.0000000FOR41164.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2026Elect Two Supervisory Account Inspectors and their Alternates; Approve their RemunerationCOMPENSATIONCORPORATE GOVERNANCEISSUER41164.0000000FOR41164.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2026Designate Risk Assessment CompaniesCORPORATE GOVERNANCEISSUER41164.0000000FOR41164.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2026Approve Investment and Financing PolicyCORPORATE GOVERNANCEISSUER41164.0000000FOR41164.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2026Other BusinessCORPORATE GOVERNANCEISSUER41164.0000000AGAINST41164.000000AGAINSTS000064728Enel Chile SA29278D105US29278D105404/28/2026Authorize Board to Ratify and Execute Approved ResolutionsCORPORATE GOVERNANCEISSUER41164.0000000FOR41164.000000FORS000064728Exelon Corporation30161N101US30161N101904/28/2026Election of Directors: W. Paul BowersDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728Exelon Corporation30161N101US30161N101904/28/2026Election of Directors: Calvin G. Butler, Jr.DIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728Exelon Corporation30161N101US30161N101904/28/2026Election of Directors: Marjorie Rodgers CheshireDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728Exelon Corporation30161N101US30161N101904/28/2026Election of Directors: David DeWaltDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728Exelon Corporation30161N101US30161N101904/28/2026Election of Directors: Linda JojoDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728Exelon Corporation30161N101US30161N101904/28/2026Election of Directors: Charisse LillieDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728Exelon Corporation30161N101US30161N101904/28/2026Election of Directors: Anna RichoDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728Exelon Corporation30161N101US30161N101904/28/2026Election of Directors: Matthew RogersDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728Exelon Corporation30161N101US30161N101904/28/2026Election of Directors: Bryan SegediDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728Exelon Corporation30161N101US30161N101904/28/2026Ratification of PricewaterhouseCoopers LLP as Exelon's Independent Auditor for 2026.AUDIT-RELATEDISSUER3734.0000000FOR3734.000000FORS000064728Exelon Corporation30161N101US30161N101904/28/2026Advisory vote to approve the compensation paid to Exelon's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3734.0000000FOR3734.000000FORS000064728Exelon Corporation30161N101US30161N101904/28/2026Advisory vote to approve the compensation paid to Exelon's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3734.0000000FOR3734.000000FOR4S000064728RPC, Inc.749660106US749660106004/28/2026To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: Susan R. BellDIRECTOR ELECTIONSISSUER29244.0000000FOR29244.000000FORS000064728RPC, Inc.749660106US749660106004/28/2026To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: Patrick J. GunningDIRECTOR ELECTIONSISSUER29244.0000000FOR29244.000000FORS000064728RPC, Inc.749660106US749660106004/28/2026To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: Richard A. HubbellDIRECTOR ELECTIONSISSUER29244.0000000AGAINST29244.000000AGAINSTS000064728RPC, Inc.749660106US749660106004/28/2026To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: Gary KolstadDIRECTOR ELECTIONSISSUER29244.0000000FOR29244.000000FORS000064728RPC, Inc.749660106US749660106004/28/2026To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: Amy R. KreislerDIRECTOR ELECTIONSISSUER29244.0000000AGAINST29244.000000AGAINSTS000064728RPC, Inc.749660106US749660106004/28/2026To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: Stephen E. LewisDIRECTOR ELECTIONSISSUER29244.0000000FOR29244.000000FORS000064728RPC, Inc.749660106US749660106004/28/2026To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: Ben M. PalmerDIRECTOR ELECTIONSISSUER29244.0000000AGAINST29244.000000AGAINSTS000064728RPC, Inc.749660106US749660106004/28/2026To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: Timothy C. RollinsDIRECTOR ELECTIONSISSUER29244.0000000AGAINST29244.000000AGAINSTS000064728RPC, Inc.749660106US749660106004/28/2026To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: Wesley N. SlagleDIRECTOR ELECTIONSISSUER29244.0000000AGAINST29244.000000AGAINSTS000064728RPC, Inc.749660106US749660106004/28/2026To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: John F. WilsonDIRECTOR ELECTIONSISSUER29244.0000000FOR29244.000000FORS000064728RPC, Inc.749660106US749660106004/28/2026To ratify the appointment of Grant Thornton LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER29244.0000000FOR29244.000000FORS000064728RPC, Inc.749660106US749660106004/28/2026To hold a nonbinding vote on executive compensation disclosed in these materials;SECTION 14A SAY-ON-PAY VOTESISSUER29244.0000000FOR29244.000000FORS000064728RPC, Inc.749660106US749660106004/28/2026To hold a nonbinding vote on executive compensation disclosed in these materials;SECTION 14A SAY-ON-PAY VOTESISSUER29244.0000000FOR29244.000000FOR4S000064728RPC, Inc.749660106US749660106004/28/2026To approve and ratify certain previous grants of performance stock units to our Chief Executive Officer;COMPENSATIONISSUER29244.0000000FOR29244.000000FORS000064728RPC, Inc.749660106US749660106004/28/2026To approve and ratify certain previous grants of performance stock units to our Executive Chairman; andCOMPENSATIONISSUER29244.0000000FOR29244.000000FORS000064728RPC, Inc.749660106US749660106004/28/2026To approve certain amendments to the Company's 2024 Stock Incentive Plan.COMPENSATIONISSUER29244.0000000AGAINST29244.000000AGAINSTS000064728Stepan Company858586100US858586100304/28/2026Election of Directors: Joaquin DelgadoDIRECTOR ELECTIONSISSUER3433.0000000FOR3433.000000FORS000064728Stepan Company858586100US858586100304/28/2026Election of Directors: Corning F. PainterDIRECTOR ELECTIONSISSUER3433.0000000FOR3433.000000FORS000064728Stepan Company858586100US858586100304/28/2026Election of Directors: F. Quinn Stepan, Jr.DIRECTOR ELECTIONSISSUER3433.0000000FOR3433.000000FORS000064728Stepan Company858586100US858586100304/28/2026Advisory vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3433.0000000FOR3433.000000FORS000064728Stepan Company858586100US858586100304/28/2026Advisory vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3433.0000000FOR3433.000000FOR4S000064728Stepan Company858586100US858586100304/28/2026Ratify the appointment of Deloitte & Touche LLP as Stepan Company's independent public accounting firm for 2026.AUDIT-RELATEDISSUER3433.0000000FOR3433.000000FORS000064728The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Stephen W. BergstromDIRECTOR ELECTIONSISSUER2760.0000000FOR2760.000000FORS000064728The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Michael A. CreelDIRECTOR ELECTIONSISSUER2760.0000000FOR2760.000000FORS000064728The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Carri A. LockhartDIRECTOR ELECTIONSISSUER2760.0000000FOR2760.000000FORS000064728The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Richard E. MuncriefDIRECTOR ELECTIONSISSUER2760.0000000FOR2760.000000FORS000064728The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Peter A. RagaussDIRECTOR ELECTIONSISSUER2760.0000000FOR2760.000000FORS000064728The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Rose M. RobesonDIRECTOR ELECTIONSISSUER2760.0000000FOR2760.000000FORS000064728The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Scott D. SheffieldDIRECTOR ELECTIONSISSUER2760.0000000FOR2760.000000FORS000064728The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: William H. SpenceDIRECTOR ELECTIONSISSUER2760.0000000FOR2760.000000FORS000064728The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Jesse J. TysonDIRECTOR ELECTIONSISSUER2760.0000000FOR2760.000000FORS000064728The Williams Companies, Inc.969457100US969457100404/28/2026Elect 11 Director Nominees for a One-Year Term: Chad J. ZamarinDIRECTOR ELECTIONSISSUER2760.0000000FOR2760.000000FORS000064728The Williams Companies, Inc.969457100US969457100404/28/2026Approve, on an Advisory Basis, the Compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER2760.0000000FOR2760.000000FORS000064728The Williams Companies, Inc.969457100US969457100404/28/2026Approve, on an Advisory Basis, the Compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER2760.0000000FOR2760.000000FOR4S000064728The Williams Companies, Inc.969457100US969457100404/28/2026Approve the Amendment and Restatement of The Williams Companies, Inc. 2007 Incentive Plan to Increase the Number of Issuable Shares from 50,000,000 to 85,000,000, Remove the Plan Expiration Date, Increase the Annual Director Equity Grant Limit, Eliminate Share Recycling for Tax Withholding, Remove Certain Change in Control Provisions, and Make Other Amendments.COMPENSATIONISSUER2760.0000000FOR2760.000000FORS000064728The Williams Companies, Inc.969457100US969457100404/28/2026Approve the Amendment and Restatement of The Williams Companies, Inc. 2007 Employee Stock Purchase Plan to Increase the Number of Issuable Shares from 5,200,000 to 7,200,000, Extend the Term Six Years, and Make Other Amendments.COMPENSATIONISSUER2760.0000000FOR2760.000000FORS000064728The Williams Companies, Inc.969457100US969457100404/28/2026Ratify the Selection of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year ending December 31, 2026.AUDIT-RELATEDISSUER2760.0000000FOR2760.000000FORS000064728VICI Properties Inc.925652109US925652109004/28/2026Election of Directors: James R. AbrahamsonDIRECTOR ELECTIONSISSUER5836.0000000FOR5836.000000FORS000064728VICI Properties Inc.925652109US925652109004/28/2026Election of Directors: Diana F. CantorDIRECTOR ELECTIONSISSUER5836.0000000FOR5836.000000FORS000064728VICI Properties Inc.925652109US925652109004/28/2026Election of Directors: Monica H. DouglasDIRECTOR ELECTIONSISSUER5836.0000000FOR5836.000000FORS000064728VICI Properties Inc.925652109US925652109004/28/2026Election of Directors: Elizabeth I. HollandDIRECTOR ELECTIONSISSUER5836.0000000FOR5836.000000FORS000064728VICI Properties Inc.925652109US925652109004/28/2026Election of Directors: Craig MacnabDIRECTOR ELECTIONSISSUER5836.0000000FOR5836.000000FORS000064728VICI Properties Inc.925652109US925652109004/28/2026Election of Directors: Edward B. PitoniakDIRECTOR ELECTIONSISSUER5836.0000000FOR5836.000000FORS000064728VICI Properties Inc.925652109US925652109004/28/2026Election of Directors: Michael D. RumbolzDIRECTOR ELECTIONSISSUER5836.0000000FOR5836.000000FORS000064728VICI Properties Inc.925652109US925652109004/28/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER5836.0000000FOR5836.000000FORS000064728VICI Properties Inc.925652109US925652109004/28/2026To approve (on a non-binding, advisory basis) the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5836.0000000FOR5836.000000FORS000064728VICI Properties Inc.925652109US925652109004/28/2026To approve (on a non-binding, advisory basis) the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5836.0000000FOR5836.000000FOR4S000064728California Resources Corporation13057Q305US13057Q305604/30/2026Election of Directors: Andrew B. BremnerDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728California Resources Corporation13057Q305US13057Q305604/30/2026Election of Directors: Tiffany (TJ) Thom CepakDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728California Resources Corporation13057Q305US13057Q305604/30/2026Election of Directors: James N. ChapmanDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728California Resources Corporation13057Q305US13057Q305604/30/2026Election of Directors: James R. JacksonDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728California Resources Corporation13057Q305US13057Q305604/30/2026Election of Directors: Christian S. KendallDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728California Resources Corporation13057Q305US13057Q305604/30/2026Election of Directors: Francisco J. LeonDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728California Resources Corporation13057Q305US13057Q305604/30/2026Election of Directors: Mark A. (Mac) McFarlandDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728California Resources Corporation13057Q305US13057Q305604/30/2026Election of Directors: William B. RobyDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728California Resources Corporation13057Q305US13057Q305604/30/2026Election of Directors: Alejandra (Ale) VeltmannDIRECTOR ELECTIONSISSUER3734.0000000FOR3734.000000FORS000064728California Resources Corporation13057Q305US13057Q305604/30/2026Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER3734.0000000FOR3734.000000FORS000064728California Resources Corporation13057Q305US13057Q305604/30/2026To approve, by non-binding vote, named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3734.0000000FOR3734.000000FORS000064728California Resources Corporation13057Q305US13057Q305604/30/2026To approve, by non-binding vote, named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3734.0000000FOR3734.000000FOR4S000064728Companhia Energetica de Minas Gerais SA204409601US204409601204/30/2026As a Preferred Shareholder, Would You like to Request a Separate Minority Election of a Member of the Board of Directors, Under the Terms of Article 141 of the Brazilian Corporate Law?CORPORATE GOVERNANCEISSUER80126.0000000FOR80126.000000NONES000064728Companhia Energetica de Minas Gerais SA204409601US204409601204/30/2026Elect Aloisio Macario Ferreira de Souza as Director Appointed by Preferred Shareholder (Fia Dinamica)DIRECTOR ELECTIONSSECURITY HOLDER80126.0000000FOR80126.000000NONES000064728Companhia Energetica de Minas Gerais SA204409601US204409601204/30/2026In Case Neither Class of Shares Reaches the Minimum Quorum Required by the Brazilian Corporate Law to Elect a Board Representative in Separate Elections, Would You Like to Use Your Votes to Elect the Candidate with More Votes to Represent Both Classes?CORPORATE GOVERNANCEISSUER80126.0000000FOR80126.000000NONES000064728Companhia Energetica de Minas Gerais SA204409601US204409601204/30/2026Elect Joao Vicente Silva Machado as Fiscal Council Member and Ricardo Jose Martins Gimenez as Alternate Appointed by Preferred Shareholder (Fia Dinamica)AUDIT-RELATEDCORPORATE GOVERNANCESECURITY HOLDER80126.0000000FOR80126.000000NONES000064728Sunstone Hotel Investors, Inc.867892101US867892101105/01/2026Election of the following nine nominees to serve as directors until the next Annual Meeting and until their successors are elected and qualified: W. Blake BairdDIRECTOR ELECTIONSISSUER17751.0000000FOR17751.000000FORS000064728Sunstone Hotel Investors, Inc.867892101US867892101105/01/2026Election of the following nine nominees to serve as directors until the next Annual Meeting and until their successors are elected and qualified: Michael BarnelloDIRECTOR ELECTIONSISSUER17751.0000000FOR17751.000000FORS000064728Sunstone Hotel Investors, Inc.867892101US867892101105/01/2026Election of the following nine nominees to serve as directors until the next Annual Meeting and until their successors are elected and qualified: Andrew BatinovichDIRECTOR ELECTIONSISSUER17751.0000000FOR17751.000000FORS000064728Sunstone Hotel Investors, Inc.867892101US867892101105/01/2026Election of the following nine nominees to serve as directors until the next Annual Meeting and until their successors are elected and qualified: Monica S. DigilioDIRECTOR ELECTIONSISSUER17751.0000000FOR17751.000000FORS000064728Sunstone Hotel Investors, Inc.867892101US867892101105/01/2026Election of the following nine nominees to serve as directors until the next Annual Meeting and until their successors are elected and qualified: Bryan A. GigliaDIRECTOR ELECTIONSISSUER17751.0000000FOR17751.000000FORS000064728Sunstone Hotel Investors, Inc.867892101US867892101105/01/2026Election of the following nine nominees to serve as directors until the next Annual Meeting and until their successors are elected and qualified: Kristina M. LeslieDIRECTOR ELECTIONSISSUER17751.0000000FOR17751.000000FORS000064728Sunstone Hotel Investors, Inc.867892101US867892101105/01/2026Election of the following nine nominees to serve as directors until the next Annual Meeting and until their successors are elected and qualified: Murray J. McCabeDIRECTOR ELECTIONSISSUER17751.0000000FOR17751.000000FORS000064728Sunstone Hotel Investors, Inc.867892101US867892101105/01/2026Election of the following nine nominees to serve as directors until the next Annual Meeting and until their successors are elected and qualified: Verett MimsDIRECTOR ELECTIONSISSUER17751.0000000FOR17751.000000FORS000064728Sunstone Hotel Investors, Inc.867892101US867892101105/01/2026Election of the following nine nominees to serve as directors until the next Annual Meeting and until their successors are elected and qualified: Douglas M. PasqualeDIRECTOR ELECTIONSISSUER17751.0000000FOR17751.000000FORS000064728Sunstone Hotel Investors, Inc.867892101US867892101105/01/2026Ratification of the Audit Committee's appointment of Ernst & Young LLP to act as the independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER17751.0000000FOR17751.000000FORS000064728Sunstone Hotel Investors, Inc.867892101US867892101105/01/2026Advisory vote to approve the compensation of Sunstone's named executive officers, as set forth in Sunstone's Proxy Statement for the 2026 Annual Meeting.SECTION 14A SAY-ON-PAY VOTESISSUER17751.0000000FOR17751.000000FORS000064728Sunstone Hotel Investors, Inc.867892101US867892101105/01/2026Advisory vote to approve the compensation of Sunstone's named executive officers, as set forth in Sunstone's Proxy Statement for the 2026 Annual Meeting.SECTION 14A SAY-ON-PAY VOTESISSUER17751.0000000FOR17751.000000FOR4S000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Accept Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER1807.0000000FOR1807.000000FORS000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Approve Remuneration ReportCOMPENSATIONISSUER1807.0000000FOR1807.000000FORS000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Elect Director Marcus RandolphDIRECTOR ELECTIONSISSUER1807.0000000FOR1807.000000FORS000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Elect Director Kojo BusiaDIRECTOR ELECTIONSISSUER1807.0000000FOR1807.000000FORS000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Elect Director Alberto CalderonDIRECTOR ELECTIONSISSUER1807.0000000FOR1807.000000FORS000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Elect Director Bruce CleaverDIRECTOR ELECTIONSISSUER1807.0000000FOR1807.000000FORS000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Elect Director Gillian DoranDIRECTOR ELECTIONSISSUER1807.0000000FOR1807.000000FORS000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Elect Director Alan FergusonDIRECTOR ELECTIONSISSUER1807.0000000FOR1807.000000FORS000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Elect Director Albert GarnerDIRECTOR ELECTIONSISSUER1807.0000000FOR1807.000000FORS000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Elect Director Jinhee MagieDIRECTOR ELECTIONSISSUER1807.0000000FOR1807.000000FORS000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Elect Director Nicky Newton-KingDIRECTOR ELECTIONSISSUER1807.0000000FOR1807.000000FORS000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Elect Director Diana SandsDIRECTOR ELECTIONSISSUER1807.0000000FOR1807.000000FORS000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Elect Director Jochen TilkDIRECTOR ELECTIONSISSUER1807.0000000FOR1807.000000FORS000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Appoint PricewaterhouseCoopers LLP as Statutory AuditorsAUDIT-RELATEDISSUER1807.0000000FOR1807.000000FORS000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Authorize Audit and Risk Committee to Fix Remuneration of AuditorsAUDIT-RELATEDISSUER1807.0000000FOR1807.000000FORS000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Appoint PricewaterhouseCoopers Inc. as Independent Registered Public AccountantsAUDIT-RELATEDISSUER1807.0000000FOR1807.000000FORS000064728Anglogold Ashanti plcG0378L100GB00BRXH266405/05/2026Authorize UK Political Donations and ExpenditureOTHER SOCIAL ISSUESISSUER1807.0000000FOR1807.000000FORS000064728DT Midstream, Inc.23345M107US23345M107105/05/2026To elect seven directors from the nominees described in the proxy statement: David SlaterDIRECTOR ELECTIONSISSUER1360.0000000FOR1360.000000FORS000064728DT Midstream, Inc.23345M107US23345M107105/05/2026To elect seven directors from the nominees described in the proxy statement: Angela ArchonDIRECTOR ELECTIONSISSUER1360.0000000FOR1360.000000FORS000064728DT Midstream, Inc.23345M107US23345M107105/05/2026To elect seven directors from the nominees described in the proxy statement: Stephen BakerDIRECTOR ELECTIONSISSUER1360.0000000FOR1360.000000FORS000064728DT Midstream, Inc.23345M107US23345M107105/05/2026To elect seven directors from the nominees described in the proxy statement: Elaine PickleDIRECTOR ELECTIONSISSUER1360.0000000FOR1360.000000FORS000064728DT Midstream, Inc.23345M107US23345M107105/05/2026To elect seven directors from the nominees described in the proxy statement: Robert Skaggs, Jr.DIRECTOR ELECTIONSISSUER1360.0000000FOR1360.000000FORS000064728DT Midstream, Inc.23345M107US23345M107105/05/2026To elect seven directors from the nominees described in the proxy statement: Peter TumminelloDIRECTOR ELECTIONSISSUER1360.0000000FOR1360.000000FORS000064728DT Midstream, Inc.23345M107US23345M107105/05/2026To elect seven directors from the nominees described in the proxy statement: Dwayne WilsonDIRECTOR ELECTIONSISSUER1360.0000000FOR1360.000000FORS000064728DT Midstream, Inc.23345M107US23345M107105/05/2026To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026;AUDIT-RELATEDISSUER1360.0000000FOR1360.000000FORS000064728DT Midstream, Inc.23345M107US23345M107105/05/2026To approve, on an advisory (non-binding) basis, the compensation of the Company's Named Executive Officers; andSECTION 14A SAY-ON-PAY VOTESISSUER1360.0000000FOR1360.000000FORS000064728DT Midstream, Inc.23345M107US23345M107105/05/2026To approve, on an advisory (non-binding) basis, the compensation of the Company's Named Executive Officers; andSECTION 14A SAY-ON-PAY VOTESISSUER1360.0000000FOR1360.000000FOR4S000064728DT Midstream, Inc.23345M107US23345M107105/05/2026Stockholder Proposal on Shareholder Right to Act by Written Consent.CORPORATE GOVERNANCESECURITY HOLDER1360.0000000FOR1360.000000AGAINSTS000064728EPR Properties26884U109US26884U109705/05/2026Election of Trustees: Peter C. BrownDIRECTOR ELECTIONSISSUER3253.0000000FOR3253.000000FORS000064728EPR Properties26884U109US26884U109705/05/2026Election of Trustees: William P. BrownDIRECTOR ELECTIONSISSUER3253.0000000FOR3253.000000FORS000064728EPR Properties26884U109US26884U109705/05/2026Election of Trustees: John P. Case IIIDIRECTOR ELECTIONSISSUER3253.0000000FOR3253.000000FORS000064728EPR Properties26884U109US26884U109705/05/2026Election of Trustees: James B. ConnorDIRECTOR ELECTIONSISSUER3253.0000000FOR3253.000000FORS000064728EPR Properties26884U109US26884U109705/05/2026Election of Trustees: Virginia E. ShanksDIRECTOR ELECTIONSISSUER3253.0000000FOR3253.000000FORS000064728EPR Properties26884U109US26884U109705/05/2026Election of Trustees: Gregory K. SilversDIRECTOR ELECTIONSISSUER3253.0000000FOR3253.000000FORS000064728EPR Properties26884U109US26884U109705/05/2026Election of Trustees: Robin P. SterneckDIRECTOR ELECTIONSISSUER3253.0000000FOR3253.000000FORS000064728EPR Properties26884U109US26884U109705/05/2026Election of Trustees: John Peter SuarezDIRECTOR ELECTIONSISSUER3253.0000000FOR3253.000000FORS000064728EPR Properties26884U109US26884U109705/05/2026Election of Trustees: Lisa G. TrimbergerDIRECTOR ELECTIONSISSUER3253.0000000FOR3253.000000FORS000064728EPR Properties26884U109US26884U109705/05/2026Election of Trustees: Caixia Y. ZieglerDIRECTOR ELECTIONSISSUER3253.0000000FOR3253.000000FORS000064728EPR Properties26884U109US26884U109705/05/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in these proxy materials.SECTION 14A SAY-ON-PAY VOTESISSUER3253.0000000FOR3253.000000FORS000064728EPR Properties26884U109US26884U109705/05/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in these proxy materials.SECTION 14A SAY-ON-PAY VOTESISSUER3253.0000000FOR3253.000000FOR4S000064728EPR Properties26884U109US26884U109705/05/2026To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER3253.0000000FOR3253.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/06/2026Ratify PricewaterhouseCoopers LLP as AuditorsAUDIT-RELATEDISSUER9725.0000000FOR9725.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/06/2026Elect Director Stephen E. BradleyDIRECTOR ELECTIONSISSUER9725.0000000FOR9725.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/06/2026Elect Director Keith M. CaseyDIRECTOR ELECTIONSISSUER9725.0000000FOR9725.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/06/2026Elect Director Michael J. CrothersDIRECTOR ELECTIONSISSUER9725.0000000FOR9725.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/06/2026Elect Director James D. GirgulisDIRECTOR ELECTIONSISSUER9725.0000000FOR9725.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/06/2026Elect Director Jane E. KinneyDIRECTOR ELECTIONSISSUER9725.0000000FOR9725.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/06/2026Elect Director Eva L. KwokDIRECTOR ELECTIONSISSUER9725.0000000FOR9725.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/06/2026Elect Director Melanie A. LittleDIRECTOR ELECTIONSISSUER9725.0000000FOR9725.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/06/2026Elect Director Richard J. MarcoglieseDIRECTOR ELECTIONSISSUER9725.0000000FOR9725.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/06/2026Elect Director Chana L. MartineauDIRECTOR ELECTIONSISSUER9725.0000000FOR9725.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/06/2026Elect Director Jonathan M. McKenzieDIRECTOR ELECTIONSISSUER9725.0000000FOR9725.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/06/2026Elect Director Claude MongeauDIRECTOR ELECTIONSISSUER9725.0000000FOR9725.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/06/2026Elect Director Alexander J. PourbaixDIRECTOR ELECTIONSISSUER9725.0000000FOR9725.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/06/2026Elect Director Frank J. SixtDIRECTOR ELECTIONSISSUER9725.0000000FOR9725.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/06/2026Elect Director Rhonda I. ZygockiDIRECTOR ELECTIONSISSUER9725.0000000FOR9725.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/06/2026Advisory Vote on Executive Compensation ApproachCOMPENSATIONISSUER9725.0000000FOR9725.000000FORS000064728Eversource Energy30040W108US30040W108005/06/2026Election of Trustees: Cotton M. ClevelandDIRECTOR ELECTIONSISSUER2462.0000000FOR2462.000000FORS000064728Eversource Energy30040W108US30040W108005/06/2026Election of Trustees: Linda Dorcena ForryDIRECTOR ELECTIONSISSUER2462.0000000FOR2462.000000FORS000064728Eversource Energy30040W108US30040W108005/06/2026Election of Trustees: Gregory M. JonesDIRECTOR ELECTIONSISSUER2462.0000000FOR2462.000000FORS000064728Eversource Energy30040W108US30040W108005/06/2026Election of Trustees: Loretta D. KeaneDIRECTOR ELECTIONSISSUER2462.0000000FOR2462.000000FORS000064728Eversource Energy30040W108US30040W108005/06/2026Election of Trustees: John Y. KimDIRECTOR ELECTIONSISSUER2462.0000000FOR2462.000000FORS000064728Eversource Energy30040W108US30040W108005/06/2026Election of Trustees: David H. LongDIRECTOR ELECTIONSISSUER2462.0000000FOR2462.000000FORS000064728Eversource Energy30040W108US30040W108005/06/2026Election of Trustees: Warren Robert MudgeDIRECTOR ELECTIONSISSUER2462.0000000FOR2462.000000FORS000064728Eversource Energy30040W108US30040W108005/06/2026Election of Trustees: Joseph R. Nolan, Jr.DIRECTOR ELECTIONSISSUER2462.0000000FOR2462.000000FORS000064728Eversource Energy30040W108US30040W108005/06/2026Election of Trustees: Daniel J. NovaDIRECTOR ELECTIONSISSUER2462.0000000FOR2462.000000FORS000064728Eversource Energy30040W108US30040W108005/06/2026Election of Trustees: Frederica M. WilliamsDIRECTOR ELECTIONSISSUER2462.0000000FOR2462.000000FORS000064728Eversource Energy30040W108US30040W108005/06/2026Consider an advisory proposal approving the compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER2462.0000000FOR2462.000000FORS000064728Eversource Energy30040W108US30040W108005/06/2026Consider an advisory proposal approving the compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER2462.0000000FOR2462.000000FOR4S000064728Eversource Energy30040W108US30040W108005/06/2026Ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER2462.0000000FOR2462.000000FORS000064728Eversource Energy30040W108US30040W108005/06/2026Vote on a shareholder proposal titled "Independent Board Chairman," if properly brought before the meeting.CORPORATE GOVERNANCESECURITY HOLDER2462.0000000AGAINST2462.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/06/2026Election of the 11 Director Nominees Named in the Proxy Statement: Sippy ChhinaDIRECTOR ELECTIONSISSUER4291.0000000FOR4291.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/06/2026Election of the 11 Director Nominees Named in the Proxy Statement: Meg A. GentleDIRECTOR ELECTIONSISSUER4291.0000000FOR4291.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/06/2026Election of the 11 Director Nominees Named in the Proxy Statement: Gregory P. HillDIRECTOR ELECTIONSISSUER4291.0000000FOR4291.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/06/2026Election of the 11 Director Nominees Named in the Proxy Statement: Ralph IzzoDIRECTOR ELECTIONSISSUER4291.0000000FOR4291.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/06/2026Election of the 11 Director Nominees Named in the Proxy Statement: Terri G. KingDIRECTOR ELECTIONSISSUER4291.0000000FOR4291.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/06/2026Election of the 11 Director Nominees Named in the Proxy Statement: Howard J. MaysonDIRECTOR ELECTIONSISSUER4291.0000000FOR4291.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/06/2026Election of the 11 Director Nominees Named in the Proxy Statement: Brendan M. McCrackenDIRECTOR ELECTIONSISSUER4291.0000000FOR4291.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/06/2026Election of the 11 Director Nominees Named in the Proxy Statement: Steven W. NanceDIRECTOR ELECTIONSISSUER4291.0000000FOR4291.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/06/2026Election of the 11 Director Nominees Named in the Proxy Statement: George L. PitaDIRECTOR ELECTIONSISSUER4291.0000000FOR4291.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/06/2026Election of the 11 Director Nominees Named in the Proxy Statement: Thomas G. RicksDIRECTOR ELECTIONSISSUER4291.0000000FOR4291.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/06/2026Election of the 11 Director Nominees Named in the Proxy Statement: Brian G. ShawDIRECTOR ELECTIONSISSUER4291.0000000FOR4291.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/06/2026Advisory Vote to Approve Compensation of Named Executive OfficersSECTION 14A SAY-ON-PAY VOTESISSUER4291.0000000FOR4291.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/06/2026Advisory Vote to Approve Compensation of Named Executive OfficersSECTION 14A SAY-ON-PAY VOTESISSUER4291.0000000FOR4291.000000FOR4S000064728Ovintiv Inc.69047Q102US69047Q102205/06/2026Ratify PricewaterhouseCoopers LLP as Independent AuditorsAUDIT-RELATEDISSUER4291.0000000FOR4291.000000FORS000064728Public Storage74460D109US74460D109005/06/2026Election of Trustees: Shankh S. MitraDIRECTOR ELECTIONSISSUER622.0000000AGAINST622.000000AGAINSTS000064728Public Storage74460D109US74460D109005/06/2026Election of Trustees: H. Thomas BoyleDIRECTOR ELECTIONSISSUER622.0000000FOR622.000000FORS000064728Public Storage74460D109US74460D109005/06/2026Election of Trustees: Tamara Hughes GustavsonDIRECTOR ELECTIONSISSUER622.0000000FOR622.000000FORS000064728Public Storage74460D109US74460D109005/06/2026Election of Trustees: Ronald L. Havner, Jr.DIRECTOR ELECTIONSISSUER622.0000000FOR622.000000FORS000064728Public Storage74460D109US74460D109005/06/2026Election of Trustees: Maria R. HawthorneDIRECTOR ELECTIONSISSUER622.0000000FOR622.000000FORS000064728Public Storage74460D109US74460D109005/06/2026Election of Trustees: Rebecca OwenDIRECTOR ELECTIONSISSUER622.0000000FOR622.000000FORS000064728Public Storage74460D109US74460D109005/06/2026Election of Trustees: Luke PetherbridgeDIRECTOR ELECTIONSISSUER622.0000000FOR622.000000FORS000064728Public Storage74460D109US74460D109005/06/2026Election of Trustees: Kristy M. PipesDIRECTOR ELECTIONSISSUER622.0000000FOR622.000000FORS000064728Public Storage74460D109US74460D109005/06/2026Election of Trustees: Avedick B. PoladianDIRECTOR ELECTIONSISSUER622.0000000FOR622.000000FORS000064728Public Storage74460D109US74460D109005/06/2026Election of Trustees: Tariq M. ShaukatDIRECTOR ELECTIONSISSUER622.0000000FOR622.000000FORS000064728Public Storage74460D109US74460D109005/06/2026Election of Trustees: Ronald P. SpogliDIRECTOR ELECTIONSISSUER622.0000000FOR622.000000FORS000064728Public Storage74460D109US74460D109005/06/2026Election of Trustees: Paul S. WilliamsDIRECTOR ELECTIONSISSUER622.0000000FOR622.000000FORS000064728Public Storage74460D109US74460D109005/06/2026Advisory vote to approve the compensation of Public Storage's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER622.0000000FOR622.000000FORS000064728Public Storage74460D109US74460D109005/06/2026Advisory vote to approve the compensation of Public Storage's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER622.0000000FOR622.000000FOR4S000064728Public Storage74460D109US74460D109005/06/2026Ratification of the appointment of Ernst & Young LLP as Public Storage's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER622.0000000FOR622.000000FORS000064728Urban Edge Properties91704F104US91704F104905/06/2026Election of Trustees to serve until the 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualify: Jeffrey S. OlsonDIRECTOR ELECTIONSISSUER8482.0000000FOR8482.000000FORS000064728Urban Edge Properties91704F104US91704F104905/06/2026Election of Trustees to serve until the 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualify: Mary L. BaglivoDIRECTOR ELECTIONSISSUER8482.0000000FOR8482.000000FORS000064728Urban Edge Properties91704F104US91704F104905/06/2026Election of Trustees to serve until the 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualify: Steven H. GrapsteinDIRECTOR ELECTIONSISSUER8482.0000000FOR8482.000000FORS000064728Urban Edge Properties91704F104US91704F104905/06/2026Election of Trustees to serve until the 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualify: Norman K. JenkinsDIRECTOR ELECTIONSISSUER8482.0000000FOR8482.000000FORS000064728Urban Edge Properties91704F104US91704F104905/06/2026Election of Trustees to serve until the 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualify: Kevin P. O'SheaDIRECTOR ELECTIONSISSUER8482.0000000FOR8482.000000FORS000064728Urban Edge Properties91704F104US91704F104905/06/2026Election of Trustees to serve until the 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualify: Catherine D. RiceDIRECTOR ELECTIONSISSUER8482.0000000FOR8482.000000FORS000064728Urban Edge Properties91704F104US91704F104905/06/2026Election of Trustees to serve until the 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualify: Katherine M. SandstromDIRECTOR ELECTIONSISSUER8482.0000000FOR8482.000000FORS000064728Urban Edge Properties91704F104US91704F104905/06/2026Election of Trustees to serve until the 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualify: Douglas W. SeslerDIRECTOR ELECTIONSISSUER8482.0000000FOR8482.000000FORS000064728Urban Edge Properties91704F104US91704F104905/06/2026The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER8482.0000000FOR8482.000000FORS000064728Urban Edge Properties91704F104US91704F104905/06/2026The approval, on a non-binding advisory basis, of a resolution approving the compensation of our named executive officers as described in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER8482.0000000FOR8482.000000FORS000064728Urban Edge Properties91704F104US91704F104905/06/2026The approval, on a non-binding advisory basis, of a resolution approving the compensation of our named executive officers as described in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER8482.0000000FOR8482.000000FOR4S000064728Canadian Natural Resources Limited136385101CA136385101705/07/2026Elect Director Shelley A.M. BrownDIRECTOR ELECTIONSISSUER5029.0000000FOR5029.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/07/2026Elect Director M. Elizabeth CannonDIRECTOR ELECTIONSISSUER5029.0000000FOR5029.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/07/2026Elect Director N. Murray EdwardsDIRECTOR ELECTIONSISSUER5029.0000000FOR5029.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/07/2026Elect Director Christopher L. FongDIRECTOR ELECTIONSISSUER5029.0000000FOR5029.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/07/2026Elect Director Gordon D. GiffinDIRECTOR ELECTIONSISSUER5029.0000000FOR5029.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/07/2026Elect Director Christine M. HealyDIRECTOR ELECTIONSISSUER5029.0000000FOR5029.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/07/2026Elect Director Grant E. IsaacDIRECTOR ELECTIONSISSUER5029.0000000FOR5029.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/07/2026Elect Director Steve W. LautDIRECTOR ELECTIONSISSUER5029.0000000FOR5029.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/07/2026Elect Director Frank J. McKennaDIRECTOR ELECTIONSISSUER5029.0000000FOR5029.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/07/2026Elect Director Scott G. StauthDIRECTOR ELECTIONSISSUER5029.0000000FOR5029.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/07/2026Elect Director David A. TuerDIRECTOR ELECTIONSISSUER5029.0000000FOR5029.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/07/2026Elect Director Annette M. VerschurenDIRECTOR ELECTIONSISSUER5029.0000000FOR5029.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/07/2026Approve PricewaterhouseCoopers LLP as Auditors and Authorize Audit Committee to Fix Their RemunerationAUDIT-RELATEDISSUER5029.0000000FOR5029.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/07/2026Advisory Vote on Executive Compensation ApproachCOMPENSATIONISSUER5029.0000000FOR5029.000000FORS000064728DTE Energy Company233331107US233331107205/07/2026Elect thirteen members of the Board of Directors for one-year terms ending in 2027: Nicholas K. AkinsDIRECTOR ELECTIONSISSUER1267.0000000FOR1267.000000FORS000064728DTE Energy Company233331107US233331107205/07/2026Elect thirteen members of the Board of Directors for one-year terms ending in 2027: David A. BrandonDIRECTOR ELECTIONSISSUER1267.0000000FOR1267.000000FORS000064728DTE Energy Company233331107US233331107205/07/2026Elect thirteen members of the Board of Directors for one-year terms ending in 2027: Deborah L. ByersDIRECTOR ELECTIONSISSUER1267.0000000FOR1267.000000FORS000064728DTE Energy Company233331107US233331107205/07/2026Elect thirteen members of the Board of Directors for one-year terms ending in 2027: Joi M. HarrisDIRECTOR ELECTIONSISSUER1267.0000000FOR1267.000000FORS000064728DTE Energy Company233331107US233331107205/07/2026Elect thirteen members of the Board of Directors for one-year terms ending in 2027: Charles G. McClure, Jr.DIRECTOR ELECTIONSISSUER1267.0000000FOR1267.000000FORS000064728DTE Energy Company233331107US233331107205/07/2026Elect thirteen members of the Board of Directors for one-year terms ending in 2027: Gail J. McGovernDIRECTOR ELECTIONSISSUER1267.0000000FOR1267.000000FORS000064728DTE Energy Company233331107US233331107205/07/2026Elect thirteen members of the Board of Directors for one-year terms ending in 2027: Mark A. MurrayDIRECTOR ELECTIONSISSUER1267.0000000FOR1267.000000FORS000064728DTE Energy Company233331107US233331107205/07/2026Elect thirteen members of the Board of Directors for one-year terms ending in 2027: Gerardo NorciaDIRECTOR ELECTIONSISSUER1267.0000000FOR1267.000000FORS000064728DTE Energy Company233331107US233331107205/07/2026Elect thirteen members of the Board of Directors for one-year terms ending in 2027: Cassandra SantosDIRECTOR ELECTIONSISSUER1267.0000000FOR1267.000000FORS000064728DTE Energy Company233331107US233331107205/07/2026Elect thirteen members of the Board of Directors for one-year terms ending in 2027: Robert C. Skaggs, Jr.DIRECTOR ELECTIONSISSUER1267.0000000FOR1267.000000FORS000064728DTE Energy Company233331107US233331107205/07/2026Elect thirteen members of the Board of Directors for one-year terms ending in 2027: David A. ThomasDIRECTOR ELECTIONSISSUER1267.0000000FOR1267.000000FORS000064728DTE Energy Company233331107US233331107205/07/2026Elect thirteen members of the Board of Directors for one-year terms ending in 2027: Gary H. TorgowDIRECTOR ELECTIONSISSUER1267.0000000FOR1267.000000FORS000064728DTE Energy Company233331107US233331107205/07/2026Elect thirteen members of the Board of Directors for one-year terms ending in 2027: Valerie M. WilliamsDIRECTOR ELECTIONSISSUER1267.0000000FOR1267.000000FORS000064728DTE Energy Company233331107US233331107205/07/2026Ratify the appointment of PricewaterhouseCoopers LLP as our independent auditorsAUDIT-RELATEDISSUER1267.0000000FOR1267.000000FORS000064728DTE Energy Company233331107US233331107205/07/2026Provide a nonbinding vote to approve the Company's executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER1267.0000000FOR1267.000000FORS000064728DTE Energy Company233331107US233331107205/07/2026Provide a nonbinding vote to approve the Company's executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER1267.0000000FOR1267.000000FOR4S000064728Invitation Homes Inc.46187W107US46187W107105/07/2026To elect director nominees: Michael D. FascitelliDIRECTOR ELECTIONSISSUER5947.0000000FOR5947.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/07/2026To elect director nominees: Dallas B. TannerDIRECTOR ELECTIONSISSUER5947.0000000FOR5947.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/07/2026To elect director nominees: Jana Cohen BarbeDIRECTOR ELECTIONSISSUER5947.0000000FOR5947.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/07/2026To elect director nominees: H. Wyman Howard IIIDIRECTOR ELECTIONSISSUER5947.0000000FOR5947.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/07/2026To elect director nominees: Jeffrey E. KelterDIRECTOR ELECTIONSISSUER5947.0000000FOR5947.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/07/2026To elect director nominees: Kellyn Smith KennyDIRECTOR ELECTIONSISSUER5947.0000000FOR5947.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/07/2026To elect director nominees: Joseph D. MargolisDIRECTOR ELECTIONSISSUER5947.0000000FOR5947.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/07/2026To elect director nominees: Frances Aldrich Sevilla-SacasaDIRECTOR ELECTIONSISSUER5947.0000000FOR5947.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/07/2026To elect director nominees: Keith D. TaylorDIRECTOR ELECTIONSISSUER5947.0000000FOR5947.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/07/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER5947.0000000FOR5947.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/07/2026To approve, in a non-binding advisory vote, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5947.0000000FOR5947.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/07/2026To approve, in a non-binding advisory vote, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5947.0000000FOR5947.000000FOR4S000064728Invitation Homes Inc.46187W107US46187W107105/07/2026To approve the Invitation Homes Inc. 2026 Omnibus Incentive Plan.COMPENSATIONISSUER5947.0000000FOR5947.000000FORS000064728Ryman Hospitality Properties, Inc.78377T107US78377T107905/07/2026Election of Directors: Rachna BhasinDIRECTOR ELECTIONSISSUER1665.0000000FOR1665.000000FORS000064728Ryman Hospitality Properties, Inc.78377T107US78377T107905/07/2026Election of Directors: H. Eric Bolton, Jr.DIRECTOR ELECTIONSISSUER1665.0000000FOR1665.000000FORS000064728Ryman Hospitality Properties, Inc.78377T107US78377T107905/07/2026Election of Directors: Alvin Bowles Jr.DIRECTOR ELECTIONSISSUER1665.0000000FOR1665.000000FORS000064728Ryman Hospitality Properties, Inc.78377T107US78377T107905/07/2026Election of Directors: Mark FioravantiDIRECTOR ELECTIONSISSUER1665.0000000FOR1665.000000FORS000064728Ryman Hospitality Properties, Inc.78377T107US78377T107905/07/2026Election of Directors: William E. HaslamDIRECTOR ELECTIONSISSUER1665.0000000FOR1665.000000FORS000064728Ryman Hospitality Properties, Inc.78377T107US78377T107905/07/2026Election of Directors: Erin Mulligan HelgrenDIRECTOR ELECTIONSISSUER1665.0000000FOR1665.000000FORS000064728Ryman Hospitality Properties, Inc.78377T107US78377T107905/07/2026Election of Directors: Christine PantoyaDIRECTOR ELECTIONSISSUER1665.0000000FOR1665.000000FORS000064728Ryman Hospitality Properties, Inc.78377T107US78377T107905/07/2026Election of Directors: Robert Prather, Jr.DIRECTOR ELECTIONSISSUER1665.0000000FOR1665.000000FORS000064728Ryman Hospitality Properties, Inc.78377T107US78377T107905/07/2026Election of Directors: Colin ReedDIRECTOR ELECTIONSISSUER1665.0000000FOR1665.000000FORS000064728Ryman Hospitality Properties, Inc.78377T107US78377T107905/07/2026Election of Directors: Michael RothDIRECTOR ELECTIONSISSUER1665.0000000FOR1665.000000FORS000064728Ryman Hospitality Properties, Inc.78377T107US78377T107905/07/2026To approve, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1665.0000000FOR1665.000000FORS000064728Ryman Hospitality Properties, Inc.78377T107US78377T107905/07/2026To approve, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1665.0000000FOR1665.000000FOR4S000064728Ryman Hospitality Properties, Inc.78377T107US78377T107905/07/2026To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2026.AUDIT-RELATEDISSUER1665.0000000FOR1665.000000FORS000064728Select Water Solutions, Inc.81617J301US81617J301405/07/2026To elect seven director nominees to the Board of Directors of Select Water Solutions, Inc.: Gayle L. BurlesonDIRECTOR ELECTIONSISSUER15168.0000000FOR15168.000000FORS000064728Select Water Solutions, Inc.81617J301US81617J301405/07/2026To elect seven director nominees to the Board of Directors of Select Water Solutions, Inc.: Richard A. BurnettDIRECTOR ELECTIONSISSUER15168.0000000FOR15168.000000FORS000064728Select Water Solutions, Inc.81617J301US81617J301405/07/2026To elect seven director nominees to the Board of Directors of Select Water Solutions, Inc.: Bruce E. CopeDIRECTOR ELECTIONSISSUER15168.0000000FOR15168.000000FORS000064728Select Water Solutions, Inc.81617J301US81617J301405/07/2026To elect seven director nominees to the Board of Directors of Select Water Solutions, Inc.: Luis Fernandez-MorenoDIRECTOR ELECTIONSISSUER15168.0000000FOR15168.000000FORS000064728Select Water Solutions, Inc.81617J301US81617J301405/07/2026To elect seven director nominees to the Board of Directors of Select Water Solutions, Inc.: Robin H. FielderDIRECTOR ELECTIONSISSUER15168.0000000FOR15168.000000FORS000064728Select Water Solutions, Inc.81617J301US81617J301405/07/2026To elect seven director nominees to the Board of Directors of Select Water Solutions, Inc.: Timothy A. RobertsDIRECTOR ELECTIONSISSUER15168.0000000FOR15168.000000FORS000064728Select Water Solutions, Inc.81617J301US81617J301405/07/2026To elect seven director nominees to the Board of Directors of Select Water Solutions, Inc.: John D. SchmitzDIRECTOR ELECTIONSISSUER15168.0000000FOR15168.000000FORS000064728Select Water Solutions, Inc.81617J301US81617J301405/07/2026To ratify the appointment, by the Audit Committee of the Board, of Grant Thornton LLP as the Company's independent registered public accounting firm for fiscal year 2026.AUDIT-RELATEDISSUER15168.0000000FOR15168.000000FORS000064728Select Water Solutions, Inc.81617J301US81617J301405/07/2026To conduct a non-binding, advisory vote to approve Named Executive Officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER15168.0000000FOR15168.000000FORS000064728Select Water Solutions, Inc.81617J301US81617J301405/07/2026To conduct a non-binding, advisory vote to approve Named Executive Officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER15168.0000000FOR15168.000000FOR4S000064728TURKCELL Iletisim Hizmetleri AS900111204US900111204705/07/2026Open Meeting and Elect Presiding Council of MeetingOTHERFormalities - This code is used to approve/acknowledge meeting procedures. This is a routine item that is required by law in some countries.ISSUER27842.0000000FOR27842.000000FORS000064728TURKCELL Iletisim Hizmetleri AS900111204US900111204705/07/2026Accept Financial Statements and Sustainability ReportCORPORATE GOVERNANCEISSUER27842.0000000FOR27842.000000FORS000064728TURKCELL Iletisim Hizmetleri AS900111204US900111204705/07/2026Approve Discharge of BoardCORPORATE GOVERNANCEISSUER27842.0000000FOR27842.000000FORS000064728TURKCELL Iletisim Hizmetleri AS900111204US900111204705/07/2026Amend Corporate PurposeCORPORATE GOVERNANCEISSUER27842.0000000FOR27842.000000FORS000064728TURKCELL Iletisim Hizmetleri AS900111204US900111204705/07/2026Approve Upper Limit of Donations for 2026 and Receive Information on Donations Made in 2025OTHER SOCIAL ISSUESISSUER27842.0000000FOR27842.000000FORS000064728TURKCELL Iletisim Hizmetleri AS900111204US900111204705/07/2026Ratify Director Appointments and Elect DirectorsDIRECTOR ELECTIONSISSUER27842.0000000AGAINST27842.000000AGAINSTS000064728TURKCELL Iletisim Hizmetleri AS900111204US900111204705/07/2026Approve Director RemunerationCOMPENSATIONISSUER27842.0000000AGAINST27842.000000AGAINSTS000064728TURKCELL Iletisim Hizmetleri AS900111204US900111204705/07/2026Ratify External AuditorsAUDIT-RELATEDISSUER27842.0000000AGAINST27842.000000AGAINSTS000064728TURKCELL Iletisim Hizmetleri AS900111204US900111204705/07/2026Appoint Auditor for Sustainability ReportingAUDIT-RELATEDISSUER27842.0000000AGAINST27842.000000AGAINSTS000064728TURKCELL Iletisim Hizmetleri AS900111204US900111204705/07/2026Approve Allocation of IncomeCAPITAL STRUCTUREISSUER27842.0000000FOR27842.000000FORS000064728TURKCELL Iletisim Hizmetleri AS900111204US900111204705/07/2026Grant Permission for Board Members to Engage in Commercial Transactions with Company and Be Involved with Companies with Similar Corporate Purpose in Accordance with Articles 395 and 396 of Turkish Commercial LawCORPORATE GOVERNANCEISSUER27842.0000000FOR27842.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027: Warner L. BaxterDIRECTOR ELECTIONSISSUER1550.0000000FOR1550.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027: Ave M. BieDIRECTOR ELECTIONSISSUER1550.0000000FOR1550.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027: Danny L. CunninghamDIRECTOR ELECTIONSISSUER1550.0000000FOR1550.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027: William M. Farrow IIIDIRECTOR ELECTIONSISSUER1550.0000000FOR1550.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027: Cristina A. Garcia-ThomasDIRECTOR ELECTIONSISSUER1550.0000000FOR1550.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027: Maria C. GreenDIRECTOR ELECTIONSISSUER1550.0000000FOR1550.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027: Thomas K. LaneDIRECTOR ELECTIONSISSUER1550.0000000FOR1550.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027: John D. LangeDIRECTOR ELECTIONSISSUER1550.0000000FOR1550.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027: Scott J. LauberDIRECTOR ELECTIONSISSUER1550.0000000FOR1550.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027: Ulice Payne, Jr.DIRECTOR ELECTIONSISSUER1550.0000000FOR1550.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027: Mary Ellen StanekDIRECTOR ELECTIONSISSUER1550.0000000FOR1550.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Election of 12 Directors, each for a 1-year term expiring in 2027: Glen E. TellockDIRECTOR ELECTIONSISSUER1550.0000000FOR1550.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Ratification of Deloitte & Touche LLP as independent auditors for 2026AUDIT-RELATEDISSUER1550.0000000FOR1550.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Advisory vote to approve executive compensation of the named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER1550.0000000FOR1550.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Advisory vote to approve executive compensation of the named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER1550.0000000FOR1550.000000FOR4S000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Amendments to the Restated Articles of Incorporation to eliminate supermajority voting requirementsCORPORATE GOVERNANCEISSUER1550.0000000FOR1550.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Amendments to the Bylaws to eliminate supermajority voting requirementsCORPORATE GOVERNANCEISSUER1550.0000000FOR1550.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/07/2026Stockholder proposal to govern by majority voteCORPORATE GOVERNANCESECURITY HOLDER1550.0000000FOR1550.000000AGAINSTS000064728Camden Property Trust133131102US133131102705/08/2026Election of Trust Managers: Richard J. CampoDIRECTOR ELECTIONSISSUER1498.0000000FOR1498.000000FORS000064728Camden Property Trust133131102US133131102705/08/2026Election of Trust Managers: Javier E. BenitoDIRECTOR ELECTIONSISSUER1498.0000000FOR1498.000000FORS000064728Camden Property Trust133131102US133131102705/08/2026Election of Trust Managers: Heather J. BrunnerDIRECTOR ELECTIONSISSUER1498.0000000FOR1498.000000FORS000064728Camden Property Trust133131102US133131102705/08/2026Election of Trust Managers: Mark D. GibsonDIRECTOR ELECTIONSISSUER1498.0000000FOR1498.000000FORS000064728Camden Property Trust133131102US133131102705/08/2026Election of Trust Managers: Scott S. IngrahamDIRECTOR ELECTIONSISSUER1498.0000000FOR1498.000000FORS000064728Camden Property Trust133131102US133131102705/08/2026Election of Trust Managers: Alexander J. JessettDIRECTOR ELECTIONSISSUER1498.0000000FOR1498.000000FORS000064728Camden Property Trust133131102US133131102705/08/2026Election of Trust Managers: Renu KhatorDIRECTOR ELECTIONSISSUER1498.0000000FOR1498.000000FORS000064728Camden Property Trust133131102US133131102705/08/2026Election of Trust Managers: D. Keith OdenDIRECTOR ELECTIONSISSUER1498.0000000FOR1498.000000FORS000064728Camden Property Trust133131102US133131102705/08/2026Election of Trust Managers: Frances Aldrich Sevilla-SacasaDIRECTOR ELECTIONSISSUER1498.0000000FOR1498.000000FORS000064728Camden Property Trust133131102US133131102705/08/2026Election of Trust Managers: Steven A. WebsterDIRECTOR ELECTIONSISSUER1498.0000000FOR1498.000000FORS000064728Camden Property Trust133131102US133131102705/08/2026Election of Trust Managers: Kelvin R. WestbrookDIRECTOR ELECTIONSISSUER1498.0000000FOR1498.000000FORS000064728Camden Property Trust133131102US133131102705/08/2026Approval, by an advisory vote, of executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1498.0000000FOR1498.000000FORS000064728Camden Property Trust133131102US133131102705/08/2026Approval, by an advisory vote, of executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1498.0000000FOR1498.000000FOR4S000064728Camden Property Trust133131102US133131102705/08/2026Ratification of Deloitte & Touche LLP as the independent registered public accounting firm.AUDIT-RELATEDISSUER1498.0000000FOR1498.000000FORS000064728Camden Property Trust133131102US133131102705/08/2026Approval of Amended and Restated 2018 Share Incentive PlanCOMPENSATIONISSUER1498.0000000FOR1498.000000FORS000064728Camden Property Trust133131102US133131102705/08/2026Approval of Amended and Restated 2018 Employee Share Purchase PlanCOMPENSATIONISSUER1498.0000000FOR1498.000000FORS000064728CMS Energy Corporation125896100US125896100205/08/2026ELECTION OF DIRECTORS: Deborah H. ButlerDIRECTOR ELECTIONSISSUER2331.0000000FOR2331.000000FORS000064728CMS Energy Corporation125896100US125896100205/08/2026ELECTION OF DIRECTORS: Ralph IzzoDIRECTOR ELECTIONSISSUER2331.0000000FOR2331.000000FORS000064728CMS Energy Corporation125896100US125896100205/08/2026ELECTION OF DIRECTORS: Richard P. KeyesDIRECTOR ELECTIONSISSUER2331.0000000FOR2331.000000FORS000064728CMS Energy Corporation125896100US125896100205/08/2026ELECTION OF DIRECTORS: Diane LeopoldDIRECTOR ELECTIONSISSUER2331.0000000FOR2331.000000FORS000064728CMS Energy Corporation125896100US125896100205/08/2026ELECTION OF DIRECTORS: Garrick J. RochowDIRECTOR ELECTIONSISSUER2331.0000000FOR2331.000000FORS000064728CMS Energy Corporation125896100US125896100205/08/2026ELECTION OF DIRECTORS: John G. RussellDIRECTOR ELECTIONSISSUER2331.0000000FOR2331.000000FORS000064728CMS Energy Corporation125896100US125896100205/08/2026ELECTION OF DIRECTORS: Suzanne F. ShankDIRECTOR ELECTIONSISSUER2331.0000000FOR2331.000000FORS000064728CMS Energy Corporation125896100US125896100205/08/2026ELECTION OF DIRECTORS: Myrna M. SotoDIRECTOR ELECTIONSISSUER2331.0000000FOR2331.000000FORS000064728CMS Energy Corporation125896100US125896100205/08/2026ELECTION OF DIRECTORS: John G. SznewajsDIRECTOR ELECTIONSISSUER2331.0000000FOR2331.000000FORS000064728CMS Energy Corporation125896100US125896100205/08/2026ELECTION OF DIRECTORS: Ronald J. TanskiDIRECTOR ELECTIONSISSUER2331.0000000FOR2331.000000FORS000064728CMS Energy Corporation125896100US125896100205/08/2026ELECTION OF DIRECTORS: Laura H. WrightDIRECTOR ELECTIONSISSUER2331.0000000FOR2331.000000FORS000064728CMS Energy Corporation125896100US125896100205/08/2026Approve, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2331.0000000FOR2331.000000FORS000064728CMS Energy Corporation125896100US125896100205/08/2026Approve, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2331.0000000FOR2331.000000FOR4S000064728CMS Energy Corporation125896100US125896100205/08/2026Ratify the appointment of independent registered public accounting firm (PricewaterhouseCoopers LLP).AUDIT-RELATEDISSUER2331.0000000FOR2331.000000FORS000064728CMS Energy Corporation125896100US125896100205/08/2026Approve an Amendment to the Restated Articles of Incorporation Increasing the Number of Authorized Shares of Common Stock from 350 Million Shares to 700 Million Shares.CAPITAL STRUCTUREISSUER2331.0000000FOR2331.000000FORS000064728CMS Energy Corporation125896100US125896100205/08/2026Approve an Amendment to the Restated Articles of Incorporation to Allow Shareholders to Call a Special Meeting.CORPORATE GOVERNANCEISSUER2331.0000000FOR2331.000000FORS000064728CMS Energy Corporation125896100US125896100205/08/2026Vote on a Shareholder Proposal: Shareholder Right to Act by Written Consent.CORPORATE GOVERNANCESECURITY HOLDER2331.0000000FOR2331.000000AGAINSTS000064728Magnolia Oil & Gas Corporation559663109US559663109405/08/2026Election of Directors: Christopher G. StavrosDIRECTOR ELECTIONSISSUER7459.0000000FOR7459.000000FORS000064728Magnolia Oil & Gas Corporation559663109US559663109405/08/2026Election of Directors: Dan F. SmithDIRECTOR ELECTIONSISSUER7459.0000000FOR7459.000000FORS000064728Magnolia Oil & Gas Corporation559663109US559663109405/08/2026Election of Directors: Arcilia C. AcostaDIRECTOR ELECTIONSISSUER7459.0000000FOR7459.000000FORS000064728Magnolia Oil & Gas Corporation559663109US559663109405/08/2026Election of Directors: Edward P. DjerejianDIRECTOR ELECTIONSISSUER7459.0000000FOR7459.000000FORS000064728Magnolia Oil & Gas Corporation559663109US559663109405/08/2026Election of Directors: David M. KhaniDIRECTOR ELECTIONSISSUER7459.0000000FOR7459.000000FORS000064728Magnolia Oil & Gas Corporation559663109US559663109405/08/2026Election of Directors: James R. LarsonDIRECTOR ELECTIONSISSUER7459.0000000FOR7459.000000FORS000064728Magnolia Oil & Gas Corporation559663109US559663109405/08/2026Election of Directors: R. Lewis RoppDIRECTOR ELECTIONSISSUER7459.0000000FOR7459.000000FORS000064728Magnolia Oil & Gas Corporation559663109US559663109405/08/2026Election of Directors: Shandell M. SzaboDIRECTOR ELECTIONSISSUER7459.0000000FOR7459.000000FORS000064728Magnolia Oil & Gas Corporation559663109US559663109405/08/2026Approval of the advisory, non-binding resolution regarding the compensation of our named executive officers for 2025 ("say-on-pay vote")SECTION 14A SAY-ON-PAY VOTESISSUER7459.0000000FOR7459.000000FORS000064728Magnolia Oil & Gas Corporation559663109US559663109405/08/2026Approval of the advisory, non-binding resolution regarding the compensation of our named executive officers for 2025 ("say-on-pay vote")SECTION 14A SAY-ON-PAY VOTESISSUER7459.0000000FOR7459.000000FOR4S000064728Magnolia Oil & Gas Corporation559663109US559663109405/08/2026Ratification of appointment of KPMG LLP as our independent registered public accounting firm for the 2026 fiscal yearAUDIT-RELATEDISSUER7459.0000000FOR7459.000000FORS000064728Essex Property Trust, Inc.297178105US297178105705/12/2026Election of Directors: John V. ArabiaDIRECTOR ELECTIONSISSUER623.0000000FOR623.000000FORS000064728Essex Property Trust, Inc.297178105US297178105705/12/2026Election of Directors: Keith R. GuerickeDIRECTOR ELECTIONSISSUER623.0000000AGAINST623.000000AGAINSTS000064728Essex Property Trust, Inc.297178105US297178105705/12/2026Election of Directors: Anne B. GustDIRECTOR ELECTIONSISSUER623.0000000FOR623.000000FORS000064728Essex Property Trust, Inc.297178105US297178105705/12/2026Election of Directors: Maria R. HawthorneDIRECTOR ELECTIONSISSUER623.0000000FOR623.000000FORS000064728Essex Property Trust, Inc.297178105US297178105705/12/2026Election of Directors: Amal M. JohnsonDIRECTOR ELECTIONSISSUER623.0000000FOR623.000000FORS000064728Essex Property Trust, Inc.297178105US297178105705/12/2026Election of Directors: Mary KasarisDIRECTOR ELECTIONSISSUER623.0000000FOR623.000000FORS000064728Essex Property Trust, Inc.297178105US297178105705/12/2026Election of Directors: Angela L. KleimanDIRECTOR ELECTIONSISSUER623.0000000FOR623.000000FORS000064728Essex Property Trust, Inc.297178105US297178105705/12/2026Election of Directors: Irving F. Lyons, IIIDIRECTOR ELECTIONSISSUER623.0000000FOR623.000000FORS000064728Essex Property Trust, Inc.297178105US297178105705/12/2026Election of Directors: George M. MarcusDIRECTOR ELECTIONSISSUER623.0000000FOR623.000000FORS000064728Essex Property Trust, Inc.297178105US297178105705/12/2026Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026.AUDIT-RELATEDISSUER623.0000000FOR623.000000FORS000064728Essex Property Trust, Inc.297178105US297178105705/12/2026Advisory vote to approve the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER623.0000000FOR623.000000FORS000064728Essex Property Trust, Inc.297178105US297178105705/12/2026Advisory vote to approve the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER623.0000000FOR623.000000FOR4S000064728Tenaris SA88031M109US88031M109905/12/2026Receive and Approve Board's and Auditor's Reports Re: Consolidated Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER3298.0000000FOR3298.000000FORS000064728Tenaris SA88031M109US88031M109905/12/2026Approve Consolidated Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER3298.0000000FOR3298.000000FORS000064728Tenaris SA88031M109US88031M109905/12/2026Approve Financial StatementsCORPORATE GOVERNANCEISSUER3298.0000000FOR3298.000000FORS000064728Tenaris SA88031M109US88031M109905/12/2026Approve Allocation of Income and DividendsCAPITAL STRUCTUREISSUER3298.0000000FOR3298.000000FORS000064728Tenaris SA88031M109US88031M109905/12/2026Approve Discharge of DirectorsCORPORATE GOVERNANCEISSUER3298.0000000FOR3298.000000FORS000064728Tenaris SA88031M109US88031M109905/12/2026Elect Directors (Bundled)DIRECTOR ELECTIONSISSUER3298.0000000AGAINST3298.000000AGAINSTS000064728Tenaris SA88031M109US88031M109905/12/2026Approve Remuneration of DirectorsCOMPENSATIONISSUER3298.0000000FOR3298.000000FORS000064728Tenaris SA88031M109US88031M109905/12/2026Approve Remuneration ReportCOMPENSATIONISSUER3298.0000000AGAINST3298.000000AGAINSTS000064728Tenaris SA88031M109US88031M109905/12/2026Approve Auditors and Authorize Board to Fix Their RemunerationAUDIT-RELATEDISSUER3298.0000000FOR3298.000000FORS000064728Tenaris SA88031M109US88031M109905/12/2026Approve Share RepurchaseCAPITAL STRUCTUREISSUER3298.0000000AGAINST3298.000000AGAINSTS000064728Tenaris SA88031M109US88031M109905/12/2026Allow Electronic Distribution of Company Documents to ShareholdersCORPORATE GOVERNANCEISSUER3298.0000000FOR3298.000000FORS000064728Tenaris SA88031M109US88031M109905/12/2026Approve Reduction in Share Capital through Cancellation of SharesCAPITAL STRUCTUREISSUER3298.0000000FOR3298.000000FORS000064728Tenaris SA88031M109US88031M109905/12/2026Amend Article 5 Re: Cancellation of SharesCAPITAL STRUCTURECORPORATE GOVERNANCEISSUER3298.0000000FOR3298.000000FORS000064728Acadia Realty Trust004239109US004239109605/13/2026Election of Trustees: Kenneth F. BernsteinDIRECTOR ELECTIONSISSUER7901.0000000FOR7901.000000FORS000064728Acadia Realty Trust004239109US004239109605/13/2026Election of Trustees: Mark A. DenienDIRECTOR ELECTIONSISSUER7901.0000000FOR7901.000000FORS000064728Acadia Realty Trust004239109US004239109605/13/2026Election of Trustees: Kenneth A. McIntyreDIRECTOR ELECTIONSISSUER7901.0000000FOR7901.000000FORS000064728Acadia Realty Trust004239109US004239109605/13/2026Election of Trustees: William T. SpitzDIRECTOR ELECTIONSISSUER7901.0000000FOR7901.000000FORS000064728Acadia Realty Trust004239109US004239109605/13/2026Election of Trustees: Lynn C. ThurberDIRECTOR ELECTIONSISSUER7901.0000000FOR7901.000000FORS000064728Acadia Realty Trust004239109US004239109605/13/2026Election of Trustees: Lee S. WielanskyDIRECTOR ELECTIONSISSUER7901.0000000FOR7901.000000FORS000064728Acadia Realty Trust004239109US004239109605/13/2026Election of Trustees: Hope B. WoodhouseDIRECTOR ELECTIONSISSUER7901.0000000FOR7901.000000FORS000064728Acadia Realty Trust004239109US004239109605/13/2026Election of Trustees: C. David ZobaDIRECTOR ELECTIONSISSUER7901.0000000FOR7901.000000FORS000064728Acadia Realty Trust004239109US004239109605/13/2026THE RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.AUDIT-RELATEDISSUER7901.0000000FOR7901.000000FORS000064728Acadia Realty Trust004239109US004239109605/13/2026THE APPROVAL, ON A NON-BINDING ADVISORY BASIS, OF THE COMPENSATION OF NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE COMPANY'S 2026 PROXY STATEMENT.SECTION 14A SAY-ON-PAY VOTESISSUER7901.0000000FOR7901.000000FORS000064728Acadia Realty Trust004239109US004239109605/13/2026THE APPROVAL, ON A NON-BINDING ADVISORY BASIS, OF THE COMPENSATION OF NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE COMPANY'S 2026 PROXY STATEMENT.SECTION 14A SAY-ON-PAY VOTESISSUER7901.0000000FOR7901.000000FOR4S000064728HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Anne-Marie N. AinsworthDIRECTOR ELECTIONSISSUER3489.0000000FOR3489.000000FORS000064728HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Anna C. CatalanoDIRECTOR ELECTIONSISSUER3489.0000000FOR3489.000000FORS000064728HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Leldon E. EcholsDIRECTOR ELECTIONSISSUER3489.0000000FOR3489.000000FORS000064728HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Manuel J. FernandezDIRECTOR ELECTIONSISSUER3489.0000000FOR3489.000000FORS000064728HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Rhoman J. HardyDIRECTOR ELECTIONSISSUER3489.0000000FOR3489.000000FORS000064728HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Jeanne M. JohnsDIRECTOR ELECTIONSISSUER3489.0000000FOR3489.000000FORS000064728HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: R. Craig KnockeDIRECTOR ELECTIONSISSUER3489.0000000FOR3489.000000FORS000064728HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Robert J. KostelnikDIRECTOR ELECTIONSISSUER3489.0000000FOR3489.000000FORS000064728HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Ross B. MatthewsDIRECTOR ELECTIONSISSUER3489.0000000FOR3489.000000FORS000064728HF Sinclair Corporation403949100US403949100005/13/2026Election of Directors: Franklin MyersDIRECTOR ELECTIONSISSUER3489.0000000FOR3489.000000FORS000064728HF Sinclair Corporation403949100US403949100005/13/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3489.0000000FOR3489.000000FORS000064728HF Sinclair Corporation403949100US403949100005/13/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3489.0000000FOR3489.000000FOR4S000064728HF Sinclair Corporation403949100US403949100005/13/2026Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2026 fiscal year.AUDIT-RELATEDISSUER3489.0000000FOR3489.000000FORS000064728Independence Realty Trust, Inc.45378A106US45378A106005/13/2026ELECTION OF DIRECTORS: Scott F. SchaefferDIRECTOR ELECTIONSISSUER9426.0000000FOR9426.000000FORS000064728Independence Realty Trust, Inc.45378A106US45378A106005/13/2026ELECTION OF DIRECTORS: Ned W. BrinesDIRECTOR ELECTIONSISSUER9426.0000000FOR9426.000000FORS000064728Independence Realty Trust, Inc.45378A106US45378A106005/13/2026ELECTION OF DIRECTORS: Richard D. GebertDIRECTOR ELECTIONSISSUER9426.0000000FOR9426.000000FORS000064728Independence Realty Trust, Inc.45378A106US45378A106005/13/2026ELECTION OF DIRECTORS: Melinda H. McClureDIRECTOR ELECTIONSISSUER9426.0000000FOR9426.000000FORS000064728Independence Realty Trust, Inc.45378A106US45378A106005/13/2026ELECTION OF DIRECTORS: James J. SebraDIRECTOR ELECTIONSISSUER9426.0000000FOR9426.000000FORS000064728Independence Realty Trust, Inc.45378A106US45378A106005/13/2026ELECTION OF DIRECTORS: Ana Marie del RioDIRECTOR ELECTIONSISSUER9426.0000000FOR9426.000000FORS000064728Independence Realty Trust, Inc.45378A106US45378A106005/13/2026ELECTION OF DIRECTORS: DeForest B. Soaries, Jr.DIRECTOR ELECTIONSISSUER9426.0000000FOR9426.000000FORS000064728Independence Realty Trust, Inc.45378A106US45378A106005/13/2026ELECTION OF DIRECTORS: Lisa WashingtonDIRECTOR ELECTIONSISSUER9426.0000000FOR9426.000000FORS000064728Independence Realty Trust, Inc.45378A106US45378A106005/13/2026ELECTION OF DIRECTORS: Craig MacnabDIRECTOR ELECTIONSISSUER9426.0000000FOR9426.000000FORS000064728Independence Realty Trust, Inc.45378A106US45378A106005/13/2026The Board of Directors recommends: a vote FOR ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER9426.0000000FOR9426.000000FORS000064728Independence Realty Trust, Inc.45378A106US45378A106005/13/2026The Board of Directors recommends: a vote FOR the advisory, non-binding resolution to approve the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER9426.0000000FOR9426.000000FORS000064728Independence Realty Trust, Inc.45378A106US45378A106005/13/2026The Board of Directors recommends: a vote FOR the advisory, non-binding resolution to approve the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER9426.0000000FOR9426.000000FOR4S000064728Independence Realty Trust, Inc.45378A106US45378A106005/13/2026The Board of Directors recommends: a vote for EVERY YEAR as the frequency of future advisory votes on the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER9426.0000000ONE YEAR9426.000000FORS000064728Independence Realty Trust, Inc.45378A106US45378A106005/13/2026The Board of Directors recommends: a vote for EVERY YEAR as the frequency of future advisory votes on the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER9426.0000000ONE YEAR9426.000000FOR4S000064728Murphy Oil Corporation626717102US626717102205/13/2026Election of Directors: C.P. DemingDIRECTOR ELECTIONSISSUER1.0000005128.000000FOR1.000000FORS000064728Murphy Oil Corporation626717102US626717102205/13/2026Election of Directors: L.R. DickersonDIRECTOR ELECTIONSISSUER1.0000005128.000000FOR1.000000FORS000064728Murphy Oil Corporation626717102US626717102205/13/2026Election of Directors: M.A. EarleyDIRECTOR ELECTIONSISSUER1.0000005128.000000FOR1.000000FORS000064728Murphy Oil Corporation626717102US626717102205/13/2026Election of Directors: E.M. HamblyDIRECTOR ELECTIONSISSUER1.0000005128.000000FOR1.000000FORS000064728Murphy Oil Corporation626717102US626717102205/13/2026Election of Directors: E.W. KellerDIRECTOR ELECTIONSISSUER1.0000005128.000000FOR1.000000FORS000064728Murphy Oil Corporation626717102US626717102205/13/2026Election of Directors: R.M. MurphyDIRECTOR ELECTIONSISSUER1.0000005128.000000FOR1.000000FORS000064728Murphy Oil Corporation626717102US626717102205/13/2026Election of Directors: J.W. NolanDIRECTOR ELECTIONSISSUER1.0000005128.000000FOR1.000000FORS000064728Murphy Oil Corporation626717102US626717102205/13/2026Election of Directors: R.N. Ryan, Jr.DIRECTOR ELECTIONSISSUER1.0000005128.000000FOR1.000000FORS000064728Murphy Oil Corporation626717102US626717102205/13/2026Election of Directors: L.A. SuggDIRECTOR ELECTIONSISSUER1.0000005128.000000FOR1.000000FORS000064728Murphy Oil Corporation626717102US626717102205/13/2026Election of Directors: R.B. Tudor, IIIDIRECTOR ELECTIONSISSUER1.0000005128.000000FOR1.000000FORS000064728Murphy Oil Corporation626717102US626717102205/13/2026Advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000005128.000000FOR1.000000FORS000064728Murphy Oil Corporation626717102US626717102205/13/2026Advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000005128.000000FOR1.000000FOR4S000064728Murphy Oil Corporation626717102US626717102205/13/2026Approval of proposed 2026 Stock Plan for Non-Employee Directors.COMPENSATIONISSUER1.0000005128.000000FOR1.000000FORS000064728Murphy Oil Corporation626717102US626717102205/13/2026Approval of the appointment of KPMG LLP as independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER1.0000005128.000000FOR1.000000FORS000064728Agree Realty Corporation008492100US008492100805/14/2026Election of Directors: John Rakolta, Jr.DIRECTOR ELECTIONSISSUER1.0000002247.000000FOR1.000000FORS000064728Agree Realty Corporation008492100US008492100805/14/2026Election of Directors: Jerome RossiDIRECTOR ELECTIONSISSUER1.0000002247.000000FOR1.000000FORS000064728Agree Realty Corporation008492100US008492100805/14/2026To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER1.0000002247.000000FOR1.000000FORS000064728Agree Realty Corporation008492100US008492100805/14/2026To approve, by non-binding vote, executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000002247.000000FOR1.000000FORS000064728Agree Realty Corporation008492100US008492100805/14/2026To approve, by non-binding vote, executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000002247.000000FOR1.000000FOR4S000064728Ameren Corporation023608102US023608102405/14/2026COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR: CYNTHIA J. BRINKLEYDIRECTOR ELECTIONSISSUER1635.0000000FOR1635.000000FORS000064728Ameren Corporation023608102US023608102405/14/2026COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR: WARD H. DICKSONDIRECTOR ELECTIONSISSUER1635.0000000FOR1635.000000FORS000064728Ameren Corporation023608102US023608102405/14/2026COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR: JAMIE L. ENGSTROMDIRECTOR ELECTIONSISSUER1635.0000000FOR1635.000000FORS000064728Ameren Corporation023608102US023608102405/14/2026COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR: ELLEN M. FITZSIMMONSDIRECTOR ELECTIONSISSUER1635.0000000FOR1635.000000FORS000064728Ameren Corporation023608102US023608102405/14/2026COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR: RAFAEL FLORESDIRECTOR ELECTIONSISSUER1635.0000000FOR1635.000000FORS000064728Ameren Corporation023608102US023608102405/14/2026COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR: RICHARD J. HARSHMANDIRECTOR ELECTIONSISSUER1635.0000000FOR1635.000000FORS000064728Ameren Corporation023608102US023608102405/14/2026COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR: CRAIG S. IVEYDIRECTOR ELECTIONSISSUER1635.0000000FOR1635.000000FORS000064728Ameren Corporation023608102US023608102405/14/2026COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR: STEVEN H. LIPSTEINDIRECTOR ELECTIONSISSUER1635.0000000FOR1635.000000FORS000064728Ameren Corporation023608102US023608102405/14/2026COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR: MARTIN J. LYONS, JR.DIRECTOR ELECTIONSISSUER1635.0000000FOR1635.000000FORS000064728Ameren Corporation023608102US023608102405/14/2026COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR: LEO S. MACKAY, JR.DIRECTOR ELECTIONSISSUER1635.0000000FOR1635.000000FORS000064728Ameren Corporation023608102US023608102405/14/2026COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR: TIMOTHY S. RAUSCHDIRECTOR ELECTIONSISSUER1635.0000000FOR1635.000000FORS000064728Ameren Corporation023608102US023608102405/14/2026COMPANY PROPOSAL - ELECTION OF DIRECTORS-NOMINEES FOR DIRECTOR: STEVEN O. VONDRANDIRECTOR ELECTIONSISSUER1635.0000000FOR1635.000000FORS000064728Ameren Corporation023608102US023608102405/14/2026COMPANY PROPOSAL - ADVISORY APPROVAL OF COMPENSATION OF THE NAMED EXECUTIVE OFFICERS DISCLOSED IN THE PROXY STATEMENT.SECTION 14A SAY-ON-PAY VOTESISSUER1635.0000000FOR1635.000000FORS000064728Ameren Corporation023608102US023608102405/14/2026COMPANY PROPOSAL - ADVISORY APPROVAL OF COMPENSATION OF THE NAMED EXECUTIVE OFFICERS DISCLOSED IN THE PROXY STATEMENT.SECTION 14A SAY-ON-PAY VOTESISSUER1635.0000000FOR1635.000000FOR4S000064728Ameren Corporation023608102US023608102405/14/2026COMPANY PROPOSAL - RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.AUDIT-RELATEDISSUER1635.0000000FOR1635.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/14/2026Election of Trustees: John A. KiteDIRECTOR ELECTIONSISSUER6800.0000000FOR6800.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/14/2026Election of Trustees: Derrick BurksDIRECTOR ELECTIONSISSUER6800.0000000FOR6800.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/14/2026Election of Trustees: Victor J. ColemanDIRECTOR ELECTIONSISSUER6800.0000000FOR6800.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/14/2026Election of Trustees: Steven P. GrimesDIRECTOR ELECTIONSISSUER6800.0000000AGAINST6800.000000AGAINSTS000064728Kite Realty Group Trust49803T300US49803T300505/14/2026Election of Trustees: Christie B. KellyDIRECTOR ELECTIONSISSUER6800.0000000FOR6800.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/14/2026Election of Trustees: Peter L. LynchDIRECTOR ELECTIONSISSUER6800.0000000FOR6800.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/14/2026Election of Trustees: David R. O'ReillyDIRECTOR ELECTIONSISSUER6800.0000000FOR6800.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/14/2026Election of Trustees: Barton R. PetersonDIRECTOR ELECTIONSISSUER6800.0000000FOR6800.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/14/2026Election of Trustees: Charles H. WurtzebachDIRECTOR ELECTIONSISSUER6800.0000000FOR6800.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/14/2026Election of Trustees: Caroline L. YoungDIRECTOR ELECTIONSISSUER6800.0000000FOR6800.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/14/2026To approve, on an advisory (non-binding) basis, the compensation of Kite Realty Group Trust's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6800.0000000FOR6800.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/14/2026To approve, on an advisory (non-binding) basis, the compensation of Kite Realty Group Trust's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6800.0000000FOR6800.000000FOR4S000064728Kite Realty Group Trust49803T300US49803T300505/14/2026To ratify the appointment of KPMG LLP as the independent registered public accounting firm for Kite Realty Group Trust for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER6800.0000000FOR6800.000000FORS000064728Rayonier Inc.754907103US754907103005/14/2026Election of Directors: Eric J. CremersDIRECTOR ELECTIONSISSUER7580.0000000FOR7580.000000FORS000064728Rayonier Inc.754907103US754907103005/14/2026Election of Directors: Scott R. JonesDIRECTOR ELECTIONSISSUER7580.0000000FOR7580.000000FORS000064728Rayonier Inc.754907103US754907103005/14/2026Election of Directors: Keith E. BassDIRECTOR ELECTIONSISSUER7580.0000000FOR7580.000000FORS000064728Rayonier Inc.754907103US754907103005/14/2026Election of Directors: Linda M. BreardDIRECTOR ELECTIONSISSUER7580.0000000FOR7580.000000FORS000064728Rayonier Inc.754907103US754907103005/14/2026Election of Directors: Michael J. CoveyDIRECTOR ELECTIONSISSUER7580.0000000FOR7580.000000FORS000064728Rayonier Inc.754907103US754907103005/14/2026Election of Directors: Gregg A. GonsalvesDIRECTOR ELECTIONSISSUER7580.0000000FOR7580.000000FORS000064728Rayonier Inc.754907103US754907103005/14/2026Election of Directors: D. Mark LelandDIRECTOR ELECTIONSISSUER7580.0000000FOR7580.000000FORS000064728Rayonier Inc.754907103US754907103005/14/2026Election of Directors: Mark D. McHughDIRECTOR ELECTIONSISSUER7580.0000000FOR7580.000000FORS000064728Rayonier Inc.754907103US754907103005/14/2026Election of Directors: Ann C. NelsonDIRECTOR ELECTIONSISSUER7580.0000000FOR7580.000000FORS000064728Rayonier Inc.754907103US754907103005/14/2026Election of Directors: Lenore M. SullivanDIRECTOR ELECTIONSISSUER7580.0000000FOR7580.000000FORS000064728Rayonier Inc.754907103US754907103005/14/2026Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER7580.0000000FOR7580.000000FORS000064728Rayonier Inc.754907103US754907103005/14/2026Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER7580.0000000FOR7580.000000FOR4S000064728Rayonier Inc.754907103US754907103005/14/2026Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER7580.0000000FOR7580.000000FORS000064728SunCoke Energy, Inc.86722A103US86722A103405/14/2026To elect two directors to the class of directors whose term expires in 2029: Martha Z. CarnesDIRECTOR ELECTIONSISSUER22741.0000000FOR22741.000000FORS000064728SunCoke Energy, Inc.86722A103US86722A103405/14/2026To elect two directors to the class of directors whose term expires in 2029: Katherine T. GatesDIRECTOR ELECTIONSISSUER22741.0000000FOR22741.000000FORS000064728SunCoke Energy, Inc.86722A103US86722A103405/14/2026To hold a non-binding advisory vote to approve the compensation of the Company's named executive officers ("Say-on-Pay").SECTION 14A SAY-ON-PAY VOTESISSUER22741.0000000FOR22741.000000FORS000064728SunCoke Energy, Inc.86722A103US86722A103405/14/2026To hold a non-binding advisory vote to approve the compensation of the Company's named executive officers ("Say-on-Pay").SECTION 14A SAY-ON-PAY VOTESISSUER22741.0000000FOR22741.000000FOR4S000064728SunCoke Energy, Inc.86722A103US86722A103405/14/2026To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER22741.0000000FOR22741.000000FORS000064728Westlake Corporation960413102US960413102205/14/2026Election of Class I Directors: Catherine T. ChaoDIRECTOR ELECTIONSISSUER1.0000002185.000000WITHHOLD1.000000AGAINSTS000064728Westlake Corporation960413102US960413102205/14/2026Election of Class I Directors: Roger A. CreggDIRECTOR ELECTIONSISSUER1.0000002185.000000FOR1.000000FORS000064728Westlake Corporation960413102US960413102205/14/2026Election of Class I Directors: Jean-Marc GilsonDIRECTOR ELECTIONSISSUER1.0000002185.000000WITHHOLD1.000000AGAINSTS000064728Westlake Corporation960413102US960413102205/14/2026Election of Class I Directors: Kimberly S. LubelDIRECTOR ELECTIONSISSUER1.0000002185.000000FOR1.000000FORS000064728Westlake Corporation960413102US960413102205/14/2026Election of Class I Directors: Jeffrey W. SheetsDIRECTOR ELECTIONSISSUER1.0000002185.000000FOR1.000000FORS000064728Westlake Corporation960413102US960413102205/14/2026An advisory vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000002185.000000FOR1.000000FORS000064728Westlake Corporation960413102US960413102205/14/2026An advisory vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000002185.000000FOR1.000000FOR4S000064728Westlake Corporation960413102US960413102205/14/2026To ratify the appointment of PricewaterhouseCoopers LLP to serve as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1.0000002185.000000FOR1.000000FORS000064728Xenia Hotels & Resorts, Inc.984017103US984017103005/14/2026Election of Directors: Marcel VerbaasDIRECTOR ELECTIONSISSUER10949.0000000FOR10949.000000FORS000064728Xenia Hotels & Resorts, Inc.984017103US984017103005/14/2026Election of Directors: Keith E. BassDIRECTOR ELECTIONSISSUER10949.0000000FOR10949.000000FORS000064728Xenia Hotels & Resorts, Inc.984017103US984017103005/14/2026Election of Directors: Thomas M. GartlandDIRECTOR ELECTIONSISSUER10949.0000000FOR10949.000000FORS000064728Xenia Hotels & Resorts, Inc.984017103US984017103005/14/2026Election of Directors: Beverly K. GouletDIRECTOR ELECTIONSISSUER10949.0000000FOR10949.000000FORS000064728Xenia Hotels & Resorts, Inc.984017103US984017103005/14/2026Election of Directors: Arlene Isaacs-LoweDIRECTOR ELECTIONSISSUER10949.0000000FOR10949.000000FORS000064728Xenia Hotels & Resorts, Inc.984017103US984017103005/14/2026Election of Directors: Mary E. McCormickDIRECTOR ELECTIONSISSUER10949.0000000FOR10949.000000FORS000064728Xenia Hotels & Resorts, Inc.984017103US984017103005/14/2026Election of Directors: Terrence MooreheadDIRECTOR ELECTIONSISSUER10949.0000000FOR10949.000000FORS000064728Xenia Hotels & Resorts, Inc.984017103US984017103005/14/2026Election of Directors: Dennis D. OklakDIRECTOR ELECTIONSISSUER10949.0000000FOR10949.000000FORS000064728Xenia Hotels & Resorts, Inc.984017103US984017103005/14/2026To approve, on an advisory and non-binding basis, the compensation of the named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER10949.0000000FOR10949.000000FORS000064728Xenia Hotels & Resorts, Inc.984017103US984017103005/14/2026To approve, on an advisory and non-binding basis, the compensation of the named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER10949.0000000FOR10949.000000FOR4S000064728Xenia Hotels & Resorts, Inc.984017103US984017103005/14/2026Ratification of the appointment of KPMG LLP as Xenia Hotels & Resorts, Inc.'s independent registered public accounting firm for fiscal year 2026.AUDIT-RELATEDISSUER10949.0000000FOR10949.000000FORS000064728Sylvamo Corporation871332102US871332102905/15/2026Elect the seven director nominees named in the proxy statement to our Board of Directors: Christine S. BrevesDIRECTOR ELECTIONSISSUER3316.0000000FOR3316.000000FORS000064728Sylvamo Corporation871332102US871332102905/15/2026Elect the seven director nominees named in the proxy statement to our Board of Directors: Lizanne M. BruceDIRECTOR ELECTIONSISSUER3316.0000000FOR3316.000000FORS000064728Sylvamo Corporation871332102US871332102905/15/2026Elect the seven director nominees named in the proxy statement to our Board of Directors: Jeanmarie DesmondDIRECTOR ELECTIONSISSUER3316.0000000FOR3316.000000FORS000064728Sylvamo Corporation871332102US871332102905/15/2026Elect the seven director nominees named in the proxy statement to our Board of Directors: Joia M. JohnsonDIRECTOR ELECTIONSISSUER3316.0000000FOR3316.000000FORS000064728Sylvamo Corporation871332102US871332102905/15/2026Elect the seven director nominees named in the proxy statement to our Board of Directors: David PetratisDIRECTOR ELECTIONSISSUER3316.0000000FOR3316.000000FORS000064728Sylvamo Corporation871332102US871332102905/15/2026Elect the seven director nominees named in the proxy statement to our Board of Directors: John V. SimsDIRECTOR ELECTIONSISSUER3316.0000000FOR3316.000000FORS000064728Sylvamo Corporation871332102US871332102905/15/2026Elect the seven director nominees named in the proxy statement to our Board of Directors: James P. ZallieDIRECTOR ELECTIONSISSUER3316.0000000FOR3316.000000FORS000064728Sylvamo Corporation871332102US871332102905/15/2026Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER3316.0000000FOR3316.000000FORS000064728Sylvamo Corporation871332102US871332102905/15/2026Approve, on a non-binding advisory basis, the compensation of our named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER3316.0000000FOR3316.000000FORS000064728Sylvamo Corporation871332102US871332102905/15/2026Approve, on a non-binding advisory basis, the compensation of our named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER3316.0000000FOR3316.000000FOR4S000064728Weyerhaeuser Company962166104US962166104305/15/2026Election of Directors: Rick BeckwittDIRECTOR ELECTIONSISSUER6858.0000000FOR6858.000000FORS000064728Weyerhaeuser Company962166104US962166104305/15/2026Election of Directors: Mark A. EmmertDIRECTOR ELECTIONSISSUER6858.0000000FOR6858.000000FORS000064728Weyerhaeuser Company962166104US962166104305/15/2026Election of Directors: Rick R. HolleyDIRECTOR ELECTIONSISSUER6858.0000000FOR6858.000000FORS000064728Weyerhaeuser Company962166104US962166104305/15/2026Election of Directors: Sara Grootwassink LewisDIRECTOR ELECTIONSISSUER6858.0000000FOR6858.000000FORS000064728Weyerhaeuser Company962166104US962166104305/15/2026Election of Directors: Deidra C. MerriwetherDIRECTOR ELECTIONSISSUER6858.0000000FOR6858.000000FORS000064728Weyerhaeuser Company962166104US962166104305/15/2026Election of Directors: Al MonacoDIRECTOR ELECTIONSISSUER6858.0000000FOR6858.000000FORS000064728Weyerhaeuser Company962166104US962166104305/15/2026Election of Directors: James C. O'RourkeDIRECTOR ELECTIONSISSUER6858.0000000FOR6858.000000FORS000064728Weyerhaeuser Company962166104US962166104305/15/2026Election of Directors: Nicole W. PiaseckiDIRECTOR ELECTIONSISSUER6858.0000000FOR6858.000000FORS000064728Weyerhaeuser Company962166104US962166104305/15/2026Election of Directors: Lawrence A. SelzerDIRECTOR ELECTIONSISSUER6858.0000000FOR6858.000000FORS000064728Weyerhaeuser Company962166104US962166104305/15/2026Election of Directors: Devin W. StockfishDIRECTOR ELECTIONSISSUER6858.0000000FOR6858.000000FORS000064728Weyerhaeuser Company962166104US962166104305/15/2026Election of Directors: Kim WilliamsDIRECTOR ELECTIONSISSUER6858.0000000FOR6858.000000FORS000064728Weyerhaeuser Company962166104US962166104305/15/2026Approve, on an Advisory Basis, Compensation of the Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER6858.0000000FOR6858.000000FORS000064728Weyerhaeuser Company962166104US962166104305/15/2026Approve, on an Advisory Basis, Compensation of the Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER6858.0000000FOR6858.000000FOR4S000064728Weyerhaeuser Company962166104US962166104305/15/2026Ratify Appointment of the Independent Auditors.AUDIT-RELATEDISSUER6858.0000000FOR6858.000000FORS000064728CubeSmart229663109US229663109405/19/2026Election of Trustees: Piero BussaniDIRECTOR ELECTIONSISSUER4550.0000000FOR4550.000000FORS000064728CubeSmart229663109US229663109405/19/2026Election of Trustees: Jit Kee ChinDIRECTOR ELECTIONSISSUER4550.0000000FOR4550.000000FORS000064728CubeSmart229663109US229663109405/19/2026Election of Trustees: Martin P. ConnorDIRECTOR ELECTIONSISSUER4550.0000000FOR4550.000000FORS000064728CubeSmart229663109US229663109405/19/2026Election of Trustees: Dorothy DowlingDIRECTOR ELECTIONSISSUER4550.0000000FOR4550.000000FORS000064728CubeSmart229663109US229663109405/19/2026Election of Trustees: Jair K. LynchDIRECTOR ELECTIONSISSUER4550.0000000FOR4550.000000FORS000064728CubeSmart229663109US229663109405/19/2026Election of Trustees: Christopher P. MarrDIRECTOR ELECTIONSISSUER4550.0000000FOR4550.000000FORS000064728CubeSmart229663109US229663109405/19/2026Election of Trustees: John F. RemondiDIRECTOR ELECTIONSISSUER4550.0000000FOR4550.000000FORS000064728CubeSmart229663109US229663109405/19/2026Election of Trustees: Jefrrey F. RogatzDIRECTOR ELECTIONSISSUER4550.0000000FOR4550.000000FORS000064728CubeSmart229663109US229663109405/19/2026Election of Trustees: Jennie WeberDIRECTOR ELECTIONSISSUER4550.0000000FOR4550.000000FORS000064728CubeSmart229663109US229663109405/19/2026To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER4550.0000000FOR4550.000000FORS000064728CubeSmart229663109US229663109405/19/2026To cast an advisory vote to approve our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER4550.0000000FOR4550.000000FORS000064728CubeSmart229663109US229663109405/19/2026To cast an advisory vote to approve our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER4550.0000000FOR4550.000000FOR4S000064728Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: Deborah L. ByersDIRECTOR ELECTIONSISSUER1.0000004704.000000FOR1.000000FORS000064728Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: David I. FoleyDIRECTOR ELECTIONSISSUER1.0000004704.000000FOR1.000000FORS000064728Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: Michael KumarDIRECTOR ELECTIONSISSUER1.0000004704.000000FOR1.000000FORS000064728Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: D. Mark LelandDIRECTOR ELECTIONSISSUER1.0000004704.000000FOR1.000000FORS000064728Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: Kevin S. McCarthyDIRECTOR ELECTIONSISSUER1.0000004704.000000FOR1.000000FORS000064728Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: John-Paul (JP) MunfaDIRECTOR ELECTIONSISSUER1.0000004704.000000FOR1.000000FORS000064728Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: William OrdemannDIRECTOR ELECTIONSISSUER1.0000004704.000000FOR1.000000FORS000064728Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: Karen PuttermanDIRECTOR ELECTIONSISSUER1.0000004704.000000FOR1.000000FORS000064728Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: Laura A. SuggDIRECTOR ELECTIONSISSUER1.0000004704.000000FOR1.000000FORS000064728Kinetik Holdings Inc.02215L209US02215L209705/19/2026Election of Directors: Jamie WelchDIRECTOR ELECTIONSISSUER1.0000004704.000000FOR1.000000FORS000064728Kinetik Holdings Inc.02215L209US02215L209705/19/2026Approval of a non-binding resolution regarding the compensation of named executive officers for 2025 (say-on-pay).SECTION 14A SAY-ON-PAY VOTESISSUER1.0000004704.000000FOR1.000000FORS000064728Kinetik Holdings Inc.02215L209US02215L209705/19/2026Approval of a non-binding resolution regarding the compensation of named executive officers for 2025 (say-on-pay).SECTION 14A SAY-ON-PAY VOTESISSUER1.0000004704.000000FOR1.000000FOR4S000064728Kinetik Holdings Inc.02215L209US02215L209705/19/2026Ratification of the appointment of KPMG LLP as the Company's independent auditor for fiscal year 2026.AUDIT-RELATEDISSUER1.0000004704.000000FOR1.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/19/2026Election of Directors: H. Eric Bolton, Jr.DIRECTOR ELECTIONSISSUER1190.0000000FOR1190.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/19/2026Election of Directors: Deborah H. CaplanDIRECTOR ELECTIONSISSUER1190.0000000FOR1190.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/19/2026Election of Directors: John P. CaseDIRECTOR ELECTIONSISSUER1190.0000000FOR1190.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/19/2026Election of Directors: Tamara FischerDIRECTOR ELECTIONSISSUER1190.0000000FOR1190.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/19/2026Election of Directors: Alan B. Graf, Jr.DIRECTOR ELECTIONSISSUER1190.0000000FOR1190.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/19/2026Election of Directors: Brad HillDIRECTOR ELECTIONSISSUER1190.0000000FOR1190.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/19/2026Election of Directors: Edith Kelly-GreenDIRECTOR ELECTIONSISSUER1190.0000000FOR1190.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/19/2026Election of Directors: Sheila K. McGrathDIRECTOR ELECTIONSISSUER1190.0000000FOR1190.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/19/2026Election of Directors: David P. StockertDIRECTOR ELECTIONSISSUER1190.0000000FOR1190.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/19/2026Advisory (non-binding) vote to approve the compensation of our named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER1190.0000000FOR1190.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/19/2026Advisory (non-binding) vote to approve the compensation of our named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER1190.0000000FOR1190.000000FOR4S000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/19/2026Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2026.AUDIT-RELATEDISSUER1190.0000000FOR1190.000000FORS000064728Permian Resources Corporation71424F105US71424F105705/19/2026To elect the ten directors nominated by the Board: Maire A. BaldwinDIRECTOR ELECTIONSISSUER11548.0000000FOR11548.000000FORS000064728Permian Resources Corporation71424F105US71424F105705/19/2026To elect the ten directors nominated by the Board: Frost W. CochranDIRECTOR ELECTIONSISSUER11548.0000000FOR11548.000000FORS000064728Permian Resources Corporation71424F105US71424F105705/19/2026To elect the ten directors nominated by the Board: Karan E. EvesDIRECTOR ELECTIONSISSUER11548.0000000FOR11548.000000FORS000064728Permian Resources Corporation71424F105US71424F105705/19/2026To elect the ten directors nominated by the Board: Steven D. GrayDIRECTOR ELECTIONSISSUER11548.0000000FOR11548.000000FORS000064728Permian Resources Corporation71424F105US71424F105705/19/2026To elect the ten directors nominated by the Board: William M. Hickey IIIDIRECTOR ELECTIONSISSUER11548.0000000FOR11548.000000FORS000064728Permian Resources Corporation71424F105US71424F105705/19/2026To elect the ten directors nominated by the Board: Aron MarquezDIRECTOR ELECTIONSISSUER11548.0000000FOR11548.000000FORS000064728Permian Resources Corporation71424F105US71424F105705/19/2026To elect the ten directors nominated by the Board: William J. QuinnDIRECTOR ELECTIONSISSUER11548.0000000FOR11548.000000FORS000064728Permian Resources Corporation71424F105US71424F105705/19/2026To elect the ten directors nominated by the Board: Jeffrey H. TepperDIRECTOR ELECTIONSISSUER11548.0000000FOR11548.000000FORS000064728Permian Resources Corporation71424F105US71424F105705/19/2026To elect the ten directors nominated by the Board: Robert M. TichioDIRECTOR ELECTIONSISSUER11548.0000000FOR11548.000000FORS000064728Permian Resources Corporation71424F105US71424F105705/19/2026To elect the ten directors nominated by the Board: James H. WalterDIRECTOR ELECTIONSISSUER11548.0000000FOR11548.000000FORS000064728Permian Resources Corporation71424F105US71424F105705/19/2026To approve, by a non-binding advisory vote, the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER11548.0000000FOR11548.000000FORS000064728Permian Resources Corporation71424F105US71424F105705/19/2026To approve, by a non-binding advisory vote, the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER11548.0000000FOR11548.000000FOR4S000064728Permian Resources Corporation71424F105US71424F105705/19/2026To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER11548.0000000FOR11548.000000FORS000064728Permian Resources Corporation71424F105US71424F105705/19/2026To approve the First Amendment to the Permian Resources Corporation 2023 Long Term Incentive Plan.COMPENSATIONISSUER11548.0000000AGAINST11548.000000AGAINSTS000064728Permian Resources Corporation71424F105US71424F105705/19/2026To approve an amendment to the Sixth Amended and Restated Certificate of Incorporation of Permian Resources Holdings Inc., our wholly owned subsidiary, to remove the "pass-through voting" provision in connection with our corporate reorganization.CORPORATE GOVERNANCEISSUER11548.0000000FOR11548.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100905/19/2026Election of Directors: Robert L. AntinDIRECTOR ELECTIONSISSUER1.0000004028.000000FOR1.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100905/19/2026Election of Directors: Laura ClarkDIRECTOR ELECTIONSISSUER1.0000004028.000000FOR1.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100905/19/2026Election of Directors: Diana J. IngramDIRECTOR ELECTIONSISSUER1.0000004028.000000FOR1.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100905/19/2026Election of Directors: Angela L. KleimanDIRECTOR ELECTIONSISSUER1.0000004028.000000FOR1.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100905/19/2026Election of Directors: Debra L. MorrisDIRECTOR ELECTIONSISSUER1.0000004028.000000FOR1.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100905/19/2026Election of Directors: Tyler H. RoseDIRECTOR ELECTIONSISSUER1.0000004028.000000FOR1.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100905/19/2026Election of Directors: David P. StockertDIRECTOR ELECTIONSISSUER1.0000004028.000000FOR1.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100905/19/2026The ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1.0000004028.000000FOR1.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100905/19/2026The advisory resolution to approve the Company's named executive officer compensation for the fiscal year ended December 31, 2025, as described in the Rexford Industrial Realty, Inc. Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000004028.000000FOR1.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100905/19/2026The advisory resolution to approve the Company's named executive officer compensation for the fiscal year ended December 31, 2025, as described in the Rexford Industrial Realty, Inc. Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000004028.000000FOR1.000000FOR4S000064728Rexford Industrial Realty, Inc.76169C100US76169C100905/19/2026The approval of the Fourth Amended and Restated Rexford Industrial Realty, Inc. and Rexford Industrial Realty, L.P. 2013 Incentive Award Plan.COMPENSATIONISSUER1.0000004028.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Accept Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Approve Remuneration PolicyCOMPENSATIONISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Approve Remuneration ReportCOMPENSATIONISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Elect Holly Koeppel as DirectorDIRECTOR ELECTIONSISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Elect Clare Scherrer as DirectorDIRECTOR ELECTIONSISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Re-elect Dick Boer as DirectorDIRECTOR ELECTIONSISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Re-elect Ann Godbehere as DirectorDIRECTOR ELECTIONSISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Re-elect Sinead Gorman as DirectorDIRECTOR ELECTIONSISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Re-elect Jane Lute as DirectorDIRECTOR ELECTIONSISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Re-elect Sir Andrew Mackenzie as DirectorDIRECTOR ELECTIONSISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Re-elect Sir Charles Roxburgh as DirectorDIRECTOR ELECTIONSISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Re-elect Wael Sawan as DirectorDIRECTOR ELECTIONSISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Re-elect Abraham Schot as DirectorDIRECTOR ELECTIONSISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Re-elect Leena Srivastava as DirectorDIRECTOR ELECTIONSISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Re-elect Cyrus Taraporevala as DirectorDIRECTOR ELECTIONSISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Reappoint Ernst & Young LLP as AuditorsAUDIT-RELATEDISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Authorise the Audit and Risk Committee to Fix Remuneration of AuditorsAUDIT-RELATEDISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Authorise Issue of EquityCAPITAL STRUCTUREISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Authorise Issue of Equity without Pre-emptive RightsCAPITAL STRUCTUREISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Authorise Market Purchase of Ordinary SharesCAPITAL STRUCTUREISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Authorise Off-Market Purchase of Ordinary SharesEXTRAORDINARY TRANSACTIONSCAPITAL STRUCTUREISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Authorise UK Political Donations and ExpenditureOTHER SOCIAL ISSUESISSUER1.0000002075.000000FOR1.000000FORS000064728Shell Plc780259305US780259305005/19/2026Request Company to Publish a Report Disclosing the Company's Strategy to Create Shareholder Value Under Scenarios of Declining Demand for Oil and GasENVIRONMENT OR CLIMATESECURITY HOLDER1.0000002075.000000AGAINST1.000000FORS000064728Alliant Energy Corporation018802108US018802108505/20/2026Election of Directors. Nominees for terms ending in 2029: Patrick AllenDIRECTOR ELECTIONSISSUER1.0000002499.000000FOR1.000000FORS000064728Alliant Energy Corporation018802108US018802108505/20/2026Election of Directors. Nominees for terms ending in 2029: Manu AsthanaDIRECTOR ELECTIONSISSUER1.0000002499.000000FOR1.000000FORS000064728Alliant Energy Corporation018802108US018802108505/20/2026Election of Directors. Nominees for terms ending in 2029: Ignacio CortinaDIRECTOR ELECTIONSISSUER1.0000002499.000000FOR1.000000FORS000064728Alliant Energy Corporation018802108US018802108505/20/2026Election of Directors. Nominees for terms ending in 2029: Michael GarciaDIRECTOR ELECTIONSISSUER1.0000002499.000000FOR1.000000FORS000064728Alliant Energy Corporation018802108US018802108505/20/2026Advisory vote to approve the compensation of our named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER1.0000002499.000000FOR1.000000FORS000064728Alliant Energy Corporation018802108US018802108505/20/2026Advisory vote to approve the compensation of our named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER1.0000002499.000000FOR1.000000FOR4S000064728Alliant Energy Corporation018802108US018802108505/20/2026Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026AUDIT-RELATEDISSUER1.0000002499.000000FOR1.000000FORS000064728American Tower Corporation03027X100US03027X100005/20/2026To elect the following Directors: Steven O. VondranDIRECTOR ELECTIONSISSUER942.0000000FOR942.000000FORS000064728American Tower Corporation03027X100US03027X100005/20/2026To elect the following Directors: Kelly C. ChamblissDIRECTOR ELECTIONSISSUER942.0000000FOR942.000000FORS000064728American Tower Corporation03027X100US03027X100005/20/2026To elect the following Directors: Teresa H. ClarkeDIRECTOR ELECTIONSISSUER942.0000000FOR942.000000FORS000064728American Tower Corporation03027X100US03027X100005/20/2026To elect the following Directors: Kenneth R. FrankDIRECTOR ELECTIONSISSUER942.0000000FOR942.000000FORS000064728American Tower Corporation03027X100US03027X100005/20/2026To elect the following Directors: Rajesh KalathurDIRECTOR ELECTIONSISSUER942.0000000FOR942.000000FORS000064728American Tower Corporation03027X100US03027X100005/20/2026To elect the following Directors: Grace D. LiebleinDIRECTOR ELECTIONSISSUER942.0000000FOR942.000000FORS000064728American Tower Corporation03027X100US03027X100005/20/2026To elect the following Directors: Craig MacnabDIRECTOR ELECTIONSISSUER942.0000000FOR942.000000FORS000064728American Tower Corporation03027X100US03027X100005/20/2026To elect the following Directors: Neville R. RayDIRECTOR ELECTIONSISSUER942.0000000FOR942.000000FORS000064728American Tower Corporation03027X100US03027X100005/20/2026To elect the following Directors: Pamela D. A. ReeveDIRECTOR ELECTIONSISSUER942.0000000FOR942.000000FORS000064728American Tower Corporation03027X100US03027X100005/20/2026To elect the following Directors: Eugene F. ReillyDIRECTOR ELECTIONSISSUER942.0000000FOR942.000000FORS000064728American Tower Corporation03027X100US03027X100005/20/2026To elect the following Directors: Bruce L. TannerDIRECTOR ELECTIONSISSUER942.0000000FOR942.000000FORS000064728American Tower Corporation03027X100US03027X100005/20/2026To approve, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER942.0000000FOR942.000000FORS000064728American Tower Corporation03027X100US03027X100005/20/2026To approve, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER942.0000000FOR942.000000FOR4S000064728American Tower Corporation03027X100US03027X100005/20/2026To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER942.0000000FOR942.000000FORS000064728American Tower Corporation03027X100US03027X100005/20/2026To approve the American Tower Corporation 2026 Equity Incentive Plan.COMPENSATIONISSUER942.0000000FOR942.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Election of Directors: Abdulaziz F. Al KhayyalDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Election of Directors: William E. AlbrechtDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Election of Directors: M. Katherine BanksDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Election of Directors: Earl M. CummingsDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Election of Directors: Murry S. GerberDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Election of Directors: Timothy A. LeachDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Election of Directors: Robert A. MaloneDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Election of Directors: Jeffrey A. MillerDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Election of Directors: J. Shannon SlocumDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Election of Directors: Maurice S. SmithDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Election of Directors: Janet L. WeissDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Election of Directors: Tobi M. Edwards YoungDIRECTOR ELECTIONSISSUER5768.0000000FOR5768.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Ratification of Selection of Principal Independent Public Accountants.AUDIT-RELATEDISSUER5768.0000000FOR5768.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Advisory Approval of Executive Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER5768.0000000FOR5768.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Advisory Approval of Executive Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER5768.0000000FOR5768.000000FOR4S000064728Halliburton Company406216101US406216101705/20/2026Approval of Halliburton Energy Services, Inc. Charter Amendment.CORPORATE GOVERNANCEISSUER5768.0000000FOR5768.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Approval to Amend and Restate the Halliburton Company Stock and Incentive Plan.COMPENSATIONISSUER5768.0000000FOR5768.000000FORS000064728Halliburton Company406216101US406216101705/20/2026Approval to Amend and Restate the Halliburton Company Employee Stock Purchase Plan.COMPENSATIONISSUER5768.0000000FOR5768.000000FORS000064728Host Hotels & Resorts, Inc.44107P104US44107P104905/20/2026Election of Directors: Mary L. BaglivoDIRECTOR ELECTIONSISSUER8728.0000000FOR8728.000000FORS000064728Host Hotels & Resorts, Inc.44107P104US44107P104905/20/2026Election of Directors: Herman E. BullsDIRECTOR ELECTIONSISSUER8728.0000000FOR8728.000000FORS000064728Host Hotels & Resorts, Inc.44107P104US44107P104905/20/2026Election of Directors: Diana M. LaingDIRECTOR ELECTIONSISSUER8728.0000000FOR8728.000000FORS000064728Host Hotels & Resorts, Inc.44107P104US44107P104905/20/2026Election of Directors: Richard E. MarriottDIRECTOR ELECTIONSISSUER8728.0000000FOR8728.000000FORS000064728Host Hotels & Resorts, Inc.44107P104US44107P104905/20/2026Election of Directors: Mary Hogan PreusseDIRECTOR ELECTIONSISSUER8728.0000000FOR8728.000000FORS000064728Host Hotels & Resorts, Inc.44107P104US44107P104905/20/2026Election of Directors: Walter C. RakowichDIRECTOR ELECTIONSISSUER8728.0000000FOR8728.000000FORS000064728Host Hotels & Resorts, Inc.44107P104US44107P104905/20/2026Election of Directors: James F. RisoleoDIRECTOR ELECTIONSISSUER8728.0000000FOR8728.000000FORS000064728Host Hotels & Resorts, Inc.44107P104US44107P104905/20/2026Election of Directors: Gordon H. SmithDIRECTOR ELECTIONSISSUER8728.0000000FOR8728.000000FORS000064728Host Hotels & Resorts, Inc.44107P104US44107P104905/20/2026Election of Directors: A. William SteinDIRECTOR ELECTIONSISSUER8728.0000000FOR8728.000000FORS000064728Host Hotels & Resorts, Inc.44107P104US44107P104905/20/2026Ratify the appointment of KPMG LLP as independent registered public accountants for 2026AUDIT-RELATEDISSUER8728.0000000FOR8728.000000FORS000064728Host Hotels & Resorts, Inc.44107P104US44107P104905/20/2026Advisory resolution to approve executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER8728.0000000FOR8728.000000FORS000064728Host Hotels & Resorts, Inc.44107P104US44107P104905/20/2026Advisory resolution to approve executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER8728.0000000FOR8728.000000FOR4S000064728Plains All American Pipeline, L.P.726503105US726503105105/20/2026The election of four Class I directors to serve on the Board until the 2029 annual meeting: Willie ChiangDIRECTOR ELECTIONSISSUER1.0000009206.000000FOR1.000000FORS000064728Plains All American Pipeline, L.P.726503105US726503105105/20/2026The election of four Class I directors to serve on the Board until the 2029 annual meeting: Ellen DeSanctisDIRECTOR ELECTIONSISSUER1.0000009206.000000FOR1.000000FORS000064728Plains All American Pipeline, L.P.726503105US726503105105/20/2026The election of four Class I directors to serve on the Board until the 2029 annual meeting: Alexandra PrunerDIRECTOR ELECTIONSISSUER1.0000009206.000000FOR1.000000FORS000064728Plains All American Pipeline, L.P.726503105US726503105105/20/2026The election of four Class I directors to serve on the Board until the 2029 annual meeting: Lawrence ZiembaDIRECTOR ELECTIONSISSUER1.0000009206.000000FOR1.000000FORS000064728Plains All American Pipeline, L.P.726503105US726503105105/20/2026Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER1.0000009206.000000FOR1.000000FORS000064728Plains All American Pipeline, L.P.726503105US726503105105/20/2026The approval, on a non-binding advisory basis, of our 2025 named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000009206.000000AGAINST1.000000AGAINSTS000064728Plains All American Pipeline, L.P.726503105US726503105105/20/2026The approval, on a non-binding advisory basis, of our 2025 named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000009206.000000AGAINST1.000000AGAINST4S000064728Plains GP Holdings, L.P.72651A207US72651A207805/20/2026The election of four Class I directors to serve on the Board until the 2029 annual meeting: Willie ChiangDIRECTOR ELECTIONSISSUER8663.0000000FOR8663.000000FORS000064728Plains GP Holdings, L.P.72651A207US72651A207805/20/2026The election of four Class I directors to serve on the Board until the 2029 annual meeting: Ellen DeSanctisDIRECTOR ELECTIONSISSUER8663.0000000FOR8663.000000FORS000064728Plains GP Holdings, L.P.72651A207US72651A207805/20/2026The election of four Class I directors to serve on the Board until the 2029 annual meeting: Alexandra PrunerDIRECTOR ELECTIONSISSUER8663.0000000FOR8663.000000FORS000064728Plains GP Holdings, L.P.72651A207US72651A207805/20/2026The election of four Class I directors to serve on the Board until the 2029 annual meeting: Lawrence ZiembaDIRECTOR ELECTIONSISSUER8663.0000000FOR8663.000000FORS000064728Plains GP Holdings, L.P.72651A207US72651A207805/20/2026Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER8663.0000000FOR8663.000000FORS000064728Plains GP Holdings, L.P.72651A207US72651A207805/20/2026The approval, on a non-binding advisory basis, of our 2025 named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER8663.0000000AGAINST8663.000000AGAINSTS000064728Plains GP Holdings, L.P.72651A207US72651A207805/20/2026The approval, on a non-binding advisory basis, of our 2025 named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER8663.0000000AGAINST8663.000000AGAINST4S000064728Summit Hotel Properties, Inc.866082100US866082100505/20/2026Election of Directors: Bjorn R. L. HansonDIRECTOR ELECTIONSISSUER32520.0000000FOR32520.000000FORS000064728Summit Hotel Properties, Inc.866082100US866082100505/20/2026Election of Directors: Jeffrey W. JonesDIRECTOR ELECTIONSISSUER32520.0000000FOR32520.000000FORS000064728Summit Hotel Properties, Inc.866082100US866082100505/20/2026Election of Directors: Kenneth J. KayDIRECTOR ELECTIONSISSUER32520.0000000FOR32520.000000FORS000064728Summit Hotel Properties, Inc.866082100US866082100505/20/2026Election of Directors: Mehulkumar B. PatelDIRECTOR ELECTIONSISSUER32520.0000000FOR32520.000000FORS000064728Summit Hotel Properties, Inc.866082100US866082100505/20/2026Election of Directors: Amina Belouizdad PorterDIRECTOR ELECTIONSISSUER32520.0000000FOR32520.000000FORS000064728Summit Hotel Properties, Inc.866082100US866082100505/20/2026Election of Directors: Jonathan P. StannerDIRECTOR ELECTIONSISSUER32520.0000000FOR32520.000000FORS000064728Summit Hotel Properties, Inc.866082100US866082100505/20/2026Election of Directors: Thomas W. StoreyDIRECTOR ELECTIONSISSUER32520.0000000FOR32520.000000FORS000064728Summit Hotel Properties, Inc.866082100US866082100505/20/2026Election of Directors: Hope S. TaitzDIRECTOR ELECTIONSISSUER32520.0000000FOR32520.000000FORS000064728Summit Hotel Properties, Inc.866082100US866082100505/20/2026Ratify the appointment of ERNST & YOUNG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER32520.0000000FOR32520.000000FORS000064728Summit Hotel Properties, Inc.866082100US866082100505/20/2026An advisory (non-binding) resolution to approve our named executive officers' compensation.SECTION 14A SAY-ON-PAY VOTESISSUER32520.0000000FOR32520.000000FORS000064728Summit Hotel Properties, Inc.866082100US866082100505/20/2026An advisory (non-binding) resolution to approve our named executive officers' compensation.SECTION 14A SAY-ON-PAY VOTESISSUER32520.0000000FOR32520.000000FOR4S000064728Xcel Energy Inc.98389B100US98389B100805/20/2026Election of Directors: Megan BurkhartDIRECTOR ELECTIONSISSUER2202.0000000FOR2202.000000FORS000064728Xcel Energy Inc.98389B100US98389B100805/20/2026Election of Directors: Lynn CaseyDIRECTOR ELECTIONSISSUER2202.0000000FOR2202.000000FORS000064728Xcel Energy Inc.98389B100US98389B100805/20/2026Election of Directors: Maria DemareeDIRECTOR ELECTIONSISSUER2202.0000000FOR2202.000000FORS000064728Xcel Energy Inc.98389B100US98389B100805/20/2026Election of Directors: Bob FrenzelDIRECTOR ELECTIONSISSUER2202.0000000FOR2202.000000FORS000064728Xcel Energy Inc.98389B100US98389B100805/20/2026Election of Directors: Netha JohnsonDIRECTOR ELECTIONSISSUER2202.0000000FOR2202.000000FORS000064728Xcel Energy Inc.98389B100US98389B100805/20/2026Election of Directors: Patricia KamplingDIRECTOR ELECTIONSISSUER2202.0000000FOR2202.000000FORS000064728Xcel Energy Inc.98389B100US98389B100805/20/2026Election of Directors: George KehlDIRECTOR ELECTIONSISSUER2202.0000000FOR2202.000000FORS000064728Xcel Energy Inc.98389B100US98389B100805/20/2026Election of Directors: Charles PardeeDIRECTOR ELECTIONSISSUER2202.0000000FOR2202.000000FORS000064728Xcel Energy Inc.98389B100US98389B100805/20/2026Election of Directors: Devin StockfishDIRECTOR ELECTIONSISSUER2202.0000000FOR2202.000000FORS000064728Xcel Energy Inc.98389B100US98389B100805/20/2026Election of Directors: Timothy WelshDIRECTOR ELECTIONSISSUER2202.0000000FOR2202.000000FORS000064728Xcel Energy Inc.98389B100US98389B100805/20/2026Approval of Xcel Energy Inc.'s executive compensation in an advisory vote (say on pay vote)SECTION 14A SAY-ON-PAY VOTESISSUER2202.0000000FOR2202.000000FORS000064728Xcel Energy Inc.98389B100US98389B100805/20/2026Approval of Xcel Energy Inc.'s executive compensation in an advisory vote (say on pay vote)SECTION 14A SAY-ON-PAY VOTESISSUER2202.0000000FOR2202.000000FOR4S000064728Xcel Energy Inc.98389B100US98389B100805/20/2026Ratification of the appointment of Deloitte & Touche LLP as Xcel Energy Inc.'s independent registered public accounting firm for 2026AUDIT-RELATEDISSUER2202.0000000FOR2202.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/21/2026Election of directors: Annell R. BayDIRECTOR ELECTIONSISSUER1.0000006660.000000FOR1.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/21/2026Election of directors: John J. Christmann IVDIRECTOR ELECTIONSISSUER1.0000006660.000000FOR1.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/21/2026Election of directors: Juliet S. EllisDIRECTOR ELECTIONSISSUER1.0000006660.000000FOR1.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/21/2026Election of directors: Kenneth M. FisherDIRECTOR ELECTIONSISSUER1.0000006660.000000FOR1.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/21/2026Election of directors: Charles W. HooperDIRECTOR ELECTIONSISSUER1.0000006660.000000FOR1.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/21/2026Election of directors: Chansoo JoungDIRECTOR ELECTIONSISSUER1.0000006660.000000FOR1.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/21/2026Election of directors: H. Lamar McKayDIRECTOR ELECTIONSISSUER1.0000006660.000000FOR1.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/21/2026Election of directors: Peter A. RagaussDIRECTOR ELECTIONSISSUER1.0000006660.000000FOR1.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/21/2026Election of directors: David L. StoverDIRECTOR ELECTIONSISSUER1.0000006660.000000FOR1.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/21/2026Election of directors: Anya WeavingDIRECTOR ELECTIONSISSUER1.0000006660.000000FOR1.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/21/2026Ratification of appointment of Ernst & Young LLP as APA's independent auditorAUDIT-RELATEDISSUER1.0000006660.000000FOR1.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/21/2026Advisory vote to approve the compensation of APA's named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER1.0000006660.000000FOR1.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/21/2026Advisory vote to approve the compensation of APA's named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER1.0000006660.000000FOR1.000000FOR4S000064728APA CORPORATION03743Q108US03743Q108505/21/2026Approval of an amendment to APA's 2016 Omnibus Compensation Plan to extend its term and increase the shares authorized for issuance thereunderCOMPENSATIONISSUER1.0000006660.000000FOR1.000000FORS000064728Kimco Realty Corporation49446R109US49446R109505/21/2026THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Ross CooperDIRECTOR ELECTIONSISSUER8118.0000000FOR8118.000000FORS000064728Kimco Realty Corporation49446R109US49446R109505/21/2026THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Philip E. CovielloDIRECTOR ELECTIONSISSUER8118.0000000FOR8118.000000FORS000064728Kimco Realty Corporation49446R109US49446R109505/21/2026THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Conor C. FlynnDIRECTOR ELECTIONSISSUER8118.0000000FOR8118.000000FORS000064728Kimco Realty Corporation49446R109US49446R109505/21/2026THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: David JamiesonDIRECTOR ELECTIONSISSUER8118.0000000FOR8118.000000FORS000064728Kimco Realty Corporation49446R109US49446R109505/21/2026THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Nancy LashineDIRECTOR ELECTIONSISSUER8118.0000000FOR8118.000000FORS000064728Kimco Realty Corporation49446R109US49446R109505/21/2026THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Henry MonizDIRECTOR ELECTIONSISSUER8118.0000000FOR8118.000000FORS000064728Kimco Realty Corporation49446R109US49446R109505/21/2026THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Mary Hogan PreusseDIRECTOR ELECTIONSISSUER8118.0000000FOR8118.000000FORS000064728Kimco Realty Corporation49446R109US49446R109505/21/2026THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Valerie RichardsonDIRECTOR ELECTIONSISSUER8118.0000000FOR8118.000000FORS000064728Kimco Realty Corporation49446R109US49446R109505/21/2026THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Richard B. SaltzmanDIRECTOR ELECTIONSISSUER8118.0000000FOR8118.000000FORS000064728Kimco Realty Corporation49446R109US49446R109505/21/2026THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ADVISORY RESOLUTION TO APPROVE THE COMPANY'S EXECUTIVE COMPENSATION (AS MORE PARTICULARLY DESCRIBED IN THE PROXY STATEMENT).SECTION 14A SAY-ON-PAY VOTESISSUER8118.0000000FOR8118.000000FORS000064728Kimco Realty Corporation49446R109US49446R109505/21/2026THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ADVISORY RESOLUTION TO APPROVE THE COMPANY'S EXECUTIVE COMPENSATION (AS MORE PARTICULARLY DESCRIBED IN THE PROXY STATEMENT).SECTION 14A SAY-ON-PAY VOTESISSUER8118.0000000FOR8118.000000FOR4S000064728Kimco Realty Corporation49446R109US49446R109505/21/2026THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2026.AUDIT-RELATEDISSUER8118.0000000FOR8118.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/21/2026Election of Directors: Bahram AkradiDIRECTOR ELECTIONSISSUER1.0000007393.000000FOR1.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/21/2026Election of Directors: Lisa BromileyDIRECTOR ELECTIONSISSUER1.0000007393.000000FOR1.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/21/2026Election of Directors: Michael FrantzDIRECTOR ELECTIONSISSUER1.0000007393.000000FOR1.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/21/2026Election of Directors: William KimbleDIRECTOR ELECTIONSISSUER1.0000007393.000000FOR1.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/21/2026Election of Directors: Stuart LasherDIRECTOR ELECTIONSISSUER1.0000007393.000000FOR1.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/21/2026Election of Directors: Nicholas O'GradyDIRECTOR ELECTIONSISSUER1.0000007393.000000FOR1.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/21/2026Election of Directors: Jennifer PomerantzDIRECTOR ELECTIONSISSUER1.0000007393.000000FOR1.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/21/2026To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER1.0000007393.000000FOR1.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/21/2026To approve, on an advisory basis, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000007393.000000FOR1.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/21/2026To approve, on an advisory basis, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000007393.000000FOR1.000000FOR4S000064728Realty Income Corporation756109104US756109104905/21/2026The election of eleven director nominees named in the Proxy Statement to serve until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified: Priscilla AlmodovarDIRECTOR ELECTIONSISSUER2869.0000000FOR2869.000000FORS000064728Realty Income Corporation756109104US756109104905/21/2026The election of eleven director nominees named in the Proxy Statement to serve until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified: A. Larry ChapmanDIRECTOR ELECTIONSISSUER2869.0000000FOR2869.000000FORS000064728Realty Income Corporation756109104US756109104905/21/2026The election of eleven director nominees named in the Proxy Statement to serve until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified: Reginald H. GilyardDIRECTOR ELECTIONSISSUER2869.0000000FOR2869.000000FORS000064728Realty Income Corporation756109104US756109104905/21/2026The election of eleven director nominees named in the Proxy Statement to serve until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified: Mary Hogan PreusseDIRECTOR ELECTIONSISSUER2869.0000000FOR2869.000000FORS000064728Realty Income Corporation756109104US756109104905/21/2026The election of eleven director nominees named in the Proxy Statement to serve until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified: Kim HourihanDIRECTOR ELECTIONSISSUER2869.0000000FOR2869.000000FORS000064728Realty Income Corporation756109104US756109104905/21/2026The election of eleven director nominees named in the Proxy Statement to serve until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified: Priya Cherian HuskinsDIRECTOR ELECTIONSISSUER2869.0000000FOR2869.000000FORS000064728Realty Income Corporation756109104US756109104905/21/2026The election of eleven director nominees named in the Proxy Statement to serve until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified: Jeff JacobsonDIRECTOR ELECTIONSISSUER2869.0000000FOR2869.000000FORS000064728Realty Income Corporation756109104US756109104905/21/2026The election of eleven director nominees named in the Proxy Statement to serve until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified: Gerardo I. LopezDIRECTOR ELECTIONSISSUER2869.0000000FOR2869.000000FORS000064728Realty Income Corporation756109104US756109104905/21/2026The election of eleven director nominees named in the Proxy Statement to serve until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified: Michael D. McKeeDIRECTOR ELECTIONSISSUER2869.0000000FOR2869.000000FORS000064728Realty Income Corporation756109104US756109104905/21/2026The election of eleven director nominees named in the Proxy Statement to serve until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified: Gregory T. McLaughlinDIRECTOR ELECTIONSISSUER2869.0000000FOR2869.000000FORS000064728Realty Income Corporation756109104US756109104905/21/2026The election of eleven director nominees named in the Proxy Statement to serve until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified: Sumit RoyDIRECTOR ELECTIONSISSUER2869.0000000FOR2869.000000FORS000064728Realty Income Corporation756109104US756109104905/21/2026The ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AUDIT-RELATEDISSUER2869.0000000FOR2869.000000FORS000064728Realty Income Corporation756109104US756109104905/21/2026A non-binding advisory proposal to approve the compensation of our named executive officers as described in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER2869.0000000FOR2869.000000FORS000064728Realty Income Corporation756109104US756109104905/21/2026A non-binding advisory proposal to approve the compensation of our named executive officers as described in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER2869.0000000FOR2869.000000FOR4S000064728SM Energy Company78454L100US78454L100805/21/2026The Board of Directors has nominated the below eleven persons to stand for election as directors until the next annual meeting of stockholders. As of the date of the accompanying Proxy Statement, no one has been nominated to serve as director other than the nominees listed below: Barton R. BrookmanDIRECTOR ELECTIONSISSUER6482.0000000FOR6482.000000FORS000064728SM Energy Company78454L100US78454L100805/21/2026The Board of Directors has nominated the below eleven persons to stand for election as directors until the next annual meeting of stockholders. As of the date of the accompanying Proxy Statement, no one has been nominated to serve as director other than the nominees listed below: Morris R. ClarkDIRECTOR ELECTIONSISSUER6482.0000000FOR6482.000000FORS000064728SM Energy Company78454L100US78454L100805/21/2026The Board of Directors has nominated the below eleven persons to stand for election as directors until the next annual meeting of stockholders. As of the date of the accompanying Proxy Statement, no one has been nominated to serve as director other than the nominees listed below: Carrie M. FoxDIRECTOR ELECTIONSISSUER6482.0000000FOR6482.000000FORS000064728SM Energy Company78454L100US78454L100805/21/2026The Board of Directors has nominated the below eleven persons to stand for election as directors until the next annual meeting of stockholders. As of the date of the accompanying Proxy Statement, no one has been nominated to serve as director other than the nominees listed below: Lloyd W. Helms, Jr.DIRECTOR ELECTIONSISSUER6482.0000000FOR6482.000000FORS000064728SM Energy Company78454L100US78454L100805/21/2026The Board of Directors has nominated the below eleven persons to stand for election as directors until the next annual meeting of stockholders. As of the date of the accompanying Proxy Statement, no one has been nominated to serve as director other than the nominees listed below: Elizabeth A. McDonaldDIRECTOR ELECTIONSISSUER6482.0000000FOR6482.000000FORS000064728SM Energy Company78454L100US78454L100805/21/2026The Board of Directors has nominated the below eleven persons to stand for election as directors until the next annual meeting of stockholders. As of the date of the accompanying Proxy Statement, no one has been nominated to serve as director other than the nominees listed below: Ramiro G. PeruDIRECTOR ELECTIONSISSUER6482.0000000FOR6482.000000FORS000064728SM Energy Company78454L100US78454L100805/21/2026The Board of Directors has nominated the below eleven persons to stand for election as directors until the next annual meeting of stockholders. As of the date of the accompanying Proxy Statement, no one has been nominated to serve as director other than the nominees listed below: Julio M. QuintanaDIRECTOR ELECTIONSISSUER6482.0000000FOR6482.000000FORS000064728SM Energy Company78454L100US78454L100805/21/2026The Board of Directors has nominated the below eleven persons to stand for election as directors until the next annual meeting of stockholders. As of the date of the accompanying Proxy Statement, no one has been nominated to serve as director other than the nominees listed below: Rose M. RobesonDIRECTOR ELECTIONSISSUER6482.0000000FOR6482.000000FORS000064728SM Energy Company78454L100US78454L100805/21/2026The Board of Directors has nominated the below eleven persons to stand for election as directors until the next annual meeting of stockholders. As of the date of the accompanying Proxy Statement, no one has been nominated to serve as director other than the nominees listed below: Wouter T. van KempenDIRECTOR ELECTIONSISSUER6482.0000000FOR6482.000000FORS000064728SM Energy Company78454L100US78454L100805/21/2026The Board of Directors has nominated the below eleven persons to stand for election as directors until the next annual meeting of stockholders. As of the date of the accompanying Proxy Statement, no one has been nominated to serve as director other than the nominees listed below: Ashwin VenkatramanDIRECTOR ELECTIONSISSUER6482.0000000FOR6482.000000FORS000064728SM Energy Company78454L100US78454L100805/21/2026The Board of Directors has nominated the below eleven persons to stand for election as directors until the next annual meeting of stockholders. As of the date of the accompanying Proxy Statement, no one has been nominated to serve as director other than the nominees listed below: Howard A. Willard IIIDIRECTOR ELECTIONSISSUER6482.0000000FOR6482.000000FORS000064728SM Energy Company78454L100US78454L100805/21/2026To approve, on a non-binding advisory basis, the compensation philosophy, policies and procedures, and the compensation of our Company's named executive officers, as disclosed in the accompanying Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER6482.0000000FOR6482.000000FORS000064728SM Energy Company78454L100US78454L100805/21/2026To approve, on a non-binding advisory basis, the compensation philosophy, policies and procedures, and the compensation of our Company's named executive officers, as disclosed in the accompanying Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER6482.0000000FOR6482.000000FOR4S000064728SM Energy Company78454L100US78454L100805/21/2026To ratify the appointment by the Audit Committee of Deloitte & Touche LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER6482.0000000FOR6482.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/22/2026Election of Directors: Glenn W. BuntingDIRECTOR ELECTIONSISSUER13372.0000000FOR13372.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/22/2026Election of Directors: Jon A. FosheimDIRECTOR ELECTIONSISSUER13372.0000000FOR13372.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/22/2026Election of Directors: Carolyn B. HandlonDIRECTOR ELECTIONSISSUER13372.0000000FOR13372.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/22/2026Election of Directors: Glade M. KnightDIRECTOR ELECTIONSISSUER13372.0000000FOR13372.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/22/2026Election of Directors: Justin G. KnightDIRECTOR ELECTIONSISSUER13372.0000000FOR13372.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/22/2026Election of Directors: Blythe J. McGarvieDIRECTOR ELECTIONSISSUER13372.0000000FOR13372.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/22/2026Election of Directors: L. Hugh ReddDIRECTOR ELECTIONSISSUER13372.0000000FOR13372.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/22/2026Election of Directors: Howard E. WoolleyDIRECTOR ELECTIONSISSUER13372.0000000FOR13372.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/22/2026Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm to serve for 2026.AUDIT-RELATEDISSUER13372.0000000FOR13372.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/22/2026Approval on an advisory basis of executive compensation paid by the Company.SECTION 14A SAY-ON-PAY VOTESISSUER13372.0000000FOR13372.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/22/2026Approval on an advisory basis of executive compensation paid by the Company.SECTION 14A SAY-ON-PAY VOTESISSUER13372.0000000FOR13372.000000FOR4S000064728The Mosaic Company61945C103US61945C103605/28/2026Election of Directors: Cheryl K. BeebeDIRECTOR ELECTIONSISSUER7819.0000000FOR7819.000000FORS000064728The Mosaic Company61945C103US61945C103605/28/2026Election of Directors: Gregory L. EbelDIRECTOR ELECTIONSISSUER7819.0000000FOR7819.000000FORS000064728The Mosaic Company61945C103US61945C103605/28/2026Election of Directors: Bruce M. BodineDIRECTOR ELECTIONSISSUER7819.0000000FOR7819.000000FORS000064728The Mosaic Company61945C103US61945C103605/28/2026Election of Directors: Timothy S. GitzelDIRECTOR ELECTIONSISSUER7819.0000000FOR7819.000000FORS000064728The Mosaic Company61945C103US61945C103605/28/2026Election of Directors: Emery N. KoenigDIRECTOR ELECTIONSISSUER7819.0000000FOR7819.000000FORS000064728The Mosaic Company61945C103US61945C103605/28/2026Election of Directors: Jody L. KuzenkoDIRECTOR ELECTIONSISSUER7819.0000000FOR7819.000000FORS000064728The Mosaic Company61945C103US61945C103605/28/2026Election of Directors: Sonya C. LittleDIRECTOR ELECTIONSISSUER7819.0000000FOR7819.000000FORS000064728The Mosaic Company61945C103US61945C103605/28/2026Election of Directors: David T. SeatonDIRECTOR ELECTIONSISSUER7819.0000000FOR7819.000000FORS000064728The Mosaic Company61945C103US61945C103605/28/2026Election of Directors: Kathleen M. ShanahanDIRECTOR ELECTIONSISSUER7819.0000000FOR7819.000000FORS000064728The Mosaic Company61945C103US61945C103605/28/2026Election of Directors: Joao Roberto Goncalves TeixeiraDIRECTOR ELECTIONSISSUER7819.0000000FOR7819.000000FORS000064728The Mosaic Company61945C103US61945C103605/28/2026Election of Directors: Gretchen H. WatkinsDIRECTOR ELECTIONSISSUER7819.0000000FOR7819.000000FORS000064728The Mosaic Company61945C103US61945C103605/28/2026Election of Directors: Kelvin R. WestbrookDIRECTOR ELECTIONSISSUER7819.0000000FOR7819.000000FORS000064728The Mosaic Company61945C103US61945C103605/28/2026Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AUDIT-RELATEDISSUER7819.0000000FOR7819.000000FORS000064728The Mosaic Company61945C103US61945C103605/28/2026An advisory vote to approve the compensation of our named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER7819.0000000FOR7819.000000FORS000064728The Mosaic Company61945C103US61945C103605/28/2026An advisory vote to approve the compensation of our named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER7819.0000000FOR7819.000000FOR4S000064728HighPeak Energy, Inc.43114Q105US43114Q105806/02/2026Election of Director: Jason A. EdgeworthDIRECTOR ELECTIONSISSUER1.00000029193.000000WITHHOLD1.000000AGAINSTS000064728HighPeak Energy, Inc.43114Q105US43114Q105806/02/2026Election of Director: Larry C. OldhamDIRECTOR ELECTIONSISSUER1.00000029193.000000FOR1.000000FORS000064728HighPeak Energy, Inc.43114Q105US43114Q105806/02/2026Election of Director: Daniel SilverDIRECTOR ELECTIONSISSUER1.00000029193.000000FOR1.000000FORS000064728HighPeak Energy, Inc.43114Q105US43114Q105806/02/2026Advisory, non-binding resolution regarding the compensation of our Named Executive Officers for 2025SECTION 14A SAY-ON-PAY VOTESISSUER1.00000029193.000000AGAINST1.000000AGAINSTS000064728HighPeak Energy, Inc.43114Q105US43114Q105806/02/2026Advisory, non-binding resolution regarding the compensation of our Named Executive Officers for 2025SECTION 14A SAY-ON-PAY VOTESISSUER1.00000029193.000000AGAINST1.000000AGAINST4S000064728HighPeak Energy, Inc.43114Q105US43114Q105806/02/2026Advisory, non-binding resolution regarding the frequency of future say-on-pay votesSECTION 14A SAY-ON-PAY VOTESISSUER1.00000029193.000000ONE YEAR1.000000FORS000064728HighPeak Energy, Inc.43114Q105US43114Q105806/02/2026Advisory, non-binding resolution regarding the frequency of future say-on-pay votesSECTION 14A SAY-ON-PAY VOTESISSUER1.00000029193.000000ONE YEAR1.000000FOR4S000064728HighPeak Energy, Inc.43114Q105US43114Q105806/02/2026Appointment of Weaver and Tidwell, L.L.P. to Serve as independent registered public accounting firm for the fiscal year ending December 31, 2026AUDIT-RELATEDISSUER1.00000029193.000000FOR1.000000FORS000064728Fresh Del Monte Produce Inc.G36738105KYG36738105306/04/2026Elect two director nominees for a three-year term expiring at the 2029 Annual General Meeting of Shareholders: Michael J. BerthelotDIRECTOR ELECTIONSISSUER4487.0000000AGAINST4487.000000AGAINSTS000064728Fresh Del Monte Produce Inc.G36738105KYG36738105306/04/2026Elect two director nominees for a three-year term expiring at the 2029 Annual General Meeting of Shareholders: Lori Tauber MarcusDIRECTOR ELECTIONSISSUER4487.0000000AGAINST4487.000000AGAINSTS000064728Fresh Del Monte Produce Inc.G36738105KYG36738105306/04/2026Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal yearAUDIT-RELATEDISSUER4487.0000000FOR4487.000000FORS000064728Fresh Del Monte Produce Inc.G36738105KYG36738105306/04/2026Approve, by non-binding advisory vote, the compensation of our named executive officers in 2025SECTION 14A SAY-ON-PAY VOTESISSUER4487.0000000FOR4487.000000FORS000064728Fresh Del Monte Produce Inc.G36738105KYG36738105306/04/2026Approve, by non-binding advisory vote, the compensation of our named executive officers in 2025SECTION 14A SAY-ON-PAY VOTESISSUER4487.0000000FOR4487.000000FOR4S000064728Fresh Del Monte Produce Inc.G36738105KYG36738105306/04/2026Approve and adopt the Third Amended and Restated Memorandum and Articles of AssociationCORPORATE GOVERNANCEISSUER4487.0000000FOR4487.000000FORS000064728VAALCO Energy, Inc.91851C201US91851C201706/04/2026To elect five directors, each for a term of one year: Andrew L. FawthropDIRECTOR ELECTIONSISSUER1.00000031071.000000FOR1.000000FORS000064728VAALCO Energy, Inc.91851C201US91851C201706/04/2026To elect five directors, each for a term of one year: George W. M. MaxwellDIRECTOR ELECTIONSISSUER1.00000031071.000000FOR1.000000FORS000064728VAALCO Energy, Inc.91851C201US91851C201706/04/2026To elect five directors, each for a term of one year: Cathy StubbsDIRECTOR ELECTIONSISSUER1.00000031071.000000FOR1.000000FORS000064728VAALCO Energy, Inc.91851C201US91851C201706/04/2026To elect five directors, each for a term of one year: Fabrice Nze-BekaleDIRECTOR ELECTIONSISSUER1.00000031071.000000FOR1.000000FORS000064728VAALCO Energy, Inc.91851C201US91851C201706/04/2026To elect five directors, each for a term of one year: Edward LaFehrDIRECTOR ELECTIONSISSUER1.00000031071.000000FOR1.000000FORS000064728VAALCO Energy, Inc.91851C201US91851C201706/04/2026To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for 2026;AUDIT-RELATEDISSUER1.00000031071.000000FOR1.000000FORS000064728VAALCO Energy, Inc.91851C201US91851C201706/04/2026To approve, on an advisory basis, the compensation of our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER1.00000031071.000000FOR1.000000FORS000064728VAALCO Energy, Inc.91851C201US91851C201706/04/2026To approve, on an advisory basis, the compensation of our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER1.00000031071.000000FOR1.000000FOR4S000064728VAALCO Energy, Inc.91851C201US91851C201706/04/2026To approve amendments to the VAALCO Energy, Inc. 2020 Long Term Incentive Plan to increase the number of shares reserved for issuance, revise share reservation and recycling rules, and extend the term of such plan.COMPENSATIONISSUER1.00000031071.000000FOR1.000000FORS000064728TXNM Energy, Inc.69349H107US69349H107706/10/2026Election of Directors: Vicky A. BaileyDIRECTOR ELECTIONSISSUER3223.0000000FOR3223.000000FORS000064728TXNM Energy, Inc.69349H107US69349H107706/10/2026Election of Directors: Norman P. BeckerDIRECTOR ELECTIONSISSUER3223.0000000FOR3223.000000FORS000064728TXNM Energy, Inc.69349H107US69349H107706/10/2026Election of Directors: Patricia K. CollawnDIRECTOR ELECTIONSISSUER3223.0000000FOR3223.000000FORS000064728TXNM Energy, Inc.69349H107US69349H107706/10/2026Election of Directors: E. Renae ConleyDIRECTOR ELECTIONSISSUER3223.0000000FOR3223.000000FORS000064728TXNM Energy, Inc.69349H107US69349H107706/10/2026Election of Directors: Sidney M. GutierrezDIRECTOR ELECTIONSISSUER3223.0000000FOR3223.000000FORS000064728TXNM Energy, Inc.69349H107US69349H107706/10/2026Election of Directors: James A. HughesDIRECTOR ELECTIONSISSUER3223.0000000FOR3223.000000FORS000064728TXNM Energy, Inc.69349H107US69349H107706/10/2026Election of Directors: Steven C. MaestasDIRECTOR ELECTIONSISSUER3223.0000000FOR3223.000000FORS000064728TXNM Energy, Inc.69349H107US69349H107706/10/2026Election of Directors: Lillian J. MontoyaDIRECTOR ELECTIONSISSUER3223.0000000FOR3223.000000FORS000064728TXNM Energy, Inc.69349H107US69349H107706/10/2026Election of Directors: Maureen T. MullarkeyDIRECTOR ELECTIONSISSUER3223.0000000FOR3223.000000FORS000064728TXNM Energy, Inc.69349H107US69349H107706/10/2026Election of Directors: Joseph D. TarryDIRECTOR ELECTIONSISSUER3223.0000000FOR3223.000000FORS000064728TXNM Energy, Inc.69349H107US69349H107706/10/2026Ratify appointment of KPMG LLP as our independent registered public accounting firm for 2026.AUDIT-RELATEDISSUER3223.0000000FOR3223.000000FORS000064728TXNM Energy, Inc.69349H107US69349H107706/10/2026Approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3223.0000000FOR3223.000000FORS000064728TXNM Energy, Inc.69349H107US69349H107706/10/2026Approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3223.0000000FOR3223.000000FOR4S000064728Chicago Atlantic Real Estate Finance, Inc.167239102US167239102606/11/2026Election of Directors: Mr. John MazarakisDIRECTOR ELECTIONSISSUER15185.0000000FOR15185.000000FORS000064728Chicago Atlantic Real Estate Finance, Inc.167239102US167239102606/11/2026Election of Directors: Mr. Anthony CappellDIRECTOR ELECTIONSISSUER15185.0000000FOR15185.000000FORS000064728Chicago Atlantic Real Estate Finance, Inc.167239102US167239102606/11/2026Election of Directors: Dr. Jason PapastavrouDIRECTOR ELECTIONSISSUER15185.0000000WITHHOLD15185.000000AGAINSTS000064728Chicago Atlantic Real Estate Finance, Inc.167239102US167239102606/11/2026Election of Directors: Ms. Elizabeth StavolaDIRECTOR ELECTIONSISSUER15185.0000000WITHHOLD15185.000000AGAINSTS000064728Chicago Atlantic Real Estate Finance, Inc.167239102US167239102606/11/2026Election of Directors: Mr. Brandon KonigsbergDIRECTOR ELECTIONSISSUER15185.0000000WITHHOLD15185.000000AGAINSTS000064728Chicago Atlantic Real Estate Finance, Inc.167239102US167239102606/11/2026The Ratification of the Selection of BDO USA, P.C. to Serve as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026AUDIT-RELATEDISSUER15185.0000000FOR15185.000000FORS000064728Matador Resources Company576485205US576485205006/11/2026Election of Director Nominees: Joseph Wm. ForanDIRECTOR ELECTIONSISSUER1.0000003199.000000FOR1.000000FORS000064728Matador Resources Company576485205US576485205006/11/2026Election of Director Nominees: Reynald A. BaribaultDIRECTOR ELECTIONSISSUER1.0000003199.000000FOR1.000000FORS000064728Matador Resources Company576485205US576485205006/11/2026Election of Director Nominees: Timothy E. ParkerDIRECTOR ELECTIONSISSUER1.0000003199.000000FOR1.000000FORS000064728Matador Resources Company576485205US576485205006/11/2026Advisory vote to approve the compensation of the Company's named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER1.0000003199.000000FOR1.000000FORS000064728Matador Resources Company576485205US576485205006/11/2026Advisory vote to approve the compensation of the Company's named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER1.0000003199.000000FOR1.000000FOR4S000064728Matador Resources Company576485205US576485205006/11/2026Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026AUDIT-RELATEDISSUER1.0000003199.000000FOR1.000000FORS000064728